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Doctor of Public Health Integrating Statement 
When I qualified as a general practitioner (GP) in 2000, I did not envisage that 
one day I would be involved in research and public health practice 15 years 
later.  
I took a year out of my GP training to work in a genitourinary medicine (GUM) 
clinic in Central London as well as some sessions in family planning clinics in 
South London. At the same time, I sought career advice from a Professor (now 
Dame) Anne Johnson. She was one of the principal investigators of the National 
Sexual Attitudes and Lifestyles (NATSAL) studies; she also a qualified in 
general practice and public health. She suggested to me to think about public 
health as a feasible career option. Little did I realise this advice would help 
shape my career path ten years later. 
I became a part-time GP principal in a small practice. I filled the rest of my week 
doing regular sessions in GUM and family planning. A locum public health 
registrar post became available and I worked in East London and the City 
Health Authority for nearly 18 months. My interest in public health took hold and 
I studied for an MSc in Public Health at LSHTM part-time. At the same time, 
primary care trusts (PCTs) were created due to NHS reforms and my local PCT 
had a vacancy for a GP member to be on their Professional Executive 
Committee (PEC). I became involved with sexual health at the PCT which 
naturally led to my MSc dissertation on implementation of chlamydia screening. 
As a GP, I was managing the health and wellbeing of a practice population – 
including secondary prevention, screening, and immunisations. As a PCT PEC 
member, I was helping to manage the health and wellbeing of a larger 
population, as well as being involved with health services and rationing of cost-
effective treatment. Working as a GP and having been involved with public 
health practice in separate roles, I was in no doubt that general practice had a 
role in improving the health of the public. With my clinical interest in sexual and 
reproductive health, I knew GPs could provide more sexual healthcare for their 
populations. I also realised there were problems with implementing health 
promotion and disease prevention programmes in practice. I noticed how public 
health programmes were promoted such as use of guidelines, educational 
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meetings, and practice visits; GPs have also been encouraged to deliver some 
services often with use of financial incentives. 
I was interested in understanding how GPs were motivated to deliver services 
to improve the health of their population. I realised that sometimes, despite 
evidence of effectiveness, some programmes were hard to implement in 
practice. HIV testing is one example; despite evidence to suggest early 
diagnosis improves lives and reduce onward transmission due to effective 
treatment, there is relatively low HIV testing in general practice, and there are 
patients who continue get diagnosed late.  Being a practicing GP with 
experience in sexual and reproductive health and public health, I thought there 
must be something that could be done to encourage GPs to improve the sexual 
health of the public. 
I was therefore naturally drawn to the Doctor of Public Health (DrPH) 
programme at the LSHTM. It is intended for “leaders and future leaders in public 
health … to equip graduates with experience of the challenges of understanding 
and adapting scientific knowledge in order to achieve public health gains, as 
well as the analytical and practical skills required by managers and leaders in 
public health.” 
The DrPH is different to a standard PhD research degree because of the taught 
elements in the programme. On reflection, I feel I have benefitted personally 
and professionally from this programme. 
The Evidence Based Public Health Practice module helped me to be critical 
about evidence, how it can be presented and implemented in practice. I learnt 
that even robust evidence did not necessarily lead to successful implementation 
in practice. One assignment was to produce a Cochrane-style systematic 
review on the use of lay health workers to improve immunisations in a low-
income country. The experience of which clearly came into use for the literature 
review chapter of my thesis.  
Part of the assignment was to write a briefing for a health minister to interpret 
the findings of the systematic review for implementation. I learnt that even 
though evidence can be objective, how it is interpreted, in what context and how 
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it could be implemented in practice required knowledge of the “dark arts”, in the 
political sense.  
This was the purpose of the next assignment where I considered the process of 
translating evidence into policy. I had another opportunity to use this for my 
thesis as one of my chapters considered the use of behaviour change strategies 
to influence behaviour of primary care doctors. 
The Leadership, Management and Organisations module enabled me to 
consider how to be an effective leader, manage other people and create an 
effective organisation. The assignment helped me to reflect on how to be a 
more effective GP principal to run my practice, and how I could be more 
effective in influencing other people and being a “change agent”. 
I completed three other modules from the MSc programme as part of the DrPH. 
I chose modules that challenged me intellectually as someone with a scientific 
background used to biomedical models of thinking and practice. The Health 
Promotion module introduced me to different methods to improve health at the 
individual and population levels. I learnt about behaviour change theories which 
led to changes in my practice as a GP and these also became the central focus 
of my thesis. Sociological Approaches to Health module enabled me to 
understand that determinants to individual’s and community’s health and well-
being are not confined to the biomedical elements. Qualitative methodologies 
module was the most intellectually challenging and gave me the theoretical 
understanding to qualitative methods, which was invaluable when thinking 
about the design and presentation of both the organisational project and this 
thesis. 
I found the Organisational and Policy Analysis (OPA) project the most 
challenging. This was partly because of the difficulties in finding a suitable 
organisation to host me for about 3 to 6 months, to do this as a part-time 
student and the time it took me to fully grasp the style of writing required for the 
project.  
At that time, Practice-Based Commissioning (PBC) started to develop in general 
practice which led to creation of local commissioning organisations and I used 
this opportunity to observe and sometimes participate in the formation and 
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running of this organisation. I learnt how long it took for a new organisation to 
develop a structure and to gain credibility from its members, which was 
considerable before it could even function effectively. Sadly, due to NHS 
reforms, organisations like these became defunct and Clinical Commissioning 
Groups replaced them. Interestingly provider organisations involving groups or 
federation of GPs are now being formed and going through the same processes 
as what I had observed in the organisation I was studying. 
What I learnt on the DrPH course helped me shape my thesis which is about 
how GPs could be influenced to deliver public health programmes. I considered 
behaviour theories that might explain the behaviour intentions of clinicians and 
how to change their practice. I conducted an overview of systematic reviews to 
consider the evidence base for using behaviour interventions directed at GPs. I 
used qualitative methods to explore the reasons for their intentions to deliver 
public health programmes and if behaviour interventions made a difference to 
their attitudes and practice.  
I am often asked if I had chosen the “right doctorate” as DrPH is still not widely 
known in the UK. From the perspective of entering a research career, which is 
what I am embarking on now late in my professional life, I think I would have 
chosen to do a PhD as a recognised point of entry. I mentioned in my thesis my 
motivation, which is determination to demonstrate how GPs could, and should 
be able to make a difference to the health and well-being of a population. I 
made a right choice from the personal and professional perspective. I would not 
have learnt all the things I have mentioned from doing a PhD. 
Academics produce research to make a difference, however this process does 
not end when research is published and in the public domain. Clinicians do not 
adopt changes to behaviour just based on evidence creation; knowledge 
translation is also an important part of the process. This includes different ways 
of influencing healthcare professionals, and how to make the message and the 
messenger credible and relevant in order for front line clinicians to adopt better 
ways of working and eventually make a difference to the health of the public. 
Richard Ma 
September 2015      (1453 words) 
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Abstract 
General practitioners (GPs) have a role in improving population health through 
health promotion and disease prevention (HPDP) activities such as 
immunisations, screening, and lifestyle advice. However, GPs must also 
respond to the patient’s agenda in a consultation. With limited time in a 
consultation, it might be difficult for GPs to prioritise HPDP with their patients. 
My thesis aimed to offer insights into the behavioural determinants of GPs to 
deliver HPDP.  
I considered behaviour theories such as Ajzen’s Theory of Planned Behaviour 
(TPB) to help understand clinician behaviour and how they could be applied to 
influence their behaviour to deliver HPDP programmes. I conducted an 
overview of systematic reviews to examine impact of behavioural interventions, 
directed at GPs, to improve health of their patients. The overview suggested 
there is insufficient evidence for any type of intervention to be consistently 
effective in influencing GPs behaviour.  
The National Chlamydia Screening Programme aims to detect and treat 
chlamydia infection in young people. Primary Care Trusts used different 
behaviour interventions to encourage GPs to deliver screening. I interviewed 
GPs and practice nurses (PNs) in London about their experiences of delivering 
chlamydia screening and the behavioural interventions, such as those 
discussed in systematic reviews, to influence their behaviour to deliver other 
public health programmes. 
The interview data suggested the constructs of TPB - behavioural beliefs, 
normative beliefs, and control beliefs – could be used as a conceptual 
framework to explain why these primary care clinicians might deliver public 
health care.  
Strategies used to implement public health programmes need to consider how 
primary care clinicians might respond to the different constructs of TPB. In 
addition, organisational factors such as contracts and financial incentives, and 
perception of intrusion into the patient’s agenda need to be managed carefully 
as they could either facilitate or impede delivery of public health programmes. 
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Chapter 1 – The role of general practitioners in health 
promotion and disease prevention  
Background 
In this chapter, I argue why public health programmes are important and 
provide an overview of diseases that threaten public health. I will describe the 
range of programmes available in the UK to respond to threats to public health, 
how general practice might be used as a setting to improve the health of the 
nation and consider possible barriers to implementing health promotion and 
disease prevention (HPDP) programmes. Then, I will introduce the National 
Chlamydia Screening Programme (NCSP) as one example of a screening 
programme and its implementation in different settings, including general 
practice. Lastly, I will discuss the barriers to delivering HPDP programmes in 
general practice, how some of these could be overcome using interventions to 
change healthcare professionals’ behaviour, and the gaps in knowledge from 
the current literature. 
The focus of my thesis is to explore what motivates general practitioners (GPs) 
rather than doctors in general. Hospital doctors and specialists usually have a 
focused demographic and/or a smaller range of health behaviours to target. For 
example, respiratory physicians might focus on smoking, whereas 
gastroenterologists might focus on diet, because they are risk factors for the 
diseases they usually treat, such as lung and gastrointestinal tract cancers 
respectively. In contrast, GPs and their teams in primary care settings deliver a 
wider range of healthcare services which also includes HPDP to the general 
population; from offering immunisations for children, influenza vaccinations for 
the elderly, chlamydia screening for sexually active young adults to smoking 
cessation for all adults who smoke.(1) GPs often have challenges such as short 
allocated time for consultations and the wide range of knowledge and skills 
needed to deliver the range of HPDP programmes. They are also expected to 
meet a wide range of demands and expectations from patients with the added 
time pressure, so these might pose more challenges for delivering public health 
programmes for GPs. Some of these contextual factors are very different to 
those of clinicians working in hospitals or other settings such as community 
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clinics, so it would be interesting to study how some GPs manage to these 
challenges. 
Apart from GPs, other members of the primary healthcare team might deliver 
HPDP activities in UK general practice; these include: practice nurses (PNs), 
health care assistants (HCAs) and other allied health professionals (AHPs), 
such as pharmacists and health visitors. PNs might be more likely to deliver 
HPDP programmes compared with GPs, because their job descriptions usually 
specify activities such as immunisations, long-term conditions management, 
smoking cessation, and cervical cancer screening; they also usually have 
dedicated appointments for these activities, which are usually of longer lengths 
than GPs. For example, practice nurses’ appointments typically range from 15 
to 20 minutes; their session is usually made up of routine health monitoring, 
screening, vaccinations and health checks, and their consultation agenda is 
usually set and follow a clinical protocol.(2) Despite working to specific HPDP 
tasks in the same settings, practice nurses might face similar challenges to 
GPs, such as patient demands and time pressure, but they might have different 
motivations and barriers to delivering HPDP programmes. Because of these 
reasons, this thesis focussed on GPs as the main subjects of behaviour 
modifying interventions; however, the interview study included PNs to compare 
their motivations to deliver public health programmes with GPs. 
Threats to Public Health 
There are two main types of threats to population health: non-communicable 
diseases (NCDs) and communicable diseases. 
The World Health Organization (WHO) highlighted non-communicable diseases 
(NCDs) such as: cancers, chronic respiratory diseases, diabetes and coronary 
heart diseases, as the leading causes of mortality in the world.(3) Of the 57 
million deaths globally in 2008, 63% of these were due to NCDs. According to 
WHO, a sizeable proportion of deaths from NCDs could be attributable to four 
main behavioural risk factors: tobacco use, physical inactivity, harmful use of 
alcohol and unhealthy diet. Prevention strategies to reduce deaths from NCDs 
might include lifestyle changes such as: stopping smoking, increased physical 
activity, moderate alcohol consumption and healthier diet.  
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Communicable diseases are also re-emerging as threats to human health and 
even international health security. These include: influenza, hepatitis, rotavirus, 
malaria, polio, measles, rubella, sexually transmitted infections (STIs), 
tuberculosis and HIV. According to WHO, the spread of communicable diseases 
is facilitated by socioeconomic, environmental and behavioural factors, as well 
as international travel and migration.(4) Again, many of these diseases are 
preventable; some strains of influenza and measles by vaccinations; hepatitis A 
and cholera by better sanitation; and HIV and other STIs through practising 
safer sex. 
Public health policies in the UK have attempted to reduce the threat of both 
communicable and non-communicable diseases through population approaches 
to prevention. The legislation on banning smoking in public places, mandatory 
food labelling and promotion of physical activity in England are examples of 
measures to improve lifestyle behaviours that cause ill health. New vaccination 
programmes against pandemic influenza and human papilloma virus (HPV) to 
prevent cervical cancer reduce morbidity and mortality. Furthermore, new 
screening programmes for chlamydia, bowel cancer and abdominal aortic 
aneurysms identify cases early so that prompt treatment can limit the extent and 
complications of disease. 
Health Promotion and Disease Prevention (HPDP) Programmes 
Public health programmes in general practice 
General practice in the UK, which is delivered by the primary health care team, 
is the main point of contact for patients in the publicly-funded National Health 
Service (NHS). A GP will assess a patient’s problems, diagnose illnesses, and 
treat them or refer them for necessary investigations and further treatment. GPs 
as well as PNs and HCAs also carry out screening for common cancers and 
promote general health and wellbeing in the allocated appointment time.(1) 
There is a range of public health programmes available in the UK and these 
differ slightly depending on the devolved country. In England, the programmes 
that general practices deliver include childhood, influenza and pneumococcal 
vaccination and cervical cancer screening; other programmes such as: breast 
cancer screening, bowel cancer screening, diabetic retinopathy screening and 
abdominal aortic aneurysm screening, use GPs’ registered patient lists to invite 
Page 18 of 295 
 
patients for screening in other healthcare settings or send self-test screening 
kits.(5) 
Health promotion in the consultation room  
GPs are expected to promote health and prevent disease as part of their work. 
The modern curriculum of GP training published by the Royal College of 
General Practitioners (RCGP) includes HPDP in the syllabus. It acknowledges 
there are opportunities to discuss healthy living with patients and for early 
detection of illness.(6) The curriculum on the general practice consultation 
states GPs have to demonstrate “commitment to health promotion, while 
recognising potential tension between this role and the patient’s own 
agenda”.(7) This suggests there might be difficulties in delivering HPDP 
interventions in general practice. 
It might seem reasonable that GPs should offer health promotion and lifestyle 
advice to their patients to prevent ill health. This is recognised in Stott and 
Davis’ consultation model, well-known to GPs, which includes health promotion 
as an important part of the consultation process.(8) With the exception of 
practices in areas such as army barracks and universities, a GP practice list 
may include a range of age bands, socioeconomic groups, employment status, 
and people with or without long-term conditions. Any of these populations, 
including military and student practices, might benefit from health promotion and 
lifestyle advice. Some might argue that HPDP might not be relevant or 
appropriate for every patient at every encounter; it might be integral to one 
model of consultation (Stott and Davis), but it is not in others such as 
Pendleton, Neighbour or Balint where focus is patient-centred and on managing 
the doctor-patient relationship.(9-11)  
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Barriers to health promotion in general practice 
Despite featuring in the training curriculum and consultation model, GPs might 
not be able to deliver HPDP to their patients at every contact or consultation. 
There might be factors that make this difficult to deliver at the individual level; 
for instance, a healthcare professional’s knowledge and attitude to health 
promotion can determine whether they offer lifestyle advice and interventions to 
their patients. Introducing a public health intervention such as lifestyle advice 
might be appropriate during a consultation but might not be expected or wanted 
by the patient. GPs typically have eight to 10 minutes per consultation and 
much of that might be spent responding to the patient’s immediate demands or 
needs.(1)  
A survey of nearly 280 GPs’ attitudes and involvement in health promotion in 
the late 1990s in England reported much activity educating patients about 
lifestyle including smoking, alcohol, and physical activity “most” or “all of the 
time”. However, there was a discrepancy between those who felt “prepared” 
and those who thought they were “effective” in their health promotion 
advice.(12) A more recent survey in 2006 of over 700 primary care 
professionals in Scotland reported lack of time and resources were more likely 
to be seen as barriers to routine advising by GPs than other professional groups 
such as health visitors and PNs; the latter two were also more likely than GPs to 
believe that patients would follow their advice.(13) It is unclear however from 
the studies how representative they are of the attitudes of GPs to health 
promotion, and if the attitudes have changed with reducing resources and 
increasing pressure in general practice. 
These barriers are not confined to UK primary care as similar issues have been 
found in other high-income countries. A study in the United States of primary 
care physicians in obesity management highlighted their perception that lifestyle 
changes were most effective over pharmacotherapy or surgery but they lacked 
confidence in their ability to initiate discussions.(14) A discussion paper in 
Australian Family Physician noted issues such as lack of understanding of the 
principles of health promotion among Australian GPs and advocated adding this 
to the undergraduate medical curriculum.(15)  
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The conflict between patients’ and doctors’ agendas has been frequently cited 
as a barrier to HPDP activities.(16-18) A study of GPs in Gloucester that 
examined secondary prevention of coronary heart disease found some GPs 
would rather forego evidence-based guidelines for prevention to preserve the 
relationship with their patients. Some of the GPs thought the interventions were 
“gratuitous” and patients might be “too distressed” from a coronary event to 
consider life-extending interventions such as the use of statins to prevent further 
events.(16) A focus group of GPs in Bradford on the views of their role in 
population approach to lifestyle advice were also concerned about the 
“detrimental effects” on the doctor-patient relationship. Instead they preferred to 
focus on secondary prevention and a multi-agency, centrally co-ordinated 
approach to improving population health.(19)  
GPs felt more comfortable discussing stopping smoking cessation for health 
promotion, only if the patient had existing smoking-related problems.(20) A 
study of smoking cessation advice given by GPs in West of England by use of 
advice slips given to patients reported “concern over doctor-patient relationship” 
was the single independent predictor of GPs giving the advice.(18) A study of 
Welsh patients’ views on smoking advice given by their GPs suggested that 
doctor-patient relationships could be damaged if doctors routinely advised all 
smokers to quit; a patient-centred approach that took account of their own views 
and styles of intervention was thought to be more acceptable.(21) These 
studies were conducted before the new GP contract was introduced. It is 
possible some clinicians might feel more motivated to offer these health 
promotion activities since these activities are now linked to income. 
Despite this apparent conflict of agendas, some patients expected advice from 
GPs. A survey in the 1980s of nearly 3500 patients from two West London 
practices found discrepancies between what lifestyle issues (weight, smoking, 
alcohol consumption and fitness) patients thought their GPs should be offering 
and what they had experienced in the consultation. The study suggested 
greater participation by GPs in health promotion would be “well received by 
most patients”.(22) This was a large study but only included patients from two 
practices in one part of London, so their attitudes might not represent those of 
other areas in or outside London which limits the generalizability. Again, as the 
study predated quality and outcomes framework (QOF – a pay-for-performance 
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system to reward quality of care in general practice), opportunistic health 
promotion might be more commonplace and expected by patients than it was 
20 years ago. The effect of QOF on the behaviour of primary care clinicians to 
give health promotion advice is discussed in the qualitative study of this thesis.  
Despite the apparent inertia from GPs, a King’s Fund report noted the 
“enormous potential” that general practice could offer in HPDP; however, many 
GPs stated their lack of skills to deliver effective health promotion.(23, 24) 
When these skills were offered to doctors training to become GPs in London, 
evaluation of this programme suggested the trainees did not appreciate the 
benefits of public health in primary care practice.(25) The report highlighted 
gaps in evidence, including: types of prevention that can be carried out in 
primary care, benefits for communities, and the best evidence for design and 
implementation of public health interventions in general practice. 
A systematic review of barriers to health promotion in general practice identified 
further issues including: lack of time, lack of skills, lack of patient motivation and 
unrealistic expectations from patients as possible reasons.(26) However, it only 
addressed barriers and did not explore what facilitated health promotion. It 
might not offer a comprehensive assessment of barriers either because it used 
a limited number of search terms (“Health Promotion” and “General Practice”); 
and one database source for publications (PubMed). For example, it did not 
consider any organisational or structural barriers to health promotion such as 
financial incentives or contractual levers, and these are examples of barriers 
and facilitators I examined in this thesis. 
The National Chlamydia Screening Programme (NCSP) 
New programmes have been introduced in England in the last 10 years which 
used general practice as a setting to deliver them; these included: NHS Health 
Check which aims to screen adults between the ages of 40 to 74 for 
cardiovascular disease; and National Chlamydia Screening Programme (NCSP) 
which is an opportunistic screening programme to detect and treat chlamydia in 
sexually active men and women under-25 to prevent onward transmission of 
infection and complications such as pelvic pain and infertility.(27) Both these 
programmes have been rolled out in phases throughout England but the 
implementation strategies have not been consistent in all the areas. In the case 
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of NCSP, general practice was not included in the beginning as a screening 
venue until a few years after the launch of the programme; the majority of 
screening in the early phases were delivered in community contraception and 
sexual health (CASH) clinics.(28) 
I was one of two GPs recruited to the National Chlamydia Screening Advisory 
Group which was a committee to advise the implementation of the NCSP. At 
that time, the programme had just been rolled out to general practice and we 
discussed ways in which GPs could participate in screening. We discussed how 
to shape Department of Health policies by suggesting chlamydia screening as 
performance indicators for primary care trusts (PCTs), encouraged GPs to 
screen by submitting a proposal for chlamydia screening as a QOF indicator in 
the national GP contract as well as promotion in the media to support screening 
in general practice. 
The Department of Health published a document ‘National Standards, Local 
Action – Health and Social Care Standards & Planning Framework 2005/06–
2007/08’ in September 2004. This set out the national requirement for PCTs to 
prepare a Local Delivery Plan (LDP) for the period 2005/06 to 2007/08. The 
document set out the framework that NHS organisations and social services 
authorities should use in planning for the following three fiscal years and the 
standards which all organisations should achieve in delivering NHS care. In 
2006, chlamydia screening became a performance indicator for PCTs in 
England and was included in the LDP.(29) The inclusion of chlamydia screening 
in the LDP meant PCTs had an incentive to improve the chlamydia screening 
rates in their areas, especially from general practices.  
In this thesis, I used the NCSP as one example of a public health programme to 
study GPs’ behaviour because there were different implementation strategies 
used by PCTs to encourage screening from general practice. Chlamydia 
screening was promoted to general practice staff in the medical press, via 
public health departments, and local programme coordinators also distributed 
flyers to practices in their areas. Some PCTs used additional strategies to 
encourage screening and these varied across England. Approaches included: 
“GP chlamydia screening champions”, educational outreach programmes for 
practices and financial incentives to increase screening volumes (such as 
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“enhanced services”1 commissioned by PCTs for GPs to provide screening). 
Thus, many GPs were subject to behaviour change interventions to encourage 
them to deliver these initiatives at the individual and population levels.  
The implementation of chlamydia screening in England has not been without 
criticism. Stephenson argued that despite evidence from two randomised trials 
which found that register‐based screening (where eligible individuals are 
identified from a population register, such as a general practice list, and invited 
to undergo screening) could reduce the incidence of pelvic inflammatory 
disease (PID), there were no trials of the effectiveness of opportunistic 
screening (where screening is offered to eligible individuals attending 
healthcare settings for any reason) which is the approach chosen by NCSP in 
England.(30)  
Low also noted the absence of evidence for opportunistic screening, and added 
that “unsubstantiated belief in success of opportunistic screening persists and 
have allowed the requirements of the National Screening Committee and the 
experience of other UK screening programmes to be overridden”. She also 
advocated that policy makers and researchers should move forward by 
generating the evidence required to determine if opportunistic screening does 
more good than harm at a reasonable cost.(31) 
Additional issues could affect public health programmes such as chlamydia 
screening. In order to inform the implementation of NCSP, McNulty and 
colleagues explored the barriers to testing for chlamydia in general practice; 
they reported the greatest barriers were poor awareness of the condition and 
the screening programme, how to take the specimen, lack of time, concerns 
about discussing sexual health and lack of guidance.(32) In another study, 
similar issues prevailed in “low-testing” practices, whereas “high-testing” 
practices had a GP or practice nurse with a special interest in sexual health who 
were more cognizant of the signs and symptoms so considered it as part of 
check-up for patients with genitourinary symptoms.(33) Particular difficulties for 
                                                          
1 The new General Medical Services (nGMS) contract for general practitioners categorised primary care 
services into three groups: essential, additional and enhanced services. All GPs must provide essential 
services such as consultations with patients who seek care because they believe they are unwell. 
“Enhanced services” cover additional services that practices can choose to provide. These can be 
commissioned nationally or locally to meet the populations healthcare needs. Chlamydia screening was 
commissioned as a “local enhanced service” in many PCTs for GPs to deliver screening. 
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some GPs and nurses were identified in discussing sexual health with patients 
of opposite genders, minority ethnic groups, middle-aged and older adults and 
non-heterosexual patients.(34) A study of GPs’ and PNs’ sexual health 
promotion activities based in Northern Ireland found this was often done ad hoc 
and not targeted at the population “at-risk”; the healthcare professionals thought 
they were inadequately trained to discuss sexual health with non-heterosexual 
clients or those with learning disabilities. Embarrassment and lack of time were 
also identified as barriers to effective sexual health care.(35)  
The National Audit Office (NAO) produced a report in 2009 which scrutinised 
the impact of the £100 million spent to date on the NCSP, and concluded the 
programme had not demonstrated value for money. The NAO reported that the 
costs of delivering the Programme were highly variable from place to place, 
indicating that there was “scope for efficiency savings”. The NCSP was cited as 
an example of the difficulties which could arise when a “national initiative is 
introduced into a locally-managed NHS, when influences and incentives for 
PCTs are not addressed from the beginning and all aspects are locally 
commissioned, regardless of economies of scale”.(36) 
Much has been written in the literature in terms of systematic reviews examining 
the impact of various behaviour interventions on physicians’ behaviour to deliver 
healthcare, which makes NCSP interesting to examine the outcomes of using 
different approaches to delivering the programme. From gaining an 
understanding of the barriers through prior research, McNulty and colleagues 
evaluated different ways to improve chlamydia screening in general practice. 
These strategies have included: training clinicians and reception staff and 
nominating “champions” for screening;(37) use of interactive workshops to 
increase screening; (38) and, in one study, they suggested making request 
forms easier to fill in, and provide financial incentives to facilitate screening.(39) 
They also demonstrated, through a randomised controlled trial, that the use of a 
structured complex intervention based on the Theory of Planned Behaviour 
(TPB) doubled chlamydia screening from GPs.(40)  
My motivation for this thesis 
When I completed general practice training, I became interested in population 
health and worked in a public health department of a health authority in East 
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London. I also studied for a master’s degree in public health at the London 
School of Hygiene and Tropical Medicine (LSHTM).   
The new general medical services contract (nGMS) for UK general practice was 
introduced in 2004, at the time during my master’s study.(41) This contract used 
a set of quality criteria (the Quality and Outcomes Framework or “QOF”) to 
remunerate GPs for the quality of clinical and non-clinical care they provide for 
their registered patients. The targets that related to public health included: 
childhood immunisations, influenza vaccinations, cervical cytology, health 
checks, smoking cessation advice and secondary prevention of people who had 
heart disease and stroke. The knowledge and experience in public health 
helped me to understand the rationale for the quality indicators that reward 
practices to improve the health of their registered population.  
My other clinical interest is in sexual and reproductive health. I was involved 
with the NCSP as one of the GP advisors whose role was to consider how to 
promote chlamydia screening in general practice. We used information 
cascades, training events, flyers and online education modules to promote 
testing. I also used media outlets relevant to GPs as a means of conveying the 
message about the programme and wrote an article in the British Journal of 
General Practice (BJGP) to consider the use of financial incentives. (42-44) 
However, as shown later, these strategies did not necessarily change the 
behaviour of GPs. 
I have been a member of a Royal College of General Practitioners’ (RCGP) 
sexual health committee whose aim is to improve sexual health care provided 
by GPs. We have encouraged HIV testing in general practice for almost a 
decade. The clinical case for early diagnosis of HIV is clear as this reduces 
morbidity, mortality and also prevents onward transmission.(45) Despite various 
educational materials, online learning, educational events, media messages 
and NICE guidance, HIV testing in high prevalence areas remained low and 
there have been cases of late diagnoses due to missed opportunities.(46, 47) 
We reflected on our approaches and wondered why HIV testing in high 
prevalence areas did not become more widespread. We considered, for 
example, if there were barriers for GPs which made it difficult to discuss testing, 
such as lack of knowledge or confidence to deal with sexual health for example. 
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I was unwilling to accept that GPs could do nothing to improve the nation’s 
public health (including sexual health). This has become the motivation for my 
thesis. I wanted to find out what factors determine the behaviour of GPs to 
deliver HPDP programmes. I wanted to know if there were ways to influence the 
behaviour of GPs other than financial incentives and educational events. 
Summary of evidence gap and the case for this thesis 
There is a clear focus on prevention in the health policies, nationally and 
globally, to reduce ill health and the burden of diseases in the population. 
Through a list-based system and good coverage of the population, general 
practice appears to be a suitable setting to implement many HPDP 
programmes. However, competing priorities in a consultation, the concern 
regarding doctor-patient relationships and some GPs’ lack of confidence and 
knowledge in health promotion might be some of the reasons why public health 
interventions are not delivered.  
The King’s Fund report highlighted general practice has “enormous potential” to 
deliver public health programmes, and yet, there appears to be a paucity of best 
evidence to design and implement public health interventions in general 
practice.(24) There is already a wealth of empirical evidence for using different 
interventions to modify behaviour of clinicians, many of these have been 
considered in systematic reviews of empirical studies. The Cochrane 
Collaboration published systematic reviews that examined the effectiveness of 
different behaviour modifying interventions ranging from computer reminders, 
educational outreach visits to financial incentives. At the time of submitting the 
thesis in May 2015, there were no published overviews of systematic reviews 
that examined literature on the use of behaviour modifying interventions on 
primary care practitioners to deliver public health interventions. An overview of 
these systematic reviews would be helpful to summarise which interventions are 
effective when applied to primary care settings to improve delivery of HPDP 
programmes.  
Interventions that modify healthcare professionals’ behaviour might work in 
different ways, have different magnitudes of effect, and have underlying 
assumptions about the mechanism of behaviour using theories that are well 
established in literature. An exploration of the theories that underpin the studies 
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on behaviour modifying interventions would help to understand how and why 
they might work, and how they could be used as a framework to design others. 
For example, the study of chlamydia screening by McNulty and colleagues used 
a cognitive theory (Theory of Planned Behaviour, TPB) to design a structured 
complex intervention to increase opportunistic chlamydia testing in general 
practice.(48) In this thesis, I used the same theoretical framework to understand 
the behaviour intentions of primary care clinicians such as GPs and PNs to 
deliver HPDP programmes. This might help to understand why some 
interventions to promote HPDP programmes might work in general practice and 
why others might fail. 
As mentioned earlier, there have been studies that considered barriers to health 
promotion but they did not consider both barriers and facilitators to delivering 
health promotion programmes; for example, if clinicians felt financial incentives 
compensated them enough to overcome barriers such as perceived lack of time 
in a consultation. This thesis will consider if barriers such as perceived lack of 
time influenced chlamydia screening and other HPDP activities, and if 
behaviour change interventions such as educational outreach and financial 
incentives were enough to overcome them, or if there were other factors outside 
the constructs of TPB that needed to be addressed such as organisational and 
political contexts. 
Drawing on the gaps in the literature, the aim of this thesis is to examine factors 
that influence the behaviour intentions of general practitioners to deliver public 
health programmes. To address this, the following are the objectives of this 
thesis: 
1. Assess the effectiveness of interventions that modify the behaviour of 
GPs and their impact on patient outcomes that relate to health promotion 
and disease prevention. 
2. Explore the reasons why primary care clinicians such as GPs and 
practice nurses responded to behaviour change interventions to deliver 
public health programmes such as chlamydia screening. 
As mentioned, I have included practice nurses in the interviews because they 
work alongside GPs, they deliver a majority of health promotion programmes as 
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part of their job description, and they might face similar challenges as GPs in 
terms of patient demands, expectations, and time pressures. The inclusion in 
the study might offer insights into the similarities and differences between these 
two professional groups in primary care.  
The first step of my enquiry was to gain a theoretical understanding of 
behaviour and examine behaviour change theories that could be useful to 
explain and predict behaviour and therefore inform behaviour interventions 
(Chapter 2). I considered some behaviour change theories commonly used to 
explain behaviour of healthcare professionals and patients. In addition to a 
critique of each theory, I gave examples of how they could be applied in 
practice, and in the design of interventions to modify behaviour of clinicians. 
In Chapter 3, I described the methods used for the main research of the thesis. I 
considered the effectiveness of different interventions that aimed to modify 
behaviour of doctors in Chapter 4 by conducting an overview of systematic 
reviews. This overview examined different types of behaviour interventions, 
what theories they were based on, and how effective they were to change the 
behaviour of general practitioners and improve patient outcomes in the context 
of HPDP. In Chapter 5, I used the example of the NCSP to look at the impact of 
different implementation strategies on chlamydia screening volumes in general 
practices in London. In Chapter 6, I presented the data from interviewing 
general practitioners and practice nurses on what influenced their behaviour to 
deliver public health programmes. The interviews were a way to understand 
why some behaviour change strategies had impact and others did not, in 
addition to understanding other influences of behaviours. In Chapter 7, I 
discussed the findings from this thesis and what they mean in practice, and 
suggested some recommendations for policy makers on what might help to 
influence the behaviour of general practitioners to improve the health of their 
populations.  
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Chapter 2 – Use of theories to understand and predict 
behaviour  
Background 
In the last chapter, I described how health promotion and disease prevention 
(HPDP) programmes have been introduced to deal with emerging threats to the 
health of the public due to communicable and non-communicable diseases. I 
also gave examples of the problems GPs might face when they deliver health 
promotion and disease prevention programmes in practice. Issues such as: lack 
of time, lack of training, lack of confidence as well as conflicts between the 
clinicians and patients’ agendas have been suggested as barriers from various 
studies on health promotion in general practice.  
To consider how to change an individual clinician’s behaviour, we first need to 
understand the determinants of behaviour. This chapter will consider and 
critique some common behaviour theories, what factors determine behaviour 
intention and where the levers could be to change them. 
Behaviour change theories 
Behaviour change theories can provide a framework to understand behaviour 
and help to identify levers to use to effect a change. According to West, theory 
can be defined as a “description of a process, derived from a process of 
inference, which provides explanation for observed phenomena and helps to 
predict events”.(49) There are many behaviour change theories available but I 
have used a few examples of cognitive theories commonly used in the context 
of HPDP programmes that are based on the individual, and I have chosen to 
apply the Theory of Planned Behaviour (TPB) in this thesis because it is useful 
in explaining and predicting behaviour of healthcare professionals.(50)  
Early behavioural theorists such as Skinner believed a behavioural response 
can be fully explained by the reinforcement contingencies alone.(51) Skinner 
hypothesised that behaviour is determined by its consequences; even a 
temporal association between behaviour and rewarding consequence that 
follows is enough to increase the probability of that “operant” behaviour being 
repeated. These behaviours are termed “operant” as they operate on the 
environment to bring about changes that result in the reinforcement. Classical 
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behaviour modification strategies do not require “thinking” or “reasoning” so 
responses are more of an innate reflex to the stimulus. Classical behaviour 
theories could be seen as too simplistic and one-dimensional to apply to 
complex processes in humans; for example, they do not consider how attitudes 
and consequences of behaviour might affect an individual’s decision to perform 
some behaviours, nor do they consider any external factors like environmental 
and peer influences. These theories might explain some behaviour associated 
with past experiences; for example, if a GP felt they missed a case of rectal 
cancer in a 60-year-old man with rectal bleeding, they might be more likely to 
refer 60-year-old men who have the same symptoms in the future. However, 
classical theories are unlikely to be helpful to explain other factors that could 
determine a healthcare professional’s behaviour in practice. Using the same 
example, a GP might have missed a case of rectal cancer because they did not 
think he was at risk, or they were unable to allocate enough time for a full 
assessment, or there could be organisational barriers that make assessment 
and referral for suspected cancer difficult; these issues might need to be 
addressed for the clinician’s behaviour to really change. 
Modern behaviour change theories focus on cognitive factors that lead 
individuals to change behaviour. Cognitive theorists believe behaviour involves 
a degree of “reasoning” and “thinking”. The behaviour intention is a function of 
the perceived value of the outcome, and the perceived probability (or 
expectation) that a behaviour will result in that outcome. Health Belief Model 
(HMB) and TPB use this cognitive process that a person normally considers the 
benefits, trade-offs, and their values of outcomes before a behaviour is 
actioned.(52-54) 
Becker’s Health Belief Model (HBM, Figure 1) was developed to help 
understand why people use preventative services; it postulates that health-
related action depends on three factors: there is sufficient motivation or health 
concern to make issues relevant; there is the belief one is susceptible to a 
serious health problem; and the belief that following a particular health 
recommendation would be beneficial in reducing this threat and the action is at 
an acceptable cost.(52) This model has been used to explain preventative 
behaviours such as: healthcare workers’ decision get vaccinated for influenza, 
bowel cancer screening in older adults, and attendance for health checks in 
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general practice.(55-57) We could apply this theory to understand why 
healthcare professionals deliver public health interventions: a doctor who is 
aware of the benefits of the influenza vaccine, who has knowledge of the 
sequelae of influenza in people at risk, would be more likely to offer the 
vaccination to their patients. 
Figure 1 Becker's Health Belief Model 
 
Despite widespread use of HBM, a recent meta-analysis found only the 
constructs of benefits and barriers had consistently strong predictive power for 
behaviour change and the authors cautioned against the continued use of HBM 
in predicting health behaviours.(58) Furthermore, this theory considers only the 
predictors of behaviour at the individual level, so influences from peers and 
social norms are not taken into account. It assumes individuals behave in a 
rational way, with behaviour resulting from assessment of perceived severity, 
threats, benefits and barriers. It also assumes behaviour is under volitional 
control and does not consider the effects of an individual’s emotional and 
unconscious reaction to situations. For example, HBM is unable to explain how 
a young person might want to take drugs or have unsafe sex; they might have 
chosen these actions to feel accepted by their peers or sexual partner, despite 
being aware of the risks. 
The effect of peers can be a determinant of behaviour and Bandura’s Social 
Cognitive Theory (Figure 2) suggests that people learn by observing others; the 
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environment, behaviour and cognition interact with one another to influence the 
observed behaviour. (59, 60) The theory goes further to say that behaviour is 
also determined by expectancies and incentives. Expectancies can be of three 
types: consequences of one’s own actions or “outcome expectations”; one’s 
own competence to perform the behaviour needed to influence outcomes or 
“self-efficacy”; and incentives or reinforcement of the outcome as interpreted 
and understood by the individual. So, if an individual believed the effect of a 
certain behaviour (e.g. change in lifestyle) was desirable, they would attempt to 
change if they believed that: their current lifestyle posed a threat to their valued 
outcomes such as their health or appearance (environmental cue); that changes 
would reduce the threats (outcome expectation); and they were personally able 
to effect the change in behaviour (self-efficacy). An example in general practice 
might be that if a clinician felt a patient might benefit from their health promotion 
advice, if action were seen to be desirably by their peers, if doing nothing it 
would harm the patient, and if they felt they had the skills to deliver this, then 
they are more likely to give this advice to their patient. 
Figure 2 Bandura's Social Cognitive Theory 
 
However, the utility of Social Cognitive Theory has shown to be inconsistent in 
delivering different prevention programmes. While it has been cited in designing 
cardiovascular prevention and treatment programmes, according to a 
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systematic review, its effectiveness in others such as physical activity has been 
mixed.(61, 62) Like the HBM, it does not consider other influences on behaviour 
such as personal habits, environmental and emotional factors but it does 
recognise social influence as a determinant of behaviour. It also suggests 
observation is an element of behaviour but not all behaviours can be observed 
and learned, which might make evaluating its efficacy difficult. 
In Ajzen and Fishbein’s Theory of Reasoned Action (TRA, Figure 3), two main 
factors determine behaviour intentions: the person’s attitude towards a certain 
behaviour (which is a function of the beliefs and perceived consequences of 
that behaviour and the outcome evaluation of these consequences); and the 
subjective norms consisting of the perception of what the individual feels he or 
she should do to comply with expectations (which is a function of the person’s 
normative beliefs regarding what they think they should do and the motivation to 
comply).(63) Using an example of influenza vaccination, a doctor’s intention to 
give vaccination to a patient at risk might depend on their attitudes about 
influenza and beliefs about effectiveness of the vaccine; and how strongly he 
felt he was expected to do so by his peers, as well as how he thought he would 
be judged by them if he chose not to give the vaccine. 
Figure 3 Ajzen and Fishbein's Theory of Reasoned Action 
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Ajzen later proposed an additional construct of “perceived behaviour control”, 
which originates from self-efficacy theory, to the TRA to improve the predictive 
power (Figure 4). In addition to a person’s attitude to the suggested behaviour 
and how they think they would be perceived by their peers, TPB includes a 
person’s confidence in their ability to perform that action.(53) Using the same 
example of vaccination to explain this additional construct, a doctor might not 
feel able to offer this to a patient because they might lack confidence in 
explaining vaccine benefit and risks to their patient. Another example of 
perceived behaviour control might be that the doctor is unable to give the 
vaccine because it is kept in a fridge in another room, and it is their perception 
that walking out to get it might incur additional time in a limited consultation; on 
the other hand, a more motivated clinician might not view that as a barrier. The 
same theory to explain a clinician’s intention to offer chlamydia screening to a 
young person at risk of chlamydia infection is illustrated in Figure 5. 
Figure 4 Ajzen's Theory of Planned Behaviour 
 
One limitation of TPB is that it does not include other factors that often have a 
role in behaviour such as self-control and emotional reactions.(64) Strong 
emotions such as threat, fear, mood, might have an influence on behaviour 
intentions. For example, someone who is depressed might feel apathetic and 
feel less inclined to stop smoking even though they were aware of the risks and 
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consequences. Nevertheless, TPB covers many aspects of behaviour, including 
non-volitional behaviour that cannot be explained by the TRA. In addition, unlike 
HBM, it can explain an individual’s social behaviour by considering the “social 
norm” as an important influence.   
Figure 5 Using Theory of Planned Behaviour to explain chlamydia screening in 
general practice 
 
Limitations across all theories of behaviour change 
Some common limitations that relate to all cognitive models of behaviour 
change include: the lack of a construct that recognises social, organisational 
and physical environments which could be important determinants of behaviour; 
the assumption that behaviour change is an event, whereas actual change is 
usually a long and complex process; and related to this, the theories do not 
consider how the change in behaviour can be maintained and how to prevent 
relapse.(65) Behaviour change theories are based on the assumption that an 
individual might wish to modify behaviour to improve health; when their use is 
applied to clinicians, who value the relationships with their patients, behaviour 
change theories do not refer to this important dimension for healthcare 
professionals, i.e. to maintain the clinician-patient relationship when discussing 
behaviour change.  
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How useful is the Theory of Planned Behaviour (TPB) in practice?  
In a meta-analysis of 185 independent studies, TPB helped to explain 27% and 
39% of variance in behaviour and intention respectively. According to the review 
authors, for a behaviour theory to have this effect, it suggests the efficacy is 
relatively high.(66) This might be the reason why TPB is commonly applied in 
the context of predicting the behaviour and intentions of individuals in 
healthcare settings. It uses important influences of behaviour including: 
intentions, attitudes, perceived control, and perceived norms. Furthermore, 
according to a systematic review of studies that used cognitive theories, TPB is 
the most useful theory in predicting behaviour of healthcare professionals.(50) 
TPB has been able to explain behaviours such as prescribing, managing 
respiratory infections, depression, offering vaccination and adherence to 
guidelines.(67-71) However, due to their designs, these studies were not able to 
show the effectiveness of approaches using TPB as a method to change 
doctors’ behaviour to improve patient outcomes.  
Behaviour theories might also be useful when considering strategies for 
dissemination and implementation of clinical practice and guidelines. A review 
of implementation research estimated that only 20% of these studies used any 
theory to inform their design.(72) Four theories in particular accounted for 63% 
of articles found; the most commonly used theories were: Trans-theoretical 
Model of Change, TPB, Social Cognitive Theory and the Information-Motivation-
Behavioural-Skills Model. The prevalence of these theories might suggest their 
usefulness in designing implementation strategies. 
Some academics have examined the interconnectedness of behaviour theories. 
In their book, ABC of Behaviour Change Theories, Michie et al suggested 
interventions for behaviour change should explicitly use theory in their design 
and demonstrated the importance of TPB as a key theory. They analysed the 
range of theories used in literature of behaviour change and identified a total of 
83 behaviour change theories in a systematic literature search of 
implementation strategies. (73) They also studied the interconnectedness of 
these theories and identified 122 connections or ties amongst the 83 behaviour 
change theories. These 83 theories have overlapping constructs and this is not 
surprising since many were developed from seven discrete behaviour theories. 
TPB was one of the seven theories and it alone contributed to development of 
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17 further theories of behaviour change. This analysis of interconnection 
suggests how important TPB is as a basic framework as well as the individual 
constructs in the development of other behaviour theories. 
There have been some practical applications of the TPB in understanding the 
behaviour of primary care professionals to deliver public health programmes, 
particularly in chlamydia screening. The conceptual framework of TPB has 
already been used to design a multifaceted educational strategy to improve 
uptake of chlamydia screening in general practice which showed increase in 
screening volume.(40) If TPB could encourage GPs to improve chlamydia 
screening, it could potentially be extended to improve other aspects of sexual 
health care in general practice setting such as HIV testing as well as other 
health promotion and disease prevention activities. 
Conclusion 
Human behaviour is complex and is influenced by many factors beyond the 
biological and medical explanatory models. This chapter has explained some of 
the theories that could be used to understand behaviour and how they could be 
used to develop behaviour change interventions. Some of these theories have 
already been used to design empirical studies published in the literature in the 
context of HPDP. TPB appears to be a behaviour theory that is well established 
in literature and covers many influences of behaviour intention. It appeared to 
be efficacious in predicting behaviour and already has applications in predicting 
health behaviour in both healthcare professionals and patients.  
There are limitations to TPB because it is based on the individual; it does not 
consider the effect of social, physical, and organisational environments as 
determinants of behaviour, nor does it consider the dimension of clinician-
patient relationships which are important for healthcare professionals.  
Some theories including TPB have been used to inform research designs to 
change behaviour of healthcare professionals, we need to understand how 
useful are they in explaining the behaviour of GPs to deliver HPDP programmes 
to improve their patients’ health. The overview of systematic reviews in Chapter 
4 will summarise the evidence for the use of behaviour change interventions, 
their effectiveness when applied in practice, and the underpinning behaviour 
theories used to design the interventions.   
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Chapter 3 – Design and Method 
Introduction  
The focus of the thesis is to understand what influences behaviour of GPs to 
deliver health promotion and disease prevention programmes. In Chapter 1, I 
stated the rationale and objectives of my study, and Chapter 2 provided a 
summary of behaviour theories which might be useful to explain and predict 
behaviour of healthcare professionals, such as GPs, to deliver public health 
programmes. This chapter will describe the design and methods to address the 
following study objectives:  
1. Assess the effectiveness of interventions that modify behaviour of GPs 
and their impact on patient outcomes that relate to health promotion and 
disease prevention 
2. Explore the reasons why general practitioners respond to behaviour 
change interventions to deliver public health programmes such as 
chlamydia screening 
 
The search for effective interventions that modify clinicians’ behaviour to 
improve practice is not new. One of the earliest reviews to explore interventions 
to improve clinical practice of GPs was provided by Horder et al; they grouped 
approaches into “themes” based on types of interventions, rather than on 
behaviour theories.(74) Their classification of themes included: financial 
incentives, personal contact, review of performance, unsolicited feedback, and 
literature on prescribing and continuing postgraduate education. They 
concluded that although these interventions changed behaviour, they were 
“slow and laborious”; they cast doubts on the effectiveness of financial 
incentives and unsolicited feedback, but suggested in some cases, multifaceted 
interventions might be “more promising”.  
Goodpastor et al also reviewed strategies to change the behaviour of doctors 
based on outcomes and effectiveness research and provided one of the earliest 
reviews of behaviour change interventions based on theories. They classified 
approaches used to influence physicians into two types of strategies: social 
influence strategies and direct behavioural strategies using financial 
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contingencies. (75) Although not meant to be comprehensive, this was one of 
the earliest reviews that used theories used to explain behaviours.  
In the mid-90s, Oxman et al provided one of the first systematic reviews of 
interventions (such as educational events, outreach visits, audit and feedback, 
conferences, opinion leaders) to improve clinical practice in health care 
professionals in various settings covering different outcomes such as 
preventative measures, specific management of conditions, prescribing and use 
of hospital services and diagnostic tests. They concluded after reviewing 102 
trials there were “no magic bullets” and suggested different proposals for 
changes in clinical practice might require not only different implementation 
strategies, but different groups of clinicians, such as GPs, might have specific 
barriers that need to be overcome.(76)  
There have been more reviews published within the last 10 years that examined 
interventions to change healthcare professionals’ behaviour to improve practice. 
Yen’s review in 2006 concluded that “active interventions” such as academic 
detailing and reminders should be used as part of a multifaceted strategy to 
engage physicians to change behaviour as they were more effective than 
“passive” approaches such as printed educational materials and continuing 
medical education”.(77) The review covered many types of health care 
professionals and outcomes; however, it was not systematic and no robust 
conclusions could be drawn regarding specific types of healthcare 
professionals, settings, behaviour or outcomes of interests.  
More recently, a review team explored the literature available on databases 
such as Cochrane Database of Systematic Reviews with the specific question 
of implementing guidelines into surgical and general practice. They also 
concluded “active forms” of continuing medical education and multifaceted 
interventions were found to be the most effective methods for implementing 
guidelines into general practice. Additionally, “active” approaches to changing 
physician performance were shown to improve practice to a greater extent than 
traditional “passive” methods.(78) 
Currently, there is no robust overview of systematic reviews that considers the 
effect of behaviour interventions on GPs to deliver HPDP programmes, which is 
what this review aims to address. Rather than classifying approaches into 
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“active” and “passive”, I used a system that referred to education, social, mass 
communication, and economic theories. This was consistent with the earlier 
review by Goodpastor which attempted to consider more theoretical ways to 
classify behaviour interventions; the use of theory is more helpful to understand 
how and why some interventions might work and where the levers might be.(75) 
Objective 1:  
Assess the effectiveness of interventions that modify behaviour of GPs 
and their impact on patient outcomes that relate to health promotion and 
disease prevention 
Methodology 
To find out which of the many available interventions are effective to modify 
behaviour of GPs, it was necessary to conduct a systematic review to examine 
available literature on interventions that modify GPs’ behaviour. To get a sense 
of the literature available, I piloted a literature search strategy that focussed on 
primary studies and reviews (including systematic and non-systematic reviews) 
that used doctors as subjects and behaviour modifying strategies such as 
education, social or financial incentives. I included patient outcomes from health 
promotion or disease prevention activities such as screening and smoking 
cessation.  
I used a more generic term for doctor or physician so as not to exclude studies 
that used synonyms but took place in primary healthcare settings such as 
general practice. I included the terms “primary care” as this is often used to 
describe general practice in other countries such as North America. The search 
was conducted in March 2011. 
I used the following search terms for: 
• Subject: physic*, doctor, general practitioner, family physician;  
• Setting: primary care, general practice, family medicine; 
• Intervention: behav*, chang*, persua*, encourage*, incenti*, influen*, 
interven* education; and  
• Outcomes: public health, health promotion, screening, motivation. 
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I used the following databases: Medline, EMBASE, HMIC (Health Management 
Information Consortium), HBE (Health Business Elite), PsycEXTRA, PsycINFO, 
Social Policy and Practice, Econlit and CINHAL. I chose these databases to 
include publications that ranged from clinical and behavioural research to 
articles on a broader level of health service policy and management; this 
enabled the search to include interventions at the organisational level such as 
financial incentives and contractual mechanisms.  
The search period was from inception of database to March 2011: PsycEXTRA 
from 1908, PsycINFO from 1906, Ovid MEDLINE from 1948, EMBASE from 
1980, HMIC from 1979, and Econlit from 1969. The results were limited to 
human subjects; articles in English; clinical trials, comparative studies, 
controlled trials, evaluation studies, multicentre studies, randomised controlled 
trials, reviews; the setting was also limited to high income countries. The search 
strategies and results are in Appendix C.  
This pilot search strategy returned many empirical studies and altogether they 
covered a large range of behavioural interventions for different outcomes and 
contexts. For example, an EMBASE search returned over 2800 original studies 
in English and a MEDLINE search yielded just over 2000 studies (Figure 6). 
The results of this pilot search offered me an overview to the types of primary 
studies available, the types of interventions that were explored, on whom, in 
which settings and what processes and outcomes were reported. 
The pilot literature search also demonstrated the plethora of trials and studies 
available which might result in difficulties in making sense of the evidence in a 
systematic way into something that might be helpful to interpret and use; this is 
often a problem in the real world of clinical evidence synthesis and policy 
making. With up to 75 trials and 11 systematic reviews of trials published per 
day, it is useful for policy and practice to have efficient and robust synthesis and 
summaries of studies to help make decisions for implementation.(79)  
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Figure 6 Ovid Medline searches 1948 to March 2011 in exploratory search 
strategy 
 
The MEDLINE searches in the pilot returned 60 systematic reviews which 
reported different types of behavioural interventions on doctors such as 
educational strategies, computer reminders and financial incentives. As there 
are already systematic reviews on these interventions to change the behaviour 
of clinicians covering many primary studies, I have therefore chosen to conduct 
an overview of systematic reviews to synthesise the available evidence. 
The Cochrane Collaboration provides a library of systematic reviews for similar 
interventions that are assessed systematically; the conclusions can be easily 
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digested and used by both clinicians and policy makers. As the search revealed 
many systematic reviews on similar topics, settings, processes and outcomes, 
that it would also be more efficient to conduct a systematic overview of 
systematic reviews so that they could be analysed to answer a particular policy 
or clinical question, to offer policy makers and clinicians robust evidence they 
need to make decisions for practice. (80)  
Systematic reviews often report many outcomes measures but an overview of 
systematic reviews usually report findings based specifically on the outcome of 
interest or the review question.(80) Individual systematic reviews might report 
interventions on different healthcare workers and different healthcare outcomes; 
for this thesis, I am specifically interested in primary care physicians, in primary 
care settings and outcomes that are related to health promotion and disease 
prevention. The purpose of this overview of systematic reviews was to examine 
the evidence for interventions that aimed to modify behaviour of general 
practitioners to deliver programmes that promote health and prevent diseases 
for their patients. I therefore extracted and synthesised the relevant data from 
systematic reviews to meet the study objectives. Smith et al have described the 
methodology for conducting a systematic review of systematic reviews of 
healthcare interventions and this is the approach I have adopted for this 
overview. (80) 
Impact on patients in any healthcare delivery or programme is important for the 
clinicians, the public and policy makers which is why I explored the types of 
patient-related outcome measures that were reported in the studies such as 
uptake of screening and immunisations, in addition to process measures that 
relate to health promotion and disease prevention activities such as giving 
advice on screening and immunisations. I focussed on short-term outcome 
measures such as uptake of screening, primary prevention, or vaccination 
rather than long-term outcomes such as disease prevented or survival rates 
because the follow-up time in most studies was short. 
Each of the published systematic reviews I explored in the pilot search also 
gave descriptions of the behaviour intervention being examined, including some 
theoretical bases. I have already explored different behavioural theories in 
Chapter 2, so I used this opportunity to examine the relationship between the 
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effectiveness of behaviour interventions and the behaviour theories that 
underpinned them in the reviews.  
The review therefore had the following specific aims: 
1. To examine the theoretical bases of the behaviour interventions in each 
systematic review. 
2. To summarise the effectiveness of interventions to modify behaviour of 
general practitioners to deliver health promotion and disease prevention 
3. To summarise the effectiveness of interventions, specifically directed at 
general practitioners, in improving patient outcomes such as increased 
uptake of lifestyle advice, screening, and immunisations 
To answer the research questions, the physician related measures include:  
• Changes in knowledge, attitudes, and behaviour 
• Prescribing for primary or secondary prevention, e.g. statins for patients 
who have increased cardiovascular risk and for patients after a 
cardiovascular event to prevent further episodes respectively 
• Offer of or advice on screening tests  
• Giving lifestyle advice such as smoking cessation advice, advice on 
harmful drinking  
• Referrals for lifestyle interventions such as dietician or exercise schemes 
 
Patient related outcome measures include: 
• Uptake of health promotion or disease prevention activities such as 
immunisations and screening 
• Changes in lifestyle or health behaviours 
Method 
Following the pilot search, the search strategy was revised to conduct an 
overview of systematic reviews but the aims and objectives of the literature 
review remained the same. The sources for of review included databases that 
specifically register systematic reviews. The Cochrane Library has a repository 
of systematic reviews; specifically, the Cochrane Effective Practice and 
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Organisation of Care Group (EPOC www.epoc.cochrane.org) has a library of 
over 100 reviews on various approaches to date (February 2017). Further 
searches for systematic reviews were done on Database of Abstracts of 
Reviews of Effects (DARE) produced by the Centre for Reviews and 
Dissemination (CRD) at the University of York (www.crd.york.ac.uk). The date 
of the original searches was between February and April 2011 but there were 
no systematic reviews of new interventions published by February 2017 (at the 
time of thesis revision) other than an update to two systematic reviews which 
are included in the overview.  
Search terms used to find systematic reviews included: professional practice, 
healthcare outcomes and patient outcomes in the title, abstract or as keywords. 
The following criteria were applied for my search of systematic reviews: 
• Primary care doctors included as subjects of intervention  
• Primary care included as a setting 
• Process measures that suggest HPDP activity, e.g. vaccinations are 
given, smoking cessation advice, diet advice  
• Interventions directed at doctors with patient related outcome measures 
including use of health care services such as uptake of screening and 
vaccinations, and health improvement 
• Studies from high-income countries  
 
The following were used as exclusion criteria: 
• Reviews that did not include primary care physicians or primary care 
settings  
• Reviews that only included interventions at the primary care organisation 
or higher levels of the health systems as changing only the culture of an 
organisation might not necessarily change the behaviour of individuals 
within it.  
• Outcome measures with no clear relationships to HPDP e.g. general 
clinical management, medicines prescribing and test ordering  
• Reviews that included only middle and low-income countries as settings 
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Method for synthesis 
I used a process of “narrative synthesis” for the review. This is a way to assess 
complex interventions where there are wide range of interventions, where the 
study data or designs might be heterogeneous, or where the outcome data are 
not suitable for meta-analysis. (81) The “narrative” element refers to the use of 
words and text primarily to summarise and explain the review and synthesis of 
findings; whilst it can involve the use of statistical data, the characteristic of this 
approach is the use of text in the process of synthesis to “tell the story”. 
 
A methodological review of systematic reviews reported some narrative 
synthesis of quantitative data in public health reviews were “inadequate”. The 
problems included poor description of methods, lack of reference to guidance, 
and inadequate links between data and narrative summary; these issues 
threaten the credibility of systematic reviews.(82) As a result, some guidance 
have been produced by Cochrane Collaboration which is based on original 
guidance by the ESRC (Economic and Social Research Council) Methods 
Programme to make the process of synthesis and reporting more transparent 
and robust.(81, 83) 
 
Narrative synthesis has various stages aimed to be transparent, rigorous, and 
robust. This process includes: 
• Considering theoretical bases of how interventions might work. 
• Summarising studies, noting any heterogeneity in designs, similarities, or 
differences in the findings, and grouping them by interventions 
• Exploring relationships within and between studies to explain reasons for 
differences in outcomes. 
• Assessing robustness  
 
The guidance suggest that the process is not necessarily linear so the above 
steps can be in any order.  
I first grouped the systematic reviews according to the mode of behaviour 
intervention, with the underlying assumption that there might be a common 
theoretical basis for each group. For example, I grouped systematic reviews 
based on educational methods together and another group based on financial 
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incentives, assuming there might be educational and economic theories 
respectively to explain the outcome effects. This preliminary step enabled me to 
consider the similarities and differences in the interventions and outcomes.  
I then considered the relationships between systematic reviews in groups, and 
how they might explain the outcomes and their magnitudes, noting particularly 
the variability in underlying theoretical bases, settings, populations. and 
outcome measures. At this stage of the process, I extracted the data that were 
relevant for the review question that is interventions that modify behaviour of 
general practitioners to deliver public health programmes.  
To assess the robustness of the synthesis, I used a validated instrument to 
assess the quality of each systematic review: Assessment of Multiple 
Systematic Reviews (AMSTAR); this is explained in more detail in the next 
section under Quality Appraisal. The use of AMSTAR as a quality assessment 
tool enabled me to minimise bias in interpreting the review findings, and 
ensured studies that were of similar quality were given equal weight.  
Finally, I explored the use of theory in the behaviour interventions. This step 
enabled me to consider how an intervention might work and why. Theory 
building is often neglected in systematic reviews; Shadish observed that 
systematic reviews focussed too much on descriptive causation (describing the 
size of an effect) and little on development of explanatory theories; and yet, 
systematic reviews are powerful than single studies to build and test 
theories.(84) For example, interventions based on different behaviour theories 
might have different effects; some interventions might use more than one 
theoretical approach and some studies compared multi-faceted approaches 
with single interventions; they help to offer explanations to understand what 
works and why, and inform future studies. 
The findings from the synthesis addressed overall completeness and 
applicability of evidence to address the study question, referring to the quality of 
evidence and potential biases in the review process. I presented the findings 
from the review in a narrative format but this was not intended to be a “narrative 
review”. Cook et al described the differences between a narrative literature 
review and systematic literature review; the latter tends to have a specific 
question, comprehensive sources with set criteria applied to the selection, 
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followed by a rigorous critical evaluation, and quantitative synthesis is often 
presented. In contrast, they described narrative reviews are often: broader in 
scope, the sources of literature and selection might not be as systematic, there 
is often no set method for appraising the literature, and so findings might be 
less objective and prone to bias.(85)  
Quality appraisal 
Systematic reviews are usually assessed against a set of criteria for 
methodological quality to make overviews more systematic and robust. I used a 
validated instrument to assess the quality of each systematic review: 
Assessment of Multiple Systematic Reviews (AMSTAR); the instrument is an 
11-item questionnaire which reviewers answer: yes, no, can't answer or not 
applicable (Table 1); it has good face value and content validity for measuring 
the quality of systematic reviews.(86) An overall score relating to review quality 
can be calculated but AMSTAR was originally developed without guidance on 
how to interpret the scores to rate the quality of systematic reviews.(87, 88) It 
was also designed to assume each item is of equal weighting; there is also no 
guidance on how to interpret a total score if an item is considered to be “not 
stated” or “not applicable”. Scoring systems can also be problematic in 
assessing the quality of systematic reviews because in some instances, lower 
quality scores do not always correlate with treatment effects in clinical trials.(89) 
In this thesis, I applied the AMSTAR scoring system to measure the relative 
strength of the reported effects and conclusions from each systematic review, 
noting the items that were not scored and their reasons, rather than using the 
score to judge individual reviews.  
Data extraction and synthesis  
I extracted information from each systematic review that was relevant to the 
research question using a table with the following headings (Appendix D): 
• Type of behaviour intervention 
• Theoretical basis for intervention 
• Types of studies included e.g. randomised controlled trials (RCTs), 
interrupted time series (ITS) 
• Types of participants, e.g. hospital/secondary care physicians, 
GPs/primary care physicians 
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• Settings – including countries and health services settings, e.g. primary 
care facilities, general practices 
• Process measures (e.g. changes in doctors’ behaviours) 
• Patient outcomes (e.g. uptake of screening, immunisations)  
 
I assessed each review to see if it identified a theoretical basis to explain the 
behaviour intervention. I summarised the magnitude of effect for each 
intervention on physicians’ behaviour and patient outcomes. It was not possible 
to combine measures into a meta-analysis due to the heterogeneity of 
behaviours and outcomes that were studied.  
The findings from this systematic overview of systematic reviews are described 
in Chapter 4 and a summary table is presented in Appendix D.  
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Table 1 The 11-item AMSTAR tool to assess methodological quality of systematic reviews - adapted from Shea et al, BMC Med Res 
Methodol 2007; 7: 10 
1. Was an ‘a priori’ design 
provided? 
The research question and inclusion criteria are clearly established before conducting review. 
2. Was there duplicate study 
selection and data extraction? 
At least two independent extractors and a procedure in place to get consensus. 
3. Was the literature search 
comprehensive? 
There should be at least two electronic sources including years and databases used which may include 
supplementary sources such as reviews, textbooks, specialised registers, consulting experts and the field 
and reviewing references in the studies found. Searches should state keywords and/or MESH terms. 
4. Was the status of publication 
(i.e. grey literature) included? 
Authors should state they searched for reports regardless of publication type and if they have been 
excluded. 
5. Was the list of studies 
provided? 
There should be a list of both included and excluded studies. 
6. Were characteristics of 
included studies provided? 
This should be presented in aggregate form such as a table which should include data from the original 
studies such as: participants, interventions, outcomes. 
7. Was the scientific quality of 
included studies assessed and 
documented? 
An ‘a priori’ method of assessment should be provided. This might be inclusion of only randomised, double-
blind placebo-controlled trials with allocation concealment. 
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8. Was scientific quality of included 
studies used appropriately in formulating 
conclusions? 
Methodological rigour and scientific quality should be considered in the analysis and conclusions. 
9. Were the methods used to combine 
findings of studies appropriate? 
Pooled results, some assessment should be done to assess their homogeneity (Chi-squared test for 
homogeneity). Otherwise, a random effects model should be used if heterogeneity exists. Does it 
also make clinical sense to combine the data? 
10. Was there assessment of publication 
bias? 
Should include a combination of graphical aids, e.g. funnel plot and/or statistical tests such as Egger 
regression test. 
11. Was conflict of interest stated? Potential sources of support should be clearly acknowledged in the review and the included studies. 
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Objective 2:  
Explore the reasons why general practitioners responded to behaviour 
change interventions to deliver public health programmes such as 
chlamydia screening. 
Methodology 
Systematic reviews might provide answers to possible associations between 
input (behaviour intervention) and output (evidence of healthcare professional 
behaviour change and patient outcomes), but they do not establish the process 
through which the input has led to the output, why one leads to the other. In 
other words, we need to have insight into the “black box” and a qualitative 
design is one way of doing so.(90, 91) This section describes the design and 
methods used to explore the reasons why healthcare professionals delivered 
public health programmes, whether behavioural interventions influenced them 
to do so, and if some of the underlying reasons could be explained by a 
behaviour theory such as TPB. 
“Inputs” to change behaviour, such as the different methods of behaviour 
intervention, might not necessarily lead to expected “outputs” which are the 
desired outcomes for each intervention. Discrepancies between expected and 
actual outcomes due to the intervention being studied are not unusual in 
experimental studies. Quantitative methods such as regression analysis can be 
used to understand which groups of subjects are more likely to have certain 
outcomes. However, not all explanatory variables can be measured and other 
methods need to be considered to make sense of the phenomena. Human 
beings make sense of the world in their own way which might be complex and 
unpredictable. Therefore, methods used in natural sciences such as 
experimental studies using quantitative methods are unlikely to be useful to 
understand this. Questions such as: “What is going on here?”, “Why do some 
people not respond to behaviour interventions?”, and “What levers influence 
behaviour?”, are not easily answered through quantitative methods because 
there are no effects being investigated or measured, and because they are 
processes that can only be explored using qualitative methods.(91) I therefore 
used an interpretative approach and qualitative methodology to explain the 
phenomenon of the “black box”.  
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Method 
I approached this study question through conducting face-to-face interviews to 
explore the underlying reasons for primary care clinicians to deliver health 
promotion and disease prevention programmes. Through thematic analysis of 
interview data, I used TPB as a conceptual framework to explain behaviour 
intentions of primary care professionals in public health practice. As mentioned 
in Chapter 1, I have included practice nurses in the interviews because they 
work alongside GPs, they deliver the majority of health promotion programmes 
as part of their job description, and they might face similar challenges as GPs in 
terms of patient demands, expectations, and time pressures. The inclusion in 
the study might offer insights into the similarities and differences between these 
two professional groups in primary care. 
To give some context to the study and aid recruiting participants for interviews, I 
used the National Chlamydia Screening Programme (NCSP) which was 
introduced in general practice 10 years ago. Primary care trusts (PCTs) used a 
range of approaches to encourage screening from general practice such as 
educational outreach visits and financial incentives. It therefore gave me the 
opportunity to examine different types of approaches used by PCTs in London, 
how they affected the clinicians, and how they related to the evidence from the 
systematic reviews.  
I used these PCTs to select practices with different screening performances to 
sample of GPs and nurses to interview. I showed participants the chlamydia 
screening data for their PCT and practice to frame some of the discussion at the 
interview, if they thought the trends in screening rates reflected the impact of 
any behavioural interventions. For example – what could have explained a 
surge in their practices’ chlamydia screening; or why they thought there were no 
significant changes despite an incentive given for screening. The use of 
chlamydia screening to start the interview also gave me the opportunity to 
discuss other public health programmes using a semi-structured interview. The 
design and methods for these are described below, starting with identifying 
PCTs and their local implementation strategies for chlamydia screening. 
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Choosing PCTs 
The populations of London PCTs were grouped according to Office for National 
Statistics (ONS) 2001 Area Classification for Health Areas into “Super Groups”, 
“Groups” and “Sub Groups”. Area classifications have been used since the 
2001 Census across the UK to identify areas of the country with similar 
characteristics using data based variables that include socioeconomic and 
demographic data from each census.(92) Using the ONS grouping, I selected 
PCTs in London with similar characteristics to minimise the effects of 
confounders such as socioeconomic and demographic variables which might 
affect chlamydia screening activity. I was not able to closely match practices in 
one PCT with others in terms of profiles such as the demographics, patient, and 
staff composition as these characteristics differed even for practices of similar 
list sizes within same PCT areas. For example, it was difficult to match a 
medium sized training practice in Lambeth with a practice with similar 
characteristics in Tower Hamlets. 
I chose ONS groups that contained PCTs that were within Central London and 
geographically adjacent to one another such as: Lambeth, Southwark, and 
Lewisham in South London; City and Hackney, Camden, Islington, Haringey 
and Tower Hamlets in North East London. This was a pragmatic decision for me 
to travel easily to GP practices in these areas for interviews. Within Central 
London, PCTs in ONS group 4.6 include City & Hackney, Haringey, Lambeth, 
Southwark, and Lewisham; PCTs in group 3.5 include Hammersmith & Fulham, 
Camden, Islington, Kensington & Chelsea, Westminster, Wandsworth and 
Tower Hamlets. 
The distribution of chlamydia diagnosis rates and coverage data of the chosen 
PCTs are shown in  
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Figure 7 and Figure 8 respectively. I selected PCTs with a different range of 
chlamydia diagnosis rates and screening coverage. Most central London PCTs 
appeared to have a relatively high diagnosis rate per 100,000 population aged 
15-24 compared with those in outer parts of London. However, the coverage of 
screening varied among central London PCTs.  
To explore the different behaviour modification strategies used to implement 
chlamydia screening in general practice in the PCTs, I requested information on 
local commissioning arrangements used in these PCTs such as “local 
enhanced service” (LES) contracts. I submitted requests regarding 
implementation strategies to the Health Protection Agency (HPA) which 
managed the NCSP at that time. Local sources were also sought such as 
sexual health commissioners from each of the PCTs as well as local chlamydia 
screening co-ordinators. I contacted local directors of public health who had 
overall strategic responsibilities on public health programmes.  
Some PCTs used implementation strategies that were similar to behaviour 
interventions studied in the systematic reviews such as financial incentives and 
educational outreach. The description of such strategies helped to understand 
the contractual levers and context in which GPs were delivering chlamydia 
screening. A description of the screening strategies and how they related to 
evidence on behavioural modification interventions were summarised. The 
contracts and implementation strategies are detailed in Chapter 5.  
The HPA, later replaced by Health Protection England (HPE), had been 
collecting detailed data on chlamydia screening from each of their programme 
areas on a quarterly basis since the beginning of the NCSP. The data included 
demographics and sexual behaviour of the target population, the types of 
venues in which screening took place, and the number of chlamydia screens 
submitted from each venue, as well as results of chlamydia screens. I obtained 
quarterly screening data for every GP practice in all the London PCTs from 
2004 to the end of 2010 directly from the NCSP to describe the trends in the 
absolute numbers of chlamydia screens from general practices, and to extract 
the screening data for the selected PCTs. As PCTs had already implemented 
the chlamydia screening programme in various settings since its launch, it was 
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not possible to design a prospective trial to investigate their effect on chlamydia 
screening from general practices. 
 
 
 
 
 
 
Figure 7 Chlamydia diagnosis rates in selected PCTs  
 
(Source: National Chlamydia Screening Programme slide set Jan-Dec 2013) 
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Figure 8 Chlamydia coverage % of population aged 15-24 tested for chlamydia 
in London PCTs 
 
 (Source: National Chlamydia Screening Programme slide set Jan-Dec 2013) 
The NCSP was only able to provide absolute numbers of screens from each GP 
practice. It did not have information on the proportion of target population of 
young people screened. This information would have been available from local 
chlamydia screening co-ordinator and offices, some of whom regularly 
produced “league tables” of chlamydia screening rates from practices in their 
area. Due to structural changes in* the NHS around the time of data collection, 
some of the personnel were no longer available. I therefore manually calculated 
the proportion of young people screened per year by using the absolute 
numbers of chlamydia screens from NCSP as numerator and population of the 
target group based on 2010 GP registration data as the denominator. 
Population estimates for practices in the years 2010 and earlier were not 
publicly available from Health and Social Care Information Centre (HSCIC). The 
chlamydia screening uptake as a percentage of 15-24 year olds in each practice 
was calculated for each year using the number of chlamydia screens under the 
NCSP per practice that year as the numerator and the number of patients 
between 15-24 year olds per practice in 2010 as the denominator.  
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I used chlamydia screening data to describe the trends in screening volumes 
and rates. The data were not intended to be used for robust statistical analysis 
because I was not studying the effect of different behaviour interventions on 
chlamydia screening volumes and rates. The intention was to use the data to 
classify levels of chlamydia screening in different practices from which to select 
interview participants, e.g. from practices that had high levels of screening to 
low levels of screening.  
A descriptive analysis of the trends in chlamydia screening was presented as 
aggregate data for all London PCTs as well as the PCTs selected for analysis. 
These are presented in Chapter 5 and provided the context for the interview 
studies that followed.   
Method - semi-structured interview  
I used face-to-face, semi-structured interviews with individual GPs and PNs as 
the qualitative method of choice. I used a topic guide which enabled me to 
systematically consider the different behaviour interventions and participants’ 
experience of some public health programmes such as chlamydia screening. I 
asked if the use of various behaviour change interventions influenced them in 
any way, and if there were other factors that influenced their behaviour. These 
prompts, though structured, were not meant to be rigid, and helped to generate 
further discussions on issues that participants considered more important. The 
nature of semi-structured interview meant I was free to explore some issues in 
more depth, thereby enriching the data. As PNs deliver much of public health 
programmes in general practice, their inclusion enabled me to compare different 
professional perspectives on motivations to deliver interventions and attitudes to 
public health programmes. 
I chose to conduct individual interviews rather than group interviews or focus 
groups. The latter can be an efficient way of getting many participants’ views in 
a relatively short period; the interaction among members can also be helpful to 
generate discussions and enrich the data. However, there were logistical 
difficulties in getting enough GPs out of their schedules for an hour or two for 
group discussions. There would be limited time during focus group discussions 
for more detailed accounts from individuals. The group dynamics might also 
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prevent some participants from divulging more personal accounts, especially if 
they felt their opinion could be considered controversial. 
Direct observation is an ethnographic approach where a researcher engages in 
the day-to-day life of research participants or settings. It would be possible to 
observe consultations between a GP or PN with patients, with a focus on how 
HPDP programmes are delivered in these interactions such as smoking 
cessation advice, screening, and vaccinations. Although this approach offers 
detailed and comprehensive observations, it is time intensive as the period of 
observation could be up to six months, not every consultation might be about 
HPDP, and it might also be at the expense of the limited number of subjects 
and settings that could be studied.(93)  
For the clinician being observed, an ethnographic approach might feel 
intimidating to have another person watching and possibly judging their 
behaviour in a consultation; they might do things differently for fear of being 
judged. There is a risk of “Hawthorne” effect and bias if they behaved in a way 
they thought might be desirable by others, therefore portraying behaviour that is 
less natural to them and making the observations less valid. Furthermore, 
because the observations might include consultations with patients, it would add 
another dimension of logistical difficulties such as ethics approval and 
requirement of patient consent for an observer during the consultation. 
However, assuming there were no barriers to this method, ethnography would 
be most enlightening because it would offer insight into the “real world” of what 
the clinicians actually do, and the behaviours that are directly observable and 
objectively recorded. 
A questionnaire could be used as an alternative to semi-structured interviews to 
study other possible determinants of behaviour. A large sample size distributed 
across different demographics of healthcare professionals in different areas 
might make the results representative and statistical analysis could add 
robustness and accuracy to findings. However, questionnaires are often limited 
by closed questions, the number of questions that could be asked and the 
amount of time the participants have to answer them. It is also difficult in 
questionnaire surveys to get an adequate response rate that is representative of 
the population being studied. The defined set of questions also means there is 
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little opportunity for interaction and for a deeper understanding of phenomena 
and opinions. The “black box” thus remains a mystery. 
I invited GPs/PNs for a face-to-face interview lasting about an hour. The 
interviews took place at their practice or another mutually convenient and quiet 
venue for voice recordings. I explained the purpose of the interview using an 
information sheet and asked them to sign a consent form once they agreed. I 
anonymised the participants and labelled them according to a key, e.g. 
“Haringey GP1”. Only I hold the key in a spreadsheet. This was clearly stated 
on the study information and consent form given to all the participants 
(Appendix B). 
The topic guide (Appendix B) was drawn from the constructs of TPB and the 
overview of systematic reviews on behaviour change interventions to cover 
theoretical basis for behaviour change and the evidence for some behavioural 
change interventions. The questions I asked covered GPs/PNs’ attitudes and 
motivation to deliver public health programmes and what components of the 
chlamydia screening implementation strategy they thought they responded to. 
The topic guide was meant to be iterative; in other words, the topics changed 
slightly depending on the themes that emerged from interviews. For example, it 
emerged that use of league tables was a motivator and generated much 
discussion so this was included in the topic guide for subsequent interviews. 
Some questions could have been interpreted as challenging practitioners’ 
attitudes, behaviour, and practice. I used interview techniques that focussed on 
helping the practitioner reflect on their public health practice and began the 
interviews with non-threatening ways to introduce the topic. These included 
open discussions about public health and prevention, examples using 
established everyday practice such as influenza immunisation, and then newer 
initiatives such as NHS cardiovascular checks and sexual health screening 
were also discussed. I was also able to use information from observations in the 
practice to prompt some discussions, e.g. “I noticed you have posters for 
chlamydia screening/flu/health checks in the waiting room, can you tell me more 
about that?”. 
I showed participants their practices’ trends in chlamydia screening data 
compared with other GPs in the same and other PCTs. This was done partly to 
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present them with the best objective evidence available regarding their 
practice’s screening behaviour and as a prompt for them to reflect and explain 
the observations. This was one way of overcoming bias of reporting behaviour 
intentions rather than explaining actual behaviour. This process could also be a 
way of validating quantitative findings by checking if GPs “exposed” to 
interventions changed their behaviour.  
I was interested in exploring issues facing “jobbing” GPs and nurses; this 
included: pressure to deliver many services, not enough time, tension between 
expectations from the patient and the practice’s perspectives, frustration about 
not meeting targets, and other bureaucratic problems facing general practices. 
Occasionally I shared some of the same frustrations and this helped me to build 
rapport and show empathy with some of the participants, to demonstrate I was 
a peer and that they could confide in me and feel comfortable with answering 
some challenging questions. The role of the interviewer as an “expert peer” and 
“judge” has been recognised as an important factor in qualitative studies.(94) 
I used similar consultation skills as a GP and peer educator to establish rapport; 
I asked open questions and with an enquiring tone; I used a non-judgemental 
and non-threatening approach to help the participant reflect on their practice 
rather than make a judgement on how or what they were doing; at times, I was 
willing to share my own experiences and ignorance on some matters. I had 
hoped by sharing and expressing similar concerns and frustrations I would 
demonstrate some empathy with some of the participants and make them feel 
more comfortable with divulging some opinions as a peer. However, I was also 
aware that I needed to probe further to understand what was going on and not 
make any assumptions.   
The interviews were recorded digitally with handwritten notes for back up. I 
used a commercial transcription service for the sake of expediency. I validated 
transcripts with original audio recording to check for accuracy. The verbatim 
transcripts were used for content coding. I was reading and coding transcripts 
throughout the period of the “field work”, and I was able to modify the interview 
schedule for subsequent interviews. The transcripts were also sent back to the 
participants for comments as part of the process of validation or “member 
checking”. I received replies from nine out of 21 participants; all were happy 
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with the transcripts but one felt uncomfortable about a discussion regarding 
their friend’s ill health in print so wanted that to be removed and I did so at their 
request. 
Analysis using Framework approach 
I used the Framework approach to analyse the interview data. This approach 
was developed by Richie and Spencer in the 1980s specifically for applied 
policy research and uses both a case and theme-based approach to analyse 
data.(95) As noted by Pope and Mays, although the Framework approach is 
based on the original accounts and observation of the interviewed subjects, it 
starts deductively from the aims and objectives already set for the study. (96) 
The topic guide under the Framework approach is usually more structured than 
other qualitative approaches. In my case, the interview questions were 
designed to understand the practitioners’ opinions and experiences of different 
behavioural interventions, their views of various public health programmes, and 
the barriers and facilitators for delivering them, which might correspond to some 
of the constructs of TPB.  
There are usually five stages in the transcription process: familiarisation, 
identifying a thematic framework, indexing (or coding), charting, mapping, and 
interpretation. Unlike other qualitative approaches to analysing interview data, 
the Framework approach tends to be more explicit and informed by a priori 
reasoning.(95) The advantages of the Framework approach are that it is 
systematic, comprehensive, and transparent. However it can be labour 
intensive and there is a risk that too much is focussed on the process at the 
expense of outcome.(97) 
I used three opportunities to familiarise myself with the data, identify a thematic 
framework and index the codes. Firstly, I annotated interview notes with themes 
that emerged after every interview; these were modified in an iterative process 
as I interviewed more participants. I checked the transcripts returned from 
commercial transcription services and used this opportunity to refine the themes 
and categories from the first attempt. Finally, I re-read all the transcripts and 
compared them with the themes that emerged already until no new concepts or 
themes emerged. This process is similar to that described by Fielding but 
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without the use of filing cards but instead, involved the use of electronic 
“tagging”.(98) 
I used a process of thematic content analysis to categorise participants’ 
accounts into recurrent or common “themes”. In their work on Grounded 
Theory, Glaser and Strauss used “coding” as an essential process for the 
analysis of qualitative data.(99) The process of “coding” (or “indexing”) refers to: 
summarising or annotating the transcripts, relating sections of data to 
categories or themes that are developed during the analysis, identify common 
themes and collect examples of themes together. These categories are 
compared with the data again (“constant comparison”) until no new categories 
or themes are produced or until “saturation” point. The codes can be chosen to 
represent the theory and the data coded to fit the categories, a process termed 
“coding down”; and the converse “coding up”.(98) The Framework method, 
unlike Grounded Theory, is not primarily used to generate theory but it can 
facilitate “constant comparison” by allowing comparison of data by reviewing 
them across the matrix – by case and by theme or category. In the Framework 
approach, once the specific research question has been addressed, the 
analysis is usually ended so the theoretical saturation point is not necessarily 
reached with the data obtained like it is with Grounded Theory.  
Another difference with the Framework approach is that, depending on the 
research question, the analysis can take either the inductive or deductive 
approach.(97) A deductive approach can be used if the analysis is based on an 
a priori theory; an example from literature is the use of TPB as a theoretical 
concept and framework to analyse the interview data, to explain GPs’ 
implementation of prescribing guidelines.(100) It is not unusual to combine both 
deductive and inductive approaches and this was the approach taken for this 
study which aimed to understand if behaviour interventions changed clinicians’ 
behaviour and whether there were any other explanations for their 
motivations.(97) Thus, the use of an a priori conceptual framework was not set 
entirely at the beginning. TPB and behavioural interventions mentioned in the 
overview of systematic reviews (Chapter 4) provided some conceptual 
frameworks to organise the themes that emerged from the data. However, 
following the mixed inductive/deductive approach, my analytical framework 
needed to be flexible enough to accommodate themes emerging from the data 
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that did not fit neatly into these schemes. I have included a coding list and an 
example of coding (using a theme of competitiveness) in Appendix G and 
Framework matrix in Appendix H (as a CD ROM). 
I used NVivo 10 for Windows (© QSR International Pty Ltd 2014) to organise 
data, create summaries and matrix displays of interview data. The analysis took 
place throughout the data collection period (between April 2014 and June 
2014); this enabled me to check and interpret the data as I went along, to 
develop tentative conclusions based on the data already collected, and to 
hypothesise for subsequent interviews. This process also helped me to look 
particularly for “deviant” or negative cases, and views that were contrary to 
emerging conclusions and hypotheses. For example, there were negative views 
that emerged about influenza vaccination programmes during the interviews, 
and there were views that some screening programmes might be harmful. It is 
common practice to analyse throughout the data collection period; continuous 
analysis “in the field” is “almost inevitable” according to Pope and Mays, as the 
researcher cannot help but start thinking about what is being heard and 
seen.(96) 
Ethics and Research Governance 
Ethics approval for the interviews was sought and received through LSHTM and 
local NHS research ethics committees as it involves interviews with human 
subjects in different PCT clusters. The study gained approval from local 
Research and Development consortia. The research governance paperwork is 
included in Appendix A. 
In the ethics application that I submitted, (Appendix A) the research was 
referred to as a “case study”. This needs to be clarified as my intention was not 
to conduct a “case study” which is a distinctive research design and 
methodological approach as described by Yin.(101) Case studies are used to 
study a phenomenon within a context and is commonly used in organisational 
studies.(102) While it is true I was studying the behaviour of primary care 
professionals in delivering public health programmes, using the NCSP as an 
interesting case to study, it is not intended to be a “case study” per se. For the 
avoidance of doubt, I have therefore clarified this in the finalised title of the 
thesis to say that NCSP is used as an “example”. 
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Method for recruitment 
The chlamydia screening data were used to identify “high” and “low” screening 
practices from where I invited GPs and PNs for an interview. “High” screeners 
screened more than 10% of their target 15-24-year-old population; “medium” 
between 3.0% and 10.0%; and “low” screeners were below 3.0%. This 
classification was consistent with two studies on chlamydia screening in general 
practice by Freeman et al and McNulty et al.(39, 103) Another study used 
different cut-off points using a centile chart; to apply the same method to this 
study would have meant calculating screening uptake for all the practices in 
London to divide them into centiles but I did not have the resources or time to 
do so.(32) 
To obtain diverse views, I conducted purposive sampling, and selected 
practices from either end of the screening uptake – the “highest” and “lowest” 
screeners – I assumed that staff from high testing practices viewed chlamydia 
screening positively and vice versa. For “high screening” practices the person 
who screened the most or had the most influence over their peers (screening 
“enthusiast” or “champion”) was identified and invited for an interview, this was 
not necessarily the GP and included PNs. As this study is primarily about 
understanding GPs’ behaviour, most of the sample was GPs; I included nurses 
to explore different perspectives on professionalism and attitudes to public 
health interventions. For “medium” or “low” screening practices, any willing GP 
or PN was invited for an interview.  
Using a purposive sampling approach, my original plan was to select at least 
two or three GPs/PNs from each of the “high” and “medium”/ “low” screening 
practices from each PCT so that there would be a range of practitioners of 
different ages, gender, large and small practices to interview. With eight 
different permutations and two or three GPs or PNs from each, the total sample 
would therefore range from 16 to 24 GPs/PNs (Table 2).  
Table 2  Sampling of GPs and practices for interview 
PCT A which used a 
financial approach 
GP/PN from a “high” screening practice GP/PN1 
GP/PN from a “low” screening practice GP/PN2 
GP/PN from a “high” screening practice GP/PN3 
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PCT B in same ONS 
group as PCT A 
GP/PN from a “low” screening practice GP/PN4 
PCT C which used a 
social approach e.g. 
opinion leader 
GP/PN from a “high” screening practice GP/PN5 
GP/PN from a “low” screening practice GP/PN6 
PCT D in same ONS 
group as PCT C 
GP/PN from a “high” screening practice GP/PN7 
GP/PN from a “low” screening practice GP/PN8 
 
GPs and PNs were recruited in the following ways: email via generic practice 
address or their practice manager (I obtained details from the practices’ 
websites)’; emails via local research networks; targeting practices where I had 
contacts; and using Twitter with hashtags for different PCT areas. I also framed 
the invitation to take part in the study as an opportunity to learn and reflect on 
one’s own public health practice; for some this might have been an opportunity 
to add to their appraisal portfolio, to attract those who were motivated by 
educational activities.  
I used “research support costs” available in some areas to help me recruit 
participants. In North Central London, this was used to reimburse GPs and 
nurses for their time (£70 and £25 respectively) with participating in the 
interview. The reimbursements were pre-determined by the research 
consortium and the differences between professional groups might reflect the 
hourly locum rate at that time. South London research network had a different 
interpretation of support costs so there were no reimbursements but those from 
Lambeth were supported for their participation in their local clinical research 
network. The financial reimbursement for those in North London was made 
clear in the body of the email to incentivise participation.  
Summary of Chapter 
In this chapter, I set out the objectives for the thesis and outlined the individual 
studies that were conducted to meet them. I justified why a systematic overview 
of systematic reviews was an efficient way to summarise the available evidence 
on the different approaches to change the behaviour of general practitioners to 
deliver HPDP in general practice for policy and practice. The review also 
extracted the theoretical bases of the behaviour change interventions to 
Page 67 of 295 
 
examine the range of behaviour theories that underpinned them. A systematic 
overview is more robust than a narrative review to search and appraise the 
evidence available.  
A qualitative study was the most appropriate design to understand why the 
behaviour interventions directed at healthcare professionals might or might not 
work, in the context of delivering public health programmes. Given that some of 
the processes (behavioural interventions) might not adequately explain the 
outcomes (behaviour change and other patient-level measures), it was 
necessary to understand the “black box” and this can only be done using a 
qualitative design.  
NCSP was one of the newest public health programmes that were implemented 
in England and included general practice as a venue for delivery, so it provided 
a convenient context to study the behaviour of primary healthcare professionals 
in response to implementation of a screening programme, particularly as PCTs 
used different methods to encourage screening from general practices. A 
selection of PCTs that used a range of approaches was used to examine 
chlamydia screening from GPs. 
The next three chapters will report the findings from the overview of systematic 
reviews, descriptive and qualitative studies.  
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Chapter 4 – What interventions influence the behaviour of 
general practitioners to deliver public health programmes? An 
Overview of Systematic Reviews 
Introduction 
In Chapter 1, I mentioned my motivation for this thesis was to find out what 
interventions are effective to modify GPs’ behaviour to deliver health promotion 
and disease prevention (HPDP) programmes. I suggested in Chapter 2, that 
some behaviour change theories could be used to explain and predict the 
behaviour of health care professionals. In this chapter, I examined the literature 
on interventions aimed to modify the behaviour of GPs to deliver HPDP 
programmes to meet the first objective of the thesis which is to: assess the 
effectiveness of interventions that modify behaviour of GPs and their impact on 
patient outcomes that relate to HPDP. 
The method used for the literature search, process of “narrative synthesis”, 
quality appraisal and extraction of data were described in Chapter 3. I 
summarised systematic reviews outlining the types of behaviour change 
interventions, the settings, subjects, and outcome measures that are relevant to 
the objectives of the thesis. I also included details of data extracted from the 
synthesis of the systematic reviews that relate to underlying theoretical bases, 
behaviour modification of GPs to deliver public health interventions, and the 
methodological quality of the systematic reviews assessed using AMSTAR 
criteria.(87) The method used for the literature search, quality appraisal and 
extraction of data were described in Chapter 3. 
Identification of systematic reviews included in this overview 
I repeated the searches for the revised thesis (February 2017). Searches using 
Cochrane Effective Practice and Organisation of Care (EPOC) and DARE 
databases returned 85 and 136 systematic reviews respectively, on specific 
types of interventions that targeted health care professionals to change 
professional practice and healthcare outcomes. I did not identify other reviews 
through reference lists or contacting authors. Out of the 210 that were 
screened, I removed a total of 191 from both databases that did not meet the 
inclusion criteria. I also removed a further seven after a full-text review as they 
were: earlier versions of included reviews, an overview of included reviews, and 
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a (DARE) review that examined the same papers as two separate Cochrane 
reviews on the same topic. I identified 12 unique reviews that fit the inclusion 
criteria of behaviour of primary care professionals with patient outcomes in high-
income countries; Figure 9 presents a flowchart of how the reviews were 
selected. 
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Figure 9 PRISMA flow chart of included and excluded reviews 
 
 
 
 
 
 
 
 
 
 
  
Records identified through 
Cochrane & DARE databases 
(n = 85 + 136) 
Additional records identified 
through other sources 
(n = 0) 
Records after (11) duplicates removed 
(n = 210) 
Records screened 
(n = 210) 
Records excluded 
(n = 191) 
Full-text articles assessed for 
eligibility 
(n = 19) 
Full-text articles excluded, with 
reasons 
(n = 7) 
One overview of financial 
incentives (included already in 
main review) 
Two were earlier versions from 
Cochrane of papers included in 
review (Audit & Feedback and 
PEM) 
One review on guidelines from 
DARE published 1997 already 
superseded by more recent 
Cochrane review on PEM 
Two reviews of computer 
reminders were earlier versions 
of one review from DARE 
One review on computer 
reminders from DARE 
duplicates references from two 
separate Cochrane reviews 
(computer reminders printed 
on paper and on-screen point 
of care reminders) 
 
Studies included in qualitative 
synthesis 
(n = 12) 
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Summary effectiveness of interventions to modify behaviour of general 
practitioners to deliver health promotion and disease prevention 
Twelve systematic reviews were included in this overview, each reported on a 
type of behaviour change intervention to modify the behaviour of physicians. I 
grouped them into five broad categories based on the method of the 
intervention: computer-based decision support, education-only approaches, 
social influences with education, mass communication methods and financial 
approaches. The details of all included reviews are summarised in Table 3. 
Computer-based decision support 
Two Cochrane systematic reviews reported interventions using computer-based 
decision support systems to remind clinicians to deliver care; one examined on-
screen, point-of-care reminders; (104) the other computer-generated reminders 
delivered on paper.(105) Neither of these reviews were explicit in use of 
behaviour theory but instead mentioned that “reminder systems”, which 
according to US National Library of Medicine (www.ncbi.nlm.nih.gov/pubmed), 
are “approaches, techniques or procedures ‘used to prompt or aid the memory’ 
of healthcare professionals”. The absence of a theoretical basis in the 
systematic reviews, however, does not mean it was not explicit in the primary 
studies. 
Computer-based decision support- On-screen, point-of-care computer 
reminders 
On-screen point-of-care computer reminders can potentially prompt clinicians to 
deliver many clinical tasks at the point of care. These reminders are embedded 
into the computer software of electronic medical records, and alert the clinician 
to action targeted clinical task at the time. The systematic review of on-screen 
point-of-care computer reminders included 28 randomised controlled or quasi-
randomised trials that reported on 32 comparisons.(104) The target 
professionals included GPs as well as hospital practitioners; settings included 
primary, community care and hospital settings. Disease prevention activities 
that were measured included prescription of recommended vaccines; I 
examined outcomes such as test ordering and adherence to guidelines if they 
related to HPDP activities, for example, ordering screening tests.  
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There were six studies that specifically looked at adherence to vaccinations, the 
median improvement was 3.8% (interquartile range [IQR] 0.5% to 6.6%). There 
were also eight comparisons that reported blood pressure and cholesterol 
targets with a median absolute improvement of 2.5% (IQR 1.3% to 4.2%); these 
outcomes are relevant for secondary prevention of cardiovascular diseases.  
The methodological quality using the AMSTAR checklist was high (scoring 9 out 
of 11). The main limitations of the review were heterogeneity of the 
interventions and the degree to which they were reported this made 
comparisons among studies difficult; there was also no assessment of conflicts 
of interests. Although findings are highly relevant for public health practice in the 
UK general practice setting, the overall effect of on-screen reminders on 
professional practice and patient outcomes was small.  
Computer-based decision support- Computer-generated reminders delivered on 
paper 
Another type of computer reminder is one that is automatically generated 
through a computerised system, printed on paper, and given to the healthcare 
professional to prompt them to deliver certain tasks. These computer-generated 
paper-based reminders can be attached to paper-based medical records.(105)  
There were 37 comparisons from 32 studies, and most took place in outpatient 
settings, which included primary care clinics. Out of the 32 studies, 29 studies 
were based in US, three were in Canada; no studies took place in the UK or 
Europe. HPDP related outcome measures included blood pressure 
measurements, faecal occult blood test (screening test for bowel cancer), 
influenza vaccination, mammography screening, and cervical cytology 
screening.  
Using pooled data measuring process of care, computer-generated reminders 
had median improvement of 7.0% (IQR 3.9% to 16.4%); reminders alone 
improved care by 11.2% (IQR 6.5% to 19.6%) compared with usual care; for 
reminders with another intervention, the improvement was 4.0% (IQR 3.0% to 
6.0%). The results were pooled, it was not possible to draw conclusions that 
were specifically related to health promotion and disease prevention. For 
patient-related outcome measures, the largest improvement and only study to 
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have sufficient power to detect meaningful change was seen in vaccination 
(median improvement 13.1%, IQR 12.2% to 20.7%). 
There was good methodological rigour to this review (AMSTAR score 10 out of 
11), failing only to report conflicts of interests for the included studies. 
Improvement in professional behaviour using computer reminders generated on 
paper was modest and although outcomes reported are relevant to public 
health, they have little relevance to UK general practice setting. 
Education-only approach -Continuing Medical Education (CME) 
Regulatory bodies such as General Medical Council expect doctors to have 
CME to improve knowledge and maintain clinical practice. Educational events 
can vary by participants, content, degree and type of interaction, length, and 
targeted practices. A Cochrane systematic review examined the effects of CME 
and workshops on professional practice and patient outcomes.(106) It 
examined the effects of educational meetings and workshops alone, the effect 
when compared with other interventions, and if there were any ways these 
meetings could be made more effective.  
There were 24 trials that compared educational meetings alone to no 
interventions, and 80 trials which tested multi-faceted interventions that included 
educational interventions versus no interventions. The most commonly used co-
interventions were any combination of reminders [5 trials], feedback [10] and 
educational outreach [12]. The settings included general practice, hospital 
settings and “community-based care” settings. The trials took place in countries 
across different continents including UK, a range of healthcare professionals 
were included, and general practice was the setting in 43 studies. Eleven trials 
considered preventative care which included smoking cessation, breastfeeding, 
exercise and a further six on screening behaviour (cancer and hypertension). 
The systematic review reported only 14 out of 81 studies (17%) were explicit in 
stating their intervention was based on a behaviour change theory, learning 
theory or diffusion of innovation theory.  
There were six comparisons made between interventions that contained 
educational meetings or educational meetings on their own; only two studies of 
good enough quality reported patient-related outcomes that compared any 
intervention that contained CME with CME alone. They found an increase in 
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screening activities such as faecal occult blood testing for bowel cancer and 
cholesterol; there was a 12% increase in the first study and no difference in the 
latter.  
The AMSTAR score was 10, failing on reporting a possible conflict of interest in 
the included studies. Although the review findings are relevant to this thesis, 
there appears to be insufficient evidence to suggest CME improves behaviour 
of primary care physicians to deliver HPDP. 
Social influences with educational elements  
There were four other systematic reviews that used social influence with 
educational elements in their delivery: audit and feedback, opinion leader, 
educational outreach, and tailored interventions. These are described 
separately below. 
Social influences with educational elements - Audit and feedback 
Healthcare providers might inherently want to improve practice but lack an 
accurate and reliable way to assess performance. Feedback and audit provide 
such mechanisms to help change awareness and clinical practice, as well as 
perceived social norms.  
A systematic review of audit and feedback considered 140 eligible studies for 
the review.(107) There were 49 studies in which audit and feedback were the 
only intervention, while audit and feedback were considered the core, essential 
component of a multifaceted intervention in 91 studies. 80 trials were based in 
North America, 21 in UK or Ireland and others in Australasia. 121 trials targeted 
physicians and the most common clinical speciality was general or family 
practice which was a setting in 84 trials. The targeted behaviour included 
prescribing (39 trials), laboratory or radiology test utilisation (31) and others on 
the management of patients with cardiovascular disease or diabetes (34). 
The review authors explained there could be theoretical reasons why some 
forms of audit and feedback were more effective than others. They also 
considered the use of theories specific to giving feedback such as Feedback 
Intervention Theory and Control Theory of Carver and Scheier, but only in the 
context of designing feedback.(108, 109)  
Page 75 of 295 
 
For dichotomous outcomes, there were 82 comparisons from 49 studies that 
were suitable for analysis; weighted mean adjusted risk difference (aRD) was 
4.3% (IQR 0.5% to 16%) absolute increase in healthcare professionals’ 
compliance with practice. For continuous outcomes, there were 26 comparisons 
from 21 studies; the weighted mean aRD relative to control was 1.3% (IQR 
1.3% to 28.9%). For patient outcomes, median RD was -0.4% (IQR -1.3% to 
1.6%) for dichotomous outcomes and median percentage change of 17% (IQR 
1.5% to 17%) for continuous outcomes. For studies that considered HPDP 
activities in primary care such as breast cancer screening, preventative care 
and pneumococcal vaccination, there were no statistically significant differences 
in specific public health-related outcomes and professional practice. The 
effectiveness of audit and feedback seems to depend on baseline performance 
and how the feedback is provided. 
The AMSTAR score was of 10 out of 11 as there was no assessment of 
publication bias. Audit and feedback appeared to have modest effects on 
improving professional practice but there were very few studies that reported 
improvements in public health practice relevant to UK primary care. 
Social influences with educational elements - Local opinion leader 
“Opinion Leaders” (OLs) are identified as influential and are at the centre of 
communication networks and use their interpersonal skills to achieve the 
desired behaviour change. This might be through individual or small group 
teaching, educational outreach visits and academic detailing. A Cochrane 
review of local opinion leaders suggested some theoretical explanations as to 
how this intervention might work.(110)  According to the Social Learning 
Theory, “opinion leaders” are individuals thought to be “credible, likeable and 
trustworthy… are likely to be persuasive agents of behaviour change”.(111) The 
degree to which this person exerts influence is not a function of the individual’s 
formal position or status but it is “earned” and maintained by their technical 
competence, social accessibility and conformity to the system’s norms.(112) 
From this description, local opinion leader strategy could include elements of 
social cognitive and education theories, with the addition of academic detailing 
as a process. Despite the theoretical background to the use of local opinion 
leaders, the systematic review did not mention whether these theories informed 
the design of the empirical studies. 
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The review analysed 18 cluster randomised controlled trials (RCTs) of which 16 
were based in North America, others in China (Hong Kong), Argentina and 
Uruguay; none in Europe or the UK. Only one trial evaluated interventions 
delivered in primary care practices; one study took place in both primary and 
secondary care; and the settings were not clear in two studies. Primary care 
physicians were included in seven trials but prevention activity was the focus of 
outcome in only one study which was a secondary prevention of coronary heart 
disease. 
There was a variety of ways in which local OLs were identified: using a 
sociometric method in 14 trials, two trials used an informant method; one using 
both informant and sociometric methods; and in another it was self-designated. 
In all the trials, OLs delivered educational initiatives to members of their own 
healthcare profession.  
Only one trial used OLs to influence primary care physicians to prescribe statin 
treatment for secondary prevention of heart disease for patients who had a 
cardiac procedure; adjusted risk difference was 0.10 and the effect was not 
significant. There were no other process measures involving primary care 
physicians with public health-related outcomes. 
The AMSTAR score was 8 out of 11, as the review did not assess and report 
combined findings, publication bias or conflicts of interests. According to this 
review, there is insufficient evidence to suggest OLs influences behaviour of 
primary care physicians to deliver health improvements. 
Social influences with educational elements - Educational Outreach Visits 
(EOVs) 
EOV involves “academic detailing” or “marketing”, which is a process that 
usually involves: an educational needs assessment; interviews to assess 
motivation for current practice and barriers to change; and a tailored 
programme of knowledge transfer and feedback on existing practice.  
A Cochrane systematic review examined the range of studies that used EOVs: 
trials that compared EOVs with no interventions, trials that compared 
interventions in which EOVs were a component, and any comparison of 
different types of EOVs.(113) Sixty-nine trials were included in the review, 22 of 
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which were based in the UK. Most of the studies (53 out of 69) used primary 
care teams (including physicians) as the target group. Potentially, EOVs might 
be supported by education or social cognitive theories but the review did not 
make it explicit which theory helped to inform the design of empirical studies. 
Six trials with six comparisons that examined EOV as part of an intervention 
compared to no interventions reported patient outcomes; all except one had a 
low or moderate risk of bias. Three trials looked at public health outcomes – 
health promotion in the elderly, blood pressure and cholesterol targets, and 
colorectal cancer screening – but did not demonstrate significant differences. 
Prescribing was the most frequently targeted behaviour, featured in 29 trials; a 
further 29 trials examined the general management of clinical problems in 
general practice (e.g. patients with increased cardiovascular risk) and 11 trials 
examined preventive services such as smoking cessation. Many interventions 
included feedback during a visit or mailed afterwards. In 30 trials, EOV was one 
component of a multi-faceted intervention that included different strategies 
directed at health care professionals; 12 trials were based on a social marketing 
framework.  
The AMSTAR score was 9; the review did not report publication bias and the 
conflict of interests in the primary studies. The review findings are relevant to 
public health practice in UK primary care but there is insufficient evidence to 
suggest EOVs have any significant effect on professional practice. EOVs with or 
without the addition of another intervention can improve their practice but the 
effect is small to moderate.  
Social influences with educational elements - Tailored interventions 
A Cochrane review examined “tailored strategies” defined as “strategies to 
improve professional practice that are planned, taking account of prospectively 
identified barriers to change”. (114)   
There were 32 cluster RCTs included in the review, out of which 15 were 
eligible for meta-regression analysis. 12 trials were based in the USA and four 
in the UK; the rest were based in Canada, the rest of Europe, South Africa and 
Indonesia. Seventeen trials were based in primary care settings and primary 
care practitioners (including family physicians and GPs) were the targeted 
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healthcare professionals in 14 studies. The targeted behaviours included 
prescribing in 12 trials and six targeted preventative care including secondary 
prevention of coronary heart disease and two targeted influenza vaccinations.  
Only five studies reported the use of behavioural theory to guide the choice of 
strategies in response to identified barriers. They used a range of behavioural 
and non-behavioural theories: communication theory and behaviour change 
research, organisational change and learner centred teaching, TPB, and social 
cognitive theory. This review was one of the few that assessed the use of theory 
to inform the design of behaviour intervention in empirical studies. Some 
constructs of cognitive behaviour theories, such as HBM and TPB, specify 
perceived barriers to change that could impede behaviour intentions. If barriers 
to improve performance were identified, strategies could then be chosen and 
implemented to overcome them. There appear to be overlaps between this 
approach and Educational Outreach Visits that use academic detailing to 
identify barriers to change. Despite these methods, the amount of information 
presented varied among the studies and was insufficient in four studies to 
identify the barriers. 
More than one method was used to identify barriers to change which included: 
interviews [10 studies], focus groups [10], questionnaire survey [6], review of 
literature [4], review of performance data [2], observation, meeting or workshop 
[2] and other methods [4]. The range of barriers which were identified included: 
professional factors [such as knowledge, motivation, perceptions of benefits and 
risks – identified in 25 studies], patient factors [8], incentives and resources [8], 
guideline factors [4], organisational capacity [9], professional interactions [3], 
and social/political/legal factors [2].  
Tailored interventions to identify barriers are more likely to improve professional 
practice; the pooled odds ratio (OR) for all 15 studies was 1.56 (95% CI 1.27 to 
1.93). Seven out of 15 studies compared tailored interventions with no 
interventions that were suitable for inclusion in a meta-regression; pooled OR 
was 1.36 (95% CI 0.92 to 1.99). Eight out of 15 studies that compared tailored 
interventions to non-tailored interventions were included in a meta-regression; 
pooled OR was 1.79 (95% CI 1.06 to 3.01).  
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One study reported a small effect of support tailored interventions to increase 
preventative services delivery and another reported significantly higher 
vaccination rates in the intervention arm. However, because the results were 
pooled, it was not possible to determine if there were any specific effects on 
patient outcomes that were relevant to health promotion and disease 
prevention. 
The review scored 9 on the AMSTAR criteria, failing to report publication bias 
and conflicts of interests. Although the included studies were highly applicable 
to primary care physicians, the pooled analysis meant it was not possible to 
isolate the effect on HPDP interventions, so there is insufficient evidence to use 
tailored interventions to improve professional practice or patient outcomes.  
Mass communication approaches - Printed Educational Materials (PEMs) 
The distribution of published or printed recommendations for clinical care 
includes clinical practice guidelines, monographs, and publications in peer-
reviewed journals, delivered personally or through mass mailing. The Cochrane 
systematic review on PEMs suggested the implementation of PEMs could be 
derived from various theories on quality improvement and implementation of 
change in healthcare.(115) From the perspective of cognitive theories, PEMs 
consider healthcare professionals’ decision making processes and learning 
styles to enable them to support decisions in practice. Educational and adult 
learning theories suggest change is driven by a desire to learn and be 
professionally competent, so PEMs could be linked to professionals’ needs and 
motivation. Attitudinal and motivational theories suggest PEMs could address 
professionals’ attitudes, beliefs, and perceived social norms. Professional 
development theories explain why PEMs could include professional standards 
for desired behaviour because professional loyalty, pride and consensus might 
lead to change. Social influence theories suggest content or message could be 
endorsed or reinforced by recognised leaders in their field. 
The newer review by Giguere et al (115) examined PEMs compared with no 
intervention, and PEMs versus another single intervention and redefined 
concept of PEMs since the earlier review by Farmer et al.(116) Persuasive 
communication theory was used as a framework to assess effectiveness using 
Page 80 of 295 
 
the domains of: source, message, channel, receiver and destination; however, 
only the first three were relevant for the systematic review.(117)  
There was a range of sources of PEMs: researchers or clinicians: national 
professional experts and local expert bodies disseminated 24 PEMs, and 23 
were delivered by publication in a peer-reviewed journal, and 19 through direct 
mailing. The delivered message was a broad range of clinical areas and three 
PEMs targeted prevention, two of which covered screening. In the 45 studies 
included in this review, 18 were from Europe (11 from the UK); 10 studies took 
place in general or family practice. Forty-two studies involved physicians, three 
were a mixture of physicians, nurses and pharmacists, psychologists, and allied 
health professionals. 
PEMs were compared to no intervention in nine RCTs with 73 categorical 
outcomes; there was a median of 2% absolute improvement in groups that 
received PEMs. When used alone and compared to no intervention, PEMs 
produced a small improvement in professional outcomes. The results were 
pooled so it was not possible to separate the process or patient outcome 
measures that were relevant to HPDP. 
The review did not assess publication bias and possible conflicts of interest of 
primary studies so methodological assessment score was nine using AMSTAR 
criteria. Overall, the effect of PEMs on public health related outcomes in UK 
general practice was inconclusive. 
Mass communication approaches - Mass media interventions 
A Cochrane systematic review examined the use of mass media to influence 
health service utilisation by professionals, patients or the public; it did not refer 
specifically to theoretical basis but provided a background to how and why the 
intervention might be used.(118) Health promotion can be done through “media 
advocacy”: by working with media outlets, to communicate health information to 
the public, particularly in prevention, risk reduction, and drug information.  
The review examined the use of media to influence health service utilisation by 
professionals, patients or the public. All campaigns relied on the use of a range 
of media – radio, television, newspapers, posters, and leaflets; electronic media 
such as the internet were not included. Nineteen studies included the public as 
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a target audience, nine studies also included healthcare professionals as 
targets but none specified whether primary or secondary care.  
Most studies evaluated the campaigns by measuring health care utilisation; 
conditions featured in media campaigns included skin cancer awareness, HIV 
testing, measles mumps rubella vaccination, colorectal cancer screening, and 
cervical cancer screening. There were no physician-related process measures 
reported. Two studies examined immunisations uptake and found statistically 
significant change; the effect was less clear with cancer screening. Reanalysis 
of studies using time-series regression found statistically significant changes in 
levels in four studies, and significant change in slope in only one study. A mixed 
pattern was observed in two studies on HIV testing; only one of them had a 
statistically significant change in level on the number of HIV tests performed.  
This review did not report publication bias and possible conflicts of interest of 
primary studies so scored 9 using AMSTAR criteria. The findings are relevant 
for UK general practice especially for uptake of immunisations and screening, 
but there was insufficient detail in the designs to ascertain if the media 
campaigns influenced the behaviour of clinicians or if they increased the uptake 
of screening and vaccinations from stimulating public demand.  
Financial approaches  
There were three Cochrane systematic reviews that examined the use of 
financial mechanisms to change behaviour: general financial incentives (119), 
mixed financial incentives (120) and use of target payment (121). Among these, 
only the systematic review of effect of financial incentives on the quality of care 
mentioned economic theories that underpinned incentives schemes.(119)  
Economic incentives that aim to change behaviour are derived from the Agency 
Theory; where both the principal (payer) and agent (the provider of services) 
attempt to maximise each of their own utilities.(122) Payment systems to 
physicians acting as “agents” can be manipulated to achieve desired improved 
quality of care, cost containment and recruitment to under-served areas.(123) 
Payment systems commonly used to compensate physicians and healthcare 
providers include: target payment, capitation, fee for service (FFS) and salaried 
contracts.  
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Target payment systems reward health care professionals or organisations only 
if they provided a minimum quantity or level of care; for example a target 
payment of a fixed sum if a practice immunises at least 70% of their registered 
patients who are aged over 65 years for influenza.(121) This system can be 
“gamed” by altering the number of people who are eligible to be in the 
denominator in order to meet the target; the organisation can also decide not to 
offer any further care even though there are people eligible once the target has 
been met. 
Capitation systems pay health care professionals or organisations a fixed 
amount of money per registered patient. This system might make them increase 
their patient list but does not necessarily encourage them to provide good 
access or high-quality care for everyone.(120) This system can also be “gamed” 
by delaying deduction of patients who are no longer registered, thereby 
“inflating” the list size. 
Salaried system pays healthcare professionals an annual salary to work a set 
number of hours or sessions per defined time. Under both capitation and 
salaried systems, healthcare professionals know in advance the amount they 
will receive; as remuneration is not correlated with the amount of effort, it may 
encourage them to shirk work.  
In contrast, in a fee-for-serve (FFS) system, the healthcare professional is 
reimbursed per procedure when it has been provided so it only rewards them 
for the effort made. However, if there is an incentive to deliver more care, it 
might lead to “supplier induced demand” to inflate income rather than meeting 
the needs.(120) 
Financial approaches - Mixed Financial Incentive  
A Cochrane systematic review examined the use of mixed financial 
incentives.(120) Four studies were identified – two RCTs and two controlled 
before and after (CBA) studies, involving primary care professionals (PCPs) 
from the USA, Denmark and Canada. Two studies compared capitation and 
FFS payment with outcomes that related to public health which was adherence 
to the guidelines for a number of visits provided by PCPs to their registered 
population of children. The results were grouped under three comparisons: 
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capitation payment versus FFS (two studies); salary payment versus FFS (one 
study); and mixed capitation system versus FFS (one study).  
Two studies examined the effects of capitation payment versus FFS on process 
and outcome measures, the only outcome related to HPDP was the adherence 
to a health promotion programme for children. The results of a regression 
analysis suggested children of all ages were more likely to receive the 
recommended number of visits to PCPs if payment system was FFS rather than 
the comparison group payment. 
One study looked at the effects of salary payment versus FFS and the only 
outcome related to health promotion was adherence of child health visits with 
guidelines; salaried PCPs had a lower percentage of visits more than the 
recommended number compared with PCPs paid on FFS contract. 
The systematic review did not report publication bias or possible conflicts of 
interest in the primary studies so scored 9 on AMSTAR. There is evidence that 
payment systems influence PCP behaviour: PCPs working under FFS provide 
higher quantity of primary care compared with capitation and salaried PCPs. 
There were not enough well-designed studies to make the findings more 
generalizable.  
Financial approaches - Target payments 
A Cochrane systematic review examined the effect of target payments in 
primary care on professional practice and healthcare outcomes.(121) Only two 
studies met all inclusion criteria for review, one was an RCT from the US and 
the other was interrupted time series (ITS) analysis in the UK; both studies 
targeted primary care professionals with immunisations as outcome measures.  
In the US study, the group receiving target payment had an influenza 
vaccination rate 5.9% higher than control but this was not statistically 
significant. The UK study reported an improvement in primary and pre-school 
immunisation rates after the introduction of target payment. The proportion of 
general practices offering at least 95% and 90% of their eligible population the 
primary immunisation increased by 50% and 20% respectively for pre-school 
immunisations. However, a logistic regression model applied did not show a 
change in overall linear trend because of target payments. 
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This review scored 9 using AMSTAR criteria because it did not report 
publication bias and conflict of interest of primary studies.(121) There is 
insufficient evidence to say whether target payments improve professional 
practice or patient outcomes; more research to evaluate the effect of target 
payments and evaluations should be planned before introducing changes. 
Financial approaches - General financial incentives  
One further review from Cochrane examined the effect of general financial 
incentives on the quality of care provided by primary care physicians.(119) Five 
took place in the US, one in the UK and one in Germany. Three cluster RCTs 
examined effects on delivering smoking cessation advice; one CBA study used 
clinical indicators such as cervical screening and childhood immunisations to 
assess the quality of care provided by the physicians; the other three studies 
assessed outcomes including: cervical cancer screening rates, blood testing for 
diabetic patients, childhood immunisation, chlamydia screening and 
mammography. 
Only the study on smoking cessation had the largest effect on one outcome 
measure. Clinics that received financial incentives had a higher mean rate of 
referral than usual care. In another cRCT, GPs who had financial incentives 
increased the smoking status recording compared to those that did not but the 
effect was not significant. The three studies that examined cervical cancer 
screening, blood testing for diabetic patients, childhood immunisation, 
chlamydia screening and mammography did not find a significant impact. For 
the studies that examined preventative care in diabetic patients, the only 
statistically significant effects of financial incentives were for cervical screening 
and eye examinations. Other studies of other outcomes did not show 
statistically significant effects from financial incentives. 
The methodological assessment scored 9 as the authors did not report 
publication bias and possible conflicts of interest in the included studies. This 
review suggests there is insufficient evidence to support the use of general 
financial incentives to improve the quality of primary health care. 
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Table 3 Summary of included studies with AMSTAR assessment, settings, targeted behaviours and outcomes of systematic reviews 
Systematic review 
and AMSTAR score 
Included study designs, settings and 
subjects 
Targeted behaviours 
 
Possible 
theoretical 
bases 
Effects – including changes in professional 
practice. patient, and healthcare outcomes 
On-screen, point-of-
care computer 
reminders (104) 
 
[AMSTAR =9] 
RCT and quasi-randomised trials. 28 
studies reported 32 comparisons (4 
studies contained 2 comparisons) 26 were 
cluster design. 
Hospital practitioners both inpatient and 
outpatient departments. 
General practitioners. 
21 on prescribing 
practices 
6 on vaccinations 
13 on test ordering 
3 on documentation 
7 to adherence to other 
processes, e.g. 
guidelines 
Not mentioned 6 studies specifically looked at adherence to 
targeted vaccinations; median improvement 
was 3.8% (IQR 0.5% to 6.6%).  
8 comparisons reported clinical endpoints 
including blood pressure and cholesterol 
targets; median absolute improvement of 2.5% 
(IQR 1.3% to 4.2%). 
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Computer-
generated 
reminders 
delivered on 
paper(105) 
[AMSTAR = 10] 
37 comparisons from 32 studies. 
27 RCTs including 1 cross-over trial. 
5 Non-Randomised controlled trials 
(NRCT) including 1 cross-over trial. 
Primarily physicians although some 
included nurse practitioners. One study 
included only nurses.  
29 studies based in the US, 3 in 
Canada. Most studies took place in 
outpatient settings (which include 
primary care clinics); 2 in inpatient 
settings and 3 were mixed. 
Processes and outcomes measured 
included: blood pressure measurements, 
faecal occult blood test, influenza 
vaccination, mammography, cervical 
cytology. 
Not 
mentioned  
Only 13/37 comparisons reported 
baseline process of care rates for study 
groups. Median marginal improvement in 
intervention group was 4.5% (IQR 0.5% 
to 7%). 
Reminders had different effects on 
different targeted behaviours and the 
largest improvement was seen in 
vaccination (median improvement 
13.1%, IQR 12.2% to 20.7%).  
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Continuing 
Medical 
Education 
(106) 
[AMSTAR = 
10] 
81 studies – 32 studies in an 
earlier review and 49 new 
studies added from new search. 
32 trials based in North America 
- 28 in USA, 4 in Canada. 
34 based in Europe (14 in UK). 
Physicians were the main 
subjects in most trials.  
General practice was the setting 
in 43 studies, 16 community-
based care, 17 hospitals based 
and 5 were “other types” of 
settings. 
Preventative care was considered in 11 of the 
trials including smoking cessation, 
breastfeeding, exercise and screening. 
32 trials used multi-faceted interventions, 
most commonly used were: reminders (5), 
patient education materials (5), supportive 
services (5), feedback reports (10), 
educational outreach (5). 
12 studies had educational meetings rated as 
main component, moderate in 13 studies, and 
minor component in 7. 
 
Behaviour 
change 
theories 
Learning 
theory 
Diffusion of 
innovation 
theory 
The results were pooled from all the 
studies so it was not possible to ascertain 
the effect specifically on public health 
activities. 
 
One trial that compared small group 
discussions combined with an office 
system and facilitator with a one-day small 
group discussion only with the aim of 
improving detection of cancer. 
There was a 12% adjusted relative 
percentage increase in patients receiving 
screening.  
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Audit and 
feedback 
(107) 
[AMSTAR 
= 10] 
140 RCTs were included in total. 
49 studies had audit and feedback 
as the only intervention, while audit 
and feedback were considered the 
core, essential component of a 
multifaceted intervention in 91 
studies. 
80 based in North America (USA 
58, Canada 9), 21 in UK or Ireland 
and the rest from Australasia.  
121 trials targeted physicians, 5 
targeted pharmacists and 16 
specifically targeted nurses.  
Most common setting or speciality 
area was general or family 
practice, targeted in 84 trials; 
others included outpatient settings 
(94 trials), inpatient (36) and the 
rest were unclear. 
Outcome measures included compliance with 
guidelines, changes in prescribing, use of 
diagnostic tests. Health promotion outcomes 
included smoking cessation and blood 
pressure management; there was also a 
range of preventative care as outcomes such 
as screening and vaccination. 
Feedback 
Intervention 
Theory  
Control Theory 
of Carver and 
Scheier 
(both in the 
context of 
designing 
feedback) 
For dichotomous outcomes, weighted 
mean adjusted risk difference (aRD) was 
4.3% (IQR 0.5% to 16%) absolute increase 
in healthcare professionals’ compliance 
with practice.  
For continuous outcomes, the weighted 
mean aRD relative to control was 1.3% 
(IQR 1.3% to 28.9%).  
For patient outcomes, median RD was -
0.4% (IQR -1.3% to 1.6%) for dichotomous 
outcomes and median percentage change 
of 17% (IQR 1.5% to 17%) for continuous 
outcomes. 
For studies that reported HPDP activities 
in primary care such as breast cancer 
screening, preventative care and 
pneumococcal vaccination, there were no 
statistically significant differences in 
specific public health-related outcomes 
and professional practice. 
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Opinion 
leader 
(110) 
[AMSTAR 
= 8] 
A total of 18 trials were included – 
6 new RCTs added to 12 RCTs 
from a previous review. 
10 trials based in USA, 6 in 
Canada, 1 in China (Hong Kong), 
1 Argentina and Uruguay. 
14 evaluated interventions 
delivered in hospitals, 1 in primary 
care practices. 1 study in both 
primary and secondary care. 2 
studies the settings were not 
clear. 
Physicians were targeted in 14 
trials, nurses in 2 and 2 trials 
targeted physicians, nurses and 
midwives. 
In all the trials, opinion leaders delivered 
educational initiatives to members of their 
own healthcare profession. 
Opinion leaders were identified using the 
sociometric method in 14 trials. 2 trials 
used informant method to identify opinion 
leaders. 2 used other methods (1 
informant and sociometric, another self-
designated). 
All of the targeted behaviours involved 
general management of a clinical 
problem. 
Social cognitive 
and education 
theories, e.g. 
Social Learning 
Theory 
Only one trial used OLs to influence primary 
care physicians to prescribe statin treatment 
for secondary prevention of heart disease for 
patients who had a cardiac procedure; 
adjusted risk difference was +0.10 and the 
effect was not significant. 
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Educational 
Outreach Visits 
(EOVs)(113) 
[AMSTAR = 9] 
51 trials added to original review 
making a total of 69 studies.  
 
53 studies included primary care 
physicians or teams as the 
subjects of interventions. 6 trials 
focussed on physicians or teams 
of health care professionals in 
hospital settings. 23 based in 
North America, 22 in UK. 
1 study used physicians working in 
either community or hospital 
settings. 4 trials used health care 
professionals including physicians, 
nurses and healthcare assistants 
working in nursing homes. 
29 trials looked at prescribing practices  
In another 29 trials, the behaviour was 
general management of a variety of 
problems. 
11 trials focussed on preventative 
services such as smoking cessation 
advice. 
41 trials had individual visits and 24 had 
group visits. It was not clear in 4 trials 
how many clinicians were visited. 
Many interventions included feedback. 
12 trials were based on social marketing 
framework. In 30 trials, educational 
outreach visit was one component of a 
multi-faceted intervention that included 
different strategies directed at health 
care professionals such as reminders. 
Social 
Marketing 
Theory 
Health 
Belief 
Model 
Theory of 
Planned 
Behaviour 
One study looked at health promotion related 
activity (reducing of harmful drinking) which was 
telephone support with EOV versus EOV alone 
and found the former was more likely to 
implement the programme; there was a 4% 
improvement in the unadjusted risk difference 
RD (59% versus 54% but the 95% CI could not 
be calculated).  
The pooled results of analysis meant that 
although some targeted behaviours included 
preventative care and disease prevention, it 
was not possible to ascertain the effect of EOV 
on these specific professional outcomes. 
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Tailored 
strategies(114) 
[AMSTAR = 9] 
32 studies included in the 
review. 12 trials were based in 
USA and 4 in the UK; the rest 
were based in Canada, rest of 
Europe, South Africa and 
Indonesia.  
17 trials were based in primary 
care settings and primary care 
practitioners (including family 
physicians and GPs) were the 
targeted healthcare 
professionals in 14 studies.  
 
  
Targeted behaviours included prescribing in 12 trials 
and 6 targeted preventative care including secondary 
prevention of coronary heart disease and 2 targeted 
influenza vaccinations. 
More than one method was used to identify barriers 
to change which included: interviews [10 studies], 
focus groups [10], questionnaire survey [6], review of 
literature [4], review of performance data [2], 
observation, meeting or workshop [2] and other 
methods [4].  
Barriers identified included: professional factors [such 
as knowledge, motivation, perceptions of benefits 
and risks – identified in 25 studies], patient factors 
[8], incentives and resources [8], guideline factors [4], 
organisational capacity [9], professional interactions 
[3], and social/political/legal factors [2]. 
Communication 
theory  
Theory of 
planned 
behaviour 
 
Social cognitive 
theory 
 
Pooled odds ratio (OR) for all 15 
studies was 1.56 (95% CI 1.27 
to 1.93).  
7 out of 15 studies compared 
tailored interventions with no 
interventions; pooled OR was 
1.36 (95% CI 0.92 to 1.99). 
8 out of 15 studies that 
compared tailored interventions 
to non-tailored interventions; 
pooled OR was 1.79 (95% CI 
1.06 to 3.01). 
Results were pooled so it was 
not possible to determine if there 
were any specific effects on 
patient outcomes that were 
relevant to health promotion and 
disease prevention.  
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Printed 
Educational 
Materials(115) 
[AMSTAR = 9] 
The concept of PEM was 
redefined so some changes 
since the last review.  
There were 45 studies – 8 C-
RCTs, 6 RCTs, 31 ITS 
Most studies took place in North 
America (Canada 12, US 11 
and 1 in both). 18 were from 
Europe (UK 11). 
10 studies took place in general 
or family practice. 
42 out of 45 studies involved 
physicians. 
39 PEMs targeted 
prescribing or treatment, 3 
PEMS targeted prevention – 
2 covered screening. 
 
Adult learning 
theories 
Cognitive theories 
Persuasive 
Communication 
Theory 
It was difficult to tell from the reporting of either 
comparison if the effects related to primary care 
professionals and public health outcomes as 
analyses were presented using pooled data.  
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Mass 
media 
(118) 
[AMSTAR 
= 9] 
26 papers met the inclusion criteria 
that reported 20 time-series 
analyses and 1 controlled before 
and after study. 
19 studies included general public 
as target audience. 9 studies also 
included healthcare professionals 
as targets but none specified 
whether primary or secondary care.  
Interventions which aimed to 
promote specific health services: 
cancer screening, immunisation 
programmes, emergency services 
for people with suspected heart 
attacks. 
All campaigns relied on use of a range of media – radio, 
television, newspapers, posters and leaflets. Electronic 
media such as internet were not included. 
Most studies evaluated the campaigns by measuring health 
care utilisation. Others used patient outcome measures 
related to the campaign. 
Most common condition for media campaign was skin 
cancer awareness (4 studies) followed by HIV testing (3), 
measles, mumps and rubella vaccination (2) and response 
for suspected heart attacks (2). Other topics related to 
prevention included prevention of childhood poisoning, 
colorectal cancer screening, cervical cancer screening. 
None 
mentioned 
A mixed pattern was observed in 
two studies on HIV testing; only 
one of them had statistically 
significant changes the number of 
HIV tests performed.  
It was not clear if the media 
campaigns influenced the 
behaviour of clinicians or if they 
increased the uptake of screening 
and vaccinations from stimulating 
demand. 
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Target 
payments(121) 
[AMSTAR = 9] 
Only 2 studies met all inclusion 
criteria for review – one was 
RCT and the other was ITS. 
Both studies targeted primary 
care professionals. 
 
1 study in USA consists of additional 
10% ($0.80) or 20% ($1.60) payment to 
standard fee of $8 for each influenza 
immunisation made over 70% or 85% 
targets respectively. 
Second study in UK looked at trend in 
pre-school immunisation rates before 
and after target payment was 
introduced. 
Economic 
theory, e.g. 
Agency 
theory 
There appeared to have been an increase in 
immunisation rates in one study after target 
payments but a logistic regression model 
applied did not show a change in overall linear 
trend because of target payments. 
Mixed financial 
incentive(120) 
[AMSTAR = 9] 
4 studies were identified – 2 
were RCTs and 2 CBAs. 
Primary care professionals from 
US, Denmark and Canada were 
included. 
2 studies compared capitation and FFS 
payment.  
One study compared PCP behaviour 
under salary and FFS systems. 
One study compared a mixed capitation 
system with FFS. 
2 studies examined care provided by 
PCPS to children, 2 examined care to 
registered population. 
Economic 
theory, e.g. 
Agency 
theory 
Children were more likely to receive the 
recommended number of visits to PCPs if 
payment system was FFS rather than the 
comparison group payment. 
Salaried PCPs had a lower percentage of visits 
in excess of recommended number compared 
with PCPs paid on FFS contract. 
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General financial 
incentives and 
the quality of 
care(119) 
[AMSTAR = 9] 
7 studies fit the inclusion 
criteria: 3 cluster-RCTs, 1 
controlled ITS, and one ITS 
that used difference-in-
difference e (DID) design. 
5 took place in the US, 1 in 
the UK and 1 in Germany. 
 
 
1 CBA study evaluated introduction of a salaried 
payment scheme in the UK using 20 general 
practices. 
5 US studies used incentives schemes devised 
by large health plans to increase quality of care 
provided the group practices. 
A German study used 82 medical practices to 
evaluate smoking cessation in general practice. 
3 cRCTs examined financial incentives on 
physicians to deliver smoking cessation advice 
using different outcome measures.  
1 CBA study used patients’ assessment of the 
process of care and satisfaction, clinical 
indicators such as cervical screening, childhood 
immunisation and pre-school boosters to assess 
the quality of care.  
The other 3 studies used outcomes such as: 
rates cervical cancer screening, blood testing for 
diabetic patients, childhood immunisation, 
adherence clinical management (asthma and 
diabetes), chlamydia screening and 
mammography. 
Economic 
theory, e.g. 
Agency 
theory 
Only one cluster-RCT looking at smoking 
cessation had largest effect on one 
outcome measure.  
Clinics that received financial incentive 
had a higher mean rate of referral than 
usual care. In another C-RCT, GPs who 
had financial incentives increased the 
smoking status recording compared to 
those that did not. 
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Limitations of the review 
Despite using two databases (Cochrane Library and DARE) to search for 
relevant systematic reviews and the search strategies used within individual 
Cochrane systematic reviews (most using at least two databases of published 
literature and other databases for grey literature) it was possible that due to 
publication bias, trials that reported negative findings might not have been 
published and were therefore not included in the search; this in turn might have 
led some systematic reviews to overestimate effect sizes in their analyses. To 
overcome this, some but not all the systematic reviews accounted for the effect 
of publication bias in their main conclusions and this was reflected in the 
methodological assessment using AMSTAR. 
Another possible source of publication bias is I did not look at sources of grey 
literature such as other databases of systematic reviews, conference abstracts, 
reviews in other languages and trials registers. The inclusion of these sources 
might reveal more interventions relevant for HPDP activities in primary care 
settings.  
The overview was also subject to reviewer bias because there was only one 
person screening the studies and extracting information. The process of 
abstract screening, extraction and analysis would be improved with at least one 
other reviewer. There might be differences in opinions between reviewers about 
inclusion, exclusion and extracting data. The process of discussion and 
mediation using a third reviewer would improve the robustness of the review.  
The Cochrane Effective Practice and Organisation of Care (EPOC) review 
group have robust protocols for how reviews should be done, from registration 
to developing search strategy, criteria for inclusion, data extraction and 
assessment of manuscripts.(124) Having an agreed study protocol for the 
review that is registered and published also enables the scientific community to 
evaluate the review methods, and to ensure the analysis and results are 
consistent with the study authors’ original intent. 
The search was originally conducted in 2011; there have been two updated 
Cochrane systematic reviews: one on tailored interventions and another on 
audit and feedback. The overall conclusion remained the same and they did not 
affect the outcome of this review.  
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Many of the outcome measures in the systematic reviews were so it was not 
possible to make conclusions on outcomes relating to HPDP without repeating 
the analysis using relevant empirical studies. In some cases, it would be difficult 
because of heterogeneity of studies; for example, different outcome measures 
were used across studies, some measuring dichotomous outcomes and others 
measuring continuous outcomes. It would still be possible to analyse the 
outcomes in a meta-analysis but this would be highly resource intensive and 
would not have been possible to complete within the doctoral study period. The 
length of follow-up period might also make a difference to the outcomes; some 
interventions might have an effect but might not be sustainable, whereas others 
might take time to take effect. 
Finally, the search criteria were not exhaustive. For instance, I did not search 
for interventions based on sanctions or penalties, or more coercive methods on 
the behaviour of GPs. From the demand side, I did not consider the effect of 
patient demand for preventative care on the behaviour of GPs. It is also 
possible to consider interventions directed at the level of the organisation; PCTs 
and GP surgeries in different areas might have the same targets and hold the 
same national contracts, but how people work in one organisation might be 
different to another. Efforts to change the “organisational culture” could improve 
organisational performance and patient outcomes. One such systematic review 
was published by Cochrane review group; they searched over 4000 studies but 
none of these met the inclusion criteria for review and it was not possible to 
draw any conclusions.(125)   
Discussion 
This overview examined 12 systematic reviews that covered five methods of 
behavioural interventions directed at GPs; but no single intervention had 
significant effect with changing behaviour of GPs to deliver HPDP programmes. 
Use of behaviour theories in design of behaviour change interventions 
The extent to which theory was explicitly reported as underpinning the 
behaviour modification intervention varied within each systematic review. There 
was also a variety of theoretical concepts that underpinned behavioural 
interventions but no single theory consistently contributed to effective 
interventions. Some of the systematic reviews, though not all, offered theoretical 
Page 98 of 295 
 
bases for the interventions that were reviewed. Continuing Medical Education 
(CME) interventions were reportedly based on: behaviour change theories, 
learning theories and diffusion of innovation theory. Social Cognitive Theory, 
Education Theory, and Diffusion of Innovation Theory informed opinion leader 
strategy. Tailored Interventions, which considered barriers to change, were 
informed by Social Cognitive Theory and TPB.   
No theoretical bases were given for computer-based reminders, audit and 
feedback, educational outreach visits or mass media interventions. I suggest 
computer reminders could have a basis in Pavlovian classical conditioning 
theory if the reminders were designed to change the behaviour of clinicians in 
response to a stimulus (e.g. a patient who needs the intervention which the 
clinician is reminded about) to the point where after repeated experiences, the 
clinician has learned to implement that behaviour in response to the stimulus 
(computer reminder about patient needs) without reminders. (126)  Although it 
was not explicitly mentioned, financial approaches such as target payments and 
mixed payment systems could have bases in economic theory and I suggested 
Agency Theory could be one example.(122) 
To understand audit and feedback interventions, Grol explained that many 
theories, with overlapping constructs, might explain how it might lead to quality 
improvement.(127). Feedback might work in many ways, including: changing 
recipients’ awareness and beliefs about current practice and clinical 
consequences, changing perceived social norms, affecting self-efficacy, or by 
directing attention to a specific set of tasks. The ways in which feedback might 
work appear to overlap with some constructs of behaviour theories such as the 
TPB, particularly relating to behavioural beliefs and social norms. 
There could be a variety of theoretical bases to explain how interventions that 
include social strategies might work. Mittman et al explained how social 
networks could be applied in approaches to implementing clinical practice 
guidelines, for example, by using peers, opinion leaders, and educational 
outreach visits.(128). The process of translating research into practice often 
uses Diffusion of Innovation theory and education delivered informally is 
regarded as a key ingredient in marketing and innovation diffusion.(111) 
Soumerai described a similar multi-component process, which included surveys 
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of practitioners to determine barriers to practice, development of interventions 
tailored to address barriers using simple messages and targeting of 
practitioners with low compliance and delivery of intervention by a “respected” 
person.(129, 130) Some EOVs were based on this and used Social Marketing 
Theory to design behaviour change based on similar processes. This might 
have overlapping constructs with the Health Belief Model to encourage 
behaviour change by assessing outcome expectations, beliefs about benefits 
and barriers to change; there are also overlaps with TPB when addressing how 
to overcome perceived barriers. 
Impact of interventions on professional behaviour and patient outcomes 
Some systematic reviews with suitable outcome measures were included in 
meta-regression and reported pooled results, thus diluting the specific effects 
relating to primary care physicians and public health. It is possible to extract 
public health related measures from each systematic review for analysis but it is 
beyond the scope of this review. 
Point-of-care computer reminders achieved small improvements in a small 
number of target clinical areas. This is highly relevant to UK general practice 
because the electronic health records of GP systems have a “pop up” function 
that reminds clinicians of the outstanding tasks that need to be addressed to 
meet the QOF targets. Computer-generated reminders delivered on paper also 
demonstrated a small improvement in vaccination; the findings from this review 
would not generalise easily to UK general practice as this method of reminders 
is not commonly used, particularly if GP computer software already have “pop 
up” functions. 
Continuing medical education (CME) or continuing professional development 
(CPD) has often been assumed to lead to desirable behaviours and improved 
healthcare outcomes. The pooled reporting of outcomes meant it was difficult to 
ascertain the effect on public health activities. The review authors suggested 
strategies to increase attendance at educational meetings, use of mixed 
interactive and didactic formats, and focusing on outcomes with serious clinical 
implications might increase the effectiveness of CME.(106, 131)  
Audit and feedback sound intuitive and help to change behaviour in a similar 
way to classical Skinnerian behaviour modification strategies.(51) According to 
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review authors, some trials were inadequately powered to detect small to 
moderate differences and others were not adequately designed to take account 
of clustering effects.(107) They suggest effectiveness of feedback could be 
increased with its frequency, with written better than verbal or graphical 
delivery, and if information about the correct solution was also included, but 
these need to be evaluated. 
Academic detailing, which is the main feature in educational outreach visits 
(EOVs), is another approach to influence behaviour.(130) Marketing strategy of 
pharmaceutical representatives to persuade physicians to change prescribing 
behaviour is an easily recognised example that is commonly used in practice. 
Despite its use in pharma marketing, there is insufficient evidence for use of 
EOVs with or without addition of another intervention to change behaviour. The 
review authors suggested the number and nature of behaviours targeted for 
improvement need to be thought out carefully as some were too complex to 
evaluate or replicate in practice; they also need to be better powered to 
increase the effects.(113)  
Tailored interventions have slight overlaps with EOVs as both involve process 
of a personal visit to health professionals.(129) Tailored interventions appeared 
to have a small effect on vaccination rates but the pooled data meant it was 
difficult to elucidate as the effects regarding other outcomes related to public 
health. The methods used to identify barriers and tailor interventions to address 
them were inconsistent and might be difficult to generalise. The process of 
personal visits has overlaps with opinion leader strategies where a small and 
insignificant difference was seen in those primary care physicians who had 
opinion leader intervention; there are issues regarding reliability and validity of 
identifying OLs and so it can be difficult to replicate empirical studies in practice. 
Mass communication strategies such as dissemination of printed educational 
materials (PEM) might be supported by communication theories, simple to 
produce and implement but their effects on changing professional practice and 
patient-related outcomes are inconclusive. Mass media strategy, however, 
appeared to have modest effects in improving HIV testing and immunisation 
rates. The mass media might be better at influencing the public who might be 
more responsive to the messages than primary care professionals; this in turn 
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might increase the demand for public health interventions such as screening or 
vaccination to which the clinicians respond. The authors of this Cochrane 
review suggested future studies of PEMs might benefit from using theories such 
as Persuasive Communication Theory to inform design.(117)  
Financial incentives could improve the quality of care but according to Cochrane 
reviews, only in the context of immunisations and there were not enough 
studies to give a robust conclusion for other areas of professional practice and 
patient outcomes. A new GP contract was implemented in 2004 that used pay-
for-performance indicators to reward practices for quality of care they 
provide.(41) A systematic review of the use of payment for performance in UK 
general practice was conducted which suggests modest improvements in 
quality of care in long-term conditions, but their effects on cost, patient 
experience and professional practice were uncertain.(132) 
Implications for research 
There is insufficient evidence on the impact of interventions directed at general 
practitioners to improve professional practice and outcomes relevant to HPDP. 
These knowledge gaps could be addressed by conducting better designed and 
well powered empirical studies with these specific objectives in mind, using 
explicit theories to inform design. If there were enough homogenous primary 
studies that reported on similar outcomes, systematic reviews with meta-
analyses of outcome data could be conducted which would improve the 
robustness of findings.  
Future studies need to focus on the explicit description of the intervention so 
that it could be replicated in practice, particularly for complex interventions such 
as educational outreach visits, tailored interventions, and co-interventions. For 
example, in the case of opinion leader strategy, there was lack of detail and 
consistency in the way OLs were identified and implemented behaviour change. 
In addition, the studies need to be designed to compare different types of 
interventions, be clear about “dosage” (e.g. how many educational visits, how 
long for, what sort of tiered target payments), and assess both process and 
outcome measures to examine where the impact might be. If controlled trials 
cannot be conducted, retrospective studies using quasi-experimental or 
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controlled before and after designs could be used, with adequate size and 
power to detect real differences. 
There was no single theory that provided the framework for behaviour change 
interventions that consistently had an impact on both professional practice and 
patient outcomes for health HPDP activities. The TPB and Agency Theory 
appeared to be the most promising as they provided theoretical bases for audit 
and feedback, educational outreach visits and the financial incentives 
respectively. However, the theoretical basis for behavioural interventions do not 
have to be confined to these theories, nor does the unit of intervention need to 
be confined to the individual as interventions directed at the organisational level 
could be an option. 
Lastly there needs to be more research on the cost implications of these 
interventions. For example, mass media strategies might have low cost at the 
outset with a large audience reach, compared to financial incentives such as 
target payments and fee-for-service that act at the level of the GP practice. Both 
appear to have some effects on immunisations uptake but one might deliver 
higher coverage in a population at a lower overall cost.  
Implications for practice 
The lack of robust evidence for many of the behavioural interventions does not 
mean we should no longer use them. For example, it would not be practical nor 
desirable to cease educational courses as clinicians still want to learn new 
things; practices still need to be paid but perhaps more could be done to 
demonstrate better outcomes and value-for-money for commissioners and 
taxpayers. The pay-for-performance structure to incentivise clinical 
management as well as health improvement in UK general practice (or the 
quality and outcomes framework QOF), has been continually evaluated to 
understand if it works and in which domains it has the most impact. Studies are 
now emerging which suggest improvements in the recording of smoking status 
and cessation advice, as well as some modest improvements in the 
management of chronic diseases.(133, 134) In the case of chlamydia 
screening, implementation programmes of primary care trusts (PCTs) have 
used financial incentives and educational outreach to improve screening (see 
Chapter 5).  
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Perhaps more importantly, irrespective of what behaviour interventions are 
being used, we need to understand why some methods work better than others 
to consistently influence the behaviour of clinicians. If individuals respond to 
certain interventions, then perhaps multi-faceted interventions might offer the 
best chance of behaviour change and patient outcomes.  
Conclusion 
This overview of systematic reviews examined 12 types of interventions across 
five behaviour domains to influence the behaviour of healthcare professionals to 
improve professional practice and patient outcomes. There is currently 
insufficient evidence to suggest any of these behavioural interventions aimed at 
primary care practitioners can consistently improve both clinical practice and 
patient outcomes for HPDP. The effects, if any, tend to be small and mainly 
limited to immunisations.  
Some of these designs were informed by theoretical bases; among these, social 
cognitive theory, theory of planned behaviour and economic theory appeared to 
have been frequently used. Although the use of theory did not necessarily 
improve the effectiveness of the intervention, it might help to understand how 
the intervention might work, as well as inform the design, and improve their 
reproducibility. 
This overview identified gaps in research, with plenty of scope for primary 
studies to include process evaluations, better description of interventions, better 
design and analysis, effect size, analytical methods, and to consider more co-
interventions or complex interventions to compare different combinations and 
investigate synergistic effects. 
Healthcare professionals might be motivated by different things to change 
practice to improve patient care, one intervention might not be adequate to 
change clinicians’ behaviour consistently; having an insight as to what and why 
they respond would inform the design of future behaviour interventions using 
complex designs. The following two chapters will explore how and why primary 
care clinicians respond to different behaviour interventions in the context of 
HPDP. The findings might help to explain the conclusions from these systematic 
reviews and help inform the design of future intervention studies using single or 
multiple interventions.  
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Chapter 5 – Chlamydia screening implementation strategies 
and the trends in screening in London PCTs 
In Chapter 4, I described the effectiveness of behaviour change interventions, 
such as educational outreach visits and financial incentives, directed at 
healthcare professionals, to deliver public health programmes such as 
screening and immunisations. This chapter describes the behavioural 
interventions used to increase chlamydia screening from general practices in 
primary care trusts (PCTs) I chose to study. I described the process of how and 
why I chose the PCTs to study in Chapter 3 (Design and Methods). The 
screening data from PCTs and practices helped me to select GPs and PNs for 
interviews. 
Chlamydia screening strategies  
I obtained contracts from four London PCTs (Haringey, Hackney, Tower 
Hamlets, and Lambeth) that detailed commissioning arrangements for local 
general practices to deliver chlamydia screening. As described in Chapter 3 
(Design and Methods), these PCTs were chosen because they had similar 
demographics and, for pragmatic reasons, their proximity to one another meant 
I could travel to practices to interview the GPs and PNs. 
The original contracts obtained from each PCT are shown in Appendix E. I was 
not able to obtain contracts that related to the specific period of interest that was 
2004 to 2010 as some PCTs were not able to locate any contracts earlier than 
2010. Despite attempts at contacting and asking local sexual health 
commissioners, I was not able to obtain any service contracts from Camden 
PCT but I had personal communication from GPs in Camden that the PCT had 
a Local Enhanced Service contract for sexual health which paid for each test for 
sexually transmitted infections (including chlamydia) so their approach was 
similar to the other PCTs in this study. 
All the PCTs that were chosen used some form of financial incentives to 
encourage GPs to deliver chlamydia screening through their commissioning 
contracts. The main difference between the four financial incentives was the 
tariff and structure of payment: fee-for-service, target payment, or a mixture of 
both. Not all contracts were specifically designed for chlamydia screening as 
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some PCTs commissioned it within a broader strategy of sexual health services 
such as testing and treating sexually transmitted infections (STIs) and 
contraception provision. 
All the PCTs used a range of personnel to promote the programme and 
facilitate local primary care teams to deliver screening. The people involved 
included: public health staff, chlamydia screening co-ordinators, chlamydia 
screening clinical leads or GP champions, all of whom visited the practices. This 
information was obtained through communication with local directors of public 
health and the interviews with local GPs and practice nurses. Lambeth was the 
only PCT that employed a “GP champion” and chlamydia co-ordinator to 
provide educational outreach, this strategy and the outcome on chlamydia 
screening were published in a peer-reviewed journal.(135)  
We might assume that as these PCTs used broadly similar approaches, we 
would expect similar responses to chlamydia screening from practices across 
all PCTs. However, this was not the case and further justified why interviews 
with individual GPs and PNs might help to explain why interventions like 
financial incentives and educational outreach visits might or might not work, and 
explore other motivations they had to deliver programmes such as chlamydia 
screening. 
It was not possible to explain why certain interventions were chosen in each of 
the PCTs. There were no explicit references to empirical or anecdotal evidence 
to support the choice of interventions in the contract specifications. The 
rationale behind their use might have been discussed during the process of 
developing the service specification within each PCT but this would have 
required further discussions with relevant commissioners and analysis of 
documentary evidence such as meeting minutes to verify. The evidence from 
systematic reviews was published between 2007 and 2015, so it was possible 
that some of these were not available at the time of devising the behaviour 
interventions in the PCTs as most of this happened prior to 2010.  
Chlamydia screening in Tower Hamlets 
The 35 practices in Tower Hamlets were organised into “networks” of about four 
practices each where each constituent practice contributed to their network 
performance on several services and outcomes. A Network Improved Service 
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(NIS) for Sexual Health and Contraception was rolled out in June 2010 which 
offered a broad remit of sexual health provision from GPs. This single contract 
replaced the previous ones for specified type of service: Local Enhanced 
Service (LES) in Sexual Health, LES chlamydia screening, and National 
Enhanced Service (NES) for intrauterine contraception and sub-dermal 
contraceptive implant LES. The payment structure was a mixture of target-
based and fee-for-service; there was an increased payment per chlamydia 
screen with a higher proportion of 15-24 year olds screened; this is summarised 
in Table 4.  
I was not able to obtain the Chlamydia Screening LES contracts for earlier than 
2010 from Tower Hamlets PCT, but communication with the assistant director of 
public health in Tower Hamlets informed me that the financial incentive had 
been of a similar structure in the past. He also informed me that in previous 
years, chlamydia screening was contracted out to a company which promoted 
the majority of chlamydia activity from local contraception and sexual health 
clinics so few GPs were involved. The only other difference with the 2010 
contract was the addition of a “GP Champion” and a local “network lead” – but 
as these were not included in previous contracts, they would not have 
influenced chlamydia screening numbers for the period I was investigating. 
Table 4 Payment structure for chlamydia screening in Tower Hamlets 2010 
% of 15 – 24 year olds screened  Payment per screen 
15% £5 
20% £6 
30% £7 
35% £10 
Over 35% £10 
 
Chlamydia screening in Haringey 
I obtained the chlamydia screening LES contracts for both 2008/09 and 2009/10 
from Haringey PCT. The payment structure in 2008/09 was, like Tower 
Hamlets, a mixture of target and fee-for-service (Table 5). For the 2009/10 
contract, it was a flat fee of £10 per test returned. The eligible population in this 
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contract referred to young people aged between 15 and 24 which was the same 
target population in the NCSP.  
Table 5 Payment structure for chlamydia screening in Haringey 2008/09 
Achievement Payment 
3% of eligible patients £3 per returned test 
5% of eligible patients £5 per returned test 
10% of eligible patients £10 per returned test 
15% of eligible patients £15 per returned test 
Chlamydia screening in Hackney 
The 2009/10 local enhanced service (LES) contract for chlamydia screening 
was the only one I could obtain from City and Hackney PCT. This was a fee-for-
service contract that paid £5 per screen carried out in the eligible population 
aged between 15 and 24. The service outline also included educational 
sessions for practices involved in the delivery of enhanced service to support 
clinical and non-clinical staff involved in programme delivery. There were no 
descriptions of the process, content, or frequency of these educational 
sessions. 
There was a separate LES for Sexual Health that facilitated the diagnosis and 
treatment of sexually transmitted infections (STIs) within primary care. The 
service included support structures such as: educational events, a local STI 
treatment guideline handbook, fast-track referral to genitourinary medicine 
clinics and employment of a GP with a special interest in sexual health. (136, 
137) 
Chlamydia screening in Lambeth 
The LES contracts for chlamydia screening delivery in Lambeth were obtained 
for the years 2009/10 and 2010/11. The payment to GPs was a target-based 
scheme with different tiers of achievement, the number of registered 15-24-
year-old patients in the practice also contributed to the payment. In 2009/10, the 
target payments were increased from 2008/09 to reflect the PCT’s Local 
Delivery Plan (LDP) target of screening 25% of the target population, which was 
a centrally driven performance indicator for all PCTs in England (Table 6).  
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Table 6 Payment structure for chlamydia screening in Lambeth PCT 2009/10 
and 2010/11 
 
The specification from Lambeth PCT also mentioned employment of a “GP 
Champion” for eight hours per month from August 2005, whose role was to 
provide support to GPs for chlamydia screening. This included practice specific 
peer support, workshops on chlamydia screening and regular feedback on 
performance. The role of the GP champion in Lambeth has been defined as one 
who delivered an “educational outreach” intervention.(135) The chlamydia 
screening GP champion in Lambeth did not visit all the practices but only visited 
those which had low screening rates; the frequency of contacts ranged from a 
one-off meeting to three contacts a year. 
Summary of contracts 
All four PCTs in London used financial incentives to encourage general 
practices to deliver the NCSP. There were differences in the payment structures 
but all used a combination of fee-for-service, target, and capitation payment. 
Only one PCT used an additional strategy which they called “GP Champion” 
model but the description corresponded with an educational outreach visit 
strategy; this support was limited to “low screening” practices. These strategies 
to influence professional practice (educational outreach visits and financial 
incentives) have been discussed in Chapter 4 (Overview of systematic 
reviews).(113, 119-121) 
Although I had information on individual contracts from these PCTs which 
detailed behaviour interventions to encourage chlamydia screening from 
Band  Registered 
15-24 yr old 
cohort 
No of 
practices 
5% 
Retainer 
Payment 
(£) 
 Total 
Payment 
at 10% (£) 
Total 
Payment 
at 17% (£) 
Total 
Payment 
at 25 %(£) 
A >1400 5 500 1100 1900 2600 
B 1101-1400 6 400 800 1500 2100 
C 801-1100 14 300 700 1200 1600 
D 500-800 14 200 400 900 1400 
E <500 13 100 250 750 850 
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general practice, I did not have information on other campaigns which could 
have also influenced their behaviour. For example, different PCTs might have 
had media campaigns and educational events, these might also have been 
implemented nationally so they might have contributed to some screening 
behaviour too. A Cochrane systematic review discussed in Chapter 4 suggests 
use of mass media might have an effect on utilisation of health services such as 
screening.(118) 
Trends in chlamydia screening in general practices  
This section describes the trends in chlamydia screening from general practices 
in London, with an emphasis on the chosen PCTs (Haringey, Hackney, Tower 
Hamlets, and Lambeth).  
The chlamydia screening programme was implemented across London PCTs at 
different times and in the beginning, there were only four PCTs which had any 
screening activity from general practices in 2004: Camden, Lambeth, 
Lewisham, and Southwark. By 2005, this had increased to six PCTs with the 
addition of Harrow and Enfield with a further increase to eight in 2006 with 
Haringey, Islington included in the total. By 2008, all but two (Hammersmith and 
Fulham PCT and Havering PCT) had chlamydia screening activity from their 
general practices. The aggregate data of chlamydia screens from all London 
PCTs appeared to suggest there had been an overall increase in chlamydia 
screening in general practices through the years from 2004 to 2010 (Figure 10 
and Table 7). 
There were differences in the rates of increase in chlamydia screening since 
they started in different PCTs. Nine PCTs had more than a 10-fold increase in 
chlamydia screens between 2008 and 2010 (Table 7). They were: Barking and 
Dagenham, Ealing, Hammersmith and Fulham, Haringey, Havering, Hillingdon, 
Kensington and Chelsea, Newham, and Westminster. The greatest increase 
was Newham PCT which increased from 61 screens in 2008 to 3345 in 2010 – 
a 55-fold increase, followed by Ealing (48-fold increase) and Haringey (27-fold 
increase). For PCTs which started with no screens in 2008, Hammersmith and 
Fulham PCT increased to 288 in 2010. Havering increased to 1222 in the same 
period. Not all PCTs had year–on-year increases in chlamydia screens from 
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their GPs; Hammersmith and Fulham, Waltham Forest, and Harrow PCTs had 
reductions in the number of screens from their GPs between 2009 and 2010. 
Although four PCTs started chlamydia screening in general practices in 2004, 
only Lambeth and Southwark appeared to have consistently high numbers 
through the years. By 2010, other PCTs including Haringey (3469), Hillingdon 
(3221) and Newham (3345) managed to return as many screens as Southwark 
(3498) but Lambeth was a significant outlier with 4890 screens returned from 
GPs (Figure 10). 
Chlamydia screening in selected PCTs 
Four PCTs were chosen for this study: Lambeth, Haringey, Hackney and Tower 
Hamlets. They were chosen because they had similar demographics and, for a 
pragmatic reason, their proximity to one another meant I could travel to 
practices to interview the GPs and nurses. Figure 11 shows the number of 
chlamydia screens returned from these PCTs: this includes a PCT which had 
consistently high numbers of screens (Lambeth), another that significantly 
increased their screens (Haringey), and two with screening rates that increased 
at a steady rate (Tower Hamlets and Hackney). 
Chlamydia screens from GPs in Lambeth PCT appeared to have increased at a 
steady rate from 2004. Tower Hamlets, Hackney and Haringey PCTs started to 
return chlamydia screens from between 2006 and 2007, although the rates of 
increase were lower than that of Lambeth. Haringey PCT had a low number 
from 2006 but the rate of increase changed significantly from 2008 to 2010. 
Lambeth had consistently high screening numbers from their GPs. In 2004, 
Lambeth GPs returned 401 screens whereas it took Tower Hamlets four further 
years to return the same number of screens.  
The large screening volume could be explained by the number of general 
practices in Lambeth (49 practices) as it was similar compared with Hackney 
(43 practices) and Haringey (51 practices); Tower Hamlets had the smallest 
number with 35 practices. According to feedback from the interviews and NCSP 
reports, Lambeth engaged GPs in screening very early in the programme. 
Hackney PCT devised a local enhanced service for STI screening from 2006 
which encouraged GPs to screen for STIs including chlamydia, this might have 
accounted for the rise in chlamydia screening from 2006.(29)  
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According to one of the assistant directors of public health for Tower Hamlets 
PCT, they initially concentrated programme implementation on non-GP services 
until 2010 when it was fully integrated into their Network Improvement Services 
(NIS). This could explain why the number of chlamydia screens from general 
practices remained low compared with other PCTs. Personal communication 
with one of the directors of public health for Haringey PCT reported their PCT 
responded strongly to the Local Delivery Plan (LDP) targets for chlamydia 
screening from 2008 and invested their resources in the LES and promotion of 
chlamydia screening to their GPs, this could explain the rise in screening from 
2008 to 2010. However, we cannot tell from the data which of these made the 
GPs respond most strongly: chlamydia screening campaign, financial 
incentives, or a combination of both.  
The chlamydia screening volume data from each PCT were pooled from all GP 
activities so they might not have reflected individual practice’s response to 
implementation strategies as some might have responded more strongly than 
others. Practices at extreme ends of screening behaviour could have distorted 
the overall chlamydia screening for the PCT. Trends in screening volumes and 
uptake for the15-24 age group by individual practices from 2004 to 2010 might 
offer a better way of analysing the effect within each PCT. Chlamydia screening 
data from each PCT are presented in the following format: volume of screen 
from all practices in the PCT, then the number of screens per 15-24 age group 
(Appendix F) and lastly the chlamydia screening rates of the practices from 
which the participants were drawn.  
The explanations offered here are presumptive, based on observing trends in 
chlamydia screening with the chronology of events such as the introduction of 
screening contracts, and anecdotal communication with those with 
commissioning responsibilities. Individual interviews with doctors and nurses in 
these PCTs might be able to offer confirmations or other explanations. The next 
section describes the chlamydia screening trends in each PCT from 2004 to 
2010.
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Table 7 Chlamydia screens from London PCTs 2004 to 2010 
 
Year 
PCT 2004 2005 2006 2007 2008 2009 2010 
Barking & Dagenham 0 0 0 0 200 936 2263 
Bromley 0 0 0 0 157 346 1277 
Camden 231 328 199 248 780 1505 2106 
City & Hackney 0 0 0 400 1059 1314 1516 
Croydon 0 0 0 0 832 916 1532 
Ealing 0 0 0 0 39 435 1885 
Enfield 0 46 203 143 126 123 1018 
Greenwich 0 0 0 0 90 185 397 
Hammersmith & Fulham 0 0 0 0 0 480 288 
Haringey 0 0 10 100 127 2261 3469 
Harrow 0 239 222 190 562 1961 1515 
Havering  0 0 0 0 0 854 1222 
Hillingdon 0 0 0 0 156 2556 3221 
Hounslow 0 0 0 63 725 1298 1459 
Islington  0 0 109 251 315 529 649 
Kensington & Chelsea 0 0 0 0 103 936 1173 
Kingston 0 0 0 0 323 326 470 
Lambeth 401 897 2084 2478 2861 3793 4890 
Lewisham 114 308 559 512 599 844 1597 
Newham 0 0 0 0 61 368 3345 
Redbridge 0 0 0 0 305 1414 1649 
Richmond & Twickenham 0 0 0 0 98 356 642 
Southwark 175 427 802 1745 1915 2626 3498 
Sutton & Merton 0 0 0 0 303 812 1274 
Tower Hamlets 0 0 0 72 410 448 782 
Waltham Forest 0 0 0 0 361 393 88 
Wandsworth 0 0 0 47 635 630 1299 
Westminster  0 0 0 0 200 1529 2417 
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Figure 11 Number of chlamydia screens from selected PCTs between 2004 and 2010 
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Chlamydia screening in Lambeth  
Lambeth appeared to have high numbers of chlamydia screens from 2004 to 
2010, compared to other PCTs in London (Figure 10). However, the graph of 
total chlamydia screens from individual practices suggested only a handful of 
practices had consistently high screening activity over the years whereas the 
rest had slower growth in the number of screens and a handful of practices had 
rapidly increasing screening rates in the latter years (Appendix F). Different 
practices emerged as the “high screeners” when the proportion of the 15-24 age 
group screened was considered rather than volume of chlamydia screens. The 
increase in the proportion of young people screened was not consistent among 
all practices as seven of them screened less than 5% of their 15-24 population 
and three had a decrease in screening from 2009. 
One of the top three practices which achieved high screening rates in Lambeth 
was Streatham High Practice, which achieved 25% screened and from where 
one of the GPs was recruited for an interview. Interview participants were drawn 
from three other practices in Lambeth: Paxton Green Group Practice, Stockwell 
Group Practice, and Lambeth Walk Practice. The first two practices had stable 
chlamydia screens from 2004 to 2010; Lambeth Walk had a slow increase 
whereas Streatham High increased from 2008 to the highest out of the four in 
2010. Streatham High practice was one of the “low screening” practices that the 
Chlamydia GP Champion had contact with (Figure 12). The screening rates in 
these practices helped me to formulate specific questions about what influenced 
these increases in each practice; for example, Streatham High Practice might 
not have responded to the same financial incentive as the other practices but it 
did so to educational outreach visits.
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Figure 12 Chlamydia screening rates from 2004 to 2010 in 15-24 year cohorts of selected Lambeth practices 
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Chlamydia screening in Haringey 
Haringey PCT appeared to have very little chlamydia screening activity from 
their GPs compared with Lambeth, Hackney and Tower Hamlets until after 2008 
when their screening volume surpassed the latter two (Figure 11). Three 
surgeries appeared to have significant increases from 2008 to 2009: Chalton 
House Medical Centre, Christchurch Hall Surgery and Morum House Medical 
Centre. Only the last seemed to have continued this increase whereas in the 
first two, chlamydia screening activities reduced a year later (Appendix F). The 
graph of screening uptake in 15-24 year olds showed a significant increase in 
GP screening activity from 2008 to 2010 and different practices appeared to 
have occupied the top positions (Appendix F). 
Participants were drawn from three practices in Haringey: Tottenham Health 
Centre, Lawrence House Surgery and The Bridge House Surgery. The first two 
had increased uptake from 2008 to 2010, reaching 11% and10% screening 
coverage respectively, while Bridge House had a minor increase in 2010 but did 
not improve beyond 1% (Figure 13). Using the screening trends, I sought to find 
out whether the introduction of a chlamydia screening enhanced service 
explained the significant rise in chlamydia screening rates from Lawrence 
House Surgery and Tottenham Health Centre, or if there were other reasons. I 
also used the trends to ask in the interview why The Bridge House Surgery did 
not appear to respond in the same way as other surgeries to the same 
chlamydia screening financial incentive offered by the PCT at that time.
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Figure 13 Chlamydia screening rates in 15-24 year cohort in selected practices in Haringey 
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Chlamydia screening in Tower Hamlets 
Tower Hamlets had the lowest number of chlamydia screens from their GPs out 
of the four PCTs that were selected. This was consistent throughout the years 
from 2004 to 2010 (Figure 11). There were no screens returned from GPs from 
2004 until 2006; it started to increase steadily from 72 in 2007 to 782 in 2010.  
Chlamydia screening data from individual practices in Tower Hamlets 
suggested a large number of screens were returned by a relatively small 
number of practices. In 2008, the top three practices were Spitalfields Practice, 
Blithehale Medical Centre and Globe Town Surgery (Appendix F). The 
proportion of 15-24 year olds screened did not increase significantly for the 
majority of practices in Tower Hamlets from 2004 to 2010 (Appendix F). In 
2008, the highest rate was from Blithehale Health Centre with 5% of their 15-24 
year olds screened. By 2010, only Gough Walk Practice managed to screen 
more than 10%, followed by Tredegar Practice which screened 8% of the target 
population.  
Participants were drawn from seven practices with a range of chlamydia 
screening uptakes in 2010: Tredegar Practice (8%), Bethnal Green Health 
Centre (4%), Blithehale Health Centre (4%), Chrisp Street Health Centre (3%), 
Island Health (2%), East One Health (1%) and Jubilee Street Practice (1%) 
(Figure 14). I asked the participants the possible reasons for very low screening 
activity until after 2007. I also sought to understand the motivation behind the 
large surge in screening rates at Tredegar Practice and the high initial rates 
from Blithehale Health Centre.
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Figure 14 Chlamydia screening rates from 2004 to 2010 in 15-24 year cohort of selected practices in Tower Hamlets 
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Chlamydia screening in Hackney 
Hackney had a steady rise in the number of chlamydia screens returned from 
their GPs, from none in 2006 to 1059 in 2008 which made them the third 
highest chlamydia screens returned from PCTs that year after Lambeth and 
Southwark PCTs. After 2008, the chlamydia screens continued to increase but it 
was overtaken by other PCTs which had a larger rate of increase from 2008 
(Figure 10). 
Chlamydia screens returned from individual practices suggested two practices 
(Trowbridge Practice and Lawson Practice) consistently returned more than 50 
screens a year since 2007 and were the top two in 2010, returning 190 and 156 
respectively; only six other practices managed to submit more than 50 screens 
that year (Appendix F). The median uptake was at 2% for Hackney practices; 
only six other practices achieved uptake of more than 10% in 2010: De 
Beauvoir Surgery, Hoxton Surgery, Latimer Health Centre, Queensbridge 
Group Practice, The Heron Practice and The Lawson Practice (Figure 15).  
Participants were drawn from three practices: The Lawson Practice (screening 
uptake in 2010 was 10%), Somerfield Grove Health Centre (5%) and Statham 
Grove Surgery (3%). The interviews offered me insight into the possible 
explanations for a range of chlamydia screening uptake in these practices, 
despite the same implementation strategy from the PCT.
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Figure 15 Chlamydia screening rates from 2004 to 2010 in 15-24 year cohorts in selected practices in Hackney 
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Limitations  
The descriptive study of chlamydia screens from GPs in each PCT should be 
interpreted carefully as it has several limitations. Firstly, the data cannot be 
used to attribute GP chlamydia screening activities directly to the behaviour 
interventions in the form of LES contracts used by PCTs. To make inferences 
between screening activities in PCTs and the introduction of implementation 
strategies, it would need to have a controlled before-and-after design, using at 
least three time points before and after the introduction of the behavioural 
intervention to measure the differences in the slopes and the step change after 
its introduction (an interrupted time series analysis). The design would also 
need to control for confounding factors that could have affected screening 
behaviour. GPs and nurses were also exposed to other influences such as: 
campaigns through the media, computer reminders, and patient requests for 
screening, so it would not be possible to attribute screening volumes to 
behaviour change strategies alone such as financial incentives that were in the 
contracts. 
Secondly, the number of chlamydia screens reflected only what was submitted 
from general practices that particular year; it was not possible to tell when 
individual PCTs actually started implementing the screening programme. It 
might be possible for the programme to be implemented one year but might 
take longer before any screens were returned from GPs.  
Thirdly, the numbers of screens from GPs do not reflect overall achievements of 
screening uptake in the wider PCTs. Practices which appeared to have low 
screening activities might have had different reasons such as: lack of 
promotion, incentives, or engagement of PCT with primary care staff. However, 
as only returns from general practices were considered in this thesis, it is 
possible that there could be a higher numbers of chlamydia screens from other 
venues if PCT resources were concentrated elsewhere such as young persons’ 
clinics and sexual health services. 
Summary   
The PCTs that were chosen for this study all used financial incentives as the 
main behaviour intervention strategy to encourage general practitioners to 
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deliver chlamydia screening. The financial incentive schemes included a 
mixture of target and fee-for-service structures.  
Lambeth appeared to be the only PCT that specifically used another strategy 
(educational outreach in the form of “GP chlamydia screening champion”) to 
facilitate screening in general practice. Although it appeared a few practices 
increased their screening activities through to 2010, not all responded and 
some remained low screeners despite the visits. It was not possible to isolate 
the effect of the financial incentives on chlamydia screening for Lambeth GPs, 
especially in the low screening practices which also had visits from the GP 
chlamydia screening champion. 
Documentary evidence was available for only two types of influencing strategies 
– financial incentives and educational outreach visits but it was not possible to 
get information for other strategies used to influence clinicians to improve 
chlamydia screening such as educational events, computer reminders and 
media campaigns. Some of these initiatives (such as local educational 
meetings) could have been locality based or, in the case of media campaign, 
nation-wide. Further information regarding these influences might have been 
useful but were outside the scope of this thesis. 
Conclusions 
Although the four PCTs used some element of financial incentives, they did not 
appear to have consistent effects across the PCTs or with the practices within 
the PCTs as there was a range of chlamydia screening uptake within each PCT 
despite these influences. It was not possible to say for certain if any increase in 
chlamydia screening behaviour was solely attributable to financial incentives or 
educational outreach because there might have been confounders that 
influenced the behaviour of GPs and nurses.  
Although the increase in screening in Haringey PCT appeared to coincide with 
introduction of financial incentives, it did not have consistent effect to increase 
chlamydia screening from general practice as the evidence for its impact on 
health promotion and disease prevention is limited.(119) A study from Australia 
suggested a co-intervention with reminder and feedback systems might improve 
the efficacy of financial incentives to improve screening.(138) The use of co-
interventions was also considered as a discussion point in the interviews with 
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participants to see if these improved the likelihood of delivering public health 
programmes such as chlamydia screening. 
To find out why some behaviour interventions affected individual clinicians (and 
by extrapolation, the practices) differently, I interviewed GPs and practice 
nurses to ask about their motivations to deliver health promotion and disease 
prevention activities such as chlamydia screening. I used their practice and 
PCTs’ screening data to set a context for the interviews. For example, to help 
explain the overall trends in chlamydia screening in their PCTs through the 
years, to explain the differences between their practice’s screening rates 
compared with others in the same PCT, despite having the same behaviour 
interventions such as financial incentives. The next chapter will present the 
findings from interviews with GPs and practice nurses. 
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Chapter 6 – What influenced general practitioners and practice 
nurses to deliver health promotion and disease prevention 
programmes? The findings from interviews 
Introduction 
This chapter addresses the second objective of the thesis: 
Explore the reasons why primary care clinicians such as GPs and practice 
nurses responded to behaviour change interventions to deliver public health 
programmes such as chlamydia screening. 
The first objective was addressed through a systematic overview of systematic 
reviews in Chapter 4. Several behaviour-modifying interventions to influence 
GPs to deliver public health programmes have been tested empirically but 
evidence from robust systematic reviews concluded that few interventions have 
had significant and consistent impact on changing behaviour of GPs and patient 
outcomes in the context of HPDP. For example, financial incentives for GPs 
improved immunisation rates but did not have the same effect for other public 
health programmes. If no behavioural intervention was consistently effective in 
changing physician behaviour, it might suggest some underlying factors were 
not accounted for in the empirical studies. Perhaps the underlying assumption 
that, other things being equal, health care professionals respond only to 
educational interventions, feedback, or financial incentives, for example, might 
have been too reductionist. Systematic reviews of empirical studies might 
provide answers to possible links between input (the behaviour intervention) 
and output (evidence of behaviour change and patient outcomes) but they 
cannot establish the process through which the input has led to the output; or in 
other words, we need to unpack the “black box”.(90)  
In Chapter 2, I discussed the use of behaviour theories that underpinned some 
of the behaviour interventions in systematic reviews; Theory of Planned 
Behaviour (TPB), social learning theory and economic theory were most 
commonly used to inform design of interventions such as audit and feedback, 
tailored interventions and financial incentives which had, at most, modest 
impact on modifying healthcare professional behaviour and to improve patient 
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care. I also suggested behaviour theories could potentially be used to provide 
explanations for the behaviours.  
This chapter presents data from the interviews I conducted to explore the 
attitudes and motivation of GPs and PNs in selected PCTs to deliver public 
health programmes such as the National Chlamydia Screening Programme 
(NCSP). The GPs and PNs were specifically chosen for the practices’ 
chlamydia screening rates as described in Chapter 5.  
I conducted semi-structured interviews using a topic guide that included 
constructs of TPB (behaviour beliefs, normative beliefs, and control beliefs) and 
different types of behavioural interventions drawn from the overview of 
systematic reviews in Chapter 4. These behavioural interventions were broadly 
classified into five groups: computer based decision support such as: computer 
reminders; education-only approaches; social influences which include 
educational elements; audit and feedback; opinion leader; tailored interventions 
and educational outreach visits; mass communication methods such as printed 
educational materials and mass media; and financial incentives such as target 
based incentives, salaried payment, or fee-for-service.  
The topic guide also included prompts for discussing NCSP, public health 
programmes in general, strategies to influence behaviour change in participants 
to deliver public health programmes such as chlamydia screening; there was 
flexibility to discuss further issues that influenced individuals’ clinical practice.  
A summary of participants and their practice characteristics is shown in Table 8. 
Interview participants were drawn from the following practices in Lambeth: 
Stockwell Group Practice, Lambeth Walk Practice, and Streatham High 
Practice; from Haringey: Tottenham Health Centre, Lawrence House Surgery, 
and The Bridge House Surgery; from Tower Hamlets: Tredegar Practice, 
Bethnal Green Health Centre, Blithehale Health Centre, Chrisp Street Health 
Centre, Island Health, East One Health, and Jubilee Street Practice;  from 
Hackney: The Lawson Practice, Statham Grove Surgery, and Somerfield Grove 
Health Centre. I have not given any further details of the participants and their 
practices to maintain anonymity. 
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The thematic analysis of interviews with GPs and PNs using the Framework 
approach suggests possible explanations why some public health programmes 
are delivered and others are not. I have included a coding list and an example 
of coding (using theme of competitiveness) in Appendix G and Framework 
matrix in Appendix H (as a CD ROM). Although TPB was used as a conceptual 
model to analyse the interview data, not all the themes corresponded exactly to 
the constructs of TPB which are: behaviour beliefs, normative beliefs, control 
beliefs and behaviour intention. Some of the themes had overlaps with more 
than one construct and there were also emerging issues that could not be 
explained by TPB alone. A schematic representation of the thematic analysis is 
presented in Figure 16. Conner and Sparks analysed each of the constructs of 
TPB in detail and suggested some determinants of each construct; these 
components are illustrated in Figure 17.(139) This has been helpful to facilitate 
mapping of themes that emerged from the data to the constructs of TPB. 
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Figure 16 Themes from interviews mapped out against constructs of Theory of Planned Behaviour 
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Figure 17 Conner and Sparks’ “components” of Theory of Planned Behaviour Constructs.  
 
From Conner & Sparks Theory of Planned Behaviour, in Conner M and Norman P (eds) Predicting Health Behaviour 2nd Edition. Open 
University Press
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. Table 8 Summary of participants and their practice characteristics 
Participant Gender Target (Quartile 1 = highest) 
      
Chlamydia 
Child imms Flu Smear  
Hackney GP1 Male Medium 1st 1st  4th  
Hackney GP2 Female Low 4th 1st 1st 
Hackney PN1 Female Medium 2nd 2nd 1st 
Haringey GP1 Female Medium 3rd  2nd 2nd 
Haringey GP2 Female High 2nd 1st 1st 
Haringey GP3 Male High 2nd 1st 1st 
Haringey GP4 Female Low 2nd  2nd  4th  
Haringey GP5 Female Low 3rd  3rd  4th  
Haringey PN1 Female Medium 3rd 2nd 2nd 
Lambeth GP1 Female High 4th 4th 2nd 
Lambeth GP2 Male Medium 3rd 1st 1st 
Lambeth GP3 Female High 3rd 4th 3rd 
Lambeth GP4 Male High 4th 4th 3rd 
Tower Hamlets GP1 Female Low 4th 4th 2nd 
Tower Hamlets GP2 Male Medium 2nd 2nd 1st 
Tower Hamlets GP3 Female Low 3rd 3rd 2nd 
Tower Hamlets GP 4 Male  Low 4th 1st 2nd 
Tower Hamlets GP5 Male Low 2nd 2nd 1st 
Tower Hamlets GP6 Female Low 3rd 2nd 1st 
Tower Hamlets PN1  Female Low 2nd 3rd 3rd 
Tower Hamlets PN2 Female Low 2nd 3rd 3rd  
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Attitudes to behaviour 
According to TPB, attitude towards a behaviour, which refers to the degree to 
which a person has a favourable or unfavourable evaluation or appraisal, as 
well as the individual's belief about its consequences (“outcome expectations”), 
can affect the intention, which immediately predicts the likelihood of that 
behaviour being implemented. In other words, attitudes are a function of salient 
behavioural beliefs which represent perceived consequences or other effects of 
the behaviour. Components of this construct also include “instrumental” and 
“affective” elements (Figure 17), such as whether the individual regards the 
behaviour as: desirable or undesirable, valuable or worthless, pleasant or 
unpleasant and interesting or boring.(139)  
Outcomes expectations: benefits at individual level 
Some participants strongly believed that health promotion and screening 
programmes had a direct, individual benefit to prevent ill health and that is why 
they delivered them. These programmes included smoking cessation, cervical 
screening and chlamydia screening.  
“For smoking, you know the danger for the patient or the injury to the patient is 
bad, very bad with smoking, so I will give [smoking cessation advice] even if 
you don’t give money.” Haringey GP3  
However, not everyone shared the belief that there are benefits to health 
promotion at the individual level; some participants thought health promotion 
efforts are futile without addressing the determinants of ill health. For example, 
having secure employment and income would make a difference to a person’s 
life and probably their health, through better living conditions and diet. Insisting 
people changed their habits which might be a consequence of their 
circumstance might risk “shaming” them and jeopardising the relationship with 
their clinician. These beliefs made some more hesitant to discuss health 
promotion with patients. 
“I think public health has … become an issue of individual responsibility and 
individual autonomy rather than social responsibility and inter-relational 
autonomy. And I think it’s damaging for patients, it risks shaming people, 
making problems worse. ... But positing public health interventions at the level 
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of individuals in the situation of the doctor-patient relationship seems to me 
unhelpful and possibly harmful.” Hackney GP1  
“And I think that’s … what actually would make the most difference to people 
around here would be a job.” Lambeth GP1  
Outcome expectations: benefits at population level 
Health care professionals might be more likely to deliver public health 
programmes if they believed they had desirable outcomes at the population 
level as well. The main reason given by all GPs and PNs was they wanted to 
prevent ill-health and improve health in their population. There were different 
views of HPDP programmes; some were favoured more than others. For 
example, some participants believed childhood vaccination has benefits due to 
herd immunity which confers protection at a population level and seemed to be 
something worth promoting.  
“Particularly, we feel, for primary care, immunisation is a very good way of 
preventing illness so our primary imms for the children are very high as well.” 
Lambeth GP2  
The influenza programme, in contrast, did not receive this much support; some 
participants were not persuaded by the evidence that influenza vaccinations for 
children and over-65s were an effective public health intervention. The two 
participants who were sceptical about influenza vaccinations (Haringey PN1 
and Lambeth GP1) were also drawn from practices whose influenza vaccination 
rates for over-65s were 2nd and 4th quartiles respectively in their PCTs. 
“They’re rolling out the flu vaccination to children and I do think it’s crazy 
…Children don’t get the flu, very few children get the flu!” Haringey PN1 
Ambivalence about perceived benefits was not the only reason some 
participants did not promote certain public health programmes. Beliefs that 
certain diseases and conditions had a low prevalence in some populations 
made some feel the efforts on prevention work would be futile and they would 
be better off concentrating on other areas. 
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“… We have a very small incidence and prevalence of cardiovascular [disease] 
… how much are you going to do because when that’s not prevalent, something 
else will be more important.” Haringey GP4 
One Tower Hamlets GP gave an example of how alcohol screening might not be 
very relevant at the population level for his largely Muslim population and 
thought the resources could be put in another public health initiative. 
“… so 99% of the patients I’m asking, the Bengali patients, they don’t drink, so 
I personally think it’s not really a valid thing to do in Tower Hamlets to do that. 
… Muslim patients don’t drink alcohol, they smoke, almost every man smokes 
so I think it’s much more valuable to put more money, or to put more resources 
into the smoking.” Tower Hamlets GP4 
Whereas others were motivated to do more case finding of diseases, to look for 
“hidden health needs” of their population so would support population screening 
to prevent ill health. 
 “… some of our patients look fairly affluent ... but there is a lot of hidden and 
unmet need and I think you have to look for that.” Haringey GP3 
Apart from perceived prevalence of disease, there were other assumptions 
about the local population's needs; these included how, rightly, or wrongly, their 
patients might not be the demographic to benefit so assumed they would not 
respond to health promotion or screening; this assumption made some 
participants more reluctant to offer it to their patients. 
“You know, our patients may not be the right people for that particular 
programme, if they are not showing much interest, what is the point in us 
pushing the programme?” Haringey GP2 
In the case of chlamydia screening, some participants thought the target 
demographic of 15 to 24 year olds did not appreciate the future consequences 
and benefits of screening so did not respond to NCSP, unlike the over 25s who 
responded to cervical cancer screening; however, not everyone shared this 
view.  
“I think with … cervical screening where … it’s linked to cancer, so that’s the 
reason you need to get it checked ... Whereas most of the age group that we are 
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trying to target [for chlamydia screening] necessarily don’t think that far ahead 
about the consequences of it, so it’s a bit more difficult.” Haringey GP4  
Unintended consequences: false positive, over-diagnosis and overtreatment. 
Some public health programmes might have unintended consequences, leading 
to “unfavourable” outcome expectations affecting the behaviour beliefs, and 
participants feeling ambivalent about promoting them; for example, some 
screening programmes give “false positive” results and others generate anxiety 
in those with low risk. Screening tests that are too sensitive and lack specificity 
which give many “false positive” cases, such as breast cancer screening, could 
lead to “over-diagnosis” of breast cancer. This might result in unnecessary 
surgery. Some interventions for primary prevention could paradoxically make a 
healthy person sick, from effects of drugs such as statins for primary prevention 
of cardiovascular disease. These examples made some participants anxious 
about offering screening programmes and prevention treatments. 
“And yes, you are going to get some people who have false positive and they go 
and have it explored through surgery, very stressed it could be cancer and 
actually it isn’t.” Hackney PN1  
“…what’s so different about public health programmes, [is that] you are getting 
a population of well people to either have a test, screening in other words, or 
undergo some intervention like given statins, which may make them more ill?” 
Haringey GP4  
Unintended consequences: paradoxical [unhealthy] behaviour 
Some participants thought having a normal and reassuring screening test, 
particularly for sexually transmitted infections (STIs), might lead to unhealthy 
behaviour. For example, a negative chlamydia screening test result might give a 
paradoxical message or “permission” to behave in a way which increases risk of 
contracting other sexually transmitted infections, such as HIV. This made them 
question the value of such screening programmes as they might paradoxically 
promote unhealthier behaviour. 
“I have some concern that there’s now a kind of urban mythy [sic] type view 
that you can get tested [and treated for chlamydia] so it doesn’t really matter if 
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you get chlamydia which of course is disastrous from the point of view of HIV 
prevention, particularly.” Lambeth GP1 
Unintended consequences: “worried well” 
Doctors and nurses had mixed views of the effects of public health programmes 
that might attract healthy people to come for unnecessary checks or screening, 
creating a population of “the worried well”. While some welcomed the 
opportunity to discuss their patients’ general health, the others were concerned 
about the opportunity cost of managing anxieties and self-limiting conditions, 
where time spent during these appointments could be spent on treating other 
patients with illnesses.  
“… you give huge emphasis to one person you ‘ve found and ignore the 
overwhelming majority of whom it just wastes nurses’ appointments, and the 
person who’s really sick can’t get an appointment because you’re too busy doing 
health checks.” Hackney GP1 
“It doesn’t matter how much you say that, once you tell someone they’ve got 
mildly abnormal cells [through a smear test], it’s just - it creates huge amounts 
of anxiety and we pick all that up.” Tower Hamlets GP1 
Beliefs about evidence for public health programmes 
Personal beliefs about the value of health promotion and disease prevention 
activities might affect the attitudes and thus intention to deliver public health 
programmes; these could be determined by the belief in supporting evidence for 
these programmes, including how it was reported, interpreted, and its 
provenance. Health care professionals are increasingly aware of evidence-
based medicine and using evidence to inform their clinical practice; some 
sought and critically evaluated the evidence for some public health 
programmes, so those that have credible evidence base might be more likely to 
be supported and implemented. Participants reported that evidence to support 
public health programmes was a key factor which influenced their decision 
whether to deliver them.  
“I mean if there was no evidence I’d say well, you know, why are we doing this? 
But, you know, if they say that, you know, lowering, people with diabetes, their 
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blood pressure, controlling their blood pressure yields real outcomes then okay.” 
Tower Hamlets GP2 
Availability of evidence was not enough as this had to be associated with a 
positive attitude to the evidence to influence the behaviour intention; this was 
more likely if participants knew there was evidence of good outcomes from 
public health interventions. Participants were aware of empirical studies on 
cardiovascular disease screening and chlamydia screening to support primary 
prevention and screening respectively and these were reasons given why they 
delivered these programmes. 
“I think with most of the cardiovascular, they’ve done good studies to show the 
impact of treating things earlier on and patient education.” Haringey GP1 
“Maybe we were persuaded by the evidence… [Chlamydia screening] had been 
shown to be valuable and to avoid PID and infertility in the future. So, I think 
we were probably swayed by the value from the early trials.” Hackney GP1  
Beliefs about evidence: the provenance  
The provenance of the public health message affected some participants’ 
intention of delivering the programme. National Institute for Health and Care 
Excellence (NICE) was a common source of trusted evidence-based 
information for clinical practice. A local Clinical Effectiveness Group (CEG) in 
Tower Hamlets was also thought to disseminate trustworthy clinical guidelines 
for local GPs. For some participants, confidence in the process of producing 
evidence-based standards and clinical guidelines by academics and experts 
made them trustworthy for their clinical practice. Trust in the provenance of 
guidelines is relevant as participants reported they did not have time to appraise 
evidence themselves; having confidence in the process and people that 
produced them is therefore important.  
“Well, there is a certain amount of trust there that you’re hoping – well, 
definitely things based on NICE guidelines and things that there has been some 
– I mean I know that people obviously pick and choose their research and 
depending on the quality of research.” Tower Hamlets PN1 
“And also they [CEG] produce a lot of information about appropriate drug use 
… so the information from them has been really helpful in trying to focus us 
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particularly on cardiovascular prevention, blood pressure, diabetes. We take 
quite a lot of notice of what they say.” Tower Hamlets GP2  
Beliefs about evidence: its interpretation  
Despite the availability of objective evidence from credible sources such as 
NICE, they were not necessarily perceived or interpreted in a positive way by 
healthcare professionals. For example, they could be framed differently, casting 
doubts on the evidence; these views might be formed through reading opinion 
articles and discussion with their peers. This was demonstrated in participants’ 
beliefs and attitudes to some public health programmes such as NHS Check to 
screen for cardiovascular disease, influenza vaccination and chlamydia 
screening. The media’s influence in framing and interpreting information is 
mentioned later. 
“I think there’s some conflicting evidence about how beneficial it is to be 
implementing the program in the first place in terms of how much PID [pelvic 
inflammatory disease] we’re preventing [through chlamydia screening].” Tower 
Hamlets GP6  
Clinician’s personal factors: personal and professional experiences 
According to Conner and Sparks, affective or experiential factors have been 
known to determine a person’s attitudes to a behaviour and in turn, determine 
behaviour intention.(139) Examples of these from interviews include personal 
experiences of growing up in countries without established public health 
infrastructures, the experience of training in specialities related to public health, 
personal experience of preventable diseases and subjects of public health 
programmes. Doctors who grew up in low-income countries and saw 
preventable diseases due to poor public health infrastructures made them more 
appreciative of disease screening and immunisation programmes in the UK. 
One reported that having experienced infectious diseases that are known to be 
preventable inspired her to be a “huge believer” in immunisations.  
“I grew up in Nigeria…I was brought up with all those big stories of kind of 
epidemics and really grew up with stories of public health interventions … and 
particularly I’m a huge believer in immunisation. I had measles when I was a 
kid, and I had malaria.” Tower Hamlets GP1 
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Other experiential determinants of attitudes were reported by doctors who had a 
family member or memorable patients who were diagnosed late and died 
prematurely from preventable illnesses; they were more appreciative of 
screening and early diagnosis. These first-hand experiences had profound 
effects on their practice and intentions to deliver public health programmes.   
“I saw a couple of bad cases of cervical cancer, women in their early thirties 
dying with young children and that was quite a powerful effect on me ...  My 
own mother died when she was quite young …  these stories that we see every 
day makes us think how we can prevent them happening to other people.”  
Lambeth GP2 
Other experiential influence includes professional experience such as GPs who 
had experience working in sexual health clinics, theywere advocates for sexual 
health and chlamydia screening and their experience of talking about sexual 
health to young people and dealing with complications made them feel 
chlamydia screening was something that could be delivered in general practice.  
“I’ve done my SHO [senior house officer] job in STD [sexually transmitted 
diseases] at Charing Cross, 10 years aback as a GP registrar here, I thought oh 
that’s actually a quite good thing to screen asymptomatic patients ..it’s 
something GPs could do.” Tower Hamlets GP4  
Educational interventions – continuing medical education 
Some components of attitudes are developed through experience (affective or 
experiential), but others could be derived through cognitive means such as 
processing of information presented to the individuals (instrumental). Such 
information could be delivered through behavioural interventions; examples of 
these have been discussed in the systematic reviews such as media and 
education. 
Educational meetings are often used for professional development and medical 
education, with the aim of improving practice and patient outcomes. Not all 
participants viewed educational activities as desirable, or valuable and did not 
have the impact on their clinical practice as expected, not all were wanted or 
related to individual learning needs. This attitude was more likely if educational 
events were delivered in a way that was seen as long or uninspiring. 
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“I went to a workshop yesterday and we had a lot of long presentations which 
actually are a waste of time.  All I need is 10 minutes’ presentation.” Tower 
Hamlets GP2  
For some GPs, the quality of educational events was dependent on who was 
delivering the teaching and how it was done; some had a preference for 
educational events delivered by their peers and others felt the delivery of 
presentation made the difference between a good or bad educational 
experience. Educational events therefore could be better received and 
promoted more widely if they had better feedback, if delivered in a way that was 
novel and by someone they valued. 
“Yeah, definitely, and it’s the quality of the speakers …I would say …having 
[non-medics] talking to doctors is not always the best way. Because there’s like 
a different, I don’t know, there’s just like sharpness about medication education 
that I like, so it’s good to have doctors [teaching] doctors.” Tower Hamlets 
GP3  
Mass communication interventions – mass media 
Mass media might influence the use of health services by the public through 
campaigns by organisations, government, and other agencies. Media messages 
might also influence individual participants’ attitudes and possibly their 
behaviours. GPs and practice nurses mentioned how the media influenced their 
thinking, such as increasing awareness of diseases. Some received information 
passively while browsing through newspapers and websites, and others actively 
sought information on the internet. For example, some found out about new 
vaccination programmes through the lay media such as the BBC, but otherwise 
could not recall being informed via formal communication cascades such as the 
Department of Health bulletins. It seemed public campaigns were sometimes 
better at capturing the attention of participants than formal communication 
channels. 
“Like the rotavirus, didn’t know about that and then it was on the BBC news. 
Shingles vaccination came out in March, it’s coming out next month but we 
didn’t know about it until it was on BBC news.” Hackney PN1 
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Some doctors and nurses thought the lay media was a way of understanding 
the lay view, and being aware of the medical information in the media might 
give insight into what some patients were thinking and possibly have an impact 
on professional practice. 
“As an avid consumer of media whether it’s through news or TV or radio or 
newspapers, inevitably one soaks it all up as a clinician, one thinks one’s getting 
some insight into what one’s patients may feel. But inevitably, that impacts on 
one’s practice.” Hackney GP2  
Apart from raising awareness of medical issues, the media could cast doubts on 
established public health programmes such as influenza vaccination and breast 
screening by framing them negatively. This had a negative effect on some 
participants’ attitudes towards these programmes and made others scrutinise 
available evidence to decide for themselves before promoting them to patients. 
This also relates to the earlier point about how the same piece of evidence 
could be framed and interpreted differently by participants, depending on where 
they read it. 
“Oh, yeah, there was a lot of stuff in the media, wasn’t there? There was a huge 
debate on Radio 4 and stuff and sort of saying breast screening … it made me go 
back and look at some of the data and look at some of the research.” Tower 
Hamlets GP1 
Marketing strategies  
The influence of marketing strategies is considered here because marketing is 
often carried out through the mass media. Some participants discussed how 
marketing campaigns consciously or subconsciously influenced them, whether 
this was via the media, pharmaceutical industry, local clinical network, or direct 
marketing such as emails. The effects ranged from merely raising awareness to 
changing clinical practice. Marketing campaigns could also be used in public 
health to “stimulate demand” when patients respond to media or marketing 
campaigns to get screening; this would put expectations on GPs to provide 
them. 
“I think I would like to see it in the media so that the public are aware of it 
[chlamydia screening], they’re expecting GPs to do it.” Haringey GP5  
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There was some media publicity when the chlamydia screening was first rolled 
out, but opinion differed among the participants whether it reached both the 
professionals and the public as intended. Some GPs remembered seeing test 
kits and posters in the surgery but others could not recall the publicity 
campaign, this might have influenced their intention to offer screening 
opportunistically. The following quote from Tower Hamlets GP5 was from a “low 
screening” practice. 
“Yeah, but you know going back to the chlamydia campaign, I don’t know what 
it was that didn’t catch on my imagination or my interest in the same way.” 
Tower Hamlets GP5  
Mass communication interventions – printed educational materials 
Printed educational materials (PEMs) are often used as a passive strategy to 
disseminate information widely to improve knowledge, awareness, professional 
practice and patient outcomes. This intervention is considered together with 
mass media because of their mass approach in disseminating information; like 
media messages PEMs might also influence individual clinicians’ attitudes and 
therefore their behaviour intentions. 
Few participants appreciated the value of printed materials such as leaflets and 
guidelines to change practice. The way some PEMs were presented needed to 
be attractive and useful so some suggested it was important that the information 
was concise such as in a compact A4 size leaflet, otherwise it would not be 
read; for others, the provenance of the information mattered. Although some 
GPs would read guidelines sent to them, they were wary about their 
provenance, whether a trusted organisation endorsed them; materials sent by 
the pharmaceutical industry to promote products were less likely to be read. 
“I think the most useful educational flyers for me tend to be very visual … one 
side A4 maximum that I can just pin up on the board to refer to. I’m not very 
good at reading stuff that I’ve been given. … I often take them away and think, 
oh yes, I’ll read that, I’ll read that and I don’t, and it sits in a pile on my 
bedroom floor making a mess.” Tower Hamlets PN2 
Medical journals were often mentioned as trusted sources of information and 
participants said they would like to read more often because they trusted the 
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provenance. However, some were aware that professional magazines might 
influence their prescribing behaviour through inadvertently reading promotional 
materials about new products from pharmaceutical companies.  
“I don’t really read GP and Pulse [GP industry magazines] and stuff very often, 
only when I go to my mum’s [who is a GP], but it would be the same reaction as 
with the BMJ.  For some reason, I have in my mind that maybe they would be 
more careful about what ads they select for Pulse and GP magazine, so that’s 
nonsense actually.” Tower Hamlets GP3 
Social media as a source of information 
Social media such as Twitter and Facebook are a relatively new phenomenon 
where users share information and interact with others on internet platforms. 
The effectiveness of using social media to share information to change 
professional practice is unknown but some GPs have been using Twitter in 
different ways: as a source of medical information and education, to obtain 
insight into what the public are thinking, and interacting and debating with 
influential thinkers. Twitter has been found to be particularly useful as 
information is concise, it could be disseminated widely from a trusted source or 
individual and although the message is short (140 characters), it could include a 
link to more detailed information such as a journal article. 
“I would say that having the evidence in a bite-sized form, in a tweet maybe, 
wow, I mean that would be great ... with a little link and said, just in one 
statement, doing this, prevents this, you know, published by GP academics 
whatever” Tower Hamlets GP3 
Normative beliefs 
According to TPB, normative beliefs and subjective norms can influence a 
person's likelihood to implement behaviour. Normative belief refers to an 
individual's perception of social pressures, beliefs that he or she is expected to 
perform this behaviour. Subjective norm is an individual's perception about how 
they would be judged by significant others about a behaviour. Some forms of 
social pressures contributed to behaviour including pressure to conform, 
professional expectations and pressure to perform well compared with peers. 
Pressure to conform: Professional expectation 
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There was a feeling amongst GPs and nurses that delivering good preventative 
care made a difference to patients’ health, regardless of influence or financial 
incentive, was a strong motivating factor and professional virtue. This was an 
example of the professional value that was established through training and 
ingrained in professional culture so there was no doubt that prevention is 
delivered in practice. 
“We did that purely out of a sense that this was the right thing to be doing, not 
because we were getting incentivised in any way, although it was like being in a 
club.” Tower Hamlets GP2  
“I think as a GP, one of our aims is prevention, that’s the way I was always 
taught and brought up.” Lambeth GP2 
There were some differences in the way GPs and PNs worked to deliver HPDP. 
PNs were more likely to see it as their role and in their job description, expected 
to have and spend more time to discuss issues with the patients and have 
health promotion as expected agenda in their consultations. This view of PNs in 
the context of delivering health promotion was the same from both GPs and 
PNs; some PNs also thought they were more likely to consider health promotion 
from a patient’s perspective, 
“The most important skill of a practice nurse is advanced consultation skills … 
because you’re never going to get any engagement with any health promotion 
activity unless you do it from the patient’s viewpoint.” Tower Hamlets PN1  
The responsibility for HPDP is not confined to practice nurses as some GPs 
reported that it is a component of a well-known consultation model (Stott and 
Davies – mentioned in Chapter 1) so it is expected from GPs too.(8) 
“We try and incorporate it into every consultation, try and use the [Stott & 
Davies] model of health promotion so depending on what they’ve come in with, 
it gets a lot of time or not very much time.”  Lambeth GP2 
Pressure to perform: Reputation and pride 
Apart from professional expectations to deliver HPDP for both GPs and PNs, 
there were also expectations to perform well and failure to do so might incur a 
reputational loss, shame, or embarrassment. Having a good professional 
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reputation and a sense of pride in their work and their practice were important 
factors for delivering HPDP and good clinical care. Some GPs and PNs felt it 
was important to know that they or their practices were well-performing, 
including in public health outcome measures, as it gave them a sense of 
professional satisfaction and pride.  
“I just want to belong to a nice place and I think it’s also how patients perceive 
you, because all the data is out there for them to see. And it’s also that hope that 
having those registers we are doing nearly everything that is possible, for 
whatever we have the medical evidence that we’re doing and offering it to them. 
And if outcomes are better, why shouldn’t we be doing it?” Haringey GP5 
Not only was reputation and performance important for participants that their 
practices did well, for some GPs this extended to their PCTs too. 
“I am interested in my PCT. I want Haringey to do well”. Haringey GP3 
Some GPs attributed their ambition to perform well and their work ethic to their 
cultural background. For two GPs of Asian backgrounds, they reported how it 
was important in their culture to work hard for a good reputation and their work 
ethic permeated through to the organisational culture to perform as well as 
possible.  
“Well, we’re Asian so for Asians, reputation is important.” Lambeth GP2  
Pressure to perform: League tables, competition and shaming 
For some participants, a good performance might mean meeting targets or 
expectations, or doing better than others, using the performance of other 
practices as reference points, leading to competitive behaviours. League tables 
might influence practice by encouraging desirable performance as a pressure to 
conform by peer referencing. GPs and PNs interviewed were interested to find 
out their practices’ positions on league tables for various performance measures 
such as prescribing, cervical cytology, chlamydia screening, childhood 
immunisations and influenza vaccinations. The reactions to seeing their practice 
in the lower half of league tables ranged from disappointment and surprise to 
defensiveness. The importance of league tables was clear early in the 
interviews and this was added to the interview schedule to discuss in 
subsequent interviews. 
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“I think that works well … we get these bar charts from the prescribing advisors, 
pitching your practice amongst all the other local practices to see how you do, 
and the ones obviously in red, you don’t want to be in red.” Haringey GP4 
All GPs and PNs admitted they took notice of performance tables, but one 
reported she felt indifferent about her position in her own practice’s league table 
of influenza vaccinations; however, she did concede this put some pressure on 
her to give more vaccinations, thereby confirming the effect of peer influence.  
“I’m often in the lower quartile for that [flu vaccinations] personally but I think 
it’s really good. It’s good to audit and you’re aware of what you’re doing 
compared to others.” Lambeth GP3 
Competition could be interpreted as pressure to outperform peers, which might 
also involve the use of league tables for peer referencing. In Tower Hamlets, 
groups of neighbouring practices work within a network and their achievements 
are compared with other practice networks. This arrangement could drive up 
standards as lower performing practices within the networks work harder to be 
comparable with their peers and in return their peers support them to improve 
their collective performance. The constituent practices felt responsible for not 
“letting down the whole network”; this may produce pressure to both conform 
and perform. 
“Our network has four practices in it, two of the practices are based in wealthier 
areas and two of us are based in poorer areas demographically. So the two of us 
in the poorer areas are always making direct comparisons … so we’re always 
trying to keep up with the Joneses’” Tower Hamlets PN1 
“I think the NIS [Network Improved Services] in Tower Hamlets has definitely 
helped with the competition, not in a negative way but I think because you are 
constantly compared to other networks. There’s constantly this thinking you 
know, we definitely don’t want to be bottom.” Tower Hamlets GP5 
League tables appeared to generate strong behaviour intentions in general. 
There were strong responses to inferior performance on league tables and for 
one GP treating it as an “incident” for the practice to investigate. The league 
table position was reported to be taken quite seriously by a few GPs. The top 
quartile position was a desirable place to be for most and seeing their practice 
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in the lower quartile was a cue for them to consider ways to improve their 
performance; being in the “healthy middle” was also considered to be 
acceptable.  
“I’d be quite embarrassed to be honest, a little bit angry, disappointed [to be in 
the lower quartile]. And then immediately there will be an analysis of why has 
that happened or how has that happened.” Lambeth GP4 
“You always want to be, not necessarily at the top of the table, but you want to 
be somewhere healthily in the middle, don’t you?” Haringey GP5 
Sometimes it was not the position that mattered but to be aware that one was 
not the “outlier” and to help benchmark one’s performance with similar 
practices. 
“Gosh, I don’t think it’s a competition but certainly it’s significant if we’re an 
outlier and not achieving what our colleagues nearby are achieving for your 
population.” Hackney GP2  
League tables also provoked anxieties in some who were wary that practices 
could be open to judgement by the public based on their position on league 
tables as some performance indicators are publicly available from the internet, 
so it was important to perform reasonably well to maintain public confidence 
and not be considered as a practice “in trouble”. The way league tables were 
used as peer referencing needs to be interpreted with caution, especially when 
there are very minor differences between the best and worst performers, small 
fluctuations could make significant differences on the scale, thereby unfairly 
affecting the reputation of a practice. 
“A graph like that [league table], it only takes a minute amount of deterioration 
and you suddenly are on that end.  So, although the red bar is within the top 
quarter, a tiny difference could drop you two-quarters on.” Tower Hamlets GP5  
The anxiety of not wanting to appear to be at the bottom of any league tables 
also led some participants to consider the effects of “shaming” and questioned if 
public humiliation was necessarily the best approach to change people’s 
behaviour; a low position on league table might make a practice judged to be 
inferior by their peers and the public. 
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“I think there’s a certain degree of like shaming when, or fear of shame, because 
when you know your data is going to be discussed at a meeting, then you might 
think oh, you know, we’ve been a bit slack there.” Tower Hamlets GP3  
A good rating or league table position was not just a matter of reputation and 
pride for participants but some thought it might also reflect practice 
achievements and quality patient care. However, the validity of using league 
tables to measure quality could be questioned; for example, it is difficult to judge 
individual clinical performance using referral rates to hospital, and surgeons’ 
performance using crude outcome measures such as death rates. 
“We get data but I don’t think it’s – you would necessarily relate it to quality … 
you can compare it to all other clinicians and you can see whether you’re 
referring more or less for example, although I think – I know that that has very 
little to do with quality of care.” Hackney GP1  
Overlapping constructs – behaviour beliefs and social norms 
Some behavioural modifying interventions might have effects on more than one 
construct of TPB. For example, strategies that inform clinicians of their practice 
performance against their peers might help them to conform to professional 
expectations (normative beliefs) as well as change their attitudes to clinical 
practice (behaviour beliefs). These interventions might include audit and 
feedback, opinion leader, educational outreach visits and tailored interventions.  
Social strategies with educational elements: Audit and feedback 
Healthcare professionals might be prompted to modify their practice if they were 
given feedback, if their performance were inconsistent with that of their peers or 
accepted guidelines; this could be a way to encourage clinicians to conform to 
certain expectations and change their beliefs and, therefore, behaviour 
intention.  
The response from participants regarding this strategy was generally positive 
and there was a desire for feedback on screening performance from GPs and 
practice nurses, regardless of practice type, area, and public health/screening 
performance. The type of feedback ranged from monthly returns, practice visits 
and league tables comparing performance with different practices or other 
areas.  
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“Well I do think it does make a difference to actually have a sense of how you're 
doing, so I do believe that’s a very important ingredient in terms of partly 
motivating but also partly actually highlighting something.  The trouble is, if 
you don’t know, you haven't got any idea how you're doing in those or even that 
it's an issue, then, you know, that’s not helpful. If you really want to make this 
work you need, you know.” Tower Hamlets GP2  
Some participants mentioned that they wanted feedback about the impact of 
their HPDP activities to evaluate if their effort had been worthwhile, for example, 
if chlamydia screening had any impact for their patients. Feedback not only 
helped to compare a practice against a benchmark, but might help individuals to 
go through a cognitive process of reflection to consider how to improve their 
practice. If positive outcomes of screening programmes were fed back to 
participants, this might encourage some to deliver even more screening. 
For some GPs, their medical training meant they were “socialised” into looking 
for pathology so wanted to see if screening resulted in finding diseases that 
they could treat. Not seeing any results despite the effort of screening could be 
demotivating, resulting in negative feedback to the participants to test less 
often. Similarly, picking up a case of chlamydia through screening encouraged 
some to offer more testing because this demonstrated screening programme 
influenced case findings. 
“I just have not picked up a few but very, very few positives … this sounds 
really terrible but being a doctor and the way you’re trained … but like 
pathology is actually quite interesting and then it kind of …it’s just not very 
interesting.  It’s like an administrative exercise.” Tower Hamlets GP1 
Social strategies with educational elements: Local opinion leader, Educational 
Outreach Visits, and Tailored interventions 
Although the Cochrane systematic reviews described opinion leader, 
educational outreach visits, and tailored interventions as discrete interventions, 
it was difficult for the participants to differentiate them as they had similar 
processes, e.g. delivery of an educational event, delivery by a peer or trusted 
individual (e.g. a local prescribing advisor) and discussion of barriers to change.  
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Like audit and feedback, the other behaviour modifying interventions might 
influence two constructs of TPB: subjective norms and attitudes. Opinion leader, 
educational outreach visits and tailored interventions might use feedback to 
enable clinicians to compare their practice with standard practice or their peers, 
and some educational elements to help them improve their practice by changing 
attitudes and therefore behaviour intention. 
Only GPs in Lambeth had the influence from a “GP Champion” in the context of 
chlamydia screening but this was confined to “low screening practices” where 
the GP champion would visit and support them to improve their screening. One 
practice improved their chlamydia screening performance after their input and 
achieved highest rate in that PCT. The GP from that practice felt that their 
involvement to support their peers felt like a “motivational boost” for them and 
encouraged them to maintain their behaviour.  
“For us I mean I wouldn’t say he [chlamydia screening GP Champion] 
influenced what we did on the ground, but his role for us as a high achieving 
practice was to give encouragement to get to other surgeries. So, he presented it 
as I just want to find out what you guys do because there are other practices that 
aren’t doing so well and I’d like to be able to share that. So, that was quite a 
motivational thing. That’s good, we like that, you know.” Lambeth GP4 
Some participants had experience of educational outreach visits in other forms. 
The purpose of these ranged from disseminating information about campaigns 
such as obesity to quality assurance (e.g. prescribing advisor), chlamydia 
screening, to promote a local “enhanced” service that the practice was expected 
to deliver, establishing relationships with local hospital and specialists to 
improve long-term condition care. There was a range of responses about the 
visits and the effects ranged from a clear memory of the message leading to 
behaviour change to a vague recollection of detail. 
Some of the educational outreach visits were “top down”, meaning the agenda 
was set externally and not by the practice or clinician’s learning need. This 
meant the learning might not be as valued as one that was initiated by the 
clinician themselves. Sometimes the meetings were held when clinicians were 
distracted by other issues so the content was not necessarily useful at the time. 
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“… people coming in and presenting their thing about some programme to get 
people active and it was such a boring waste of time and it was really sad 
because they’d wanted this meeting and all of us were just so overwhelmed with 
work that having half an hour out of our day, when you could be doing, you 
know, consultations and paperwork or home visits,” Tower Hamlets GP3 
However, some visits were received very differently, such as a visit by a 
prescribing advisor to a practice to change prescribing practice, the delivery of 
the main message was retained vividly by the GP which made her change her 
prescribing behaviour and made a difference for her patient’s asthma 
management. 
“Yeah …the Fostair [a type of asthma inhaler] one was quite convincing. And 
he did attend the practice because it sounded great and these little particles that 
are going to go right down to your lungs and it was so much cheaper and I did 
change a patient to Fostair who was really happy with it. He wasn’t using his 
inhalers before.” Haringey GP5  
Control Beliefs 
In TPB, knowledge of the role of perceived behavioural control came from 
Bandura's concept of self-efficacy.(54, 140) Perceived behavioural control 
include beliefs concerning whether one has the necessary resources and 
opportunities to perform the behaviour; how difficult it is to perform the 
behaviour and how confident an individual is that they could do it. Their 
perceptions of factors that facilitate or inhibit the behaviour are referred to as 
“control beliefs”. These can be internal (such as personal skills, abilities, and 
emotions) and external (such as opportunities and physical barriers) control 
factors. People who believe they have the necessary resources and think that 
there are opportunities (or lack of obstacles) to perform the behaviour are likely 
to perceive a high degree of behavioural control.(60) 
The interview data also suggests other determinants that influence an individual 
clinician’s perception of facilitating factors or barriers to performing certain 
behaviours, these include: computer reminders, organisational barriers, and 
health care professional-patient relationship. 
Computer reminders  
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Clinicians might have the necessary skills to deliver public health interventions 
but forget to do so during a busy consultation. Computer reminders or “pop-up” 
help clinicians to offer public health interventions in a timely manner because 
they remind the clinicians to perform the necessary tasks during the 
consultation with the patient who might benefit, so can be interpreted as an 
enabler of behaviour intention. 
All participants had experience of computer reminders that “popped up” to 
remind them to offer certain checks when patients attended consultations. 
Participants who viewed reminders as helpful also adapted their consultation 
styles to be efficient in addressing them, such as checking what needed to be 
addressed before calling a patient in. Some only executed the reminder if they 
felt it was appropriate for that consultation. A computer reminder was added for 
chlamydia screening for the target age group which facilitated opportunistic 
screening for some participants. Those GPs who initially found them 
“bothersome” realised how much they facilitated a consultation and attitudes to 
these computer reminders changed as a result.  
“Before a patient comes in, I look at the record when they were last in, I can 
read the hospital letters, look at investigation results and may look at the QOF as 
well so I incorporate that into the time we have together.” Lambeth GP4  
“When I first started doing training posts in general practice, I found them 
absolutely bothersome, loathsome, and they distracted me from the problem, 
because I wasn’t able to manage with all that stuff as a very junior trainee. I 
could not survive without them because how can you think to yourself to check 
whether they’ve had a smear and had their blood pressure checked and had their 
smoking business recorded and you know, prevention advice given.” Tower 
Hamlets GP3 
In addition to computer “pop-up” reminders, structured consultation templates 
could also be interpreted as “on-screen computer reminders”; they are often 
used in some consultations to standardise consultation entries and could help to 
ensure essential information is gathered. Unlike the “pop-up” alerts which 
automatically appear when a patient’s notes are pulled, clinicians must load the 
templates during a consultation. Templates might feel restrictive for some but 
for GPs doing postnatal checks on women, the use of computer templates 
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made consultations more structured and helped to offer information such as 
vitamin D to patients. A sexual health template has been used in a PCT to 
deliver chlamydia screening and sexual health checks but the participants in 
one practice had been used to offering them so the template did not add much 
to their practice. These templates can therefore be tools that facilitate certain 
behaviour intentions such as delivery of public health programmes. 
“Because it is at the eight-week check and it is a structured interview and it is on 
a template and I have the right leaflet so there’s more structure to it. I think it is 
the opportunistic nature and doing consultation.” Haringey GP4  
There were participants who regarded pop-ups negatively and thought they 
were an annoyance and either ignored them, switched them off, and some even 
became desensitised. Even for those who found them helpful, there was a 
feeling that they could be intrusive, inappropriate or irrelevant to the 
consultation. Clinicians had control over whether to carry out the reminders 
depending on the context, one practice even had administrative staff that 
regularly monitored alerts that were not actioned and fed back to the doctors to 
address them. 
“I try not to ignore them but it’s difficult… if your patient’s coming in with 
depression and they’re crying and the pop-up comes up for checking their 
diabetic peripheral, their pulses and stuff, I’m sorry but that’s just something I’m 
not going to address.” Lambeth GP1 
“To be quite honest, the pop-ups come up too often. I don’t - they go into my 
subconscious now and I don’t really, yeah, I don’t see them anymore.” Tower 
Hamlets PN2 
Organisational barriers 
For chlamydia screening programme, the participants thought there were 
organisational issues that affected their likelihood of whether to offer screening 
or not. These were ease of access to or availability of chlamydia screening 
packs and the ease of filling in the forms and dealing with the samples. Others 
mentioned organisational aspects such as reception or administrative staff 
engaging patients and having chlamydia screening packs in convenient 
locations for patients to pick up which facilitated the screening process.  
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All participants agreed about the complexity of forms that had to be filled in and 
some of the sampling techniques were barriers to screening. Some complained 
it was not worth the financial remuneration; others complained they had patients 
with problems understanding English and had to assist them, potentially adding 
time to an overrunning consultation. The opinion was similar across practices 
with all levels of chlamydia screening achievements. It is important to note that 
it was the perception rather than actual difficulty of filling in the form that was 
the determinant of control belief. 
“With the forms, yeah, to fill in the forms, so it’s kind of time-consuming…so 
you ended up having to write it all down and the whole thing took five minutes, 
the mobile number and all this, so I don’t think seven quid or eight quid was 
appropriate for that.” Tower Hamlets GP4 
Healthcare professional-patient relationship 
Although health promotion might be a component in some models of GP 
consultations, some GPs (as well as PNs) were concerned about how it fitted 
within the consultation, especially when they thought the priority should be to 
deal with the patient’s agenda in a patient-centred consultation.(8) This might 
be an example of a barrier, such as “perceived behaviour control”, where 
participants felt unable to perform certain behaviours due to perceived intrusion 
or being unwelcome by the patient. GPs and PNs raised specifically concerns 
about appropriateness, the lack of time and undermining the doctor-patient 
relationship. Some of this tension might explain why participants felt they are 
not able to initiate discussions about health promotion or screening.  
“That’s the tension between the kind of patient-centred care and disease 
prevention of the population isn’t it because I know that the patient sitting in 
front of me, their cervical smear is not the most important thing on their agenda. 
But equally, I know that they’re potentially quite a high-risk group for cervical 
cancer and therefore it is important.” Lambeth GP1  
“The thing that bothers me about it is the intrusion on the patient’s agenda. If 
you’ve got 10 or 12 minutes for an appointment and you were taking your job 
seriously and your patient seriously then it’s really in danger of undermining the 
doctor-patient relationship.” Hackney GP1 
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Behaviour intention 
TPB suggests three main predictors of behaviour intentions – behaviour beliefs, 
subjective norms and perceived behaviour control.(53, 54) Behaviour is the 
individual’s observable response to a given situation with respect to a given 
target. Whereas behaviour intention is an indication of an individual’s readiness 
to perform a behaviour; it is the antecedent of that behaviour. Additional 
predictors for behaviour intention have been suggested by Conner and Sparks 
and these include: self-identity, anticipated regret, past behaviour and moral 
norms (Figure 17).(139) Personal characteristics or self-identity (in terms of 
gender and lifestyles) was a theme that was evident in the data that affected 
participants’ likelihood of delivering health promotion and disease prevention.  
Clinician’s personal factors: gender 
Female participants acknowledged their gender had a part to play in how they 
promoted screening to women and for those who experienced public health 
programmes such as cervical cytology and breast screening, reflected on the 
advice they gave their own patients. This ranged from feeling obliged to lead by 
example, feeling ambivalent about screening, and being more evangelical about 
promoting screening because of experiencing an abnormal test.  
“I suppose in my head, I’m a woman and I think it’s important… is more about 
the women’s experience and I feel quite passionate about cervical screening...  
And yes, I do want to get every woman, I want to get the message about there, 
but I’m also using my time with individual women to spread the message” 
Tower Hamlets PN1 
 “. … when I was very young, I had an abnormal smear myself and that was, you 
know, very troubling.” Tower Hamlets GP3 
Clinicians’ personal factors: lifestyle 
Some GPs with lifestyles judged to be healthy reported they felt keen to 
promote these to their own patients; these ranged from healthy eating and 
physical activity, smoking and alcohol. However, their enthusiasm could be 
interpreted as evangelical or patriarchal by some, particularly if patients were 
not able to leave the room without being “talked to” and “brainwashed”.  
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“One of our salaried doctors is particularly keen on nutrition and weight. He’s a 
sports medicine doctor, so he is very keen on giving weight advice, the 
overweight children, he will not let them get out the room before they’re 
weighed and the parents have been talked to. I’m a non-smoker.  I don’t 
particularly like smoking so I tend to give smoke related advice. Alcohol, again 
I’m not a big drinker, so yes I’m happy to give (advice).” Haringey GP4  
Two further themes were identified by the interview data that were not 
adequately explained by Ajzen’s TPB framework (or Conner and Sparks’ 
determinants of the constructs) that could influence behaviour intentions; these 
include organisational influences such as policy and contracts, and financial 
incentives. 
Organisational influence – policies and contracts 
Government health policies such as those from the Department of Health (DH) 
in England, local “enhanced services” and GP national contract influenced 
some participants’ behaviour as these were sometimes linked to financial 
reimbursements. Examples include NHS Health Checks, DH advice on vitamin 
D in pregnant women, and new vaccination programmes such as influenza, 
shingles, and rotavirus. Some participants described how they readily accepted 
some of the programmes, especially nurses who tend to deliver the vaccination 
programmes. 
“In a way, as long as I’m not harming people, if it’s part of a national 
programme I will go with that for as long as the government are putting money 
into it” Tower Hamlets PN2 
“So some because it’s a national programme, so national screening programmes, 
for example, some because it’s part of the GP contract. Some because it’s part of 
locally enhanced service.” Hackney GP1  
Although some participants delivered these initiatives without question there 
was healthy scepticism from some GPs and practice nurses who preferred to 
appraise the policies critically before deciding to implement them and to help 
patients make informed decisions. 
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“I think we would always question programmes that are given to us by external 
bodies and we would challenge them as well if we felt they were unworkable.” 
Haringey GP5  
In some instances, contractual obligations to deliver some types of care felt 
authoritative or coercive. Some practices which held Personal Medical Services 
(PMS) contracts with the government to deliver primary care had strict key 
performance indicators (KPIs) attached to their contracts. Sometimes this 
meant there were financial penalties for not meeting some targets, such as 
having funding clawed back. For these practices, the threat of financial 
penalties meant they faced pressure to deliver some public health programmes 
to meet or exceed these KPIs so had little choice but to comply. 
“It’s part of our PMS contract review. All new patients should be offered an 
HIV test… So there’s a heavy push from the CCG, one of its seven health goals 
is to diagnose more HIV cases early. So from CCG to internally and part of our 
contract, there’s all these different reasons why we have to.” Lambeth GP4  
Organisational influence - Financial incentives 
Financial incentives are attached to some public health programmes to 
encourage general practitioners to deliver them. These include target and fee-
for-service payments for immunisations, cervical cytology screening and 
influenza vaccinations. General practitioners now deliver some health care 
under the quality and outcomes framework (QOF) of the national GP contract 
which is one example of a pay-for-performance system that many GPs and 
practices nurses are familiar with. All the participants had a view about how 
financial incentives affected their practice. For some, financial incentives 
attached to certain activities were strong motivators especially if there were 
doubts regarding effectiveness without which they would not have otherwise 
participated.  
Financial incentives were used by PCTs to encourage chlamydia screening 
from GPs, as described in Chapter 5. Most participants recalled some form of 
financial incentives offered by their PCTs to screen for chlamydia such as 
payment per screen, target payments or a mixture of both. Although some 
thought the reimbursement was enough to change practice, others felt that if it 
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were not for the financial incentive, the programme would not have had the 
support in general practice. 
“Even the Chlamydia screening programme, the payment for that is not that 
great. So, in the great scheme of things to either get paid or not get paid for an 
organisation like us is not a major issue.” Lambeth GP1 
General practice is a business so it is not surprising to hear GPs and PNs 
discussing the realities of having to maximise income streams to run their 
practices. They were pragmatic about delivering services which earned them 
money which they would otherwise felt ambivalent about, but it meant they 
could spend the money on something they valued more but that was not directly 
funded. Some GPs felt specific financial reward was just a reality of how 
general practices earn their income, and reimbursement would need to be fair 
to reflect the work.  
“It’s because we’re fiscally corrupt and we’ll do things of marginal clinical 
benefit for significant financial benefit, justifying it on the grounds that maybe 
we’ll use that money that we get for doing something of marginal benefit for 
something that’s a bit more useful. ...” Hackney GP1  
Others felt morally troubled by the money attached and thought some activities 
should not be incentivised as it is what is expected of GPs and PNs. For some, 
financial incentive was not important if the intervention was believed to be of 
value to the patient, and some would deliver it even without the incentive. 
“I do not give a toss about [financial incentives] to be honest.  If giving flu jabs 
is good for the patient, which I believe it is, and saves lives, prevent unnecessary 
deaths, and it can help keep our lovely punters happy and well, then I’ll push for 
it.” Tower Hamlets GP3  
PNs as well as recently qualified GPs were especially vigilant with targets and 
their relationship with practice income. The former group are used to working 
towards targets such as cervical cytology, childhood and influenza 
immunisations, all of which have payments associated with them.  
“Any practice nurse knows that if you’re going to stay in employment you need 
to earn your way and therefore you need to be producing something that’s an 
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income earner for the practice otherwise you’re not worth employing.” Tower 
Hamlets PN2  
Younger and more recently qualified GPs remembered being taught about 
practice income and financial management as part of their training.  
“Certainly, as a trainee, all I would hear being into us: because of the income, if 
there’s no income … and I think that does come drummed into you slightly, just 
because that’s what you see your peers doing or talking about or discussing.” 
Lambeth GP3 
Finally, there were minor differences between the professional groups. The 
responses from PNs reflected their roles in health promotion such as giving 
immunisations, performing cervical cytology, and discussing lifestyle issues with 
patients, whereas GPs said they would discuss these if relevant to the 
consultations or responding to computer reminders. The nurses felt it was not 
just their role to deliver the public health programmes but also because they 
were aware many of these are linked to practice targets and income, and as 
mentioned above, they felt these reflected their performance. They had 
otherwise similar behavioural influences and were just as likely to be sceptical 
about some programmes as the GPs, for example, influenza vaccination in 
children. 
Summary 
I used the constructs of TPB as a conceptual framework to present the findings 
from the interview: behaviour beliefs, normative beliefs, and control beliefs, as 
well as behaviour intention.  
Behaviour beliefs 
Beliefs and values about the outcome of public health programmes could affect 
the likelihood of the behaviour being implemented. Participants were more likely 
to have a positive attitude to a programme if they believed the evidence, had 
positive beliefs about the evidence and its provenance. However, different 
clinicians could interpret the same evidence differently; examples of different 
interpretations included influenza vaccination and chlamydia screening.  
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The way the participants felt about the outcomes of HPDP activities was likely 
to affect their intentions to deliver health promotion and the same was also true 
about the perception of the patient’s capacity to benefit from a programme. On 
the other hand, participant’s attitudes to an HPDP programme might be less 
favourable if the expectant outcomes for patients were detrimental, including 
unintended consequences of screening programmes, such as “overdiagnosis” 
and “overtreatment”. 
Some behavioural interventions such as educational events, audit and 
feedback, educational outreach and media strategies could influence the 
attitudes to some public health programmes, thereby facilitate or deter the 
clinicians’ intentions to deliver them. Mass media appears to be a strong 
influence on attitudes and behaviour; it could facilitate messages about public 
health programmes quickly to healthcare professionals such as new 
vaccinations, but conversely could cast doubts about others such as breast 
screening.  
Normative beliefs 
Peer influences and social expectations appeared to have contributed to some 
behavioural intentions. Some HPDP work was expected for both GPs and PNs. 
There was pressure to adhere to guidance from the Department of Health or 
NICE and a pressure to perform well in front of their peers. The use of league 
tables provided a way of comparing practice performance and “competing” with 
their peers, but there was caution on how these should be interpreted, 
particularly as a way of “shaming” practices to conform. Behaviour interventions 
such as audit and feedback, educational outreach visits, local opinion leaders 
also make use of comparisons with other practices in benchmarking exercises 
and might help to change attitudes and improve clinical practice.   
Control beliefs 
Organisational and structural barriers such as not having the correct equipment 
or the complexity of forms were enough to make some less likely to implement 
programmes such as chlamydia screening. While some participants found on-
screen computer reminders helpful to facilitate their consultations, others found 
them distracting and “intrusive”; for most participants, they seemed to be an 
accepted part of everyday consultations.  
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Reconciling the tension in the consultation room between a clinicians’ and 
patients’ priorities and agendas had a direct effect on the likelihood to deliver 
some public health programmes. There was a concern among some healthcare 
professionals that some public health interventions might be intrusive to the 
point of affecting the therapeutic relationship between the health care 
professional and the patient, and others who found it difficult to raise the topic of 
health promotion because it was “inappropriate” or perceived to be “blaming” an 
individual’s unhealthy behaviour. 
Behavioural intentions 
Personal attributes are known to affect behaviour intention. The data suggests 
attributes such as a clinician’s gender and lifestyles might affect likelihood to 
deliver public health programmes. Female participants had experiences of 
screening programmes such as cervical cytology and breast screening; 
sometimes this made them reflect on the advice they gave to patients. Non-
smokers and non-drinkers were keen to promote these messages to patients. 
One further theme emerged which was not mapped by TPB or Conner and 
Sparks’ predictors of individual constructs. Organisational influences such as 
government policies and contractual obligations affected behaviour intentions 
but these could be viewed as authoritative and coercive. Similarly, financial 
incentives are another type of influence directed at the level of the organisation 
that affected some participant’s behaviour intention to deliver HPDP 
programmes. Sometimes organisational factors such as working under a 
contract with penalties for not meeting key performance indicators meant there 
was pressure to comply but with a sense of threat and control. 
Conclusions 
These interviews helped gain an insight into why GPs and PNs implemented 
some HPDP programmes and provided explanations why they would not. TPB 
was useful to understand the behaviour intentions, particularly as most themes 
could be mapped to the constructs of TPB and their “components” as outlined 
by Conner and Sparks.(139) Not all of the themes could be mapped discretely 
onto each of the components or constructs as there were some overlaps 
between them, nevertheless, this conceptual framework was useful to help 
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understand the determinants of primary care clinicians’ behaviour to deliver 
public health programmes (Figure 16).  
The fact that most of the themes generated through analysis of interview data 
could be mapped to the individual constructs of TPB suggests this theory is 
useful in explaining their behaviour intentions. For example, believing that a 
public health intervention has benefits encourages clinicians to deliver it to their 
patients (behaviour beliefs); having a system where public health targets from 
practices are compared, such as league tables, can generate a sense of 
competitiveness and pressure to conform to peer expectations (normative 
beliefs); some clinicians might feel some public health interventions might be 
inappropriate for their patients, or they might not have the skills to deliver them 
(behaviour beliefs); some personal attributes such as gender and lifestyles can 
also determine if certain health promotions and screening programmes are 
offered by clinicians (behaviour intention).  
The interviews also help gain further insight into why some interventions, based 
on empirical studies to modify the behaviour of clinicians as outlined in the 
overview of systematic reviews in Chapter 4, might or might not work. Not 
everyone responded to these behaviour interventions in the same way; this 
could explain why multi-faceted interventions might be more effective than 
single-intervention based behaviour change methods to maximise response 
from individuals. The interviews also offered some insights into how some of the 
interventions could be made more effective – for example, according to some 
healthcare professionals, they are more likely to respond to printed educational 
materials if they were concise and produced by a trusted organisation. 
In addition to behavioural interventions based on the constructs of TPB that are 
directed at the individual, interventions directed at the organisation – such as 
contractual levers and financial incentives – could also influence behaviour. 
Contractual mechanisms can have a strong, sometimes coercive, influence on 
performance with financial penalties for not meeting delivery targets. Financial 
incentives could be considered to act on the individual or the organisation, 
depending on who benefits directly or indirectly. Systematic reviews suggest 
financial incentives have modest effects on healthcare professionals to increase 
immunisation rates,(121) but there is currently insufficient evidence to support 
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interventions at the level of organisations that improved professional 
practice.(141) 
So far in this thesis, I have explained that we have some understanding of how 
people in general behave using behaviour theories, evidence of behavioural 
interventions from systematic reviews and insights from a qualitative study into 
how GPs and PNs are influenced to deliver public health programmes. In the 
next chapter, I will summarise the findings of this thesis, its contribution to 
current understanding of modifying behaviour primary care clinicians, and 
discuss how these findings could be used to influence GPs and PNs to deliver 
other HPDP programmes and suggest implications for research, policy, and 
practice. 
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Chapter 7 – Discussion  
This chapter forms the final part of the thesis: it summarises preceding chapters 
including: findings from overview of systematic reviews and qualitative study; 
contributions to knowledge, implications of the findings for policy and practice; 
limitations of studies; and suggestions for future research.  
Health promotion and disease prevention (HPDP) in general practice 
In Chapter 1, I suggested general practice in the UK NHS is an important 
setting for delivering public health interventions at both the individual and 
population levels. At the individual level, GPs and PNs see patients, offer health 
promotion and other health advice to their patients.(1) At the population level, 
the list of registered patients is often used to invite those who are eligible for 
public health programmes such as immunisations and screening. However, 
HPDP programmes might not be delivered consistently or effectively in general 
practice. The barriers for GPs and PNs might include: limited consultation time, 
lack of skills to deliver health promotion, different priorities between clinician 
and patients and different expectations from patients, so it might be difficult to 
address public health issues during the consultation.(26) 
I have been an advocate of public health and sexual and reproductive health 
throughout my career and wanted to find out what motivated GPs to deliver 
public health programmes. I wanted to use what I found in this thesis to involve 
GPs in health improvement; this has been the motivation for my thesis.  
Behaviour change theories and their applications 
Behaviour theories could be used to explain and predict healthcare 
professionals’ behaviour and help to design interventions to modify them. Some 
popular theories were considered in Chapter 2 as applied to HPDP, these 
include Health Belief Model, Theory of Reasoned Action and Theory of Planned 
Behaviour.(53, 63, 142) These behaviour theories explain and predict behaviour 
at the individual level. 
Ajzen’s Theory of Planned Behaviour (TPB) suggests that the best predictor of 
a behaviour being implemented is the intention. The intention of a behaviour is 
dependent on three factors: personal attitude (derived from beliefs about 
behaviour), subjective norms (derived from normative beliefs) and perceived 
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behaviour control (derived from control beliefs). TPB appears to be efficacious 
in predicting behaviour intentions according to a meta-analysis of 185 
independent studies and has been applied in predicting health behaviour.(66) 
The theory was also used to design a trial to improve chlamydia screening in 
general practice.(48) I therefore thought it would be a useful a conceptual 
framework to consider the influences of behaviour in primary care professionals 
to deliver public health programmes. 
The use of TPB to explain a clinician’s intention to offer chlamydia screening to 
a sexually active young person at risk of chlamydia infection is illustrated in 
Figure 18.  
Figure 18 Theory of Planned Behaviour using example of chlamydia screening 
 
Drawing on the complexities of delivering HPDP programmes in general 
practice, and the understanding based on behaviour theories such as TPB, this 
thesis aimed to explore what influences general practitioners to deliver health 
Attitude
Believes offering chlamydia screening 
to a young person can help diagnose 
an asymptomatic infection and prevent 
complications and onward 
transmission
Subjective norm Intention Behaviour
Perceived pressure from other 
doctors, nurses and parents to offer 
chlamydia screening
Motivation to offer chlamydia 
screening to a sexually active 
young person under 25 years 
old
Gives chlamydia 
screening pack to 
young person at risk of 
chlamydia
Perceived behaviour control
Availability of information and 
strategies to screen young people for 
chlamydia. Able to access screening 
packs and fill necessary forms
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promotion and disease prevention programmes and how this knowledge could 
be used to design implementation strategies.  
The following were specific objectives: 
1. Assess the effectiveness of interventions that modify the behaviour of 
GPs and their impact on patient outcomes that relate to health promotion 
and disease prevention. 
2. Explore the reasons why primary care clinicians such as GPs and 
practice nurses responded to behaviour change interventions to deliver 
public health programmes such as chlamydia screening. 
Design and methods 
In Chapter 3, I outlined the design and methods used to meet the aims of the 
thesis. I justified using an overview of systematic reviews as an efficient method 
to summarise the systematic reviews of empirical studies that examined the 
behavioural interventions on healthcare professionals to improve professional 
practice and patient outcomes. Using a process of narrative synthesis and a 
validated checklist (AMSTAR criteria), I assessed the methodological quality of 
each systematic review, extracted relevant data to study the effect of the 
intervention on the behaviour of general practitioners to deliver HPDP, the 
relevant patient outcomes, as well as the theoretical bases that underpinned 
them. The findings from this overview of systematic reviews enabled me to 
assess the effectiveness of the different interventions (Objective 1).  
I used data on chlamydia screening in different PCTs in London, obtained 
through the National Chlamydia Screening Programme (NCSP), to observe the 
trends in chlamydia screening and information on behaviour interventions that 
were used to encourage screening from GPs. The chlamydia screening data 
provided some context for enquiring further about how individual practices in 
each PCT responded, and what GPs and PNs in each practice offered as 
explanations for their practice’s performance. It also helped me to choose GPs 
and PNs to interview and to explore their experiences of the different chlamydia 
screening strategies as well as other behaviour interventions to deliver public 
health programmes. 
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Lastly, I justified a qualitative methodology was the most appropriate to 
understand why the behaviour interventions directed at healthcare professionals 
might or might not work, in the context of delivering HPDP programmes. I 
interviewed a sample of GPs and PNs about their motivations to deliver these 
programmes, using a topic guide that was based on the empirical evidence from 
the systematic reviews and TPB as a theoretical framework. Although grounded 
theory might have been useful to generate new theories and ideas when 
analysing qualitative data, I explained the Framework approach had the 
advantage that data could be analysed systematically, comprehensively, and 
flexibly. It also offered an opportunity to analyse the data both inductively and 
deductively; the latter was used to explore clinicians’ motivations using 
established behaviour theory such as TPB while offering the flexibility to explore 
new ideas that emerged from the data. 
The following section is a summary of my findings. 
Summary of findings 
I conducted an overview of systematic reviews, reported in Chapter 4, to 
address the first research question for this thesis, which was to assess 
effectiveness of interventions aimed to modify behaviour of general practitioners 
to deliver health promotion and disease prevention (HPDP) programmes. This 
overview suggested there is currently insufficient evidence these interventions 
were effective in improving both clinical practice and patient outcomes for 
HPDP. The effects, if any, tended to be small and mainly limited to delivery of 
immunisations. The methodological quality of the systematic reviews was 
generally high so their individual findings were likely to be robust. However, not 
all reviews specifically reported interventions that targeted primary care 
professionals, primary care as a setting, or public health related outcomes; 
hence there was insufficient evidence to draw conclusions that related 
specifically to my research question.  
In Chapter 5, I described implementation strategies and chlamydia screening 
data in London PCTs to set the context and select the interview participants. 
The four PCTs I chose used financial incentives as the main lever to encourage 
general practitioners to deliver chlamydia screening in addition to educational 
outreach visits. Although this chapter was not designed as an individual study, I 
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observed these implementation strategies did not have consistent effects 
across the PCTs or on individual practices as there was a range of chlamydia 
screening rates in each area.  
I reported findings of interviews with GP and practices nurses in Chapter 6. I 
used the constructs of Theory of Planned Behaviour (TPB): behaviour beliefs, 
normative beliefs, control beliefs, as well as other influences of behaviour 
intention to structure the analysis of the interview data. Interview participants 
were more likely to deliver a programme if they had positive attitudes and 
beliefs about it, and if they believed the evidence and its provenance; but less 
likely if there could be harms such as “over-diagnosis” and “over-treatment” of 
an otherwise healthy person. Behavioural interventions such as educational 
events, audit and feedback, educational outreach visits and some media 
strategies might influence their attitudes and beliefs, which could either facilitate 
or deter intentions to deliver public health programmes.  
Peer influences and social expectations contributed to some behavioural 
intentions and could be summarised as “pressure to conform” and “pressure to 
perform”. Some participants were concerned about unintended consequences 
of ranking performance as a way of “shaming” practices to conform. Behaviour 
interventions such as audit and feedback, educational outreach visits, local 
opinion leaders often use benchmarking to compare practice performance and 
could help to change attitudes and improve clinical practice.   
Barriers to implement HPDP programmes included organisational and logistical 
issues such as: lack of access to equipment, and complexity of form-filling. 
Computer reminders could facilitate clinicians to deliver HPDP-related tasks, but 
some participants thought these were unwelcomed intrusion into the 
consultation which might affect doctor-patient relationships. 
Personal factors such as a clinicians’ gender and lifestyles could influence 
behaviour intentions and some of this was to do with individuals’ experiences. 
Although financial incentives affected some to deliver public health 
programmes, others had moral ambivalence about being paid for things that 
they thought should be doing anyway. Related to financial incentives are 
organisational regulations such as contracts which could affect a practice’s 
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income if they did not meet performance targets, sometimes resulting in 
financial penalties. 
Drawing on the findings from the systematic overview of 12 systematic reviews, 
I conclude there is insufficient evidence to suggest any behaviour intervention is 
effective in modifying behaviour of healthcare professionals to deliver public 
health interventions. Not all systematic reviews I examined offered theoretical 
explanations of how the interventions might work. The most prevalent theories 
used to design behavioural interventions included: Social Cognitive Theory, 
Theory of Planned Behaviour, Agency Theory, and adult education theories.  
The behaviour theories offered insights into why some of the behaviour 
modifying interventions might not work; for example, constructs of TPB suggest 
there are different determinants for behaviour intentions so unless an 
intervention addressed these determinants, it might not be surprising that the 
effectiveness of a single approach is limited. Different clinicians might have 
different motivations and intentions, they might respond to behaviour 
interventions differently, so perhaps a multifaceted approach might be more 
likely to address these factors and better at modifying behaviour. Although 
some systematic reviews considered multifaceted interventions, not all were 
effective and it was unclear which combinations would have the most optimal 
effect.  
This review also highlighted gaps in empirical research to evaluate single and 
multifaceted interventions based on behaviour theory, with a robust 
methodology, that addressed implementation of public health programmes in 
primary care settings. 
Systematic reviews can tell us if interventions work and by how much, but they 
do not explain why; it was clear that I needed to get better insights into how 
clinicians behave and respond to public health programmes and to offer 
explanations to findings from empirical studies and to inform future studies. The 
qualitative study demonstrated the complexities of the determinants of interview 
participants’ behaviour and TPB was a useful theoretical framework to 
understand some of this. This study helped to understand why some behaviour 
interventions might not be effective in practice because they often only 
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addressed one determinant; the interview data suggest participants responded 
to public health programmes and behaviour interventions differently.  
TPB as a conceptual framework to analyse interview data did not explain all the 
determinants of behaviour; for example, how financial incentives and 
contractual frameworks could influence an individual’s intention to action. There 
were also contextual factors why some behavioural interventions did not have 
impact at the individual level; for example, some participants would ignore 
computer alerts and financial incentives because the public health intervention 
was a distraction to the consultation.  
Given the complexities of how different determinants of behaviour interact and 
the context in which they could be influenced, interventions to modify clinicians’ 
behaviour might need to be designed to address these factors. In the following 
sections, I discuss what my research findings have added to the knowledge 
base and the implications for research, policy, practice, and education. Further 
critique of the methodologies and use of TPB are discussed under sub-heading 
of “Limitations”. 
Comparison with literature and contribution of study to knowledge base 
So far in this thesis, I explained how people generally behave using behaviour 
theories; and using evidence of behavioural interventions from systematic 
reviews and insights from a qualitative study, gained some understanding of 
what can influence GPs and PNs to deliver HPDP programmes. This thesis has 
three main contributions to understand how GPs and PNs could be influenced 
to deliver HPDP programmes compared with what is currently available in the 
literature. I will outline these in terms of the systematic reviews and findings 
from the interview data. 
Contributions to knowledge from overview of systematic reviews 
To my knowledge and through searching the available literature, there have not 
been any reviews that explored the effectiveness of interventions to modify the 
behaviour of primary care physicians to deliver health promotion and disease 
prevention programmes.  
The findings from my overview of systematic reviews are broadly similar to 
other published reviews that examined the literature on a broader topic. A 
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literature review published recently suggests there is a range of interventions 
which could be used to modify the behaviour of healthcare professionals.(77) 
Another review team also considered the impact of different interventions for 
implementing clinical guidelines into surgical and general practice and found 
continuing medical education and multifaceted interventions to be most 
effective.(78)   
One review (published at the time of initial submission of this thesis) examined 
strategies to implement complex interventions in primary care also concluded 
most strategies were associated with small to modest improvement in 
professional practice and process outcomes. They also found most reviews 
considered interventions based on individuals and a lack of research on 
organisational-level strategies and context-level strategies, my review also 
reached similar conclusions . (143) 
I concluded no single intervention was significantly effective in changing the 
behaviour of primary care clinicians to improve public health practice. The 
interventions that have been shown to have some effect were: on-screen 
computer reminders, audit and feedback, educational outreach visits, continuing 
medical education and possibly some financial incentives. However, the effects 
of these interventions were small and the context was mainly limited to 
immunisations as a public health outcome.  
I have also offered a theoretical perspective on behaviour interventions. 
Although cognitive theories such as TPB and economic theories underpinned 
some behaviour interventions in systematic reviews, not all reported the use of 
theories to inform the design of interventions. My review also highlighted if 
single interventions were not effective to modify behaviour, multi-faceted 
interventions might work better because clinicians might respond better to more 
than one intervention to change behaviour. This means we need to better 
understand how and why some interventions work, and hypothesise which 
combinations might work, and design primary studies that can demonstrate the 
effectiveness of co-interventions. The use of theory could thus inform the design 
of future studies on behaviour interventions to make them more effective.  
Contributions to knowledge from interview data 
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This thesis used TPB as a framework for understanding the influences of 
behaviour intentions of GPs and PNs using constructs of behaviour beliefs, 
normative beliefs, and control beliefs. The added value of my framework is that I 
considered not only the main constructs of TPB, but I also referred to Conner 
and Spark’s components of individual constructs to map themes that emerged 
from the interview data to the theoretical framework.(139) For example, it was 
through using the components of constructs that I could establish a relationship 
between the theme of “self-identity” such as gender to the construct of 
behaviour intention.  
The findings from this study seemed to correlate well with what is already in the 
literature about HPDP in primary care. A systematic review of the literature on 
the barriers and facilitators for implementation of primary prevention and health 
promotion activities in primary care used TPB as a theoretical framework.(144) 
There were some overlaps with what was found in this study including: beliefs 
and experiences about public health programmes; the (perceived) attitudes of 
patients towards health promotion programmes; beliefs about time, resources 
and financial incentives; the influence of messages via media and 
pharmaceutical industry and government policies. I was also able to add further 
themes related to the construct of normative beliefs, including: pressure to 
conform (to professional expectations) and pressure to perform (through peer 
comparison and competition). In addition, organisational interventions such as 
contractual levers that used financial penalties and sanctions for not meeting 
specified targets also made primary care clinicians comply to meet their 
contractual obligations; these could be considered within the same theme as 
financial incentives which reward desirable behaviour rather than penalise it. 
The interview data offered further insights into how and why some of the 
behaviour interventions mentioned in the overview of systematic reviews might 
or might not work. For any public health programme to be delivered, the 
clinicians must believe they have benefits for patients based on evidence; some 
clinicians did not believe influenza vaccinations were useful, particularly in 
children, so there are limits to the use of financial incentives to improve uptake. 
Educational events, outreach visits and opinion leaders might help to promote 
certain programmes, but the information needs to be delivered by someone 
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whom the clinicians could trust, in a concise manner because of the pressure 
on their time, and in a format that is engaging and memorable. 
The study findings have added more to the literature regarding strategies on 
how to improve chlamydia screening such as: framing the evidence in a way 
that helps to clarify benefits of screening and how unintended consequences 
could be minimised; using of computer reminders; and reducing the 
bureaucracy of forms. These are in addition to what is already known about the 
impact of financial incentives, educational outreach visits (using a “GP 
champion”) and tailored interventions that used TPB to identify barriers to 
chlamydia screening in general practice.(40, 135) 
Study limitations 
The study has several limitations. It is limited in scope because it only studied 
the contribution of general practitioners’ (and to a lesser extent practice nurses’) 
contribution to public health programmes; the contributions of other healthcare 
professionals such as hospital practitioners, public health practitioners and 
pharmacist were not included.  
I did not explore the effect of patient empowerment and demand for HPDP. If 
there were ways to stimulate the demand for health promotion from the public 
(e.g. request for screening and health promotion advice), this might circumvent 
many of the barriers that GPs and PNs had such as concerns about intrusion 
into consultation agenda and offending the patient. This might be one idea that 
could have been suggested if I had a Patient and Public Involvement (PPI) in 
the research design. 
Design  
The data on chlamydia screening volumes suggested increases in chlamydia 
screens in the selected PCTs but the study was not designed to analyse the 
effects of various influences on screening outcomes. However, the trends in 
chlamydia screens from practices in different PCTs in response to different 
strategies helped to generate some hypotheses and gave context for the 
interviews.  
The use of 2010 registration data rather than individual GP practice registration 
data to estimate target population for each year might have produced 
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inaccuracies in calculating the chlamydia screening rates from each practice 
over the years due to turnover of GP registered patient list, particularly the 16-
24-year-old demographic who might move around more often because of 
education or employment opportunities. However, for this study, it was not 
essential to have accurate figures as I only needed to know the trends within 
each practice to assess the changes in their screening behaviour over the years 
and the relative positions of practices within each PCT to select the “high”, 
“medium” and “low” screeners. 
There were problems interpreting the screening behaviour from GPs as there 
might have been confounders that influenced their attitudes to screening; the 
literature suggests healthcare professionals’ attitudes, beliefs, and competence 
about public health interventions all have a role in influencing their likelihood to 
screen, so it might not be valid to attribute behaviours directly to influencing 
strategies. However, the interviews that followed helped to explain some 
influences of their screening behaviour in terms of the constructs of the TPB. 
Literature review 
One main weakness of the literature review was a risk of bias due to one 
researcher extracting and appraising the reviews. Having another researcher to 
screen and select the studies based on the abstracts, assess the quality of each 
review, extract the data and interpret the findings, and using one other 
researcher to mediate any disagreements would improve the reliability and 
validity of the findings. More quantitative methods like meta-regression could be 
used to analyse the effects and outcomes but the heterogeneity of the studies 
made this challenging. 
Recruitment 
Although sampling of GPs and nurses from both extremes of chlamydia 
screening behaviour and in PCTs with and without certain behavioural 
interventions might have represented a broad view, there were problems with 
recruiting from these specific categories. The responses to interview request 
were slow and as it was also not possible to recruit specifically the “high” and 
“low” screening practices, I made a pragmatic decision to accept any willing 
participant so long as they reflected a range of practices under a broad range of 
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strategies in different PCTs. I also ensured that I had a balance of large, 
teaching practices and small practices in each PCT sampled. 
The use of chlamydia screening performance to recruit participants might not 
necessarily reflect the practice’s overall attitude and performance in different 
areas of public health, especially if there were discrepancies between 
chlamydia screening rates and other public health programmes. Recruiting 
clinicians from practices from the high or low rates in other programmes might 
have offered insight into the differences in attitudes to other public health 
programmes. The participants were drawn from practices with a diverse range 
of achievements for other public health programmes (i.e., high screeners for 
chlamydia did not necessarily have high achievements for cervical cytology, 
influenza or childhood immunisations), which suggested their practices might 
have had different values on different programmes, so it made the interviews 
more interesting and the data richer. 
Data analysis and interpretation 
There might have been issues of reliability if one researcher undertook 
interpretation and categorisation of data. This was minimised by repeating the 
coding exercise for every transcript and discussing the themes from transcripts 
with my supervisor. I used a modified Framework approach to analyse interview 
data as it is systematic, comprehensive, and transparent so it would be possible 
to have another researcher validate the data using the same process. The use 
of NVivo® to organise the data also made the analysis transparent and possible 
for another researcher to follow through the process. The code list, an example 
of coding and the Framework matrix are enclosed in Appendix G and Appendix 
H. 
As the interviews relied on participants’ recall of events, there was a possibility 
of recall bias with what they could remember. They might have felt judged when 
discussing their practice’s public health outcome data which could introduce 
courtesy bias where they discussed what I as the interviewer might have 
wanted to hear. There was also a risk of participants discussing what they 
intended to do rather than describing actual behaviour, which is a common 
issue with qualitative studies and is to be expected. However, this was 
minimised by using objective evidence as a context for interviews, such as their 
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practice’s data on public health outcomes, e.g. childhood immunisations rates, 
influenza vaccination rates and cervical cytology coverage. 
Due to the methods of recruitment for a qualitative study, there is the likelihood 
that subjects are self-selected and could therefore introduce bias in the study 
findings. Recruiting from the same source or method might introduce bias 
because participants might have similar characteristics and opinions. I tried to 
minimise the risk of selection bias by using different methods to recruit 
participants. This enabled me to get as diverse a range of participants and 
views as possible. 
Theory of Planned Behaviour as conceptual framework 
The use of TPB helped me to structure the analysis but it was not possible to 
quantify the contribution of an individual construct on overall behavioural 
intention. For example, in the construct of control beliefs, the clinicians might 
feel intrusion of patient’s agenda was a greater barrier to HPDP than the 
possible financial gains from incentives, so it might be challenging to find 
financial compensation that would be adequate to overcome this barrier. The 
TPB was limited as it is used to explain and predict behaviour in individuals; 
conceptual frameworks that considered an organisation as a unit could also 
have been used to explain the organisational behaviour with respect to 
delivering public health programmes. 
Most of the themes that were generated from the interview data aligned with the 
constructs of TPB which has been used widely to understand and implement 
behaviour change strategies in health care professionals, and concurred with 
findings from a systematic review that looked at the influences of primary care 
practitioners to deliver public health interventions.(144) The findings however, 
are context-specific, so it might not necessarily translate to healthcare 
professionals working in hospital settings.  
Psychological theories such as TPB are intended to explain relationship 
between intention and action in particular contexts, and in relation to specific 
practices. However, some psychologists have criticised them for relying on 
analyses of correlation rather than causes;(145, 146) as well as assuming too 
much about instrumental relation between attitude and intention.(147) May and 
Finch proposed a theory of normalization processes (Normalisation Process 
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Theory NPT) that focusses on how complex interventions become routinely 
embedded and sustained in practice.(148) There has been some considerable 
interest in using NPT to address factors needed for successful implementation 
and integration of complex interventions into routine practice to improve health, 
and there are calls for this to be considered when designing trials.(149) 
Generalizability of findings 
Qualitative studies cannot be judged in the same way as quantitative research 
because they aim to explore different dimensions of phenomena. Qualitative 
methods use “concepts which help us to understand social phenomena in 
natural (rather than experimental) settings, giving due emphasis to the 
meanings, experiences and views of all the participants”.(91) For example, 
qualitative studies offer insights into why chlamydia screening rates varied 
considerably amongst practices within PCTs despite financial incentives and 
educational outreach. Explanations why some behaviour interventions (inputs) 
do not produce expected behaviour change (outputs) could be offered through 
interviews with clinicians. Understanding the reasons for these phenomena 
might therefore help to design different implementation strategies to better 
control for these influences; in other words, explain the phenomenon of the 
“black box”, why “inputs” did not result in expected “outputs”. 
Although this study only used 21 participants, the data that it generated became 
“saturated” by the last few interviews. In other words, I did not feel that any new 
data emerged after the last few interviews and having more participants might 
not have added more to the findings. Therefore, a larger sample size would not 
have necessarily changed the conclusions.  
Study strengths 
Despite the weaknesses stated above, this thesis has several important 
strengths. This thesis related what was found in systematic reviews with 
experience of individual clinicians to explain why some behavioural 
interventions worked and others did not. Hence, any further research on 
interventions aimed to change the behaviour of primary care professionals 
could use these findings to design strategies that they are more likely to 
respond to. 
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The study’s main strength includes the use of several methods to understand 
the motivations of general practitioners to deliver public health programmes, 
using an overview of systematic reviews, a qualitative study and use of theory 
to provide a conceptual framework. 
For the qualitative work, I used a modified Framework approach to analyse the 
interview data, which is systematic and comprehensive. However, following the 
mixed inductive/deductive approach, the analytical framework needed to be 
flexible enough to accommodate themes emerging from the data that did not fit 
neatly into  a scheme using TPB.(97) For example, organisational influences on 
behaviour including contractual levers and financial incentives could not be 
mapped to the constructs of TPB. 
The use of several methods of enquiry also enabled me to unpack the “black 
box” to explain the why some implementation programmes appeared to have 
had no impact and some had relatively modest success.  
Reflexivity - effect of the “GP Researcher”  
There might be issues with interview dynamics when the interviewer is in the 
same profession or field as the participants. The responses to my questions and 
therefore the data collected could have been influenced by these and the 
perception of my role in the interview: as a GP peer, as a GP with interest in 
sexual health/public health and as a researcher. 
The effect of the professional identity of the researcher on the interview process 
plays an important part in collecting interview data. In a study that used GP 
researchers to interview GPs about their consultations on back pain and drug 
misuse found that access to the GPs was easier when the GP researcher was 
known to the participant. The interviews tended to be broader in scope and 
provide richer and more personal accounts of attitudes and behaviour in clinical 
practice. However the GP researcher was also identified as an “expert and 
judge”, not just in clinical decision making but also about moral judgements on 
the work of the GPs who were being interviewed.(94)  
These were very similar issues I encountered during my interviews. I felt I could 
have open and broad discussions about public health practice which helped to 
enrich the data. However, when discussions moved on to the practice’s 
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performance on outcomes such as influenza vaccinations, I sensed that some 
participants were trying to defend or explain their practice’s poor performance 
as if I were judging them or their practice. Although I did not feel there were 
many occasions when the participants appeared or seemed uncomfortable 
about their practice’s performance, many were quick to defend and explain why 
they were in that position, sometimes deflecting from individual performance to 
attributing to patient demographics or organisational issues. 
My other role as a sexual health and public health practitioner might have 
affected some of their responses to questions about chlamydia screening and 
other public health programmes. For example, they might have felt compelled to 
say something positive about the programmes, or that they agreed with the 
principles and objectives, leading to “courtesy bias”. One GP assumed because 
I was involved with the chlamydia screening programme at a national level that I 
was supportive and agreed on the evidence base for it. On the other hand, 
some of the participants did not hesitate to criticise the evidence base of some 
public health programmes, including chlamydia screening. There were others 
who tested boundaries to check if they could voice their opinion without 
reprieve, as implied by responses such as “am I going to get into trouble for 
saying this but …”, “I might be saying things out of turn but…”, “as this is 
anonymised …” made me believe that some participants felt comfortable 
enough to share their opinions openly and honestly. 
In Chapter 1, I mentioned the motivation for my thesis; I was unwilling to accept 
that primary care clinicians such as GPs and practice nurses could do nothing 
to improve the nation’s public health. The findings from this thesis suggest 
although there might not be the “magic bullet” intervention to change clinicians’ 
behaviour, I was heartened to hear the GPs and nurses I interviewed were 
supportive of most public health programmes- provided they believed they 
worked, they were in their patients’ best interest, with minimal risk of unintended 
consequences, and it didn’t matter about the remuneration – they just wanted 
the best for their patients. With the help of behaviour theories such as TPB 
directed at the level of the individual and the organisation, we are closer to 
understanding, and finding the “magic bullet”. 
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Implications for policy, research, practice, and education 
The findings from my thesis have added to the evidence base for delivering 
HPDP programmes in general practice. There are further implications of the 
thesis findings for policy, research, practice, and education. 
Implications for policy 
The conclusions from this overview of systematic reviews are not substantially 
different to those of other reviews. A recent review that examined behaviour 
interventions on primary care professionals also concluded most strategies 
were associated with small to modest improvement in professional practice and 
process outcomes.(143) They also found most reviews considered interventions 
based on individuals and a lack of research on organisational-level strategies 
and context-level strategies. Interventions that involved an element of education 
were likely to improve practice but the effect was modest and a multi-faceted 
approach was probably more effective.(150) However, when it applied to 
primary care professionals and public health, there was no single intervention 
that was deemed to be effective for both.  
It is probably prudent to accept that a one-dimensional or linear approach to 
implementing any evidence-based programme, e.g. only relying on guideline 
dissemination or educational events, would not be effective and the qualitative 
data from this thesis has confirmed the addition of implementation strategies 
based on the three constructs of TPB need to be considered too.(76) 
Multifaceted approach and tailored interventions, which are more likely to 
address these constructs, might be better at addressing the determinants of 
behaviour intention.  
Based on TPB and the findings from this thesis, I propose an implementation 
strategy for an HPDP programme might need to consider the following: 
• To address behaviour beliefs (one construct of TPB) 
o Robust evidence to demonstrate effectiveness of public health 
intervention 
o Explanation of unintended consequences and how they could be 
overcome 
• To address normative beliefs 
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o Evidence to suggest it is desirable or expected for healthcare 
professionals to deliver this programme 
o Feedback in terms of performance compared with peers 
• To address control beliefs 
o Consider specific barriers and facilitators for clinicians to 
implement the programme 
o Evidence that the programme is wanted by and seen as desirable 
by patients 
• Any combination of behaviour modification that addresses any of the 
above, e.g. mass media to raise awareness, computer reminders to 
facilitate implementation during consultations, tailored interventions to 
explore specific barriers in practice and suggestions on how to overcome 
these, financial incentives to encourage behaviour change. 
Implications for future research 
Future empirical studies should consider multi-faceted approaches to create 
better evidence bases for future policy on delivery of preventative health in 
primary care. New ideas have been identified in this thesis that might be worthy 
of exploration, such as the use of communication theory to “package” 
information to influence attitudes,(117) use of performance data to improve 
public health outcomes, and perhaps the use of mass media or social marketing 
to “stimulate demand” for public health to aid patient empowerment. The last 
might overcome the issues of eroding the doctor-patient relationship and the 
issue of starting a “difficult conversation” as the main barriers to implementing 
public health programmes. 
The review highlighted the need for primary studies to be better designed to 
demonstrate treatment effects, to improve the use of theory to inform their 
designs, the need for systematic reviews that specifically considered the impact 
of interventions on the behaviour of general practitioners and related patient 
outcomes in the context of HPDP. Through more qualitative studies, we need to 
better understand how and why some interventions work, and hypothesise 
which combinations might work synergistically, and design primary studies that 
can demonstrate their effectiveness, as well as cost-effectiveness. 
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While I am not suggesting that my proposed model for an implementation 
strategy offers a significant contribution to implementation literature, it does 
however warrant further research to evaluate its validity, effectiveness, and 
utility. 
Implications for practice and education 
The Health and Social Care Act 2012 set out changes to the public health 
system; local authorities were given new responsibilities and funding, taking a 
greater role in improving health and reducing health inequalities.(151) With 
support from Public Health England, they will deliver a public health outcomes 
framework, which aims to increase healthy life expectancy, and reduce 
differences in life expectancy and healthy life expectancy between 
communities.(152) The NHS also has a legal duty to improve health 
inequalities, this includes working with clinical commissioning groups (CCGs) to 
improve the health of the local population.(153)  
However, with reduced resources and demand for more cost-effective 
prevention, there might be more demands for HPDP from GPs, with reduced 
remuneration. This might mean relying less on financial incentives and 
considering other ways to achieve the same public health outcomes. The 
findings from the overview of systematic reviews and interviews suggest 
financial incentives are not the panacea to encourage GPs to deliver HPDP. 
There are other ways to implement public health programmes according to the 
findings from the overview of systematic reviews, including: setting up computer 
reminders to prompt clinicians to deliver programmes, visits by CCG or local 
authority staff to discuss health improvement programmes (using opinion 
leader, EOV or tailored interventions), educational programmes and materials to 
deliver these messages, as mass media approach for public and professional 
awareness. There may also be a “dashboard” to feedback individual practice’s 
performance compared with others and their standing in each CCG area. 
The qualitative study has also highlighted different perceptions and attitudes to 
various public health programmes which includes interpretation of current 
evidence, own values about some programmes, and the experiences of 
delivering them. It might be useful for some CCGs and local authorities to 
consider running an educational event on poorly performing measures or an 
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educational visit to practices with low achievements to address barriers to 
implementing programmes. These might reveal insights such as 
misconceptions about evidence or interpretations, logistical barriers and their 
perceptions about population needs. 
Conclusions 
In the mid-90s, Oxman et al concluded there were “no magic bullets” to change 
clinical practice as they might require not only different implementation 
strategies, but different groups of clinicians might have specific barriers that 
need to be overcome.(76) Twenty-five years later, we are no closer to finding 
the elusive “magic bullet” but we understand much more about what works and 
we have better insights into how healthcare professionals think about delivering 
HPDP programmes. 
In his book, A New Kind of Doctor, which was a rallying call for more GP 
involvement in improving the health of their communities, Dr Julian Tudor Hart, 
who is now a retired GP, lamented about the reluctance of GPs to consider the 
health of the wider population:(154)  
“Just as it was necessary for doctors to pursue medical knowledge in blinkered 
isolation from its social context, the good doctor was supposed to fix his gaze 
only on the patient in hand, in the ‘patient-tight compartments’, forgetting the 
other 30 in the waiting room or the thousands outside, to reach clinical 
perfection for a few rather than what was possible and useful for the many.” 
[page 47] 
Thirty years since the publication of Tudor-Hart’s book, we have seen more 
HPDP delivered by GPs. However, the expansion of the prevention agenda has 
unintended consequences. Its intrusion into the consultation has become more 
of a problem as patients’ agendas have become “unheard” as they are 
subjected to biomedical “surveillance” as part of the quality and outcomes 
framework (QOF) of the new GP contract.(155) Not all conversations about 
HPDP need to be intrusive or inappropriate, particularly if the patient could 
benefit. The challenge might be how the clinician could find the opportunity to 
raise it as an issue in a sensitive manner, and make it relevant for the patient in 
that consultation.   
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APPENDIX B – interview schedules, participant information and 
consent 
Invitation letters 
 
 
 London School of Hygiene and Tropical Medicine 
Date: 5/3/2013 
Dear Colleague, 
 
Re: What strategies influence general practitioners’ behaviour to deliver public health 
programmes? A case study using the National Chlamydia Screening Programme 
 
I would like to ask you for your help with my research study.  
 
I am a part-time GP principal with an interest in public health. I am studying for a Doctor of 
Public Health (DrPH) degree at the London School of Hygiene and Tropical Medicine.  
I am trying to find out what sort of things influence our behaviour, as primary care 
professionals, to deliver public health programmes.  
I am using the National Chlamydia Screening Programme as an example because different PCTs 
have used different ways to influence the behaviour of GPs to deliver chlamydia screening.  
Your practice has been chosen because the screening rates appeared to be either higher or 
lower than expected and I would like to come and discuss with you about why this might be. 
This is not a performance management exercise but an open discussion, without prejudice, 
about what makes GPs/practice nurses deliver public health interventions.  
If this is agreeable, I can come to your practice at a mutually convenient time. It will take no 
more than 1-1½ hours of your time. I am afraid this project is self-funding so there will be no 
financial remuneration and I am relying on your goodwill.  
It is possible however to give you a copy of the transcript as a record of our discussion on 
reflective public health practice which you can retain for your CPD log. 
Please let me know if it would be possible to interview you. 
Yours sincerely 
Dr Richard Ma 
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 London School of Hygiene and Tropical Medicine 
Date: 05/February/2013 
Dear Colleague, 
 
Re: What strategies influence general practitioners’ behaviour to deliver public health 
programmes? A case study using the National Chlamydia Screening Programme 
 
I would like to ask you for your help with my research study.  
 
I am a part-time GP principal with an interest in public health. I am studying for a Doctor of 
Public Health (DrPH) degree at the London School of Hygiene and Tropical Medicine.  
 
I am trying to find out what sort of things influence our behaviour, as primary care 
professionals, to deliver public health programmes.  
 
I am using the National Chlamydia Screening Programme as an example because different PCTs 
have used different ways to influence the behaviour of GPs to deliver chlamydia screening.  
 
If this is agreeable, I can come to your practice at a mutually convenient time. It will take no 
more than 1 hour of your time. The research network that covers Haringey has agreed to fund 
financial reimbursements for taking part in this study: £70 per GP and £25 per practice nurse. 
 
Please let me know if it would be possible to interview you. 
 
Yours sincerely 
Dr Richard Ma 
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 London School of Hygiene and Tropical Medicine 
Date: 05/February/2013 
Dear Colleague, 
 
Re: What strategies influence general practitioners’ behaviour to deliver public health 
programmes? A case study using the National Chlamydia Screening Programme 
 
I would like to ask you for your help with my research study.  
 
I am a part-time GP principal with an interest in public health. I am studying for a Doctor of 
Public Health (DrPH) degree at the London School of Hygiene and Tropical Medicine.  
 
I am trying to find out what sort of things influence our behaviour, as primary care 
professionals, to deliver public health programmes.  
 
I am using the National Chlamydia Screening Programme as an example because different PCTs 
have used different ways to influence the behaviour of GPs to deliver chlamydia screening.  
 
If this is agreeable, I can come to your practice at a mutually convenient time. It will take no 
more than 1 hour of your time. The research network that covers Haringey, Hackney, Tower 
Hamlets, Camden and Islington has agreed to fund financial reimbursements for taking part in 
this study: £70 per GP and £25 per practice nurse. 
Please let me know if it would be possible to interview you. 
Yours sincerely 
 
Dr Richard Ma 
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Participant information sheet 
London School of Hygiene & Tropical Medicine 
Keppel Street, London, WC1E 7HT, United Kingdom 
 
Study title: What strategies influence general practitioners’ behaviour to deliver public 
health programmes? A case study using the National Chlamydia Screening 
Programme 
Investigator Name and Contact No: Dr Richard Ma 07979 752 420 
Background 
This project forms the thesis component of the Doctorate in Public Health degree (DrPH) that is 
being undertaken by the investigator at the London School of Hygiene and Tropical Medicine, 
University of London. The Doctor of Public Health degree provides doctoral level training for 
future leaders in public health. The purpose of the research project is to help candidates learn 
about the role of research in public health practice through undertaking their own high quality 
public health relevant research. Because of the time allocated to research in the DrPH 
programme, the DrPH thesis is shorter in length and more limited in scope than a PhD thesis; 
however, the academic rigour is the same. 
Study aim  
The aim of the research is to explore the effects of different types of behaviour-modifying 
strategies on general practitioners and practice nurses to deliver chlamydia screening in young 
people as part of the National Chlamydia Screening Programme. The study will use semi-
structured interviews to ask about factors which influence GPs’ and practices nurses’ behaviour 
in the context of public health interventions. 
Your participation 
Participation in this research is confidential (participants will only be identified by a study code, 
not by name) and entirely voluntary. Withdrawal with no adverse consequences is possible at 
any time without having to give a reason. If you agree to take part, you will be invited to 
participate in an interview to explore your views. The interview will be recorded using digital 
audio recording device and transcript typed up. 
How confidentiality will be ensured 
The transcripts of interviews are available to the investigator (ie R Ma) and his supervisor only. 
Information obtained through interviews will be used in aggregate form. Where transcripts are 
quoted no reference will be made to your name, age or gender. All transcripts will be kept by the 
investigator in a secured file and for the duration of the doctorate study, after which they will be 
destroyed.  
Ethical approval 
This study has been approved by the London School of Hygiene and Tropical Medicine’s 
Research Ethics Committee and National Research Ethics Committee. If you have any further 
questions or queries about the study please do not hesitate to contact me at 
richard.ma@lshtm.ac.uk.  
If you have any concerns about the conduct of this study, please contact my supervisor Dr 
Pauline Allen at Pauline.Allen@lshtm.ac.uk. 
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Participant Information Sheet 
       6/11/15 
Dear Participant, 
Re: What strategies influence general practitioners to deliver public health programmes? 
Thank you very much for participating in this study. I am pleased to tell you that I am in the 
final stages of submitting the final version of the doctoral thesis and producing a couple of 
original research articles. 
As part of good research practice and data validation, I enclose a copy of the interview 
transcript for you to read and keep. The transcription was done professionally and I am 
confident that it was an accurate reflection of our interview. However, please let me know as 
soon as possible if you feel there might be any inaccuracies – preferably before the end of 
November 2015.  
How has my interview been used? 
All the data from the transcripts have been analysed according to a qualitative method called 
“Framework Analysis” which groups emerging issues into a chart and matrix which ensures all 
the material are analysed systematically. 
Data from qualitative studies are usually presented into “themes” or discrete conceptual 
categories, sometimes a theoretical framework is applied to the data.  Due to the restriction 
on word counts not every participant has been quoted. In addition, quotes are only used if 
they add to the narrative. 
Will I be identified? 
Every effort has been made to anonymise participants and have not been identified by name. 
Every participant is coded in the form: PCT name/gender/size of practice/training or non-
training.  For articles submitted for publication, the participant codes will be limited to PCT 
name & gender. 
Will the study be in the public domain?  
The doctoral thesis will be submitted for examination in October 2015. Once the thesis has 
been approved and passed, it will be available publicly from the London School of Hygiene and 
Tropical Medicine as a hard copy to view and electronically. I anticipate two original articles 
that will be submitted to peer reviewed journals – one on chlamydia screening and another 
one other public health programmes. I can send a link to these papers once they are accepted 
for publication. Thank you once again for your generosity and your help with my doctoral 
thesis. Please let me know by the end of August if there are any issues with the interview 
transcript. 
Yours sincerely 
Dr Richard Ma 
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Interview Schedule 
What strategies influence general practitioners’ behaviour to deliver 
public health programmes? A case study using the National Chlamydia 
Screening Programme in London 
1. Welcome and housekeeping (this section will not be recorded on tape) 
a. Introduction and explanation of study 
b. Consent and ethics 
c. Interview, transcription and validation process 
d. Sign consent form 
2. General conversation about public health practice to ease interviewee into further 
discussions 
a. Open question: “Can you tell me about the public health activities that you 
do?”  
o If interviewee struggles – give examples such as cervical cytology 
screening, immunisations, health checks, smoking cessation 
o “How do you feel/what are your opinions about these programmes?” 
o Looking for responses such as evidence, support, confidence in delivering 
them and other motivations 
b. Open questions to understand reasons for delivering these interventions 
o “Why do you think some health care professionals deliver them?” 
o “Why do you think some don’t?” 
c. “I want to understand what makes doctors/nurses deliver X – can you tell me 
what drives you to deliver X?” 
3. Questions specifically relating to behaviour change strategies (if not already covered 
above): “Reflecting on your public health practice, what factors influence your 
decision to promote certain programmes?” Using following prompts to elicit 
different behaviour modifying techniques 
a. Behavioural approaches: 
i. “Knee jerk” reaction or “auto-pilot” 
ii. Feedback encourage more of same behaviour 
iii. Have you started doing something because of peer pressure? 
iv. Do you respond to league tables/”scobiegrams”? 
v. Do you have your own views on some programmes? (Health belief 
model - effectiveness/susceptibility/risks/benefits) 
b. Educational approaches 
i. Do reading about/attending courses on certain conditions make you 
change practice/offer X? 
ii. Did you start offering this after a learning event? 
c. Marketing approaches 
i. Did media: leaflets/TV/radio/newspapers affect how you promoted X? 
d. Educational outreach visits 
i. Have you had visits from prescribing advisors/drug reps/other to 
persuade you to change practice? And did they work? 
e. Financial 
i. Has QOF/£ incentive made you more likely to offer X? 
Page 206 of 295 
 
f. Others 
i. Are there certain programmes that you feel less likely to offer and 
why? 
ii. Knowledge about conditions 
iii. Ability to manage questions/results of screening tests/health 
promotion 
iv. Consultation process/logistics/time pressure? 
v. Personal beliefs 
vi. Patient factors 
Questions about chlamydia screening: 
4. “I would like to talk about chlamydia screening as an example of a public health 
intervention that has used many different ways to encourage GPs to deliver. May I 
ask your opinions on the programme?  
5. “How does chlamydia screening compare with your practice/thoughts/attitudes on 
[flu vaccinations/smoking cessation/heart disease screening]?” 
6.  “According to the NCSP data, your practice screens X% of young people in your 
practice/is ranked Y in 2010. Is this a fair reflection of your chlamydia screening 
practice?” 
a. If not why not? 
7. “Do you know if your PCT/how your PCT encouraged you to screen?” 
8. If yes – “Did it change your behaviour?” 
9. If not – “Should they have used any behaviour-modifying strategy?” 
10. “Can you think of any barriers that have impeded chlamydia screening in your 
experience/practice?” 
11.  “What sort of things would increase your/your peers’ screening rates?” 
a. League tables 
b. Educational events 
c. Flyers 
d. Financial incentives 
e. Outreach visits 
12. Summary of responses 
13. Transcription and validation process 
14. Expressing thanks 
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Interview consent form 
 
 
A research project for the degree of Doctor in Public 
Health DrPH  London School of Hygiene and Tropical 
Medicine 
 
What strategies influence general practitioners’ behaviour to deliver 
public health programmes? A case study using the National Chlamydia 
Screening Programme 
 
I,________________________________ give permission to Dr Richard Ma to use notes based 
on his interviews with me on the study above, or to use transcripts of recordings of such 
interviews, for scholarly and educational purposes. 
 Please 
initial  
1. I have read and understand the information sheet dated 05/03/2013 for the 
above study. I have had the opportunity to consider the information, ask 
questions and have had these answered satisfactorily. 
 
2. I understand that taking part in the study is entirely voluntary.  
3. I understand that it is my right to decline to answer any questions that I am 
asked. 
 
4. I understand that I am free to end the interview at any time.  
5. I may request that the interview is not tape recorded.  
6. I allow the researcher to use suitably anonymised verbatim quotations from 
the interview in which I am taking part. 
 
7. I understand the interview that I participate in will be audio-taped and 
transcribed.                                                                    
 
 
Signature of participant Signature of researcher 
Print name Print name 
Date Date 
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APPENDIX C – literature searches 
Database: EMBASE <1980 to 2011 Week 14> 
Search Strategy: 
-------------------------------------------------------------------------------- 
1     general practitioner/ (43349) 
2     primary medical care/ (43007) 
3     general practice/ (60075) 
4     1 or 2 or 3 (129639) 
5     nurse/ (50980) 
6     nursing/ (175772) 
7     5 or 6 (219280) 
8     4 not 7 (126193) 
9     behavior change/ (6364) 
10     medical education/ (148799) 
11     motivation/ (53284) 
12     reimbursement/ (27568) 
13     9 or 10 or 11 or 12 (232921) 
14     health care quality/ (144929) 
15     screening/ (57473) 
16     health promotion/ (55017) 
17     clinical practice/ (118321) 
18     14 or 15 or 16 or 17 (360197) 
19     8 and 13 and 18 (3041) 
20     limit 19 to English language (2804) 
21     limit 20 to (article or journal) (2802) 
22     limit 20 to (evidence based medicine or consensus development or meta-analysis or 
outcomes research or "systematic review") (293) 
23     limit 22 to (article or journal) (293) 
 
Database: HMIC Health Management Information Consortium <1979 to March 2011>, Econlit 
<1969 to March 2011> Search Strategy: 
-------------------------------------------------------------------------------- 
1     *general practitioner/ (0) 
2     *general practice/ (0) 
3     *family medicine/ (0) 
4     primary medical care/ (10221) 
5     1 or 2 or 3 or 4 (10221) 
6     nurse/ (0) 
7     5 not 6 (10221) 
8     *behavior change/ (0) 
9     *behavior/ (0) 
10     [*behavior/di, ep, et, pc, th [Diagnosis, Epidemiology, Etiology, Prevention, Therapy]] (0) 
11     *MOTIVATION/ (0) 
12     *economics/ (0) 
13     health program/ or economic aspect/ or medicare/ or REIMBURSEMENT/ or "health care 
cost"/ or health service/ or "cost"/ or public health service/ (764) 
14     "organization and management"/ or economic aspect/ or health care quality/ (0) 
15     Education, Medical/ (0) 
16     Family Practice/ or Quality Assurance, Health Care/ or Primary Health Care/ or "Quality of 
Health Care"/ or "Outcome Assessment (Health Care)"/ or quality of care.mp. or Adult/ 
(20643) 
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17     [Health Promotion/cl, ec, ed, mt, og, st, sn, ut [Classification, Economics, Education, 
Methods, Organization & Administration, Standards, Statistics & Numerical Data, Utilization]] 
(0) 
18     [Mass Screening/di, ec, mt, og, st, sn, sd, td [Diagnosis, Economics, Methods, 
Organization & Administration, Standards, Statistics & Numerical Data, Supply & Distribution, 
Trends]] (0) 
19     Evidence-Based Medicine/ or Practice Guidelines as Topic/ or clinical practice.mp. or 
Randomized Controlled Trials as Topic/ (4699) 
20     "Attitude of Health Personnel"/ or Attitude/ (3056) 
21     8 or 9 or 10 or 11 (0) 
22     8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 (764) 
23     16 or 17 or 18 or 19 or 20 (27556) 
24     7 and 22 and 23 (21) 
 
 
Database: Ovid MEDLINE(R) <1948 to March Week 5 2011> Search Strategy: 
-------------------------------------------------------------------------------- 
1     General Practitioners/ (174) 
2     Physicians, Family/ (13942) 
3     Family Practice/ or General Practice/ or Primary Health Care/ (97135) 
4     Nursing/ (46846) 
5     Nurses/ (25702) 
6     4 or 5 (70559) 
7     1 or 2 or 3 (107001) 
8     7 not 6 (106001) 
9     Motivation/ (41675) 
10     Reimbursement Mechanisms/ or Reimbursement, Incentive/ (11341) 
11     Education, Continuing/ or Education, Medical/ or Health Education/ or Education, 
Professional/ or Education/ or Education, Public Health Professional/ or Education, Medical, 
Graduate/ or Education, Medical, Continuing/ (146740) 
12     9 or 10 or 11 (197867) 
13     Attitude to Health/ or Health Promotion/ or Health Behavior/ or behaviour change.mp. or 
Adult/ (3509192) 
14     Mass Screening/ (69675) 
15     Quality Indicators, Health Care/ or Management Quality Circles/ or "Quality of Health 
Care"/ or Total Quality Management/ or Quality Improvement/ (64982) 
16     13 or 14 or 15 (3609625) 
17     8 and 12 and 16 (2325) 
18     limit 17 to English language (2069) 
19     limit 18 to (clinical trial, all or clinical trial or comparative study or controlled clinical trial 
or evaluation studies or journal article or meta-analysis or multicentre study or randomized 
controlled trial or "review") (1989) 
20     limit 19 to systematic reviews (60) 
21     limit 19 to "review articles" (113) 
22     from 21 keep 8-9,33,46,67-68,105 (7) 
 
Database: PsycEXTRA <1908 to March 28, 2011>, PsycINFO <1806 to April Week 1 2011>, 
Social Policy and Practice <201101> Search Strategy: 
-------------------------------------------------------------------------------- 
1     *general practitioner/ (2494) 
2     *general practice/ (0) 
3     *family medicine/ (717) 
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4     primary medical care/ (0) 
5     1 or 2 or 3 or 4 (3191) 
6     nurse/ (0) 
7     5 not 6 (3191) 
8     *behavior change/ (6018) 
9     *behavior/ (12596) 
10     [*behavior/di, ep, et, pc, th [Diagnosis, Epidemiology, Etiology, Prevention, Therapy]] (0) 
11     *MOTIVATION/ (22312) 
12     *economics/ (7312) 
13     health program/ or economic aspect/ or medicare/ or REIMBURSEMENT/ or "health care 
cost"/ or health service/ or "cost"/ or public health service/ (7319) 
14     "organization and management"/ or economic aspect/ or health care quality/ (0) 
15     Education, Medical/ (0) 
16     Family Practice/ or Quality Assurance, Health Care/ or Primary Health Care/ or "Quality of 
Health Care"/ or "Outcome Assessment (Health Care)"/ or quality of care.mp. or Adult/ 
(22424) 
17     [Health Promotion/cl, ec, ed, mt, og, st, sn, ut [Classification, Economics, Education, 
Methods, Organization & Administration, Standards, Statistics & Numerical Data, Utilization]] 
(0) 
18     [Mass Screening/di, ec, mt, og, st, sn, sd, td [Diagnosis, Economics, Methods, 
Organization & Administration, Standards, Statistics & Numerical Data, Supply & Distribution, 
Trends]] (0) 
19     Evidence-Based Medicine/ or Practice Guidelines as Topic/ or clinical practice.mp. or 
Randomized Controlled Trials as Topic/ (32035) 
20     "Attitude of Health Personnel"/ or Attitude/ (0) 
21     8 or 9 or 10 or 11 (40289) 
22     8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 (54575) 
23     16 or 17 or 18 or 19 or 20 (53344) 
24     7 and 22 and 23 (12) 
25     [from 24 keep 1-21] (0) 
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APPENDIX D – Overview of Systematic Reviews  
AMSTAR criteria score sheet 
1. Was an 'a priori' design provided? 
The research question and inclusion criteria should be 
established before the conduct of the review. 
Note: Need to refer to a protocol, ethics approval, or pre-
determined/a priori published research objectives to score a 
“yes.” 
 Yes 
 No 
 Can't 
answer 
 Not 
applicable 
 
2. Was there duplicate study selection and data 
extraction? 
There should be at least two independent data extractors and 
a consensus procedure for disagreements should be in place. 
Note: 2 people do study selection, 2 people do data 
extraction, consensus process or one person checks the 
other’s work. 
 Yes 
 No 
 Can't 
answer 
 Not 
applicable 
 
3. Was a comprehensive literature search performed? 
At least two electronic sources should be searched. The report 
must include years and databases used (e.g., Central, 
EMBASE, and MEDLINE). Key words and/or MESH terms must 
be stated and where feasible the search strategy should be 
provided. All searches should be supplemented by consulting 
current contents, reviews, textbooks, specialized registers, or 
experts in the particular field of study, and by reviewing the 
references in the studies found. 
Note: If at least 2 sources + one supplementary strategy 
used, select “yes” (Cochrane register/Central counts as 2 
sources; a grey literature search counts as supplementary). 
 Yes 
 No 
 Can't 
answer 
 Not 
applicable 
 
4. Was the status of publication (i.e. grey literature) 
used as an inclusion criterion? 
The authors should state that they searched for reports 
regardless of their publication type. The authors should state 
whether or not they excluded any reports (from the 
systematic review), based on their publication status, 
language etc. 
Note: If review indicates that there was a search for “grey 
literature” or “unpublished literature,” indicate “yes.” SINGLE 
database, dissertations, conference proceedings, and trial 
registries are all considered grey for this purpose. If searching 
a source that contains both grey and non-grey, must specify 
that they were searching for grey/unpublished lit.   
 Yes 
 No 
 Can't 
answer 
 Not 
applicable 
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5. Was a list of studies (included and excluded) 
provided? 
A list of included and excluded studies should be provided. 
Note: Acceptable if the excluded studies are referenced. If 
there is an electronic link to the list but the link is dead, select 
“no.” 
 Yes 
 No 
 Can't 
answer 
 Not 
applicable 
 
6. Were the characteristics of the included studies 
provided? 
In an aggregated form such as a table, data from the original 
studies should be provided on the participants, interventions 
and outcomes. The ranges of characteristics in all the studies 
analyzed e.g., age, race, sex, relevant socioeconomic data, 
disease status, duration, severity, or other diseases should be 
reported. 
Note: Acceptable if not in table format as long as they are 
described as above. 
 Yes 
 No 
 Can't 
answer 
 Not 
applicable 
 
7. Was the scientific quality of the included studies 
assessed and documented? 
'A priori' methods of assessment should be provided (e.g., for 
effectiveness studies if the author(s) chose to include only 
randomized, double-blind, placebo controlled studies, or 
allocation concealment as inclusion criteria); for other types 
of studies alternative items will be relevant. 
Note: Can include use of a quality scoring tool or checklist, 
e.g., Jadad scale, risk of bias, sensitivity analysis, etc., or a 
description of quality items, with some kind of result for EACH 
study (“low” or “high” is fine, as long as it is clear which 
studies scored “low” and which scored “high”; a summary 
score/range for all studies is not acceptable). 
  
 Yes 
 No 
 Can't 
answer 
 Not 
applicable 
 
8. Was the scientific quality of the included studies 
used appropriately in formulating conclusions? 
The results of the methodological rigor and scientific quality 
should be considered in the analysis and the conclusions of 
the review, and explicitly stated in formulating 
recommendations. 
Note: Might say something such as “the results should be 
interpreted with caution due to poor quality of included 
studies.” Cannot score “yes” for this question if scored “no” 
for question 7. 
 Yes 
 No 
 Can't 
answer 
 Not 
applicable 
 
9. Were the methods used to combine the findings of 
studies appropriate? 
For the pooled results, a test should be done to ensure the 
studies were combinable, to assess their homogeneity (i.e., 
Chi-squared test for homogeneity, I2). If heterogeneity exists 
a random effects model should be used and/or the clinical 
 Yes 
 No 
 Can't 
answer 
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appropriateness of combining should be taken into 
consideration (i.e., is it sensible to combine?). 
Note: Indicate “yes” if they mention or describe 
heterogeneity, i.e., if they explain that they cannot pool 
because of heterogeneity/variability between interventions. 
 Not 
applicable 
 
10. Was the likelihood of publication bias assessed? 
An assessment of publication bias should include a 
combination of graphical aids (e.g., funnel plot, other 
available tests) and/or statistical tests (e.g., Egger regression 
test, Hedges-Olken). 
Note: If no test values or funnel plot included, score “no”. 
Score “yes” if mentions that publication bias could not be 
assessed because there were fewer than 10 included studies. 
 Yes 
 No 
 Can't 
answer 
 Not 
applicable 
 
11. Was the conflict of interest included? 
Potential sources of support should be clearly acknowledged 
in both the systematic review and the included studies. 
Note: To get a “yes,” must indicate source of funding or 
support for the systematic review AND for each of the 
included studies. 
 Yes 
 No 
 Can't 
answer 
 Not 
applicable 
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Methodological assessment of included studies using AMSTAR tool 
 
AMSTAR 
Criteria 
 
 
Paper 
A priori 
design 
provided 
Independent 
data 
extraction 
Literature search 
comprehensive? 
Was grey 
literature 
considered? 
List of 
included 
and 
excluded 
studies? 
Characteristics of 
included studies 
Assessmen
t of 
scientific 
quality of 
included 
studies 
Use of quality 
assessment in 
formulating 
conclusions 
Methods 
used to 
combine 
findings from 
studies 
appropriate? 
Assessment of 
publication 
bias? 
Conflict of 
interest 
stated? 
Total 
Scor
e 
The effects of 
on-screen, 
point of care 
computer 
reminders on 
processes 
and 
outcomes of 
care (1) 
Yes 
Original 
protocol was 
first 
published in 
1998. 
Research 
questions 
and selection 
criteria 
clearly 
defined. 
Criteria 
considered 
types of 
studies 
(RCTs, quasi 
RCTs), types 
of 
participants 
such as 
physicians. 
Types of 
intervention
s and 
Yes.  
Two 
investigators 
independently 
screened 
citations. 
 
There was a 
process for 
resolving 
discrepancies 
 
Yes.  
MEDLINE, 
EMBASE, CINAHL 
and CENTRAL 
databases until 
July 2008. MESH 
headings 
included. 
Yes – 
included 
Cochrane 
Central 
database. 
No restriction 
on language 
Inclusion 
criteria RCT 
and quasi-
randomised 
trials. 
Yes. 
Reference
s to 
included 
studies, 
excluded 
studies 
and 
others for 
reference. 
Yes. 
Summary of 
characteristics of 
included studies. 
Yes – 
considered 
only RCT 
and quasi-
randomise
d trials. 
Yes. Use of 
EPOC group 
data collection 
checklist. 
Yes.  
Accepted 
meta-
regression 
might use 
many 
assumptions 
so resorted to 
reporting 
median 
improvement
. 
Not mentioned Only 
acknowledge
d as authors 
of the review 
but 
assessment 
not made of 
the included 
studies 
9 
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outcomes 
specified. 
Computer-
generated 
reminders 
delivered on 
paper to 
healthcare 
professionals; 
effects on 
professional 
practice and 
healthcare 
outcomes (2) 
Yes  
Protocol was 
published 
first on EPOC 
in 1998. 
Objectives 
are set out 
clearly. 
Inclusion and 
exclusion 
criteria are 
explicit. 
Included 
controlled 
trials 
Yes 
2 authors 
independently 
carried out 
data 
extraction. 
 
Any 
discrepancies 
between 
authors were 
resolved by 
discussion and 
involvement 
of a third 
author. 
Yes 
Cochrane Central 
Register of 
Controlled Trials 
(CENTRAL), 
MEDLINE 1946 to 
current, EMBASE 
1947 to current, 
CINAHL 1980 to 
current. 
Yes 
Included 
trials register 
and EPOC 
group 
specialist 
register 
Yes 
Reference
s to 
included 
studies 
and 
excluded 
studies. 
Yes 
Table of included 
studies  
Yes 
Included 
controlled 
trials 
Yes  
Using 
Cochrane 
Collaboration 
“Risk of bias” 
tool 
Yes 
Evidence so 
far suggests 
moderate 
quality for 
recommendat
ion. 
Yes. 
Assessment of 
heterogeneity 
and reporting 
bias 
Not stated. 10 
Audit and 
feedback: 
effects on 
professional 
practice and 
healthcare 
outcomes (3) 
Yes. 
Protocol was 
submitted 
and first 
published in 
1996, and 
amended 
2010. 
Research 
objectives 
clearly 
stated. 
Inclusion 
criteria 
stated. 
Yes. 
Two 
reviewers 
independently 
assessed 
studies. 
There was a 
process for 
resolving 
discrepancies 
Yes. 
CENTRAL 2010 
and EPOC register 
Dec 2010. 
MEDLINE from 
1950 to Nov week 
3 2010. 
EMBASE 1980 to 
2010 week 48. 
CINAHL 1981 to 
2010. 
Science Citation 
Index and Social 
Sciences Citation 
Yes 
Searches 
included 
registers of 
trials. 
 
No restriction 
on language 
Yes. 
Included 
and 
excluded 
studies 
listed in 
reference
s 
Yes. 
Summary of 
characteristics of 
included studies. 
Yes. 
Only RCTs 
or Clinical 
Controlled 
Trials 
considered
. 
Yes. 
Use of EPOC 
checklist. 
Yes. 
 
Tested for 
heterogeneity 
using bubble 
plots and box 
plots. 
 
Main analysis 
used multiple 
linear 
regressions. 
 
Not mentioned Yes 10 
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RCTs 
considered 
Index and 
reference lists. 
Local opinion 
leaders: 
effects on 
professional 
practice and 
health care 
outcomes (4) 
Yes 
Protocol first 
published in 
1996. 
Objectives 
clearly 
stated and 
included 
studies that 
described 
randomised 
controlled 
trials. 
Yes  
Two review 
authors 
extracted 
data. 
There was a 
process for 
resolving 
discrepancies 
Yes. 
EPOC register to 
April 2009, 
MEDLIN 1966, to 
May 2009, 
EMBASE 1980 to 
May 2009 
Yes 
Grey 
literature 
specifically 
searched for 
e.g. 
Conference 
proceedings, 
Index to 
Theses, 
WorldCat 
Dissertations, 
HMIC 
No language 
restrictions 
Yes 
Table of 
included 
and 
excluded 
studies 
Yes 
Summary 
included 
Yes 
Only RCT 
included 
Yes  
Cochrane tool 
for assessing 
risk of bias. 
NA 
No single 
estimate of 
effect could 
be found 
between 
trials. 
Not mentioned. No 
assessment 
made 
8 
Tailored 
interventions 
to address 
determinants 
of practice (5) 
Yes 
Study 
protocol was 
first 
published in 
1999. 
Objectives 
stated and 
only 
considered 
RCTs 
Yes 
Two 
reviewers 
independently 
extracted 
data. 
There was a 
process for 
resolving 
discrepancies 
Yes 
Cochrane Library 
and EPOC 
specialised 
register MEDLINE 
from 1946, 
EMBASE 1947, 
CINHAL from1980,  
British Nursing 
Index 1994 
onwards 
HMIC 1983 to 
2009 
Study in all 
languages 
included. 
Yes 
Attempt at 
looking for 
unpublished 
studies 
including 
Department 
of Health and 
King’s Fund 
Information 
and Library 
Services 
Yes. 
List of 
included 
and 
excluded 
studies 
provided 
Yes 
Table of 
characteristics of 
included studies 
provided. 
Yes 
Only RCTs 
included 
Yes 
Use of EPOC 
criteria for 
RCTs 
Yes 
Meta-
regression 
analysis.  
Not mentioned 
 
Not 
mentioned 
9 
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Continuing 
education 
meetings and 
workshops: 
effects on 
professional 
practice and 
health care 
outcomes (6) 
Yes 
Review first 
published 
2001 with 
original 
protocol.  
Objectives 
stated and 
inclusion 
criteria were 
RCTs. 
Yes 
Two review 
authors 
independently 
screened and 
identified 
studies. 
There was a 
process for 
resolving 
discrepancies 
Yes 
EPOC trials 
register, Scopus,) 
and EMBASE. 
Search strategy 
for an earlier 
review included 
MEDLINE and 
Research 
Development 
Resource Base in 
Continuing 
Medical 
Education. 
 
Yes  
Trials 
register. 
Yes. 
Table of 
included 
and 
excluded 
studies. 
Yes 
 table of study 
characteristics. 
Yes  
Only RCTs 
included 
Yes 
Use of EPOC 
criteria for 
RCTs 
Yes 
Visual 
analyses 
combined 
with meta-
regression. 
However 
latter had to 
be 
abandoned 
due to large 
number of 
variables that 
were eligible 
relative to 
number of 
included 
comparisons 
and would 
have risked 
spurious 
findings. 
Yes 
Used funnel plot 
to consider risk 
of publication 
bias 
Not 
mentioned. 
10 
Educational 
outreach 
visits: effects 
on 
professional 
practice and 
health care 
outcomes (7) 
Yes.  
Protocol first 
published 
1996. 
Objectives 
clearly 
stated as 
were 
selection 
criteria. 
Yes. 
2 reviewers 
independently 
selected the 
trials to be 
included. 
There was a 
process for 
resolving 
discrepancies 
Yes 
EPOC register, 
MEDLINE, 
EMBASE and 
CINAHL. 
This was an 
updated review so 
original review 
(published in 
2000) included 
MEDLINE search 
up to 1997, 
Research and 
Yes 
Trials register 
Yes. 
Table of 
included 
and 
excluded 
studies 
Yes. 
Table of study 
characteristics  
Yes 
Only RCTs 
included. 
Yes 
Use of EPOC 
assessment 
criteria for 
RCTs 
Yes. 
Apart from 
visual 
analyses with 
multivariate 
statistical 
analyses, also 
included 
meta-
regression. 
Not mentioned. Not reported  9  
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Development 
Resource Base in 
Continuing 
Medical Education 
Mass media 
interventions: 
effects on 
health 
services 
utilisation (8) 
Yes  
Protocol first 
published 
1997. 
 
RCTs, CCTs, 
CBAS and ITSs 
were explicitly 
mentioned in 
inclusion 
criteria. 
 
 
Yes  
2 assessors 
screened 
titles and 2 
assessed the 
papers.  
 
There was 
mention of 
how to 
resolve 
discrepancie
s. 
Yes 
MEDLINE and 
EMBASE up to 1996 
EPOC specialised 
register. 
Also other journals: 
Communication 
Research, European 
Journal of 
Communication, 
Communication 
Theory, Journalism 
Quarterly 
Yes 
Specialis
t 
registers 
and 
journals 
were 
used. 
 
Yes 
Reference list 
of included 
and excluded 
studies 
Yes 
Table of 
characteristic
s of included 
studies. 
Yes 
RCTs, CCTs, 
CBAs, ITSs 
were 
assessed 
using 
explicitly 
quality 
criteria used 
by EPOC 
Yes  
Quality of 
studies as well 
as publication 
bias inferred 
in conclusions. 
Yes 
Results from 
individual 
studies 
addressing 
the same 
aspect of care 
were not 
pooled, due 
to the 
substantial 
heterogeneity 
in both the 
setting and 
subjects 
between 
studies 
No 
Acknowledged 
but not 
assessed. 
No 
Not 
mentioned 
9 
Printed 
educational 
materials: 
effects on 
professional 
practice and 
healthcare 
outcomes 
(9)  
 Yes  
Protocol 
was first 
published in 
2003 
Objectives 
and 
inclusion 
criteria 
were clearly 
stated. 
Yes. 
2 review 
authors 
independently 
screened titles 
and abstracts of 
papers that met 
criteria.  
There was a 
process for 
resolving 
discrepancies 
Yes 
Databases 
included: 
MEDLINE OVID 
(1948 to June 
2011), EMBASE 
OVID (1947 to 
June 2011), 
Cochrane Central 
Register of 
Controlled Trials 
(CENTRAL), CAB 
Abstracts via 
Yes 
Included in 
search 
strategy e.g. 
CAB 
Abstracts 
Yes 
Table 
provided 
Yes 
Table provided 
Yes 
RCTs, quasi-
randomised 
studies, 
controlled 
before and 
after studies 
(CBAs) and 
interrupted 
time series 
(ITS) analyses 
were 
included. 
Yes 
At least two 
reviewers 
assessed the 
studies for risk 
of bias using 
an EPOC check 
list. Any 
discrepancies 
were resolved 
through 
discussions 
Yes 
Studies 
grouped by 
their design, 
end point and 
type of 
comparison. 
Statistical 
analysis was 
described for 
each group as 
well as how 
Mentioned but 
not assessed. 
Not stated. 9 
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EbscoHost (1973 
to June 201) 
amongst 
authors 
to deal with 
missing data.  
 
Target 
payments in 
primary 
care: effects 
on 
professional 
practice and 
health care 
outcomes 
(10) 
Yes. 
Protocol 
first issued 
1997. 
 
Objectives 
stated with 
inclusion 
criteria  
Yes  
 
2 reviewers 
independently 
assessed the list 
of studies.  
There was a 
process for 
resolving 
discrepancies. 
Yes 
At least two 
databases 
including: 
MEDLINE (1966 to 
Oct 1997), 
EconLit (1969 to 
Oct 1997), Health 
Start (1975 to Oct 
1997), BIDS 
EMBASE (1980 to 
Oct 1997). 
 
Yes 
Health 
economics 
discussion 
paper series 
of 
Universities 
of York, 
Aberdeen, 
Sheffield, 
Bristol, 
Brunel, 
McMaster; 
Swedish 
Institute of 
Health 
Economics 
and the 
RAND 
corporation. 
Yes. 
Table 
provided 
Yes 
Table provided 
Yes 
Quality 
assessmen
t using 
EPOC 
criteria. 
 
Yes 
 
Yes 
There were only 
2 studies and 
also 
heterogeneity in 
content, design 
and outcomes 
Not 
mentioned 
Not 
mentioned 
9 
Capitation, 
salary, fee-
for-service 
and mixed 
systems of 
payment: 
effects on 
the 
behaviour of 
primary care 
physicians 
(11) 
Yes 
Protocol 
published in 
1998. 
Study 
objectives 
stated from 
the start 
and clear 
inclusion 
criteria. 
Yes 
2 reviewers 
independently 
selected and 
assessed the 
papers. 
There was a 
process for 
resolving 
discrepancies. 
Yes 
At least 2 
databases 
searched 
including: BIDS 
EMBASE ) 1980 to 
Oct 1997), 
MEDLINE (1966 to 
Oct 1997), 
ECONLIT (1969 to 
Oct 1997), Health 
Yes 
Trial register 
included. 
Yes 
Table 
provided 
of 
included 
and 
excluded 
studies. 
Yes 
Table of 
characteristics of 
included studies. 
Yes 
Quality 
assessmen
t using 
EPOC 
group 
check list. 
Yes 
Methodologic
al weaknesses 
of included 
studies 
informed 
conclusions. 
Yes 
Study results 
were not pooled 
due to 
heterogeneity. 
No 
Publication 
bias not 
mentioned  
Not 
mentioned 
9 
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Start (1975 to Oct 
1997). 
Also EPOC register 
and Cochrane 
Controlled Trials 
register. 
The effect of 
financial 
incentives 
on the 
quality of 
health care 
provided by 
primary care 
physicians 
(12)  
Yes 
Protocol 
first 
published in 
2010 
Study 
objectives 
and 
inclusion 
criteria 
stated. 
Yes 
Two authors 
independently 
screened titles 
and abstracts of 
all studies for 
inclusion. 
 
There was a 
process for 
resolving 
discrepancies. 
Yes 
MEDLINE, 
EMBASE, CINAHL, 
PsycINFO, EconLit, 
PAIS, Cochrane 
Library, DARE, 
Cochrane Central 
Register of 
Controlled Trials– 
all until August 
2009. 
 
All languages 
included. 
 
Yes 
Grey 
literature 
specifically 
searched 
including 
RePEc 
(Research 
Papers in 
Economics, 
Social 
Science 
Research 
Network 
(ERN) 
Yes 
List of 
included 
and 
excluded 
studies 
provided. 
Yes 
Table of 
characteristics of 
included studies.  
Yes 
Quality 
assessmen
t using 
EOPC 
criteria 
Yes 
Assessment 
criteria 
referred in 
conclusions. 
Yes 
It was noted that 
pooled analysis 
not possible due 
to important 
heterogeneity 
between studies. 
Not 
mentioned 
Not 
mentioned  
9 
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Summary of systematic reviews findings 
Review Types of studies Possible 
theoretical 
bases 
Target professionals 
and settings 
Targeted behaviours Outcomes Conclusions  
Interventions that used computer decision support 
The effects of on-
screen, point of 
care computer 
reminders on 
processes and 
outcomes of care 
(1) 
RCT and quasi-
randomised trials. 
 
28 studies reporting 
32 comparisons (4 
studies contained 2 
comparisons) 
 
26 were cluster 
design. 
Not mentioned Hospital practitioners both 
inpatient and outpatient 
departments 
 
General practitioners 
 
21 re prescribing practices 
 
6 re vaccinations 
  
13 re test ordering 
 
3 to documentation 
 
7 to adherence to other processes 
e.g. guidelines 
9 comparisons reported pre-intervention 
process adherence for intervention and 
control groups. Marginal improvement in 
the intervention was 3.8%, IQR 0.4% to 
7.9% 
 
Using post-intervention difference 
between study groups, median 
improvements in process adherence 
associated with computer reminders were:  
4.2% IQR 0.8% to 18.8% across all process 
outcomes,  
3.3% IQR 0.5% to 10.6% for improvement 
in prescribing behaviour 
3.8% IQR 0.5% to 6.6% for improvements 
in vaccination 
3.8% IQR 0.4% to 16.3% for test ordering. 
 
8 comparisons reported dichotomous 
clinical endpoints e.g. blood pressure and 
cholesterol targets. Intervention patients 
had median absolute improvement of 
2.5% IQR 1.3% to 4.2%. 
“Small to modest improvements 
in care.” 
 
Wide range of effects of 
intervention and difficult to 
provide suggests about how to 
maximise effects. 
 
Future trials need to consider the 
key factors e.g. target quality 
problem or design of reminder 
system to reliably predict 
improvements in care 
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Computer-
generated 
reminders delivered 
on paper to 
healthcare 
professionals; 
effects on 
professional 
practice and 
healthcare 
outcomes (2) 
There were 37 
comparisons from 32 
studies. 
 
27 were RCTs 
including 1 cross-
over trial. 
5 were Non-
Randomised 
controlled trials 
(NRCT) including 1 
cross-over trial. 
Not mentioned Healthcare professionals 
were primarily physicians 
although some included 
nurse practitioners. One 
study included only nurses. 
 
29 studies were based in US, 
3 in Canada. 
 
Most studies took place in 
outpatient settings (which 
include primary care clinics); 
2 in inpatient settings and 3 
were mixed. 
 
 
 
 
25 comparisons used physician 
reminders alone with usual care. 
 
13 comparisons looked at 
physician reminders combined 
with other interventions to other 
interventions without reminders. 
 
1 co-intervention in 7 
comparisons, 2 co-interventions 
in 4 comparisons, and 3 co-
interventions in 2 comparisons. 
 
The most common co-
interventions were patient 
reminder, educational meeting 
for healthcare professionals and 
audit and feedback. 
 
Processes and outcomes 
measured included: blood 
pressure measurements, faecal 
occult blood test, influenza 
vaccination, mammography, 
cervical cytology. 
 
 
 
1. Effectiveness of computer-generated 
reminders delivered on paper to 
healthcare professionals in proving 
process of care. 
 
Only 13/37 comparisons reported baseline 
process of care rates for study groups. 
Median marginal improvement in 
intervention group was 4.5% (IQR 0.5% to 
7%).  
 
Pooled data from 37 comparisons show a 
median improvement in process of care 
associated with reminder intervention was 
7.0% (IQR 3.6% to 12.9%).  
Comparisons that had no co-interventions 
(e.g. reminders alone vs usual care) 
showed median improvement in process 
of care of 11.2% (IQR 6.5% to 19.6%).  
 
Studies of multifaceted interventions e.g. 
reminders + additional interventions vs 
same additional interventions showed a 
lower median improvement of 4.0% (IQR 
3.0% to 6.0%).  This may be because co-
interventions delivered to both group’ 
leaves little room for additional 
improvement from computer reminders. 
 
2. Impact of reminder features on process 
of care effect size. 
 
Effect size was significantly associated with 
2 features: availability of space for 
Computer-generated reminders 
delivered on paper to healthcare 
professionals can have moderate 
improvements in process of care.  
 
Significant predictors for 
improvement include: providing 
space on the reminder for a 
response from the clinician and 
providing an explanation of the 
reminder’s content or advice. 
 
Future trials could consider the 
following: detailed description of 
the reminder system, cluster 
design may reduce sample size 
and rigorous statistical methods 
are needed to report all relevant 
data, outcome measures should 
be assessed blindly to reduce 
reporting bias. 
 
 
Page 224 of 295 
 
healthcare professionals to enter a 
response (median 13.7% vs 4.3% for no 
space, p=0.01); and reminders that include 
an explanation for their content or advice 
(median 12.0% vs 4.2% for no explanation, 
p=0.02). Reminder features that did not 
have significant effect include: explicitly 
from or justified by reference to an 
influential source (median 15.5% vs 6.0%, 
p=0.09); specific advice included in 
reminder (median 6.3% vs 13.9%, p=0.45); 
reminders available at point-of-care 
(median 7.0% vs 6.6%, p=0.45).  
 
Reminders also had different effects on 
different targeted behaviours; the largest 
improvement was seen in vaccination 
(median improvement 13.1%, IQR 12.2% 
to 20.7%) and smallest was in professional-
patient communication (median reduction 
of -0.2%, IQR -2% to 9.2%).  
 
The more behaviours that are targeted, 
the less the improvement. Improvement 
was 7.1% (IQR 3.6% to 11.5%) when 1 
behaviour was targeted by the reminder; 
6.1% (IQR 4.4% to 19.2%) with 2; and 4% 
(IQR 1.5% to 20.0%) when 3 behaviours 
are targeted.  
 
3. Impact of study features on process of 
care effect size 
There were no significant association 
between effect size and study features.  
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4. Effectiveness of computer-generated 
reminders delivered on paper in 
improving outcomes of care 
Only one study with sufficient power 
measured outcome of care to evaluate the 
effectiveness of reminders and found no 
association. 
 
A sensitivity analysis was conducted using 
the 32 studies (22% high quality, 28% 
moderate quality and 50% low quality), 
median improvement in process of care 
was 4.0% (IQR 3.0% to 23%) when only 
high quality studies were considered, 7.4% 
(IQR 4.2% to 18.9%) with moderate quality 
studies and 7.0% (IQR 6.0% to 11.5%) for 
low quality studies.  
 
Other analyses did not make substantial 
changes to the main findings.  
Interventions that used education-only approaches 
Continuing 
education meetings 
and workshops: 
effects on 
professional 
practice and health 
care outcomes (3) 
A total of 81 studies 
– 32 studies in 
earlier review and 49 
new studies added 
from new search. 
 
 
Behaviour change 
theories 
Learning theory 
Diffusion of 
innovation theory 
32 trials based in North 
America - 28 in USA, 4 in 
Canada 
34 based in Europe – 14 in 
UK, 10 in Netherlands, 3 in 
Norway, 2 in France, 1 in 
Sweden, 1 Denmark, 1 
Belgium, 1 Spain and 1 
Scotland. 
3 based in Australia, 2 in 
Indonesia, 2 South Africa, 1 
Preventative care was considered 
in 11 of the trials including 
smoking cessation, breast 
feeding, exercise and screening. 
3 studies focussed on test 
ordering, 6 on screening 
behaviour, 13 on prescribing, 41 
on general management of a rage 
of clinical problems, remaining 
studies focussed on handling 
“frequent attenders” at out-of-
hours service, improvement of 
Large variation in number of outcome 
measures – 62% had dichotomous 
measures, 32% used continuous and 4 
used both.  
 
1. Any intervention involving educational 
meetings vs no interventions 
 
Educational meetings alone or in 
combination with other 
interventions can improve 
professional practice and patient 
outcomes.  
 
Effect “likely to be small” and 
similar to other types of medical 
education such as audit and 
feedback and educational 
outreach visits. 
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each in Mali, Thailand, Peru, 
Mexico, Zambia, Sri Lanka, 
New Zealand and Brazil 
 
Physicians were the main 
subjects in most trials. In 2 
studies, nurses were the 
healthcare providers, 3 used 
pharmacists or non-physician 
prescribers, 18 had mixed 
providers. 
 
In 43 studies, general 
practice was the setting, 16 
community based care, 17 
hospitals based and 5 were 
“other types” of settings. 
 
skills in spirometry, back surgery, 
positioning of stroke patients, 
patients’ trust building and 
promotion of advanced directives 
of end of life care. 
 
 
32 trials used multi-faceted 
interventions, most commonly 
used were: reminders (5), patient 
education materials (5), 
supportive services (5), feedback 
reports (10), educational 
outreach (5). 
 
12 studies had educational 
meetings rated as main 
component, moderate in 13 
studies, and minor component in 
7. 
 
1 study had “intensive” 
educational meetings; 25 
moderately intensive, 54 as non-
intensive meetings. 
80 trials examined but 20 had high risk of 
bias, 13 had no baseline data, and 3 did 
not have sufficient data to be extracted.  
 
Professional practice – 30 trials with 36 
comparisons of dichotomous outcomes. 
Adjusted RD in compliance with desired 
practice varied from -2.0% to 36.2%, 
median improvement of 6% (IQR 1.8 to 
15.9%). A sensitivity analysis that included 
studies judged to have a high risk of bias 
did not change overall results.  
Higher attendance at educational 
meetings was associated with larger 
adjusted RD; mixed interactive and 
didactic meetings were more effective 
than didactic meetings; but interactive 
meetings seemed to be less effective.  
 
Patient outcomes – 21 trials out of which 
13 were of low or moderate risk of bias 
and included baseline values.  
 
5 trials reported dichotomous outcomes. 
Adjusted RDs in achievement of treatment 
goals varied between -0.9% to 4.6% 
median improvements of 3.0% IQR 0.1% to 
4.0%. 
8 trials reported continuous outcomes. 
Adjusted RDs ranged from -1% to 26%, 
median 4%, IQR 0% to 11%. 
  
 
Strategies to increase attendance 
at educational meetings, use of 
mixed interactive and didactic 
formats, and focusing on 
outcomes with serious clinical 
implications may increase 
effectiveness.   
 
Future studies should include 
clear, detailed descriptions of 
interventions that include: target 
audience, size of group at 
meetings, length and number of 
sessions, teaching techniques, 
any skills practice, and also 
report using CONSORT 
recommendations. 
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2. Educational meetings alone compared 
with no interventions.  
 
24 trials of 26 comparisons were judged to 
have low or moderate risk of bias and 
reported baseline data.  
 
Professional practice – 19 trials (21 
comparisons) had dichotomous data. 
Median adjusted RDs ranged from -2.0% to 
29.3% with median of 6% IQR 2.9% to 
15.3%. 
5 trials of 5 comparisons reported 
continuous data. Median adjusted change 
ranged from 0% to 50% with median of 
10%, IQR 8% to 32%. 
 
Patient outcomes – only 9 out of 17 trials 
were considered to be of low or moderate 
risk of bias and had baseline data.  
3 trials reported dichotomous data, 
adjusted RDs varied from -0.9 to 4.0 with 
median improvement of 3, IQR -0.9 to 4.0). 
6 trials used continuous outcomes, 
adjusted relative percentage ranged from -
1% to 26%, median 8%, IQR 0% to 12.0% 
 
3. Educational meetings compared with 
other interventions 
 
2 trials were considered which had 
moderate risk of bias and used 
dichotomous outcomes. Comparisons 
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were: facilitated implementation of an 
office system to improve cancer detection 
and an educational outreach visit to 
improve prescribing for patients with 
arthritis. Adjusted RD for educational 
meetings vs office meetings was -8.0% i.e. 
a decrease in compliance for educational 
intervention; adjusted RD for educational 
meetings vs educational outreach was -
1.4% decrease in compliance in 
educational intervention group. 
4.  Any intervention that included 
educational meetings compared with 
educational meetings alone 
Only 1 out of 7 trials that used multi-
faceted intervention that included 
educational meetings compared with 
educational meetings alone was judged to 
have low to moderate risk of bias and 
reported baseline data. This study aimed 
to improve detection of cancer; adjusted 
relative percentage increase was 12% in 
patients receiving testing.  
5. Interactive educational meetings 
compared to didactic meetings 
 
1 out of 2 trials had low or moderate risk 
of bias that reported baseline data. Aim of 
the study was to improve appropriate drug 
use in treating diarrhoea; a larger 
improvement was reported with 
interactive education group but there was 
no significant difference between them. 
 
6. Any other comparison of different types 
of educational meetings 
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One study was in this category but was 
judged to have a high risk of bias and had 
no baseline data. 
Interventions based on social influences and educational approaches 
Audit and feedback: 
effects on 
professional 
practice and 
healthcare 
outcomes (4) 
140 RCTs (only RCTs 
were included) 
Feedback 
Intervention 
Theory  
 
Control Theory of 
Carver and 
Scheier  
 
(both in the 
context of 
designing 
feedback) 
 
 
80 based in North America 
(USA 58, Canada 9), 21 in UK 
or Ireland and the rest from 
Australasia. 
 
121 trials targeted 
physicians, 5 targeted 
pharmacists and 16 
specifically targeted nurses.  
 
Most common setting or 
speciality area was general or 
family practice, targeted in 
84 trials; others included 
outpatient settings (94 
trials), inpatient (36) and the 
rest were unclear. 
Outcome measures included 
compliance with guidelines, 
changes in prescribing, use of 
diagnostic tests. Health 
promotion outcomes included 
smoking cessation and blood 
pressure management; there 
were also a range of preventative 
care as outcomes such as 
screening and vaccination. The 
weighted median adjusted RD 
was 3.0% (IQR 1.8% to 7.7%). 
A total of 5 comparisons were analysed: 
 
Comparison A.  
Audit and feedback (A&F) alone or as the 
core/essential feature of a multifaceted 
intervention compared with usual care 
(includes comparisons B and C). 
For dichotomous measures of compliance 
with desired practice, the weighted 
median adjusted RD was a 4.3% increase in 
compliance with desired practice 
(interquartile range (IQR) 0.5% to 16%). No 
trials reported public health-specific 
outcomes in primary care settings. 
For continuous measures, the weighted 
median adjusted change relative to 
baseline control was a 1.3% increase in 
compliance with desired practice (IQR 
1.3% to 23.2%). One trial reported 139% 
relative increase in smoking cessation 
referrals. 
 
In terms of patient outcomes, for 
dichotomous outcomes, the weighted 
median adjusted RD was a 0.4% decrease 
in desired outcomes (IQR -1.3% to 1.6%) 
and for continuous outcomes, the 
“Small to moderate” effects.  
 
The effectiveness of audit and 
feedback depends on baseline 
performance and how the 
feedback is provided. 
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weighted median adjusted change relative 
to baseline control was a 17% 
improvement (IQR 1.5% to 17%). 
 
Comparison B.  
Audit and feedback (alone) compared with 
usual care. 
For studies with audit and feedback alone 
targeting professional practice with 
dichotomous outcomes, weighted median 
adjusted RD was 3.0% (IQR 1.8% to 7.7%). 
For studies with audit and feedback alone 
targeting professional practice with 
continuous outcomes, the weighted 
median adjusted change relative to 
baseline control was 1.3% (IQR 1.3% to 
11.0%). 
 
Comparison C.  
Audit and feedback as the core/essential 
feature of a multifaceted intervention 
compared with usual care. 
For professional practice with 
dichotomous outcomes, weighted median 
adjusted RD was 5.5% (IQR 0.4% to 16%), 
and weighted median adjusted change 
relative to baseline control was 26.1% (IQR 
12.7% to 26.1%) for continuous outcomes. 
 
Comparison D.  
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Head-to-head comparisons of different 
types of audit and feedback interventions 
(effect of changing the way that audit and 
feedback is designed or delivered). 
 
Peer comparison- small differences when 
adding peer comparison data for asthma 
management (adjusted RD 2%), diabetics 
(adjusted RD 3%) and influenza vaccination 
for diabetics (OR 1.33, 95% CI 1.05 to 
1.69). 
 
Presentation of feedback and inclusion of 
additional information – there were small 
differences such as small but insignificant 
improvement in quality of cervical 
cytology but the effects were inconsistent. 
 
Source and delivery – there were no 
significant differences when comparing 
written or verbal feedback. 
 
Recipient participation -  two studies 
tested role of recipient participation: one 
reported worse management of anaemia 
in hospitalised patients and another found 
small but insignificant improvement in 
breast screening and influenza vaccination 
rates. 
 
Comparison E.  
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Audit and feedback as the core/essential 
feature of a multifaceted intervention 
compared with audit and feedback alone 
(effect of adding different co-interventions 
to audit and feedback). 
A&F with reminders vs A&F alone – only 
one study considered preventative 
services by internal medicine trainees and 
reported unadjusted RD of 8.0%. 
A&F with educational outreach vs A&F 
alone – there were inconsistent findings 
including small improvements in primary 
care providers in cardiovascular risk 
assessment (adjusted RD=22%), diabetic 
care (adjusted change =35%) and 
mammography advice (adjusted RD 4.75%) 
but no increase in actual mammography 
rates. 
A&F with other educational interventions 
vs A&F alone – there were no studies that 
reported outcomes related to health 
promotion and disease prevention. 
A&F with case management or 
organisational interventions vs A&F alone. 
One study using telephone follow up and 
feedback did not result in improved 
pneumococcal vaccine coverage. 
A&F with financial incentives vs A&F alone 
– improved immunisation rates were seen 
in the “financial bonus” group from 29% to 
54% (adj RD 12.7%), but the enhanced fee-
for-service group decreased performance 
relative to feedback alone (adj RD -8.3%). 
Page 233 of 295 
 
A&F with patient-mediated interventions 
vs A&F alone – no difference reported in 
influenza vaccination rates. 
 
Comparison F. 
Audit and feedback alone or as the 
core/essential feature of a multifaceted 
intervention compared with other 
interventions 
Reminders vs A&F – reminders were 
better than monthly feedback to medical 
residents delivering preventative services 
(unadjusted RD 4.5%). 
Educational outreach vs A&F – no studies 
reported outcomes relevant to public 
health. 
Other educational intervention vs A&F - no 
studies reported outcomes relevant to 
public health. 
Case management of organisational 
interventions vs A&F - no studies reported 
outcomes relevant to public health. 
Financial incentives vs A&F - no studies 
reported outcomes relevant to public 
health. 
Patient-mediated interventions vs A&F - 
no studies reported outcomes relevant to 
public health. 
Local opinion 
leaders: effects on 
professional 
A total of 18 trials 
were included – 6 
new RCTs added to 
Social cognitive 
and education 
theories e.g. 
10 trials based in USA, 6 in 
Canada, 1 in China (Hong 
Kong), 1 Argentina & 
Uruguay. 
All of the targeted behaviours 
involved general management of 
a clinical problem. 
Median adj RD from 63 usable objective 
outcomes from 15 studies varied from 15% 
decrease to 72% increase in compliance in 
the intervention group. Overall adjusted 
OL interventions may improve 
performance and can be 
comparable to other strategies 
used to disseminate and 
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practice and health 
care outcomes (5) 
12 RCTs from a 
previous review. 
Social Learning 
Theory 
 
14 evaluated interventions 
delivered in hospitals. 
1 in primary care practices 
1 study in both primary and 
secondary care. 
2 studies the settings were 
not clear. 
 
Physicians were targeted in 
14 trials, nurses in 2 and 2 
trials targeted physicians, 
nurses and midwives. 
 
In all the trials, opinion 
leaders delivered educational 
initiatives to members of 
their own healthcare 
profession. 
 
Opinion leaders were 
identified using sociometric 
method in 14 trials. 2 trials 
used informant method to 
identify opinion leaders.  2 
used other methods (1 
informant and sociometric, 
another self-designated) 
 RD for 15 studies was +0.12, ie 12% 
absolute increase in compliance. 
 
1. Opinion leaders (OL) compared to no 
intervention  
 
5 trials of 37 usable dichotomous 
outcomes. RDs varied from -0.15 to +0.38. 
median adj RD +0.09. 
 
2. OL alone compared to a single 
intervention 
 
2 trials of 3 outcomes for this comparison 
but one study was judged to be “high risk” 
of bias. RD varied from -0.12 to +0.17. 
median RD for two studies 0.14. 
 
3. OL with one or more additional 
intervention compared to the other one 
or more additional intervention(s) only 
 
4 trials of 10 outcomes. Overall increase in 
compliance ranged from RD of -0.08 to 
+0.25. median adjusted RD was +0.10. 
 
4. OL as part of multiple interventions 
(OLs + at least one more intervention) 
compared to no intervention 
 
7 trials of 13 dichotomous outcomes. RDs 
ranged from -0.04 to +0.72. median 
adjusted RD across 7 trials +0.10. 
implement evidence based 
practice in healthcare. 
 
However, identifying OL can be 
labour intensive and there are 
issues regarding reliability and 
validity of identifying OLs. 
Page 235 of 295 
 
 
Tailored 
interventions to 
identify 
determinants of 
practice (6) 
32 studies included 
in the review which 
were cluster RCTs. 
Communication 
theory  
 
Theory of planned 
behaviour 
 
Social cognitive 
theory 
12 trials were based in USA 
and 4 in the UK; the rest 
were based in Canada, rest 
of Europe, South Africa and 
Indonesia. 
 
17 trials were based in 
primary care settings and 
primary care practitioners 
(including family physicians 
and general practitioners) 
were the targeted healthcare 
professionals in 14 studies. 
 
 
Targeted behaviours included 
prescribing in 12 trials and 6 
targeted preventative care 
including secondary prevention of 
coronary heart disease and 2 
targeted influenza vaccination. 
More than one method was used 
to identify barriers to change 
which included: interviews [10 
studies], focus groups [10], 
questionnaire survey [6], review 
of literature [4], review of 
performance data [2], 
observation, meeting or 
workshop [2] and other methods 
[4]. 
Barriers identified included: professional 
factors [such as knowledge, motivation, 
perceptions of benefits and risks – 
identified in 25 studies], patient factors 
[8], incentives and resources [8], guideline 
factors [4], organisational capacity [9], 
professional interactions [3], and 
social/political/legal factors [2] 
 
Tailored interventions to identify barriers 
are more likely to improve professional 
practice; the pooled odds ratio (OR) for all 
15 studies was 1.56 (95% CI 1.27 to 1.93). 
7 out of 15 studies compared tailored 
interventions with no interventions that 
were suitable for inclusion in a meta-
regression; pooled OR was 1.36 (95% CI 
0.92 to 1.99). 8 out of 15 studies that 
compared tailored interventions to non-
tailored interventions were included in a 
meta-regression; pooled OR was 1.79 (95% 
CI 1.06 to 3.01). 
Tailored implementation can be 
effective, but the effect is 
variable and tends to be small to 
moderate. 
 
Included trials used different 
methods to identify 
determinants of practice and 
different approaches to selecting 
interventions to address the 
determinants so it is difficult to 
tell how best to tailor 
interventions and therefore not 
clear what the effect of an 
optimally tailored intervention 
would be. 
 
Results were pooled so it was not 
possible to determine if there 
were any specific effects on 
patient outcomes that were 
relevant to health promotion and 
disease prevention. 
Educational 
outreach visits 
(EOVs): effects on 
professional 
practice and health 
care outcomes (7) 
51 trials added to 
original review 
making a total of 69 
studies.  
 
 
 
Social Marketing 
Theory 
Health Belief 
Model 
Theory of Planned 
Behaviour 
53 studies included primary 
care physicians or teams as 
the subjects of interventions.  
 
23 based in North America, 
22 in UK, 14 in other 
European countries, 8 in 
Australia, 2 Indonesia and 1 
in Thailand.  
29 trials looked at prescribing 
practices – 17 of these aimed to 
reduce inappropriate prescribing.  
 
In another 29 trials, the behaviour 
was general management of a 
variety of problems encountered 
in general practice such as 
Four comparisons were considered. 
1. Any intervention that included EOV 
compared to no intervention. 
 
56 trials of 63 comparisons had healthcare 
professional outcomes; out of these, 37 
had dichotomous and 19 had continuous 
outcomes.  
 
EOVs with or without addition of 
another intervention can 
improve practice but the effect is 
“small to moderate”. There 
seems to be a small but 
consistent effect on prescribing. 
The effect on other professional 
behaviours is more variable. 
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6 trials focussed on 
physicians or teams of health 
care professionals in hospital 
settings. 
1 study used physicians 
working in either community 
or hospital settings.  
4 trials used health care 
professionals including 
physicians, nurses and 
healthcare assistants working 
in nursing homes. 
2 trials included pharmacists. 
In another 2, providers were 
generic healthcare workers. 
Only 1 trial included dentists. 
 
41 trials had individual visits 
and 24 had group visits. It 
was not clear in 4 trials how 
many clinicians were visited. 
 
Many interventions included 
feedback. 12 trials were 
based on social marketing 
framework. In 30 trials, 
educational outreach visit 
was one component of a 
multi-faceted intervention 
that included different 
strategies directed at health 
patients at risk of cardiovascular 
disease. 
 
11 trials focussed on preventative 
services such as smoking 
cessation advice. 
 
 
In 37 trials with dichotomous outcomes, 
28 trials of 34 comparisons contributed to 
calculation of adjusted RD. adjusted RD of 
compliance to desired behaviour ranged 
from -0.3% to 64%, median improvement 
of 5.6%, IQR 3% to 9.0%. 
 
A meta-regression based on 31 
comparisons only showed EOV to have a 
small effect on prescribing.  
 
There were 17 trials with 18 comparisons 
that provided baseline data for analysis. 
Adjusted relative percentage change 
ranged from 0% to 617%k median 21%, 
IQR 11% to 41%. Of the 8 studies in which 
relative percentage change was over 20%, 
3 had multi-faceted interventions and the 
outcomes were a mix of prescribing and 
non-prescribing practices. 
 
6 trials with 6 comparisons that had 
patient outcomes. All trials except 1 were 
deemed to be of low or moderate risk of 
bias. All the 5 trials reported improvement 
in patient outcomes but it was difficult to 
determine if there was sufficient power to 
detect an important difference.  
 
2. EOVs alone compared with no 
interventions 
 
Future trials should compare 
different ways of delivering EOVs 
in head-to-head comparisons. 
The number and nature of 
behaviours targeted for 
improvement needs to be 
thought out carefully as some 
were too complex to evaluate or 
replicated in practice. They 
should also be better powered to 
increase the effects. 
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care professionals such as 
reminders. 
 
34 trials of 37 comparisons were 
considered. 16 studies with 18 
comparisons that reported dichotomous 
outcomes had baseline data that could be 
used in the analysis. Median adjusted RD 
ranged from 1% to 20%, median 5.0%, IQR 
3.0% to 6.2%. 
 
14 trials with 15 comparisons reported 
continuous data and had baseline data 
that could be used in the analysis. The 
adjusted relative percentage changes 
ranged from 0% to 617%, median of 23%, 
IQR 12% to 39%. 
 
2 trails that had patient outcomes were 
already included in comparison 1 
 
3. Any intervention using EOV as a 
component compared to another 
including audit and feedback and 
reminder 
 
8 trials with 12 comparisons reported 
health professional outcomes in this 
comparison. 3 trials compared EOV + audit 
& feedback vs audit & feedback alone but 
only 1 showed small difference – adjusted 
RD 5% in favour of EOV + audit & 
feedback.  
1 study of EOV + audit & feedback + 
reminders vs audit & feedback – the 
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former group had better outcome – 
adjusted RD 6%, p >0.2. 
1 study comparing EOV + audit & feedback 
+ educational meetings vs audit & 
feedback alone also showed 20% relative 
improvement in the multi-faceted group. 
 
Another study used 2x2 factorial design 
with EOVs and coordinator; the group that 
had EOVs + co-ordinator showed 
improvement in care, adjusted RD 39%. 
In another trial EOVs were compared to 
audit & feedback + reminder. Adjusted 
relative improvement was 8% favouring 
the EOV group. 
 
Generally, interventions that included EOV 
appeared to be slightly more effective 
than audit & feedback alone. 
 
In one trial that had patient outcomes, 
there was an adjusted RD of 5.9% (95% CI -
0.3 to 12.2), favouring the group which 
had EOV + audit & feedback + reminder. 
 
4. Any comparison of different types of 
EOVs 
 
6 studies examined different types of visits 
in head-to-head comparisons.  
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3 studies compared EOVs given 
individually vs EOVs in a group.1 study 
showed improvement in prescribing in 
group visit arm; another trial also showed 
improvement in practice in individual visit 
arm; while one study did not find any 
differences in prescribing between two 
groups. 
 
One trial looked at different ways of 
presenting the content during a visit, one 
group had case study and another was 
presented with statistical information. The 
latter group had a larger reduction in 
inappropriate prescribing (adjusted RD 
8.7%). 
 
One study looked at EOV + telephone 
support vs EOV alone and found the 
former more likely to improve care. 
Another trial compared different types of 
visitors – physician peers vs non-physician 
peers with both groups given feedback 
during visits. The group that had visit by 
their peers resulted in greater degree of 
improvements.  
 
 
Mass communication 
Printed educational 
materials: effects 
on professional 
practice and 
Randomised 
controlled trials 
RCTs, cluster-RCTs 
(C-RCTs), controlled 
Adult learning 
theories 
Cognitive theories 
The concept of PEM was 
redefined so some changes 
since the last review. 
Persuasive communication theory 
was used as framework to assess 
effectiveness: source, message, 
channel, receiver and destination 
There were two comparisons considered 
in the review: 
 
1. PEM only compared to no intervention 
PEMS can have a “small 
beneficial effect” on professional 
practice outcomes if used alone. 
There is insufficient evidence to 
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healthcare 
outcomes (8) 
[updated] 
clinical trials (CCTs), 
controlled before 
and after studies 
(CBAs) and 
interrupted time 
series analyse (ITS). 
 
Not explained why 
other non-RCTs were 
considered. 
Persuasive 
Communication 
Theory 
 
29 new studies added to this 
review but 4 studies 
removed making a new total 
of 45 studies – 8 C-RCTs, 6 
RCTs, 31 ITS 
 
Most included studies took 
place in North America 
(Canada 12, US 11 and 1 in 
both). 18 were from Europe 
(UK 11), 2 Japan and 1 Brazil. 
 
10 studies took place in 
general or family practice, 9 
in outpatient or ambulatory 
care settings, 6 in hospitals, 3 
in mixed settings, 1 in a 
municipal health centre and 
1 in managed behaviour 
healthcare organisation. 
 
42 out of 45 studies involved 
physicians, 3 were a mixture 
of physicians, nurses and 
pharmacists, psychologists 
and allied health 
professionals. 
 
 
 
– but only first 3 considered 
relevant for this review. 
 
Source – 24 PEMs by researchers 
or clinicians, 14 by national 
professional experts, 4 from local 
expert bodies. 
39/52 were endorsed by a 
professional body or corporate 
source; out of the 39, 22 were 
peer reviewed journal 
publications. 
 
Message – broad range of clinical 
areas including: cardiovascular 
diseases (10), oestrogen 
replacement therapy (8), 
hypertension (5) and diabetes (4).  
 
Channel – 33 disseminated 
passively; 23 by publication in a 
peer-reviewed journal, 9 actively 
through direct mailing (8 of which 
was delivered only once and 1 
four times), 6 through mass 
mailings (4 once, 1 twice and 
others over a 3 year period), 4 
were delivered once through a 
mode that was not made clear in 
the paper. 
 
39 PEMs targeted prescribing or 
treatment, 8 general 
 
73 outcomes within 9 RCTs were evaluated 
that looked at professional practice 
outcomes but data from 7 studies and 69 
outcomes were suitable for re-analysis. 
Median adjusted RD across all outcomes 
was 0.02 (range 0 to 0.11), i.e. a 2% 
absolute improvement. 
3 RCTs with 8 continuous outcomes with 
complete data that could be included in 
analysis. A 0.13 improvement in standard 
median effect size (ranged -0.16 to 0.36)  
 
54 professional practice related outcomes 
were analysed from 25 ITS studies using 
time series regression. There were 
statistically significant improvements in 16 
studies of 27 outcomes from the slopes or 
levels between the periods before and 
after the PEM were disseminated. 
However, in 11 outcomes, there was 
improvement in one measure and 
deterioration in the other; in one study 
there was a significant deterioration in 
both slop and level in the period before 
and after PEM dissemination. 
Overall, standardized median change  in 
level was 1.69 (range -6.96 to +14.26).  
 
Only 1 study had categorical patient 
outcome and reported adjusted RD of 
0.13.  
reliably estimate the effect on 
patient outcomes. 
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 management and 6 addressed 
procedures. 5 were for test 
ordering, 5 for referrals, 5 at 
surgery, 4 patient education or 
advice, 4 on diagnoses.  
3 PEMS targeted prevention – 2 
covered screening. 
 
 
An RCT reported 5 continuous outcomes, 
overall median standardised effect size 
was -0.14 across these 5 outcomes.  
2 ITS reported 4 patient health outcomes 
and overall standardised median 
improvement was 3.79 across all four. 
 
2. PEM only versus single intervention 
 
1 RCT compared group exposed to a PEM 
to another using computerised guidelines. 
9 categorical professional outcomes were 
measured and none of these showed 
significant changes; standardised median 
adjusted RD was -0.02 
 
Box plots were done to explore what 
characteristics of PEMs might influence 
their effectiveness to change professional 
practice. Visual inspection of the graphs 
suggested the following have more 
potential to influence effectiveness: 
source of information, tailoring, clinical 
areas, type of targeted behaviour, 
purpose, level of evidence and format. 
 
The bar graphs seemed to suggest 
effectiveness does not vary much 
depending on mode, frequency or 
duration of delivery. 
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Mass media 
interventions: 
effects on health 
services utilisation 
(9)  
26 papers met the 
inclusion criteria that 
reported 20 time 
series analyses and 1 
controlled before 
and after study 
None mentioned Most described in included 
studies were planned 
interventions which aimed to 
promote specific health 
services: cancer screening, 
immunisation programmes, 
emergency services for 
people with suspected heart 
attacks. 
 
All campaigns relied on use 
of a range of media – radio, 
television, newspapers, 
posters and leaflets. 
Electronic media such as 
internet were not included. 
 
19 studies included general 
public as target audience. 9 
studies also included 
healthcare professionals as 
targets but none specified if 
primary or secondary care. 
 
Most studies evaluated the 
campaigns by measuring 
healthcare utilisation. Others 
used patient outcome measures 
related to the campaign. 
 
Most common condition for 
media campaign was skin cancer 
awareness (4 studies) followed by 
HIV testing (3), measles, mumps 
or rubella vaccination (2) and 
response for suspected heart 
attacks (2).  
 
Other topics related to 
prevention included prevention 
of childhood poisoning, colorectal 
cancer screening, cervical cancer 
screening. 
2 studies looked at immunisations uptake 
and statistically significant change was 
found using time-series regression.  
 
The effect was less clear regarding cancer 
screening. Reanalysis of studies using 
time-series regression found statistically 
significant changes in level in 4 studies, 
and significant change in slop in only 1 
study. 
 
A mixed pattern was observed in 2 studies 
on HIV testing; only 1 of them had 
statistically significant change in level on 
the number of HIV tests performed when 
results were reanalysed using time series 
regression. 
 
Use of media campaign to reduce delay in 
admission to hospital for suspected heart 
attacks also appear mixed. 
 
Overall, direction of effect of media 
interventions was towards change from 
0.1 to -13.1.  
 
Media campaigns may have 
positive effect on health services 
utilisation but important to 
ensure reporting of health-
related issues in lay media 
represents best available 
knowledge and effectiveness of 
healthcare interventions. 
 
There were limitations in 
methodological quality and 
completeness of reporting in 
many studies. Time series 
regression or other appropriate 
statistical tests should be used. 
 
 
Financial approaches 
Target payments in 
primary care: 
effects on 
professional 
Only 2 studies met 
all inclusion criteria 
for review – one was 
Economic theory 
e.g. Agency 
theory 
1 study in USA consists of 
additional 10% ($0.80) or 
20% ($1.60) payment to 
standard fee of $8 for each 
influenza immunisation 
Target payments vs fee for 
service  
 
Both studies showed increased 
immunisation and vaccination rates after 
introduction of target payments.  
 
There is insufficient evidence to 
say if target payments provide a 
method of improving primary 
health care. 
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practice and health 
care outcomes (10) 
RCT and the other 
was ITS 
 
made over 70% or 85% 
targets respectively. 
 
Second study in UK looked at 
trend in pre-school 
immunisation rates before 
and after target payment 
was introduced. 
 
Both studies targeted 
primary care professionals. 
 
 In the US study, the group receiving target 
payment had influenza vaccination rate 
5.9% higher than control but this was not 
statistically significant. The change in 
influenza vaccination rate from baseline 
was also larger in the intervention group – 
6.8% and was statistically significant. 
 
The UK study reported an improvement in 
primary and pre-school immunisation 
rates after target payment was 
introduced. The proportion of general 
practices offering at least 95% and 90% of 
their eligible population the primary 
immunisation increased by 50% and 20% 
respectively. for pre-school 
immunisations, the proportion offering at 
least 95% and 90% improved by 42% and 
41% respectively. However, a logistic 
regression model applied did not show a 
change in overall linear trend as a result of 
target payments. 
 
 
More research to evaluate effect 
of target payments and 
evaluations should be planned 
before introducing changes. 
Capitation, salary, 
fee-for-service (FFS) 
and mixed systems 
of payment: effects 
on the behaviour of 
primary care 
physicians (11) 
4 studies were 
identified – 2 were 
RCTs and 2 CBAs. 
Economic theory 
e.g. Agency 
theory 
Primary care professionals 
from US, Denmark and 
Canada were included in the 
studies. 
 
 
2 studies compared capitation 
and FFS payment.  
 
One study compared PCP 
behaviour under salary and FFS 
systems. 
 
One study compared a mixed 
capitation system with FFS. 
FFS was the control group payment system 
in 3 of the 4 studies; the remaining study 
had a mixed system of FFS + capitation. 
The results were thus grouped under 3 
comparisons: 
 
1. Capitation payment vs FFS (2 studies) 
 
Primary care physician and contacts - In 
the 2 studies that examined this, effect on 
There is evidence that payment 
systems influence PCP behaviour. 
PCPs working under FFS provide 
higher quantity of primary care 
compared with capitation and 
salaried PCPS. 
 
However, there were not enough 
well designed studies to give a 
robust generalisation to apply in 
every policy context. 
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2 studies examined care provided 
by PCPS to children, 
2 examined care to registered 
population. 
remained the same before and after the 
intervention (capitation) was introduced. 
 
Prescriptions – the number of repeat 
prescriptions made by PCPs in the 
intervention (FFS+ capitation) group fell 
but was significant only after 12 months.  
 
Diagnostic and curative services – PCPs 
working under capitation + FFS increased 
significantly after the change in payment 
structure even after 12 months compared 
with FFS group. 
Referrals – one study showed fewer 
referrals under capitation. Another study 
showed significantly lower referrals in the 
capitation group. 
Emergency department visits – no 
differences over time between capitation 
and FFS groups. 
Hospitalisation – no difference over time 
between capitation and FFS groups. 
Compliance with guidelines on number of 
patient visits – one study showed children 
of all ages were more likely to receive the 
guideline number of visits to see PCPs in 
FFS rather than capitation system. 
However, there was a small difference in 
different age groups of children between 
capitation and FFS groups. 
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Expenditure and cost – one study 
suggested net expenditure per year was 
higher for capitation group. 
2. Salary payment vs FFS (1 study) 
Patient visits – no significant differences 
between salaried and FFS systems. 
Number of patients enrolled – there was 
27% relative difference and significantly 
higher in salaried compared with FFS. 
Continuity of care - PCPs on salaried 
system were significantly less likely to 
attend to their own patients compared 
with PCPs on FFS.  
 
Compliance with guidelines on the number 
of patient visits – salaried PCPs had lower 
percentage of visits in excess of 
recommended number compared with 
FFS.  
 
Patient satisfaction – four dimensions of 
patient satisfaction were measured but 
only access to PCP was significantly 
significant and was higher for salaried 
PCPs. 
 
3. Mixed capitation system vs FFS (1 
study) 
 
Hospital utilisation – no difference in 
absolute admission rates between 2 
groups. 
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The effect of 
financial incentives 
on the quality of 
health care 
provided by primary 
care physicians 
(12)_ 
7 studies fit the 
inclusion criteria: 3 
cluster-RCTs, 1 
controlled ITS, and 
one ITS that used 
difference-in-
difference e (DID) 
design. 
 
5 took place in Us, 1 
UK and 1 in Germany 
 
 
Economic theory 
e.g. Agency 
theory 
5 US studies used incentives 
schemes devised by large 
health plans to increase 
quality of care provided the 
medical group practices. 
 
1 CBA study evaluated 
introduction of a salaried 
payment scheme in UK using 
20 general practices. 
 
The German study used 82 
medical practices to evaluate 
new strategies to enhance 
promotion of smoking 
cessation in general practice. 
3 cluster RCTs looked at 
influences of financial incentives 
on physicians to deliver smoking 
cessation advice using different 
outcome measures.  
 
1 CBA study used patients’ 
assessment of the process of care 
and satisfaction using the General 
Practice Assessment Survey 
(GPAS). In addition to this, clinical 
indicators such as cervical 
screening, childhood 
immunisation and pre-school 
boosters were used to assess the 
quality of care provided by the 
physicians.  
 
The other 3 studies used 
outcomes such as: rates cervical 
cancer screening, blood testing 
for diabetic patients, childhood 
immunisation, adherence clinical 
management (asthma and 
diabetes), chlamydia screening 
and mammography. 
 
 
Overall different financial interventions 
had modest and variable effects. 
 
Only one cluster-RCT looking at smoking 
cessation had the largest effect on one 
outcome measure.  Clinics that received 
financial incentive had a higher mean rate 
of referral than usual care. In another C-
RCT, GPs who had financial incentives 
increased the smoking status recording 
compared to those that didn’t. 
 
For the studies that examined screening 
services in diabetics, the only statistically 
significant effects of financial incentives 
were for cervical screening and eye 
examinations.  
 
Other studies of other outcomes did not 
show statistically significant effects due to 
financial incentives.  
There is “insufficient” evidence 
to support or not support the use 
of financial incentives to improve 
the quality of primary health 
care. 
 
The authors suggest incentive 
design as well as study design 
should be more aligned to 
theory. 
 
There should be more rigorous 
study designs to account for 
selection of physicians into 
incentive schemes.  
 
There should be more detail on 
1- type of payment scheme at 
baseline or in control group, how 
payments are made to medical 
groups, and the size of new 
payments as a proportion of total 
revenue.  
TS – interrupted time series RCT – randomised controlled trial PCP – primary care professional IQR – interquartile range RD – risk difference 
1. Shojania KG, Jennings A, Mayhew A, Ramsay CR, Eccles MP, Grimshaw J. The effects of on-screen, point of care computer reminders on processes and outcomes of care. 
Cochrane Database Syst Rev. 2009(3):CD001096. 
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APPENDIX E – PCT Contracts 
City and Hackney 
Local Enhanced Service Specification – Chlamydia Screening (2006-07)  
Introduction 
All practices are expected to provide all essential and those additional services they are contracted to provide to all their 
patients. This enhanced service specification outlines the more specialised services to be provided. The specification of 
this service is designed to cover the enhanced aspects of clinical care of the patient, all of which are beyond the scope of 
essential services. No part of the specification by commission, omission or implication defines or redefines essential or 
additional services 
Background 
Chlamydia is the commonest sexually transmitted infection in the population affecting over 8% of the screened General 
Practice population in the Chlamydia screening pilots of the Wirral and Portsmouth.  The infection is commonly 
asymptomatic (70% women and 50% men) and it is estimated that less than 10% of Chlamydia infections are 
diagnosed.  Untreated, the infection accounts for significant long-term complications including infertility and pelvic 
inflammatory disease. 
City and Hackney is part of the phase 3 rollout of the National Chlamydia screening programme and has already 
established screening of under 25 year olds in other community settings.  Screening in General Practice will provide the 
opportunity for young people who are not necessarily in contact with sexual health services to receive testing. 
The newer screening test for Chlamydia infection using nucleic acid amplification technology (NAAT) is highly sensitive, 
specific and non-invasive; in addition, CHPCT will introduced the use of dual NAAT test that provide simultaneous 
testing for Chlamydia and gonorrhoea on a single specimen, overcoming the need for other more invasive testing. 
The specification is designed to promote: 
• Practices offering enhanced care to their own patients 
This specification has been developed through discussions with practitioners, Consultant at Department of Sexual 
Health. 
 
Clinical lead:   Dr Alison Gibb 
PCT Director lead:  Lesley Mountford/Jose Figueroa 
***Development Vehicle:  Chlamydia Steering Committee  
Aims 
• To screen sexually active men and women under the age of 25 for Chlamydia and Gonorrhoea infection 
• To widen the reach of the Chlamydia screening programme in City & Hackney 
• To reach sexually active young men and women who do not use sexual health services 
• To increase screening of asymptomatic patients consulting for unrelated conditions 
• To increase acceptability of testing for both chlamydia and gonorrhoea by non invasive testing 
• To increase understanding and raise awareness of importance of Chlamydia and gonorrhoea infections in 
young sexually active clients 
• To de-stigmatise Chlamydia and gonorrhoea infections and raise awareness of safer sexual practices 
• To reduce the burden on secondary care services by diagnosing and treating infections in the community 
• To increase early detection and treatment of both chlamydia and gonorrhoea and therefore reduce 
transmission and complications associated with these infections. 
Service outline 
The service will fund: 
• PCT programme of educational sessions for practices involved in delivery of enhanced service to support 
clinical and non-clinical staff involved in programme delivery.   
 The programme will effectively dovetail with the existing programme for the Sexual Health enhanced 
service.  
 A separate programme will also be provided for practices participating in the Chlamydia screening 
enhanced service alone. 
• Treatment of Chlamydia and gonorrhoea infection through voucher system for cases and contacts not entitled 
to free treatment. 
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• Provision of free condoms and sexual health advice 
Requirements 
• Appropriate provision of patient information e.g. posters and leaflet in the waiting areas 
• Attendance at agreed training by practice and cascade training to relevant practice personnel 
• To order and maintain appropriate supplies including standard screening programme laboratory forms 
• To be familiar with how to store and transport specimens 
• To develop mechanisms to receive and manage results  
• To be competent in issuing tests (urine in men, self taken swabs in women), in the context of providing 
information on how to prevent infection and the need for re screening on an annual basis or with each new 
partner   
• To agree the method for informing patients of positive and negative results – SH LES only 
• Develop mechanisms to flag individuals under 25 eligible for screening 
• To collect appropriate data on tests taken as per requirements of National Chlamydia Screening Programme 
and report to chlamydia screening office  
Practices participating in the enhanced service for sexual health should treat patients with a diagnosed infection in the usual 
way including carrying out partner notification.   
Practices that are not part of the enhanced sexual health service will only be able to offer screening to under 25 year olds and 
to develop a system to appropriately manage results. 
Audit requirements  
 All practices: 
• Number of patients screened for Chlamydia and gonorrhoea infection (through CSO)  
• Number and proportion of positive diagnoses made (CSO) 
Audit of quality of service provided re; treatment, management and partner notification, please refer to Sexual 
Health LES specification. 
Payments  
The Service Level Agreement is effective from the date received by the PCT until  
31st March 2007 and 1st April 2007 to 31st March 2008. 
Practices participating in the Enhanced Service for Sexual Health 
• £5 per dual NAAT test carried out in under 25 year olds as part of screening programme.  This includes 
ensuring the effective receipt of positive and negative results.  The service will not distinguish between tests 
carried out under existing arrangements and additional tests offered opportunistically. 
• Treatment of a positive case including the offer of a full sexual health screen and partner notification carried 
out in the usual manner will be paid as per positive diagnoses rather than as a screen. 
• Positive cases referred to alternative provider will be paid at the screen rate. 
Practices participating in the Screening Enhanced Service only 
• £5 per dual NAAT test carried out in under 25 year olds as part of screening programme.  Practices will be 
expected to carry out the testing and develop a system to appropriately manage results. 
Service Level Agreement: Local Enhanced Service for Chlamydia screening 
Section 1 
Practice Name 
Practice Lead 
Position 
I have read and understood the specifications for the Local Enhanced Service for Chlamydia screening, and agree to 
participate as per attached specifications.       
       Yes/No 
Section 2 
 
Work to be undertaken: 
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1. To screen under 25s for Chlamydia and Gonorrhoea. 
2. To issue tests (urine in men, self taken swabs in women). 
3. To provide information on how to prevent infection and the need for re screening on an annual basis or with 
each new partner. 
4. To inform patients of positive and negative results – SH LES practices only 
5. To treat patients with a positive result in the usual way including carrying out partner notification. (This relates to 
practices already participating in the Sexual Health Enhanced Service). 
6. To collect appropriate data on tests taken as per the requirements of the national screening programme and 
submit it to the Chlamydia screening office on a fortnightly basis. 
7. To order and maintain appropriate supplies including standard laboratory forms. 
8. To record appropriate READ code (to be confirmed by CEG)  
Section 3 
 
Payments for Enhanced Service 
£5 per dual NAATS test carried out in under 25 years old as part of screening programme. Please refer to section 6 of 
the specification for additional details. 
Section 4 
 
The Practice named in section 1 of this document has agreed to provide the Local Enhanced Service for Chlamydia 
screening. This enhanced service will run from the date received by the PCT until 31st March 2007 and 1st April 2007 to 
31st March 2008. 
Name of person completing this form________________________________ 
Once signed this agreement is binding for all partners in the practice named in section 1. By signing this SLA practices 
agree to provide the enhanced service as directed above during the financial year 2006/07 and 2007/08. 
Sign name_____________________________________________________ 
Job Title_______________________________________________________ 
Date__________________________________________________________ 
 
Local Enhanced Services – City & Hackney 
Sexual Health, HIV and Chlamydia Screening Part 1 Service Specification 
2012/13 
 
Contents 
Chapter  Page 
1 Introduction 2 
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Introduction 
 
This specification has been developed in line with the National Strategy for sexual health and HIV, to provide practices 
with the necessary resources to work towards decreasing the number of people in City and Hackney who are infected 
by a Sexually Transmitted Infection (STI) and HIV, by actively offering HIV testing to all new adult (15 to 59) 
registrations and STI screening to those who are identified as at risk or who present with symptoms.  
 
The specification also rewards practices for screening 15-24 year olds patients for Chlamydia as identified in 
the National Chlamydia Screening Programme.  
 
1.  Aims 
 
The aims of the service are to: 
• Reduce the prevalence and incidence of STIs in the residents of City & Hackney; 
• Promote early diagnosis and treatment of STIs including HIV, reducing transmission and morbidity and 
improving outcomes for patients; 
• Actively offer HIV testing to all new adult (15 to 59) registrations and adequately support and refer those 
individuals who test positive; 
• To screen for Chlamydia and Gonorrhoea all sexually active men and women under the age of 25 providing 
adequate partner notification and treatment;   
• Enhance confidence and skill levels of GPs and Practice staff with regard to sexual health and HIV; 
• Improve patient experience, access and choice and empower patients to practice safer sex. 
2. Pre-requisites for joining the service 
 
• Practices will identify a clinical lead for the service; 
• Clinicians will be accredited to provide services prior to starting the service. Clinicians will also be required to 
undergo update training as appropriate;  
• Practices wishing to provide services for the first time will need to be visited by the Sexual Health Leads in the 
Public Health Directorate. 
3. Service Outline 
 
Practices participating in the LES will be subject to annual or ad hoc review as deemed necessary by NHS East 
London and The City (NHS ELC).  Please note the information listed sections 5-9, and 12-13 are liable to be 
included in the auditing process.  Failure to comply with the audit requirements will result in a payment delay or 
decommissioning of the enhanced service. 
Practices who sign up to this service will need to undertake the following: 
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1. Identify a named practice lead clinician for the service and provide NHSELC with their contact details. Any change 
to the lead within the practice should be communicated immediately to NHSELC in order to keep records up to 
date. The email address provided must be from a secure provider e.g. nhs.net. 
2. Provide appropriate screening, management, treatment, partner notification and follow-up or referral as per 
specification below for Chlamydia; Syphilis; Gonorrhoea; Genital warts (HPV) Herpes Simplex (HSV); 
Trichomoniasis and HIV. 
3. Be trained to provide the following at sexual health consultations: 
a. Raise and discuss issues related to sexual health and safe sex practice; 
b. Recognise risk behaviours in both men and women and record patients’ sexual history; 
c. Provide STI testing including Syphilis; Hepatitis B and HIV serology and near patient testing; 
d. Manage uncomplicated Chlamydia, Gonorrhoea, Tricohomoniasis, HSV, HPV, including partner notification; 
e. Syndromic management as well as management of laboratory confirmed STIs; 
f. Offer HIV testing to all new adult registrations; 
g. Provide HIV pre and post-test discussion and advice to those testing negative and counselling and referral to 
those testing positive;  
h. Provide preventative management e.g. Hepatitis B immunisation in high-risk groups; 
i. Refer complicated STIs including HIV to GUM secondary care services using fast-track pathway (For further 
information see appendix A) For patients who wish to use services at Homerton, the referral form for GUM 
should be fully completed; 
j. Adequately code HIV tests offer to all new adult registrations; 
k. Adequately code all tests performed as well as positive diagnoses using READ codes. 
4. Release the relevant staff for training and submit evidence of training. Please see section 5 below for list of 
approved courses. Where training has been cascaded the documentation submitted must include a register of 
attendees and material covered. 
5. Maintain a list of all patients managed under the LES who have been screened and treated. This will include age, 
sex gender, sexuality and ethnicity. 
6. Demonstrable activity on partner notification. Practices are required to discuss partner notification with the patient 
and READ code that the discussion has taken place.   
7. Maintain a list of positive diagnosis of sexual infections made within the practice accompanied by anonymised lab 
results. Patients not wishing to have sexual health notes in their General practice notes can be directed to 
community sexual health services (see appendix 1 for further details).  
8. Be able to demonstrate satisfactory clinical management and use of CEG templates via a notes review if requested 
and deemed necessary by NHSELC. 
9. Provide the CSO with information on treatment, management, partner notification and follow-up of positive patients 
screened through the Chlamydia Screening Programme when requested. 
10. Organise the ordering of condoms, Chlamydia screening packs and pregnancy tests  and laboratory associated 
stock i.e. swabs and media bottles; and be familiar with recommendations regarding maintenance and transport 
e.g. temperatures for storage etc. ensuring they are adhered to. 
11. Pro-actively promote in-practice advertising of the services available and ensure an appropriate environment for 
sexual health consultations by: 
a. Ensuring information posters and leaflets are freely available; 
b. Using mail outs to contact target groups and raise awareness of sexual health screening and advisory 
services; 
c. Promoting sexual services during travel clinics and health checks; 
d. Including questions on HIV testing and HIV test offer in new patient registration forms; 
e. Using any other appropriate means of marketing, including using established methods of communication. 
12. Have an effective mechanism for informing patients of screening results. If the result is: 
a. Positive – Patient should be contacted within two working days of the lab result arriving at the practice; 
HIV positive results should be given face to face and ensure adequate referral for treatment and support. All 
patients testing reactive for near patient HIV testing should be referred for confirmatory serology. 
b. Negative – Practices should have arrangements in place to ensure patients are made aware of the results of 
their test within five working days of the lab result arriving at the practice. Patients should be fully briefed on 
how they can obtain a negative result. 
 
4. Training and Education 
 
Practices must ensure that all staff have attended the appropriate training. Clinicians new to providing the service must 
attend at least one of the NHSELC approved training sessions or other approved sexual health training course at 
inception. Clinicians must also ensure that once trained they remain competent in the management of STIs by updating 
their training.  
All practices offering HIV testing at registration and those interested in using point of care testing (POCT) should 
organise a practice training session – provided by the Public Health Team at NHS ELC. 
All clinicians involved in delivering this LES will undertake a minimum of 4 hours accredited education annually, to 
increase knowledge, skills and confidence in dealing with sexual health issues.  The minimum 4 hours training per year 
could consist of any or a combination of the options below: 
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• Attendance at a Sexually Transmitted Infections Foundation (STIF) course or other accredited course; 
• Support the organisation of an HIV training session provided at the practice; 
• Cascading sexual health training to other practice staff; 
• 4 hours documented self-directed learning; 
• active participation in training GP registrars on sexual health; 
• Attendance at conferences; 
• Training sessions with the community GUM consultant. And/or HIV liaison Nurse 
 
In addition at least one member of reception staff must attend the ‘let’s talk about sex training’ on an annual basis 
provided by NHSELC. 
 
Training Evidence All training including cascade training should be formally documented and demonstrable; a register 
of attendees including new staff (GP registrars, salaried GPs) and material covered must be kept to be submitted to 
NHSELC upon request. 
 
5.  Payments  
 
Payments for diagnosis of STI will be paid only where: 
• The practice has discussed partner notification with the patient and read coded accordingly; 
• Practices demonstrate that they have completed the required training before being eligible to sign up to the LES; 
• Practices can demonstrate that they have maintained competencies by attending the necessary training. Any 
practice that does not submit evidence that the appropriate clinicians have attended training will not be paid under 
this LES.  
 
Payments under this enhanced service are as follows: 
Payment Additional information £ Frequency & time of 
payment 
HIV screening In order to receive payment practices must 
demonstrate evidence of offer of HIV test to at least 
90% of new adult (15 to 59) registration using 
appropriate READ codes and test at least 10% of 
new adult registrations. 
Practices screening 10% to 30% of their new adult 
registrations and adequately recording READ codes  
£5.00 per test once a 
practice has screened 
10% of the target 
group 
Quarterly audit. 
Information validated by 
year end CEG audit.  
 
Bonus Payment 1 Practices screening 31 to 50% of their new adult 
registrations and adequately recording READ codes 
will receive and additional payment on those tests 
above the 30% threshold 
£7.00 per test once a 
practice has screened 
30% of the target 
group 
Quarter 4 Data validated 
at year end and 
payment adjustment will 
be made using CEG 
audit  
HIV diagnosis Where patient is not known to have infection prior to 
testing and appropriate treatment is provided 
including appropriate bi-annual review where 
possible.  
£265 per diagnosis Quarterly audit. 
Information validated by 
year end CEG audit 
Acute STI 
diagnosis and 
management as 
per section 4 
 
Only one claim per patient episode can be made. 
However, a patient presenting with two different 
episodes of STIs during the same year may be 
claimed twice assuming a full STI screening is 
carried out in each episode and where clinical 
episodes are more than 6 weeks apart. HSV and 
HPV can only be claimed upon initial diagnosis, 
not subsequent episodes.  
£160 per diagnosis Quarterly audit. 
Information validated by 
year end CEG audit.  
Chlamydia 
Screening 
Dual NAAT test performed in under 25 year old 
individuals.  
£5.00 per test  Quarterly audit. 
Information validated by 
year end CEG audit.  
Bonus 
Payment 1 
Practices screening more than 30% of their 
population aged 15-24 will receive an additional 
payment on screens above the 30% threshold. 
£5.00 per screen paid 
quarterly  
Extra £2 per screen 
above 30% of target 
population will be paid 
once data has been 
validated 
Quarter 4 Data validated 
at year end and 
payment adjustment will 
be made based National 
Chlamydia Screening  
  
6. Links with other services 
 
Practices must be providing services under the Sexual Health LES Part One in order to provide services under the 
IUCD specification Sexual Health Part Two. 
 
 
7. Data Collection 
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Practices are advised to use the LES template provided and refer to the READ coding guide issued by the Clinical 
Effectiveness Group (CEG) for this LES. Practice must use the template to ensure the correct READ codes are used in 
order to trigger payment. Data will be collected nd reported by the CEG on a quarterly and annual basis. Practices are 
able to view the  
Appendix 1 - Additional Information  
 
Additional Resources 
Practices who need additional information or support can contact the Public Health Department on 0207 683 4335. 
 
For advice on Chlamydia please contact Mike Spraggon on 020 7683 4113. 
 
Training sessions will be run via the PCT. This includes STIF courses, local clinical training and ‘let’s talk about sex’ 
training for non-clinical staff. 
 
Additional information for Sexual Health Enhanced Service 
Complicated STIs include untreated syphilis; solitary genital ulcers; herpes or other STIs in pregnancy; conditions not 
responding to first line therapy and new HIV Diagnosis. These and other rare conditions (e.g. Reiters disease, 
Bartholin’s cyst) should be referred to the appropriate specialty. 
 
Patients who do not want sexual health consultations recorded in their GP record can go to community services via the 
fast track pathway. The services available include: 
 
• City and Hackney Community Sexual Health Clinics  
• (Central Booking: 020 7683 4103) 
• The Ivy 
• Homerton Department for sexual health (DOSH)  
 
Practices are responsible for ordering their own supplies of condoms; however the PCT will continue to fund this in the 
same way as 2011/12. 
Practices will be required to report positive STI diagnoses to the HPA as part of the implementation of GUMCAD2.  
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Local Enhanced Service Specification – Chlamydia Screening (2006-07)  
Introduction 
All practices are expected to provide all essential and those additional services they are contracted to provide to all their 
patients. This enhanced service specification outlines the more specialised services to be provided. The specification of this 
service is designed to cover the enhanced aspects of clinical care of the patient, all of which are beyond the scope of essential 
services. No part of the specification by commission, omission or implication defines or redefines essential or additional services 
Background 
Chlamydia is the commonest sexually transmitted infection in the population affecting over 8% of the screened General Practice 
population in the Chlamydia screening pilots of the Wirral and Portsmouth.  The infection is commonly asymptomatic (70% 
women and 50% men) and it is estimated that less than 10% of Chlamydia infections are diagnosed.  Untreated, the infection 
accounts for significant long-term complications including infertility and pelvic inflammatory disease. 
 
City and Hackney is part of the phase 3 rollout of the National Chlamydia screening programme and has already established 
screening of under 25 year olds in other community settings.  Screening in General Practice will provide the opportunity for 
young people who are not necessarily in contact with sexual health services to receive testing. 
 
The newer screening test for Chlamydia infection using nucleic acid amplification technology (NAAT) is highly sensitive, specific 
and non-invasive; in addition, CHPCT will introduced the use of dual NAAT test that provide simultaneous testing for Chlamydia 
and gonorrhoea on a single specimen, overcoming the need for other more invasive testing. 
 
The specification is designed to promote: 
• Practices offering enhanced care to their own patients 
 
This specification has been developed through discussions with practitioners, Consultant at Department of Sexual Health. 
 
Clinical lead:   Dr Alison Gibb 
PCT Director lead:  Lesley Mountford/Jose Figueroa 
Development Vehicle:  Chlamydia Steering Committee  
 
Aims 
• To screen sexually active men and women under the age of 25 for Chlamydia and Gonorrhoea infection 
• To widen the reach of the Chlamydia screening programme in City & Hackney 
• To reach sexually active young men and women who do not use sexual health services 
• To increase screening of asymptomatic patients consulting for unrelated conditions 
• To increase acceptability of testing for both chlamydia and gonorrhoea by non invasive testing 
• To increase understanding and raise awareness of importance of Chlamydia and gonorrhoea infections in young 
sexually active clients 
• To de-stigmatise Chlamydia and gonorrhoea infections and raise awareness of safer sexual practices 
• To reduce the burden on secondary care services by diagnosing and treating infections in the community 
• To increase early detection and treatment of both chlamydia and gonorrhoea and therefore reduce transmission and 
complications associated with these infections. 
Service outline 
The service will fund: 
• PCT programme of educational sessions for practices involved in delivery of enhanced service to support clinical and 
non-clinical staff involved in programme delivery.   
 The programme will effectively dovetail with the existing programme for the Sexual Health enhanced 
service.  
 A separate programme will also be provided for practices participating in the Chlamydia screening 
enhanced service alone. 
• Treatment of Chlamydia and gonorrhoea infection through voucher system for cases and contacts not entitled to free 
treatment. 
• Provision of free condoms and sexual health advice 
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Requirements 
• Appropriate provision of patient information e.g. posters and leaflet in the waiting areas 
• Attendance at agreed training by practice and cascade training to relevant practice personnel 
• To order and maintain appropriate supplies including standard screening programme laboratory forms 
• To be familiar with how to store and transport specimens 
• To develop mechanisms to receive and manage results  
• To be competent in issuing tests (urine in men, self taken swabs in women), in the context of providing information on 
how to prevent infection and the need for re screening on an annual basis or with each new partner   
• To agree the method for informing patients of positive and negative results – SH LES only 
• Develop mechanisms to flag individuals under 25 eligible for screening 
• To collect appropriate data on tests taken as per requirements of National Chlamydia Screening Programme and report 
to chlamydia screening office  
 
Practices participating in the enhanced service for sexual health should treat patients with a diagnosed infection in the usual way including 
carrying out partner notification.   
Practices that are not part of the enhanced sexual health service will only be able to offer screening to under 25 year olds and to develop a 
system to appropriately manage results. 
Audit requirements  
 All practices: 
• Number of patients screened for Chlamydia and gonorrhoea infection (through CSO)  
• Number and proportion of positive diagnoses made (CSO) 
Audit of quality of service provided re; treatment, management and partner notification, please refer to Sexual Health LES 
specification. 
Payments  
The Service Level Agreement is effective from the date received by the PCT until  
31st March 2007 and 1st April 2007 to 31st March 2008. 
Practices participating in the Enhanced Service for Sexual Health 
• £5 per dual NAAT test carried out in under 25 year olds as part of screening programme.  This includes ensuring the 
effective receipt of positive and negative results.  The service will not distinguish between tests carried out under existing 
arrangements and additional tests offered opportunistically. 
• Treatment of a positive case including the offer of a full sexual health screen and partner notification carried out in the 
usual manner will be paid as per positive diagnoses rather than as a screen. 
• Positive cases referred to alternative provider will be paid at the screen rate. 
Practices participating in the Screening Enhanced Service only 
• £5 per dual NAAT test carried out in under 25 year olds as part of screening programme.  Practices will be expected to 
carry out the testing and develop a system to appropriately manage results.  
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Service Level Agreement: Local Enhanced Service for Chlamydia screening 
Section 1 
Practice Name 
Practice Lead 
Position 
I have read and understood the specifications for the Local Enhanced Service for Chlamydia screening, and agree to participate 
as per attached specifications.         
            
     Yes/No 
Section 2 
Work to be undertaken: 
 
1. To screen under 25s for Chlamydia and Gonorrhoea. 
2. To issue tests (urine in men, self taken swabs in women). 
3. To provide information on how to prevent infection and the need for re screening on an annual basis or with each new 
partner. 
4. To inform patients of positive and negative results – SH LES practices only 
5. To treat patients with a positive result in the usual way including carrying out partner notification. (This relates to practices 
already participating in the Sexual Health Enhanced Service). 
6. To collect appropriate data on tests taken as per the requirements of the national screening programme and submit it to the 
Chlamydia screening office on a fortnightly basis. 
7. To order and maintain appropriate supplies including standard laboratory forms. 
8. To record appropriate READ code (to be confirmed by CEG)  
Payments for Enhanced Service 
£5 per dual NAATS test carried out in under 25 years old as part of screening programme. Please refer to section 6 of the 
specification for additional details. 
 
Section 4 
The Practice named in section 1 of this document has agreed to provide the Local Enhanced Service for Chlamydia 
screening. This enhanced service will run from the date received by the PCT until 31st March 2007 and 1st April 2007 to 
31st March 2008. 
Name of person completing this form________________________________ 
Once signed this agreement is binding for all partners in the practice named in section 1. By signing this SLA practices agree to 
provide the enhanced service as directed above during the financial year 2006/07 and 2007/08. 
Sign name_____________________________________________________ 
Job Title_______________________________________________________ 
Date__________________________________________________________ 
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Specification for the provision of a Local Enhanced Service  
Service: Chlamydia Screening by General Practices 
 
Period: April 2008 to March 2009 
 
Updated:  October 2008 
 
 
1. Aim  
 
The aim of this enhanced service is to increase the uptake of Chlamydia screening in people aged 15 to 24 years by offering 
practices an incentive payment to help establish this service for patients.   
2. Strategic fit: national and local 
Chlamydia is a sexually transmitted infection which the Department of Health estimates approximately 10% of young people have 
contracted. Initial results in Haringey indicate that 25% of people tested are positive for Chlamydia.  
If left untreated Chlamydia can result in complications such as pelvic inflammatory disease, ectopic pregnancy in women and 
infertility in both women and men; however, it is easily treated.  It is important that we offer young people the opportunity to find 
out if they have contracted Chlamydia so that they can receive the treatment that they need. 
Chlamydia screening of sexually active people aged under 25 is a national target and is part of the PCT’s Operating Plan for 
2008/09 to 2010/11, with the target ranging from 15% to 35% over the three years. Achievement of this target will have a 
significant impact on the reputation of the PCT and its practices.   
At a local level, the PCT is working closely with local schools and higher education establishments to encourage uptake of 
screening, as well as offering screening kits over the internet. In addition, the PCT is investing in social marketing, however this will 
take some time to come on stream, which is why offering opportunistic screening and screening through practices continues to be a 
key way of increasing uptake  
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3. Summary of service 
Practices will offer patients aged 15 to 24 Chlamydia screening tests. The practice should look to screen opportunistically wherever 
possible, as well as at appointments made solely for this purpose. The practice may wish to invite patients for screening to 
increase uptake rates. The methodology is left to the practice to decide what is most suitable for their patients. 
The test is very straightforward and takes only minutes; the actual taking of the sample can be done by the person themselves in 
private on the practice premises or as part of a consultation where appropriate.  
The samples are sent to a central lab for testing and the results are available in a couple of weeks.  The young person will be 
contacted directly by the Chlamydia Screening Office with their results. 
4. Impact on current services and pathways 
Practices in other boroughs have found that they can provide this screening opportunity at a range of contacts with young people. 
• Routine appointments for family planning such as contraceptive pill checks 
• Appointments for emergency contraception 
• Pregnancy testing 
• New patient health checks 
• Ante-natal clinics 
• Childhood immunisation clinics 
All of these approaches have proved effective in some practices although obviously each practice will know what will be most 
effective with their population. 
5. Quality mechanism 
The practice must ensure that the form accompanying the test is completed correctly to include the following information: 
• date of birth 
• postcode 
• contact number for the young person 
 
The practice should send the test sample and paperwork to the address in the kit. 
Practices will not be paid for tests which are accompanied by an incorrectly completed form.  
6. Performance management 
 
The actual number of screens is reported through the Chlamydia Screening Office. This data feeds into the quarterly data returns 
the PCT makes to the Department of Health. The practice does not need to submit any other data. 
Each practice will be sent a report of their performance at the end of each quarter between now and year end, showing which 
payment milestone they have reached and therefore what minimum payment they can expect if that level of screening is 
maintained.  
Practices will also have their screening rates included in the sixth-monthly performance report which the PCT issues. 
7. Eligibility 
 
All practices will be eligible to provide this service if they fulfil the following criteria: 
• Practices must be able to return a fully completed form, accompanying the screening kit supplied by Enfield 
and Haringey Chlamydia Screening Programme, along with the sample 
• Practices must indicate if they are intending to take part in this enhanced service by returning the form at the 
end of this specification. 
8. Training required  
 
There are no training requirements associated with this LES. Support to implement this scheme is available from Innovision; you 
can contact them at: 
Innovision Healthcare Limited 
Suite 2 
2 Elm  Park Road 
Winchmore Hill 
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London N21 2HN 
Tel:  020 8360 5405 
Fax:  020 8360 9527 
debbieharris@nhs.net 
9. Payment mechanism 
 
Those practices which have already been offering Chlamydia screening will still be paid under the terms of this scheme 
retrospectively for the work that they have done since the beginning of this financial year.  Payments will be made after the end 
of March 2009 once all results have been returned from the labs.  
Payments will only be made where: 
• The screening kit supplied by Enfield and Haringey Chlamydia Screening Programme is used. 
• The patient is within the age range 
• The form is completed correctly with all the fields completed: 
Date of birth 
Postcode 
Contact number  
• Name and date of birth is filled out on the bottle 
• The screening programme receives notification from the lab of a returned test. 
 
Payments for 2008/09: 
Achievement Payment 
3% of eligible patients £3 per returned test 
5% of eligible patients £5 per returned test 
10% of eligible patients £10 per returned test 
15% of eligible patients £15 per returned test 
 
The percentage of eligible patients is calculated according to practice lists on Exeter as at October 2008. 
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CONFIRMATION FORM FOR CHLAMYDIA LOCAL ENHANCED SERVICE 
For the Practice to complete and return to Sadeana Smith, Performance Manager, Primary Care Directorate, Block A2 St Ann’s 
Hospital, St Ann’s Road, London N15 3TH. 
I intend to take part in the Chlamydia local enhanced service. By signing and returning this form I confirm that I am eligible 
to take part in the LES according the eligibility criteria in the specification.  
Lead GP name: 
Lead GP signature: 
Practice name: 
Practice address: 
Haringey PCT 
 
 
Specification for the Provision of a Local Enhanced Service  
 
 
Service: Chlamydia Screening by General Practices 
 
Period: April 2009 to March 2010 
 
Introduction 
All practices are expected to provide essential and those services they are contracted to provide to their patients. No part of the 
specification by commission, omission or implication defines or redefines essential or additional services. 
Aim  
The aim of this enhanced service is to build on the 2008/9 LES and continue to increase the uptake of Chlamydia screening in 
people aged 15 to 24 years by offering practices an incentive payment to help establish this service for patients.  The target for 
Haringey is 25% of sexually active 15 – 24 year olds. 
Strategic fit: national and local 
Chlamydia is a sexually transmitted infection which the Department of Health estimates approximately 10% of young people have 
contracted. Initial results in Haringey indicate that 7% of people tested are positive for Chlamydia.  
If left untreated Chlamydia can result in complications such as pelvic inflammatory disease, ectopic pregnancy in women and 
infertility in both women and men; however, it is easily treated.  It is important that we offer young people the opportunity to find 
out if they have contracted Chlamydia so that they can receive the treatment that they need. 
Chlamydia screening of sexually active people aged under 25 is a national target and is part of the PCT’s Operating Plan for 
2008/09 to 2010/11, with the target ranging from 15% to 35% over the three years. Achievement of this target will have a 
significant impact on the reputation of the PCT and its practices.   
At a local level, the PCT is working closely with local schools and higher education establishments to encourage uptake of 
screening, as well as offering screening kits over the internet. In addition, the PCT is investing in social marketing, however this will 
take some time to come on stream, which is why offering opportunistic screening and screening through practices continues to be a 
key way of increasing uptake. 
Summary of service 
Practices will offer patients aged 15 to 24 Chlamydia screening tests. The practice should look to screen opportunistically wherever 
possible, as well as at appointments made solely for this purpose. The practice may wish to invite patients for screening to 
increase uptake rates. The methodology is left to the practice to decide what is most suitable for their patients. 
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The test is very straightforward and takes only minutes; the actual taking of the sample can be done by the person themselves in 
private on the practice premises or as part of a consultation where appropriate.  
The samples are sent to a central lab for testing and the results are available in a couple of weeks.  The young person will be 
contacted directly by the Chlamydia Screening Office with their results. 
1. Impact on current services and pathways 
Practices in other boroughs have found that they can provide this screening opportunity at a range of contacts with young people. 
• Routine appointments for family planning such as contraceptive pill checks 
• Appointments for emergency contraception 
• Pregnancy testing 
• New patient health checks 
• Ante-natal clinics 
• Childhood immunisation clinics 
• Mail outs to all 15 – 24 year olds on your list, inviting them to come in for a screen or to request a postal kit, can result in a return 
rate of 15% 
• Pop up reminders on you computer system can ensure you make the most of all opportunities to offer screens to this population 
group  
All of these approaches have proved effective in some practices although obviously each practice will know what will be most 
effective with their population. 
2. Quality mechanism 
The practice must ensure that the form accompanying the test is completed correctly to include the following information: 
• date of birth 
• postcode 
• contact number for the young person 
The practice should send the test sample and paperwork to the address in the kit. 
Practices will not be paid for tests which are accompanied by an incorrectly completed form.  
3. Performance management 
The actual number of screens is reported through the Chlamydia Screening Office. This data feeds into the quarterly data returns 
the PCT makes to the Department of Health. The practice does not need to submit any other data. 
4. Eligibility 
All practices will be eligible to provide this service if they fulfil the following criteria: 
• Practices must be able to return a fully completed form, accompanying the screening kit supplied by Enfield and Haringey 
Chlamydia Screening Programme, along with the sample 
• Practices must indicate if they are intending to take part in this enhanced service by returning the form at the end of this 
specification. 
5. Training required  
There are no specific training requirements associated with this LES. Support to implement this scheme is available from 
Innovision; you can contact them at: 
Innovision Healthcare Limited 
Suite 2 
2 Elm  Park Road 
Winchmore Hill 
London N21 2HN 
Tel:  020 8360 5405 
Fax:  020 8360 9527 
debbieharris@nhs.net 
6. Payment mechanism 
Those practices which have already been offering Chlamydia screening will still be paid under the terms of this scheme 
retrospectively for the work that they have done since the beginning of this financial year.  Payments will be made after the end 
of each of quarter once all the all results have been returned from the labs for that period.  
Payments will only be made where: 
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• The screening kit supplied by Enfield and Haringey Chlamydia Screening Office is used. 
• The patient is within the age range 
• The Chlamydia Screening Office form is completed correctly with all the fields completed: 
Date of birth 
Postcode 
Contact number  
• Name and date of birth is filled out on the bottle 
• The screening programme receives notification from the lab of a returned test. 
Payments for 2009/10: 
The practice will be paid a fee of £10 per test returned that meet the payment criteria above. 
CONFIRMATION FORM FOR CHLAMYDIA LOCAL ENHANCED SERVICE 
For the Practice to complete and return to Sue.Eaves@haringey.nhs.uk or fax to 020 8442 6939.  
I intend to take part in the Chlamydia local enhanced service 2009/10. By signing and returning this form I confirm that I 
am eligible to take part in the LES according the eligibility criteria in the specification.  
Lead GP name: 
Lead GP signature: 
Practice name: 
Practice address: 
Date: 
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Chlamydia screening in Lambeth general practices 
- Q&A update January 2012 
-  
Improving sexual health remains one of NHS Lambeth’s priorities. Local GPs and other health services have provided a very 
successful screening programme for Chlamydia as part of the national programme, and this work will continue as a part of 
mainstream services.   Following recent changes to the local programme, this Question & Answer sheet adds to and repeats 
some of the information sent out in November 2011. 
Q:    Should we continue to screen asymptomatic patients under 25s?  
Yes - we had the highest screening coverage in England during 2010-11, but our Chlamydia positivity rate in the 15-24 cohort in 
Lambeth is 8.6%, compared to 5.2% nationally and 4.7% across London.   Analysis of local CSP Quarter 2 data suggests we 
expect to exceed our annual screening coverage target, with a positivity rate of 9.8%.  
Q: How can we find out about our Chlamydia screening activity to end October 2011, and any incentive payments 
for which we qualify? 
Practices were informed by Rumbi Mugezi late in 2011 of their activity against 10%, 17%, 25% and 35% coverage thresholds.   
A further attachment showing a chart of GP screening activity shows your activity in relation to other practices. Payments for 
those practices which met targets will be made in February through contract variation.  
Q: What read codes should we be using to assist clinical management and data analysis now that Chlamydia 
Screening forms are no longer in use? 
The Chlamydia Screening Read Code List is provided as an additional attachment.  NHS Lambeth expects to be able to analyse 
and feedback Practice Focus data quarterly, and we are speaking to the labs about alternative data collection methods.    
Q: What forms should we use for Chlamydia Screening? 
You should use your standard pathology request forms: 
• Services using Guys & St Thomas’ Laboratory - sample should be sent using the Pathology form ‘Routine Request 
Form 2’. 
• Kings Pathology Laboratory – sample should be sent using the routine Microbiology ‘Blue’ form. 
• The laboratories have been looking into the inclusion of microbiology requests on tQuest and similar electronic 
systems, but this is not yet available. 
• Practices should ensure that all clinicians have stopped using the yellow CSP forms.  Any copies should be 
discarded.  If a CSP form is submitted to the laboratory with a sample, it will still be processed in the first instance, but the 
laboratories have agreed a cut off date.  
Q: Will the test continue to be a dual NAAT test for Chlamydia and gonorrhoea? 
Yes, the Aptima Combo will still be used and can be accessed via the laboratories using the current ordering system: 
• Vaginal (orange kit) for women only  
• Urine (yellow kit) for both men and women 
• Endocervical (white kit) for women, usually used if patient is having an internal examination only. 
Q: Can we obtain more photo instructions to help patients take their own samples?  
Photo instructions were supplied to all practices e.g. for display in toilets, and patients should still be reminded to make sure 
registration details, mobile phone numbers, and date of birth are filled in clearly on the sample bottle.  Pathology forms need to 
be completed by clinicians and / or receptionist responsible.  Incorrect or incomplete forms and samples will be rejected by the 
laboratories.  
Q: Who is responsible for notifying patients of results?  How? 
Notification and management of the all chlamydia and gonorrhoea results is the responsibility of the testing service, and 
individual clinician submitting the sample. 
Each practice should: 
• Notify patients of negative results by asking patients to contact the practice for their results (Department of Health 
does not recommend the ‘NO NEWS IS GOOD NEWS’ approach)  
• Notify patients of positive results and recall them for treatment, partner notification, and any further STI tests. 
• Notify patients with an equivocal result, treat the patient as positive but repeat the test. 
• Recall all patients whose samples have not been processed (either because the sample is insufficient or 
unlabelled) and re-test.  
Q: Are there other ways of informing patients of a negative result?   
Texts are no longer sent from the Chlamydia Screening Office.  You should already have adapted your own patient result 
notification system e.g. by using automated appointment reminder texts (such as MJOG on EMIS).  
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Q: How many times should we attempt to contact patients for treatment? 
• Negative results will be the responsibility of the patient to contact the GP for their results.  This should be explained 
during their consultation. 
• Positive / equivocal results will continue to be the responsibility of the practice to actively manage.   Each practice 
needs to ensure failsafe measures are reviewed to include complete positive result / treatment management 
• Positive results should be communicated as soon as possible to ensure patients receive treatment and partners 
are notified/ treated. Guidance from the Department of Health is to attempt to contact positive patients 3 times before recording 
patients as untreated.  
Q: Will the treatment of positive patients change? 
Treatment protocols are to be followed as agreed locally (2007/8 version).  Updated local guidance on gonorrhoea treatment is 
due soon, but positive gonorrhoea results should always be confirmed by culture & sensitivities test. 
Q: Partner notification slips: how will we access then post March 2012? 
Partner notification slips can be useful in initiating contact tracing for any patient with positive results.  These slips will continue 
to be available until March 2012 via the Chlamydia screening office at Mawbey Brough. We are currently reviewing their 
continuation post March 2012. 
Q: Given that sexual health remains a key local priority, will Chlamydia screening become part of the core contract 
for GPs?   
NHS Lambeth is continuing to advocate for the inclusion of sexual health supplementary indicators (e.g. Chlamydia screening 
targets) in the revised core GP practice contracts.  We'll update you when we know more. 
Q: Where can I get further advice or support on Chlamydia screening in my practice? 
Rumbi Mugezi has now left and WUSH team Specialist Nurse for Young People 
(GSTT Community Health Services) Hannah White has taken on co-ordination of the CSP until 31st March 2012  
Hannah.White@lambethpct.nhs.uk (tel. 020 3049 6832; 07824471934)  
Mawbey Health Centre, 39 Wilcox Close, London, SW8 2UD 
sebastiankalwij@mac.com  - Dr Sebastian Kalwij is GP Champion for the CSP, and can also offer peer support and training. 
Sarah.french@lambethpct.nhs.uk (tel 020 3049 5244) is also available to offer development support around your whole range of 
sexual health services, and can arrange for specialist clinical update if requested.  
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Lambeth PCT 
 
 
  
Chlamydia Screening Programme  
Artesian Health Centre 
138 Grange Road  
London 
SE1 3GF 
 
2 August 2011 
Dear Sir/Madam/Dr 
RE: Performance report for Chlamydia Screening 2011/12 
I am writing to inform you of your practice performance for Quarter 1(Apr-Jun). Below is a table that shows a breakdown of the 
thresholds that need to be achieved by your practice. 
 
Practice Name :  
Target  Threshold No of screens to achieve target 
10% threshold  
17% threshold  
25% threshold  
35% threshold  
In light of the termination of the LES in November 2011practices who achieve the minimum threshold by 31st October will 
receive the minimum incentives and those that achieve higher thresholds will receive as per threshold achieved based on 
screening done on the yellow forms only.  
Screening for Chlamydia will remain an important national Public Health issue, and the reduction of asymptomatic chlamydial 
infection, and STI prevalence more widely, remains an NHS Lambeth priority.  We expect you to continue offering screening to 
your patients now the service has been so well established within General Practice 
For further information regarding incentives and future screening from 1st November 2011 please contact me on the telephone 
numbers provided below. 
Kind Regards 
Rumbi Mugezi  
Guys and St Thomas Trust Community Health Services 
Chlamydia Screening Coordinator  
02030497946 
0777 573 5392 
 
Locally Enhanced Services Agreement for Lambeth General Practices 2009-2010 Outline  
  267 
 
General Practices continue to be play a pivotal role in increasing accessibility to Chlamydia and Gonorrhoea screening, speeding up the 
diagnostic and treatment process and reducing the possibility of onward transmission.  
GP LES 2009-2010 
Between 2009-2010 the GP screening incentive scheme will continue to operate on a revenue basis under NHS Lambeth’s (formerly 
Lambeth PCT) Sexual Health Strategy.  The LES will remain accountable to the Sexual Health Operational Group for performance reporting 
and progress. 
This financial year, Lambeth’s Chlamydia Screening LES has been revised to incorporate most recent LDP targets to screen 25% of the 
young people population by 31st March 2010. LES contracts will be issued this year in the form of an agreement letter and incentive 
schedule. 
Finances  
The revised incentive structure consists of five payment thresholds.  A 5% retainer has been introduced to reflect GP performance in 2008-
2009 and the programme’s forthcoming media and communication strategy scheduled for implementation this year.   
As mentioned in the preceding section, practice payments are dependent upon screening performance and registered target cohort size.  
Similar to previous years, only performance above the desired thresholds will be rewarded. 
Table 1 indicates incentive payments according to target cohort size for each threshold  
 
 
 
* To qualify for the Band E retainer, practices within this stratum will have to screen either in excess of 5% of their target 
population or 16 young people, which ever amounts to the greater sum. 
Under this year’s LES, repeat and first-time screens carried out between the 1st April 2009 and 31st March 2010 will contribute towards 
meeting practice performance thresholds. 
Practice Responsibilities 
Participating practices must agree to the following duties and responsibilities as a part of the LES agreement:  
• Practices must use the local Chlamydia Screening Programme (CSP) forms  
• Practices must agree a named Chlamydia lead to communicate with the Chlamydia Screening Programme 
• All front line receptionist staff providing condoms or giving sexual health information must have local receptionist 
training focused on working with young people and sexual health 
• Each Practice must work towards the criteria contained in ‘You’re Welcome: making health services young people 
friendly’ available at: http://195.33.102.76/assetRoot/04/12/15/64/04121564.pdf  
• Practices must provide appropriate literature to patients on Chlamydia and Gonorrhoea and alternative locations 
where comprehensive screening is available 
• Patients may be screened using both invasive & non-invasive techniques when appropriate 
• Screening should be offered to all target patients opportunistically as well as to those presenting for sexual health and 
contraception consultations  
• All index patients positive for Chlamydia and/or Gonorrhoea should receive treatment within 10 working days of the 
practice receiving results 
Band  
Registered  
15-24 yr old cohort 
No of practices 
5% 
Retainer 
Payment 
(£) 
 Total Payment at 
10% (£) 
Total Payment at 
17% (£) 
Total Payment at 
25%(£) 
A >1400 5 500 1100 1900 2600 
B 1101-1400 6 400 800 1500 2100 
C 801-1100 14 300 700 1200 1600 
D 500-800 14 200 400 900 1400 
E <500 13 100* 250 750 850 
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• Treatment & testing must comply with the Lambeth & Southwark 2005 STI Guidelines available here: 
http://nww.southwarkpct.nhs.uk/document_view.php?PID=0000000123&DID=00000000000000002170 
• Practices must provide the Chlamydia Screening Programme with monthly intelligence relating to basic partner 
notification and treatment of index patients. 
 
GP Support and Training  
Lambeth’s GP Chlamydia Champion and Chlamydia Screening Co-ordinator will carry out the performance monitoring, training, and 
support work to ensure that GP screening continues to represent in excess of 40% of the overall screening performance.    
Costs  
If practice performance is similar to last year, projected spend in March 2010 amounts to £28,850. 
 
GP Champion- Chlamydia Screening  £5,000 
Chlamydia screening in practices  £28,850 
Total  £33,850 
 
 
Service Level Agreement for Local Enhanced Service- Chlamydia Screening in General Practices  
This is a Service Level Agreement between:  
 
NHS Lambeth 
& 
Your practice is Band 
 
Commencement date: 1st April 2010 
Date of termination: 31st March 2011 
Overview  
This agreement details the scope and type of work to be undertaken by the Contractor for the agreed tariff.  
The service provider will offer a professional and auditable service under the terms as detailed below. 
This agreement may be terminated by any of the parties on giving three months’ written notice of intention to terminate the 
arrangement to the other parties. 
Outcomes  
The outcomes this LES seeks to deliver are:  
➢ To increase young people’s access to opportunistic Chlamydia and Gonorrhoea screening, in 
compliance with The National Chlamydia Screening Programme’s core requirements   
➢ To increase the rate at which Chlamydia Trachomatis and Gonorrhoea Neisseria are diagnosed, with the 
intent to reduce the onward transmission of infection  
➢ To integrate, develop and sustain the delivery of sexual health services in General Practices  
Service Tariff 
Under this SLA, service providers will be paid to screen their 15-24 year old cohort for Chlamydia and Gonorrhoea.  This year, 
the incentive scheme has been revised to reflect the 2009-2010 LDP targets to screen 35% of Lambeth’s young population.   
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Monies received by a practice will be dependant upon the total number of 15-24 year old patients registered and the number of 
screens performed in conjunction with this year’s target thresholds.   
The table below indicates the payment structure implemented according to cohort size  
 
 
 
 
Only performance above the desired thresholds will be rewarded and service providers should expect to receive payments via 
contract variation by end of June 2011.  
Repeat and first-time screens carried out between the 1st April 2010 and 31st March 2011 on programme patient information forms 
will contribute to meeting practice targets. 
Screening of over 25 year olds will be excluded and you will be informed every quarter of your individual performance. 
The table below shows your practice’s target screens for 2010/11 
 
10% Threshold 17% Threshold 25% Threshold 35% Threshold 
    
GP Support and Training  
Lambeth’s GP Chlamydia Champion and Chlamydia Screening Co-ordinator will carry out the performance monitoring, training, 
and support work to ensure that GP screening continues to represent in excess of 50% of the programme’s overall screening 
performance.   
Criteria for inclusion requirements  
Participating Contractors must agree to the following duties and responsibilities as a part of the LES agreement:  
➢ To try to screen over and above the retainer threshold 
➢ To use the local Chlamydia Screening Programme (CSP) patient information forms when performing 
screens on all 15-24 year olds 
➢ To have a named practice lead to communicate with the Chlamydia Screening Programme 
➢ For all front line reception staff providing condoms, screening or sexual health information, to have 
received appropriate training including working with young people.  
➢ To work towards the criteria contained in ‘You’re Welcome: making health services young people 
friendly’ available at: http://195.33.102.76/assetRoot/04/12/15/64/04121564.pdf  
➢ To provide appropriate literature to patients on Chlamydia and Gonorrhoea and alternative locations 
where comprehensive screening is available 
➢ For Patients to be screened using both invasive & non-invasive techniques when appropriate 
➢ For screening to be offered to all target patients as well as to those presenting for sexual health and 
contraception consultations  
➢ For all index patients positive for Chlamydia and/or Gonorrhoea to receive treatment within 10 working 
days of the practice receiving results 
➢ For treatment & testing to comply with the Lambeth & Southwark 2005 STI Guidelines available here: 
http://nww.southwarkpct.nhs.uk/document_view.php?PID=0000000123&DID=00000000000000002170 
Band Pop size as of Dec 2009 No of practices Incentive sum at 
10% 
Incentive sum of 
17% 
Incentive sum of  
25% 
Incentive sum of 
35% 
A >1400 5 1000 2000 3000 4000 
B 1100-1400 6 700 1400 2100 2800 
C 801-1099 11 500 1000 1500 2000 
D 500-800 16 400 800 1200 1600 
E <500 12 200 400 600 800 
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➢ To provide the Chlamydia Screening Programme with verbal or written monthly intelligence relating to 
basic partner notification and treatment of index patients. 
Monitoring Arrangements: 
➢ Whist it is advised that Contractors monitor their own screening activity, Contractor performance will only 
be assessed upon the number of patient information forms received by the Chlamydia Screening Office via contracted 
laboratories 
➢ The Chlamydia Screening Office will provide Contractors with a written overview of site and peer 
performance at the end of every quarter 
➢ As part of the overall annual review process, the Contractor may be asked to provide a report for 
evaluation on the service being provided under this agreement 
➢ As part of the annual review process the Contractor will be expected to: 
- Feedback on service quality 
- Report on relevant activity 
➢ NHS Lambeth may evaluate the contractual arrangements and share the findings with other participating 
practices, paying particular attention to patient/practice satisfaction and value for money.  These findings will be used to inform 
commissioning arrangements in future years. 
➢ May be subject to “Mystery Shopper” Surveys 
Variation 
The services may be varied if: 
➢ The Contractor and NHS Lambeth agree in writing, or a change in NHS Lambeth’s service priorities is 
required by: 
-changes in legislation, guidance or directions from the Dept of Health, or 
  -reductions in the budget of the relevant service area funding, or  
  - other exceptional circumstances 
➢ Proposals to vary the services may be initiated by either party. A variation to the services will require three 
months written notice unless both parties agree otherwise. 
➢ Under the terms of this agreement, NHS Lambeth will suspend the contract if for any reason service provision 
or patient safety is compromised in any way.  The contract will be suspended pending the outcome of a full and transparent 
investigation, following which the agreement will either terminate or be reinstated. 
Conciliation and Arbitration 
➢ It is the wish of both parties that this agreement shall not interfere with or impede the goodwill that has 
existed between the parties prior to the Agreement. 
➢ In the event or any disagreement or dispute between the parties they will use their best endeavour to reach 
a resolution without resort to conciliation or arbitration. 
➢ In the event or the parties being unable to reach a resolution jointly they will jointly agree the name of a 
conciliator. Only in the event of conciliation proving unsuccessful will they resort to arbitration. In such event either party may give 
notice that they wish to refer the disagreement or dispute to an Arbitrator. Should the parties fail to agree the nomination of a 
named individual or individuals as Arbitrator either party may apply to FHSAA to determine the dispute or settle the difference. 
Any reference to arbitration under this clause shall be deemed to be a reference to arbitration within the meaning of the Arbitration 
Acts 1950 and 1979. 
 
Force Majeure 
 
Neither the Contractor nor NHS Lambeth will be liable for delay or failure to perform the obligations of this Agreement if this delay or 
failure results from circumstances beyond their reasonable control including but not limited to: Acts of God, Government Act or Direction, 
Explosion or Civil Commotion or Industrial Dispute. 
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Appendix 2 - Application Form 
Date:  
Name of practice:  
Name of person completing form:  
 
➢ Will strive to provide screening to over 35% of our sexually active 15-24 year old patients 
➢ Will continue to meet the practice requirements outlined  
➢ Understands that the practice will receive payment via contract variation following evidence of screening 
levels towards the proposed targets.   
➢ Will ensure that information relating to this LES is included in locum packs/ orientation for all locum 
doctors 
 
Signed……………………………………………………………………………….. 
Please return this form via, post, fax or electronically (with an electronic signature, if 
possible) to  
 
Rumbidzai Mugezi Lambeth & Southwark Chlamydia Screening Coordinator 
 
Chlamydia Screening Programme 
        6th Floor Mabel Goldwin House 
49 Grange Walk 
London 
SE1 3DY 
 
Fax Number:  0207 525 0315 
Email: Rumbidzai.Mugezi@southwarkpct.nhs.uk 
 
 
Tower Hamlets PCT 
 
 
 
Vikki Pearce Sexual Health Programme Manager 
 
Introduction and background 
 ‘Improving Sexual Health’ is the local strategy aimed at improving health and well being in Tower Hamlets.  Building upon key 
priorities of the ‘National Sexual Health and HIV Strategy (2001)’, the core principles are to deliver flexible, accessible, equitable 
and high quality sexual health services and in doing so achieve sustained good sexual health for the people of Tower Hamlets. 
The vision for Tower Hamlets is a comprehensive system of sexual health providers consisting of:  
• Networks of primary care providers where all practices offer basic (level one) services and some practices in 
each network offer more advanced services  
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• Four locality based integrated contraception and sexual health services 
• Two services offering basic and intermediate services for the whole population 
• Two services offering advanced (specialist) services including termination of pregnancy, HIV care, 
management of complex GUM cases 
• User friendly with modern, pleasant, local and accessible facilities  
• Capacity for 10 - 12k attendances per year 
• Self care options for condoms, pregnancy tests and Chlamydia screening  
• links to ‘spokes’ (community centres, schools, charitable healthcare projects, etc)  
General practice has a unique opportunity and responsibility to identify and respond appropriately to sexual health need which 
may otherwise be invisible. Individuals may not define their problem as ‘sexual health,’ and general practice can play an important 
role in uncovering unmet sexual health need (e.g. opportunistic Chlamydia screening, asking young people about  contraceptive 
needs, or spotting symptoms of undiagnosed HIV). General practice is the majority provider of contraception, but data on its 
activities are limited and there is no routine surveillance of STI diagnoses or management in primary care. Studies suggest there 
is significant room for improvement, with up to two in five people attending GUM having attended their GP first. (MedFASH, 2008) 
This sexual health and contraceptive NIS integrates and replaces the previous enhanced services: 
• LES 11 (sexual health) 
• LES 22 (Chlamydia screening) 
• NES 1 (IUCD/implant) 
The cervical screening enhanced services remains in place and practices are encouraged to capitalise on screening opportunities 
to promote sexual health and contraception and vice versa.  
Aims and scope 
This NIS aims to deliver high quality services to complement and add value to the work of the dedicated sexual health and 
contraceptive services such as GUM and reproductive health. 
By taking a network approach, we anticipate that health outcomes will be improved, patient choice increased and access to 
services expanded.  It will allow for networks to respond to specific local needs and utilise skills across the network that have 
previously been isolated in specific providers.  Moreover it will encourage and develop effective partnership working within the 
networks.   
The National Strategy for Sexual Health and HIV recommendations include expanded roles for practitioners and services to 
maximise access and provision.  
A range of provision at different levels across a network allows people to make choices about their sexual healthcare based on 
convenience and accessibility, availability of expertise or comprehensiveness of service. 
 
Level To be provided by Description 
Basic All practices 
• Chlamydia screening for under 25s 
• Asymptomatic STI screening & treatment 
• HIV testing with pre- & post-test discussion 
• Hepatitis B screening & vaccination for patients at risk 
      Intermediate 
    Minimum two practitioners per network able 
toprovide each type of service 
• STI testing & treatment of symptomatic but uncomplicated 
infections 
• IUD / IUS / implant fitting 
 Advanced Hospital-based and community clinics     Specialist SRH, community gynaecology and GUM 
Core Requirements 
Network action plan 
A collaborative effort across all practices within the network is essential to ensure all elements of the sexual health and 
contraceptive NIS are met. 
Policies 
Practices are required to have in place policies on 
• Provision of service to unaccompanied patients under the age of 16 (see appendix) 
• Fraser guidelines and child protection (see appendix) 
• Confidentiality 
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All staff working with young people should maintain enhanced CRB clearance. 
Management of results 
Positive results for Chlamydia and gonorrhoea for patients between 15-24 years old will be recalled, treated and managed by 
the local Chlamydia Screening office (CSO). 
For patients other than the above, each practice within the network should have a clear protocol in place to ensure patients with 
infections are managed appropriately and to completion.  Essential elements of results management include: 
• Recall (return for results and treatment) 
• Partner notification (ensuring action undertaken to notify sexual contacts) 
• Compliance (treatment and behavioural compliance) 
• Onward referral (to specialist services as needed) 
A mechanism should be included within the practice to notify patients of negative results. 
Patients diagnosed with uncomplicated Chlamydia or gonorrhoea can be fully managed by the practice and do not require 
referral to specialist services.  
Patients with new cases of syphilis and / or HIV are excluded from the above and should be referred onward to specialist 
services. 
More detailed information about the above aspects of the management of positive results is found in the reference document 
‘Local guidance for sexual health’, available on the THPCT intranet. 
Inter-practice referrals 
A process of inter-practice referral should be in place within the network.  A failsafe mechanism should be included in this 
process to ensure referred patients are seen as requested and the referring practice is made aware of the outcome.  
A sample inter-practice agreement and proforma are included in the appendix. 
Clinical Governance 
• Clinical leadership and expertise will be led by the local sexual health and contraceptive clinical governance group 
consisting of membership from general practice and specialist services within Tower Hamlets 
• The clinical governance group will provide bi-directional support to ensure all practices have up to date and 
approved prescribing and sexual health / contraceptive management guidance 
• Mechanisms will be in place to report, review and respond formally to all clinical incidents and complaints 
Competence to deliver services 
• Level of competency will vary according to staff discipline and should be relevant to the service being provided 
• Individuals should work within the scope of their own competence 
• Disciplines may have different professional guidance around the legalities and requirements for certain 
competencies and the steps required to ensure safe practice, e.g. in relation to prescribing or the authority to use patient group 
directions (PGDs) 
Referral to specialist services 
• External referrals to specialist sexual health and contraceptive services should be undertaken for patients whose 
needs or symptoms are considered complex and unable to be managed appropriately in primary care 
• Referrals should follow pathways as outlined from specialist services (criteria found on the intranet) 
Accreditation (IUCD / subdermal implant) 
For individuals 
All new practitioners wanting to provide a service for the insertion of IUCDs and subdermal contraceptive implants should have 
appropriate training per the current requirements set out by the Faculty of Sexual and Reproductive Health (FSRH) which 
includes the Diploma of the Faculty (DFSRH) plus a letter of competence in IUCD fitting (LoC IUT), letter of competence in 
subdermal implant (LoC SDI) or the equivalent from the RCN.   
FSRH requirements 
LoC IUT (IUCD) - Perform a minimum of twelve IUD/IUS insertions over twelve months of at least two different types of device in 
conscious patients and enough essential contraceptive work to be eligible for recertification every 5 years. 
LoC SDI (subdermal implant) - Perform a minimum of six procedures to include at least one insertion and one removal 
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• A log covering a consecutive 12 month period will need to be kept within 24 months of the date of recertification for both 
the IUCD and implant 
• At least two hours education relevant to intrauterine techniques and / or subdermal implants will need to be 
undertaken 
 
Practitioners who wish to recertify are advised to refer to the criteria outlined by FSRH or RCN 
Local assessment 
Practitioners who have previously provided IUCDs and subdermal implants (e.g. via the national enhanced scheme) but do not 
meet the above requirements may still be eligible to fit them if they have previous experience or other equivalent qualifications.  
These cases will be considered on an individual basis by the Consultant Community Gynaecologist.  In these circumstances, 
practitioners should attend at least one session with an instructing doctor in the specialist IUCD / implant clinic for assessment 
of competency and be able to provide a log of the numbers of insertions they are undertaken over the preceding 12 months. 
For practices 
To deliver LARC, practices must meet the following requirements: 
• Submission of the training, qualification and accreditation proforma (see appendix), including evidence of 
qualification(s) to be kept on record at the PCT  
• Essential equipment as found in the appendix of this document 
• Compliance with current infection control regulations 
• Have in place a reliable method for recording all patients fitted with IUD, IUS and implant 
Sexual health and contraceptive teams  
The provider network and its staff agree to work collaboratively with fellow clinicians and other providers within the network, the 
GP commissioning and community health teams and the local CSO to determine and develop the optimum model of care.   
GP sexual health champion 
• The role of the GP sexual health champion is to actively promote the delivery of primary care based sexual 
health services by providing practical advice, guidance and clinical support. 
• The GP champion will provide leadership to the network clinical leads, including representation for general 
practice on the local strategy and clinical governance groups. 
Network lead 
• Each network should ideally have a sexual health lead who is jointly nominated by other practices in the 
network 
• Desirable criteria include having completed a recognized sexual health and/or family planning qualification 
(e.g. STIF) 
• The network lead should have regular contact and / or meetings with other network leads and the GP sexual 
health champion 
• The network lead shall have responsibility for ensuring all aspects of the sexual health and contraceptive NIS 
are being carried out by all practices within the network 
4. NIS objectives and payment structure 
The following section gives further detail on practice activities, support available and the payment structure.  Details of network 
payments can be found in section 6. 
4.1 Sexual health 
For sexually active men and women of any age the NIS aims to 
• Reduce the levels of undiagnosed STI / HIV 
• Reduce the transmission of STI / HIV 
• Reduce the number of unintended pregnancies 
• Improve the quality of care and access and provide choice for service users by increasing the number and 
range of service providers of sexual health  
• Increase the confidence and skill levels of general practice staff with regard to sexual health 
Health checks 
Offer of tests for HIV and Hepatitis B should be routinely incorporated into health checks for new patient registrations.  Patients 
should be informed the HIV test will be performed and have the option to opt out. HIV and Hepatitis B testing should be 
considered for patients attending for mid-life health checks.HIV positive results should be referred to the HIV Outpatients 
Department (Grahame Hayton Unit) at the Royal London Hospital.  Chronic and acute cases of Hepatitis B (sAg+) should be 
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referred to the hepatology clinic at Mile End Hospital.  Pathways for referral to these specialist services are available on the 
THPCT intranet under local guidance for sexual health. 
Payment schedule 
 
Payments are based on the number of patients having a full sexual health screen (Chlamydia / gonorrhoea / syphilis, +/- HIV, 
+/- Hepatitis B) with an incentive payment for managing new STIs detected (excluding HIV and syphilis).  Management includes 
recall, treatment and partner notification.  There is additional support available from Barts and the London sexual health service 
for complex cases, e.g. blood borne infections, multiple sexual partners or those who prefer third party notification, sex workers  
Sexually active individuals infected with hepatitis B virus will be identified through the sexual health screen. Please follow local 
guidance on management and arrange for referral to the local hepatology team. Household and sexual contacts of these 
individuals should then be screened for infection, and immunised against hepatitis B if susceptible. 
High risk individuals including IDUs, MSM, multiple/ frequent sexual partners and sex workers should be offered the hepatitis B 
vaccine if both hepatitis B surface antigen (HbsAg) and anti-Hbs (cAB) are negative as there is no evidence of prior infection. 
Immunisation should take place as soon as possible as follows: 
• First dose: immediately 
• Second dose: one month later 
• Third dose: two months after first dose 
• Booster dose: Twelve months after the first dose 
Anti-Hb sAb greater than 10 iu/l implies long term immunity. 
LES 19 covers for immunisation of children at risk through perinatal transmission and household and sexual contacts of 
pregnant women. 
 
Activity Pa   Payment 
S    Screening / testing patients for STIs including offer of    H    HIV 
test 
      £25 per patient 
      Managing patients with positive STI results and                           n 
o identifying sexual partners 
      £50 per positive 
For patients who have completed a course of                             H 
Hepatitis B vaccine and shown to have seroconverted on post 
immunisation serology 
      £177.75 
4.2  Chlamydia & gonorrhoea screening 
The National Chlamydia Screening Programme (NCSP) aims to screen young men and women aged between 15 and 24. 
• To raise awareness of Chlamydia and gonorrhoea and their effects  
• To prevent and control through early detection and treatment of asymptomatic infection  
• To reduce onward transmission to sexual partners  
• To avoid the consequences of untreated infection 
 
In Tower Hamlets Chlamydia screening is available from a range of providers including Tower Hamlets Contraception and 
Sexual health service (THCaSH), Barkantine Sexual Health Service (provided by Clinicenta), general practice and community 
pharmacies. Locally this service is managed by the Chlamydia Screening Office (CSO) based within THCaSH. 
The national target for 2011/12 is to screen 35% of young people in Tower Hamlets.  The current local rate of screening 
obtained through general practice is 6.7%.  The NIS aims to increase the uptake rate within primary care through opportunistic 
testing of the practice registered population aged 15-24. 
New patient health checks 
Sexually active patients between the ages of 15-24 should be routinely offered a CSP test pack in addition to an HIV test as 
outlined in the previous section (4.1.1). 
You’re Welcome accreditation 
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You’re Welcome is an initiative from the Department of Health that lays out quality criteria to ensure healthcare services are 
young people friendly.  It is recommended all practices gain You’re Welcome accreditation.  A companion toolkit for quality 
assurance is available on the DoH website.  
Payment schedule 
Payments for Chlamydia screening will be based on the Network reaching incremental screening targets. The network will 
receive a payment for each adequate sample (urine or self taken vaginal swab) received at the lab.  Networks should consider 
working with their local community partners and pharmacies to achieve this target.   
Activity is attributed to specific providers on the basis of unique codes.  General Practice and pharmacy specific codes would 
remain in place for kits distributed through these providers. However, networks may obtain a unique network code from the local 
CSO for screening kits which are distributed within the wider community and not exclusive to any one practice.  Practice, 
pharmacy and other community partner activity would all combine to achieve the Network target.   
The network will receive an initial payment which equates to reaching the 15% target.  Adjustments will be made at year end to 
reconcile activity above 15%. 
 
% of 15 – 24 year olds screened** Payment per screen 
15% £5 
20% £6 
30% £7 
35% £10 
Over 35% £10 
**denominator = number of patients registered with practices in the network 
4.3 IUCD and subdermal implant  
The government has highlighted unplanned pregnancies as key for change in the National Strategy on Sexual Health and HIV 
and cites unplanned pregnancies and resulting abortions as being indicators of poor sexual health. 
Long Acting Reversible Contraception (LARC) is proven to be both clinically and cost-effective in reducing unplanned pregnancy 
including reducing teenage conceptions and abortions.  
The NICE guidelines (2005) have encouraged increasing access to LARC by 8% which would have major public health and 
financial impact to the NHS.  The NICE LARC Guideline aims to increase access to LARC through better information for women, 
choice, increased provision and training and have a significant impact on resource prioritisation: 
• Women requiring contraception should be given information about and offered a choice of all methods, 
including LARC methods  
• Women should be provided with the method of contraception that is most acceptable to them, provided it is 
not contraindicated  
• Contraceptive service providers who do not provide LARC within their own practice or service should have an 
agreed mechanism in place for referring women for LARC  
• Healthcare professionals providing intrauterine or sub-dermal contraceptives should receive training to 
develop and maintain the relevant skills to provide these methods  
 
In Tower Hamlets there will already be adequate numbers of skilled doctors and nurses to allow increased provision and 
training. Thus, by taking a network approach to LARC provision we anticipate that health outcomes will be improved, patient 
choice increased and access to services expanded.   
• It will allow for Networks to respond to specific local needs and utilise skills across the Network that have 
previously been isolated in specific providers.  Moreover it will encourage and develop effective partnership working within the 
Networks   
• To deliver high quality sexual health and contraceptive services within primary care to the resident population 
of Tower Hamlets 
• To complement and add value to the work of the dedicated sexual health and contraceptive services, such 
THCaSH, Barkantine Sexual Health Service (provided by Clinicenta) and BLT. 
• Ensure a full range of contraceptives is available to all patients, including LARC    
• Increase the availability and accessibility to IUDs, IUS & the contraceptive implant 
• Maintain and increase the skill of general practices in the provision of  IUD, IUS and the contraceptive implant 
across the borough 
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Payment schedule 
Practices will receive an initial payment based on 70% of previous year’s activity and subject to year-end reconciliation. Prices 
will be reviewed annually.  
      Activity Price per patient 
I      IUCD insertion fee (PPA claim for device) £82.00* 
       IUCD removal fee £33.00 
       Implant insertion fee £43.00 
       Implant removal fee £33.00 
       IUCD / Implant follow-up check (as appropriate) £21.11 
*In the instance of a failed fitting, full payment will be made as per the above figure 
4.3.2 Prescribing and reimbursement for LARC 
IUCD 
• All IUDs and IUS can be reimbursed as personally administered 
• FP34PD (peach form) should be used by practices to claim from the PPD 
• IUCDs are listed in the Drug Tariff at http://www.ppa.org.uk/edt/June_2010/mindex.htm 
Contraceptive implant (in house) 
• Implant insertion is classified as minor surgery and therefore cannot be claimed as personally 
administered 
• An FP10 must be written and dispensed by a community pharmacy 
Contraceptive implant (inter-practice referrals) 
• The cost of the script (£79.46) will be added to the implant insertion fee as above 
• The service providing practice must ensure implant devices are available for planned procedures 
• Referring practices will not need to issue FP10s 
Practices providing fittings must agree on a notional budget with prescribing advisers for each financial year 
Monitoring and data collection 
• Practices are required to record all activity using the CEG data entry template 
• Data will be collated and fed back to the networks on a quarterly basis 
• The local Chlamydia Screening office will be responsible for reporting screening activity for 15-24 year 
olds  
• All other sexual health and contraception reporting will be via THPCT 
• All practices must maintain a register of patients fitted with IUD, IUS and implants  
 
6.  Network payment and targets 
Sexual health  
Networks will receive an initial payment based on 70% of previous year’s activity and subject to year end reconciliation. 
Payments for positives will be made at year end.  Prices will be reviewed annually.  
Chlamydia screening 
The network will receive an initial payment which equates to screening 15% of the registered network population of 15-24 year 
olds.  Adjustments will be made at year end to reconcile activity above 15%. 
IUCD and Sub-dermal implant 
Practices will receive an initial payment that equates to 70% of last years activity which will be reconciled at year end with actual 
activity.  As a guide below is a summary of practice activity for 08/09 and 09/10 by network. 
Network Summary 
Network income is summarised below if practices were to maintain last years sexual health and IUCD/Sub-dermal implant 
activity and reach the 35% Chlamydia screening target. 
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Network
Total 
Patients
Income if 09/10 SH 
activity is maintained
Income if 35% 
chamydia screening 
target is reached
Income if 09/10 IUCD 
activity is maintained Potential total
1 39,603       11,775£                    27,514£                   3,985£                           43,274£        
2 45,067       9,850£                      22,663£                   1,550£                           34,063£        
3 25,788       1,050£                      15,036£                   375£                              16,461£        
4 30,560       8,050£                      12,408£                   8,545£                           29,002£        
5 27,401       19,550£                    12,096£                   3,105£                           34,751£        
6 21,687       2,875£                      11,781£                   1,474£                           16,130£        
7 39,056       15,160£                    18,991£                   12,428£                         46,579£        
8 33,553       9,025£                      12,565£                   143£                              21,733£        
 
 Support for networks 
Supplementary materials to this document are available on the THPCT intranet and include: 
• Local guidance for delivering sexual health services in primary care  
o guidelines for taking a sexual history; assessment for post exposure prophylaxis (PEP); 
investigations (genital, extra-genital, serology); interpreting results; partner notification; Hepatitis B 
immunisation for adults 
o Pathways for patient sub-groups and the Chlamydia Screening Programme 
o Outline and key points of local protocol, including inclusion and exclusion criteria 
o Referral criteria for specialist services, including the Community Sexual Health Adviser 
• Local guidance for delivering contraceptive services in primary care  
• Clinical governance 
• Sexual health resources for primary care 
• Workforce training and development 
• Related external resources 
  
  
APPENDIX F - Chlamydia screening charts  
Chlamydia screening uptake 15-24 age group by practice in Lambeth 2004 to 2010 
 
  
Chlamydia screening volume 15-24 age group by practice in Lambeth 2004 to 2010 
 
  
Chlamydia screening in 15-24 age group by practice 2004 to 2010 Haringey 
 
  
Chlamydia Screening uptake in 15-24 age group by practice in Haringey 2004-2010 
 
  
Chlamydia screening volume from 2004 to 2010 by practices in Tower Hamlets 
 
  
Chlamydia screening uptake in 15-24 year olds in Tower Hamlets 
 
  
Number of chlamydia screens in Hackney 
 
  
Chlamydia screening uptake in 15-24 age group in Hackney 
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APPENDIX G –  An example of coding - competitiveness 
 AN : 5.4 Competitiveness 
1 : Haringey_GP3 
 
  Area = Haringey 
  Gender = Male 
  Practice Size = <6000 
  Role = GP Partner 
Oh yeah.  It’s all these things in the back of my mind, so if he’s doing so well, why am I so inferior?  Why can’t I get that target to go to that 
level?  Because I’ve got the same [Unintelligible 00:26:23] or I can do better to come up to the level. 
2 : Haringey_GP2 
 
  Area = Haringey 
  Gender = Female 
  Practice Size = <6000 
  Role = GP Partner 
No, those informations are very useful, to see how you are doing and compared to other people, how you are doing and national average, 
you know, things like that, we want to do well.  
3 : Haringey_GP1 
 
  Area = Haringey 
  Gender = Female 
  Practice Size = 6000-10000 
  Role = GP Partner 
Respondent: I think personally to me, wherever I’ve worked, I’ve wanted to be the best that you can be, for however long it might be we 
won’t have the same energy levels a few days later on and might, but. 
 
Respondent: I think though we have all these QOF and all these things, I think probably it’s only the present of 10% or 20% of our workload, 
compared to everything else, but if that’s the way the world is going to judge us by, why can’t we be the best? 
4 : Haringey_GP4 
 
  Area = Haringey 
  Gender = Female 
  Practice Size = 6000-10000 
  Role = GP Partner 
Well I know as a registrar, when I had to do a project, to get GPs to change their behaviour, to do something that they weren’t used to doing, 
and it worked well to have a little competition between the doctors, and this is obviously small scale, and offer a little prize at the end, not 
necessarily financial [Unintelligible 00:16:49], and with lots of male partners at the time, it worked well, and that was handing out condoms 
as it happened, and that worked well. 
5 : Haringey_GP5 
 
  Area = Haringey 
  Gender = Female 
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  Practice Size = 6000-10000 
  Role = GP Partner 
6 : Haringey_PN1 
 
  Area = Haringey 
  Gender = Female 
  Practice Size = 6000-10000 
  Role = Practice Nurse 
We’re pretty good here at this surgery, we’re well informed and co-operative and we keep up with these trends that are sent our way. 
 
Respondent: We do that with lots of things, at a PCT level, there are no PCTs any more but we get regular emails showing us where we are 
with cervical cytology, where we are with childhood immunisations, where we are with those things.  Yes, it does.  You want to be at the top 
of the list and when you’re halfway down the list or three quarters of the way down the list, you do tend to say, what can we do about 
this. 
 
It’s the list, if you’re halfway down the list, then you know you’ve got to improve so that’s peer pressure isn’t it, from people who are higher 
on the list. 
 
Respondent: I don’t know how we did with the graph in comparison to other practices, the one you were showing me earlier, but  I am proud 
of the practice.  I was the first practice nurse here when it started up and we have developed a lot since then, the services we give both 
nursing and from the doctors’ point of view.  
7 : Tower_Hamlets_GP2 
 
  Area = Tower Hamlets 
  Gender = Male 
  Practice Size = <6000 
  Role = GP Partner 
 
8 : Tower_Hamlets_GP4 
 
  Area = Tower Hamlets 
  Gender = Male 
  Practice Size = 6000-10000 
  Role = GP Partner 
 
9 : Tower_Hamlets_GP5 
 
  Area = Tower Hamlets 
  Gender = Male 
I think some of these... you know if you show me for example, a graph like that, it only takes a minute amount of deterioration and you 
suddenly are on that end.  So although the red bar is within the top quarter, a tiny difference could drop you two quarters on 
I mean it’s strange but of course I’m competitive.  These graphs appeal to a competitive made person don’t they.   
You want to do the best; you want to do better than...  
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  Practice Size = 10000+ 
  Role = GP Partner 
I think the [unintelligible 00:24:51] in Tower Hamlets have definitely helped with the competition, not in a negative way but I think because 
you are constantly compared at least to practices within your network and then your network compared to other networks.  There’s 
constantly this thinking you know, we definitely don’t want to be bottom. 
10 : Tower_Hamlets_PN1 
 
  Area = Tower Hamlets 
  Gender = Female 
  Practice Size = 6000-10000 
  Role = Practice Nurse 
 
11 : Tower_Hamlets_PN2 
 
  Area = Tower Hamlets 
  Gender = Female 
  Practice Size = 6000-10000 
  Role = Practice Nurse 
So I think it does make a difference and I think it’s not just the financial pressure of the NISs actually, the network element is a really 
interesting one because it’s also that competitive element of wanting to be as good as or better than your peers in the area, so… 
 
Well, out network has four practices in it.  Two of the practices are based in wealthier areas and two of us are based in poorer areas 
demographically.  So the two of us in the poorer areas are always making direct comparisons and one practice - the other practice of course 
has been established a lot longer than we have and we’re the new kid on the block relatively speaking.  And so we’re always trying to keep 
up with the Jones’.  And therefore there’s always that incentive to try and be pushing yourself that bit further to do as well as they have or 
even better do better than they have and so, yes, it drives up standards in theory, or at least it drives up your markers, whether that’s 
standards or not and whether they correlate I don’t know, but, yeah, to some extent. 
 
Yes, it’s that sort of competitive instinct isn’t it of trying to prove your worth. 
12 : Tower_Hamlets_GP3 
 
  Area = Tower Hamlets 
  Gender = Female 
  Practice Size = 6000-10000 
  Role = GP locum 
 
13 : Tower_Hamlets_GP6 
 
  Area = Tower Hamlets 
  Gender = Female 
  Practice Size = 10000+ 
  Role = GP Partner 
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14 : Tower_Hamlets_GP1 
 
  Area = Tower Hamlets 
  Gender = Female 
  Practice Size = 10000+ 
  Role = Salaried GP 
 
15 : Lambeth_GP2 
 
  Area = Lambeth 
  Gender = Male 
  Practice Size = 6000-10000 
  Role = GP Partner 
You want to look good for patients, number one, that’s the real reason and number two, we want to provide [Unintelligible 10:02] someone 
doesn’t say that we’re at this end of the scale.  Someone has to be at this end of the scale but that’s usually a type of practice in trouble 
and we want to enjoy our work and not feel like we’re in trouble. 
 
We would then launch an investigation as to why we are in the middle.  We look at it once a year.  It’s taken us a lot of years to get to that, it 
doesn’t happen overnight.  It’s a whole team quality improvement, techniques you mentioned we’ve learned about and then implemented 
so instituting innovation meetings, looking at Department of Health toolkits, a lot of training on health improvement and leadership.  We are 
one of the top ten practices in Lambeth now because of it. 
16 : Lambeth_GP4 
 
  Area = Lambeth 
  Gender = Male 
  Practice Size = 6000-10000 
  Role = GP Partner 
Even the Chlamydia screening programme, the payment for that is not that great.  So in the great scheme of things to either get paid or not 
get paid for an organisation like us is not a major issue.  It’s more reputationally we feel it’s important that we’re near the top, and we 
actually target that at the beginning of the year. 
 
From an organisational point of view we are what we call an [unintelligible 0:03:31] APMS contractor which basically means that we need to 
bid for these practices against other competitors.  So one of our key selling points is that we need to be able to show that we’re equally 
effective, not more effective clinically in terms of achieving targets than our competitors. 
 
You can say you’re good and you can see you [unintelligible 0:03:49] deliver high quality care, but actually nowadays I think you need to be 
able to prove that.  And so over a whole range of markers, not just public health indicators, we’re quite in tune with what is recorded and 
what’s measurable and what PCTs and commissioners look for.  And some of these public health markers fall heavily in that basket of things 
that people look at.  I mean of course you talk about access QOF which are really probably more important but these are important and we 
do like to tell people when we’ve done some good work. 
 
Yeah.  All the time.  It’s a core part of the way I’ve trained myself to consult because - well, obviously for the reason I went over before we 
need to aspire to full QOF points for the reasons that I just went over.  To get 990 or 1,000 the financial difference is not massive, but for us 
it’s quite - it’s quite important for us.  990 would be a bit of a disappointment whereas 1,000 is where we need to be.  So that’s why I need 
to - I can’t be telling my colleagues this is something that’s really important for the practice and trying build that culture of achievement if 
I’m not consistently doing it myself.  So something about leading by example in that.  Something about that.  
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17 : Lambeth_GP1 
 
  Area = Lambeth 
  Gender = Female 
  Practice Size = 10000+ 
  Role = GP Partner 
 
18 : Lambeth_GP3 
 
  Area = Lambeth 
  Gender = Female 
  Practice Size = 10000+ 
  Role = Salaried GP 
 
19 : City_Hackney_GP1 
 
  Area = Hackney 
  Gender = Male 
  Practice Size = 10000+ 
  Role = GP Partner 
 
20 : City_Hackney_GP2 
 
  Area = Hackney 
  Gender = Female 
  Practice Size = 6000-10000 
  Role = GP Partner 
Gosh, I don’t think it’s a competition but certainly it’s significant if we’re an outlier and not achieving what our colleagues nearby are 
achieving for our population.  Yes, of course. 
21 : City_Hackney_PN1 
 
  Area = Hackney 
  Gender = Female 
  Practice Size = 10000+ 
  Role = Practice Nurse 
In my mind, there’s a few practices I know that are very good so I compare us with them and there are some practices I know aren’t very 
good.  So if we’re near the poor performing practice, I know we’re going on a very downward spiral that’s appalling but if we’re generally 
up with the better practices that I consider, then that’s good enough for me, which might not be the best answer! 
 
To me!  I’m quite competitive!  Only within our practice and I’d like to think this is a very good practice so obviously if reality tells us we’re 
only in 50th but in your head you’re thinking we must be up in the 70s, then that’s a push to see what else we can do. 
 
And also finding out how other practices are doing.  I know it’s not reflected on there with the chlamydia one but it does psychologically give 
you a bit of a drive, just like the immunisations one.  When that comes through and you see how you’re doing on the quarterly  list, it does 
give you a push to increase these. 
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APPENDIX G – Coding chart 
Name   Sources References Created On Created By Modified On Modified By   
1 General attitudes about public health programmes   2 6 15/06/2013 10:34 RM 16/06/2013 18:02 RM   
1.1 Intentions   1 1 15/06/2013 12:33 RM 15/06/2013 13:51 RM   
1.2 Prevention of ill health   7 21 15/06/2013 14:14 RM 14/05/2014 21:03 RM   
1.3 Cynicism   4 14 16/06/2013 18:02 RM 14/05/2014 17:38 RM   
2 Attitudes to chlamydia screening   2 18 15/06/2013 11:09 RM 16/06/2013 17:09 RM   
2.1 Screening vs diagnostic testing   3 3 15/06/2013 13:15 RM 13/05/2014 17:22 RM   
2.2 Logistics of screening as barrier   7 16 20/04/2014 12:59 RM 14/05/2014 20:27 RM   
Opinions about NCSP   11 16 20/04/2014 13:49 RM 14/05/2014 20:31 RM   
3 Behaviour change strategies   0 0 15/06/2013 11:09 RM 15/06/2013 11:09 RM   
3.1 Audit & Feedback   12 40 15/06/2013 11:12 RM 14/05/2014 21:01 RM   
3.10 Educational Outreach Visits   12 29 16/06/2013 17:53 RM 14/05/2014 20:25 RM   
3.2 Computer reminders   13 31 15/06/2013 11:13 RM 14/05/2014 20:11 RM   
3.3 Opinion leader   7 14 15/06/2013 11:14 RM 13/05/2014 20:12 RM   
3.4 (Social) Marketing   7 17 15/06/2013 11:15 RM 14/05/2014 18:23 RM   
3.5 Educational   12 48 15/06/2013 11:15 RM 14/05/2014 20:20 RM   
3.6 Printed Educational Materials   6 7 15/06/2013 11:15 RM 14/05/2014 18:19 RM   
3.7 Economic   12 49 15/06/2013 11:16 RM 14/05/2014 20:37 RM   
3.8 Peer influences   12 26 15/06/2013 13:43 RM 14/05/2014 20:48 RM   
3.9 League tables   13 56 15/06/2013 14:10 RM 14/05/2014 20:48 RM   
guidelines   1 5 13/05/2014 20:01 RM 13/05/2014 20:07 RM   
4 Behaviour change theories   0 0 15/06/2013 11:10 RM 15/06/2013 11:12 RM   
4.1 Behaviour belief and attitidues   2 6 15/06/2013 12:07 RM 25/04/2014 18:21 RM   
4.1.1 Evidence   12 41 15/06/2013 12:30 RM 14/05/2014 20:48 RM   
4.1.2 Experience   12 34 15/06/2013 12:58 RM 14/05/2014 20:50 RM   
4.1.3 Belief it is worthwhile   13 76 15/06/2013 13:06 RM 14/05/2014 20:47 RM   
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4.1.4 Beliefs and values about sequelae   11 41 15/06/2013 13:13 RM 14/05/2014 20:08 RM   
4.2 Normative beliefs and subjective norms and social influences   1 5 15/06/2013 12:08 RM 15/06/2013 13:49 RM   
4.2.1 Department of health policy   6 10 15/06/2013 13:02 RM 13/05/2014 20:20 RM   
4.2.2 Fashion and trends   3 6 15/06/2013 13:50 RM 26/04/2014 11:20 RM   
4.2.3 Normal practice   7 14 20/04/2014 13:57 RM 14/05/2014 19:44 RM   
4.2.4 Influence of peers   8 15 20/04/2014 16:35 RM 14/05/2014 18:12 RM   
4.3 Control beliefs and Perceived behaviour control - perceived ease or difficulty   2 2 15/06/2013 12:13 RM 16/06/2013 11:30 RM   
4.3.1 Facilitating Factors   6 31 15/06/2013 13:04 RM 06/05/2014 19:58 RM   
4.3.2 Barriers   5 24 15/06/2013 13:04 RM 13/05/2014 16:47 RM   
4.4 Behaviour intention   4 10 15/06/2013 12:34 RM 26/04/2014 14:40 RM   
5 Other   0 0 15/06/2013 11:18 RM 15/06/2013 11:18 RM   
5.1 Professionalism   9 40 15/06/2013 11:18 RM 14/05/2014 20:49 RM   
5.2 Consultation dynamics   7 8 15/06/2013 11:19 RM 14/05/2014 18:18 RM   
5.3 Reputation of profession, self, practice   7 33 15/06/2013 14:08 RM 14/05/2014 20:48 RM   
5.4 Competitiveness   6 23 15/06/2013 14:11 RM 14/05/2014 20:17 RM   
5.5 Responding to patient agenda   10 17 15/06/2013 12:15 RM 14/05/2014 18:18 RM   
5.6 Nudges   1 2 16/06/2013 17:37 RM 16/06/2013 17:47 RM   
5.7 Use of own and other's expertise to get things done   2 2 20/04/2014 14:20 RM 14/05/2014 18:12 RM   
5.8 Non involvement with programmes   5 11 20/04/2014 16:52 RM 13/05/2014 20:18 RM   
5.9 Social or Media   9 30 25/04/2014 16:46 RM 14/05/2014 18:20 RM   
Academic network   1 4 26/04/2014 13:03 RM 26/04/2014 13:24 RM   
Behaviour change techniques   2 2 13/05/2014 17:11 RM 14/05/2014 19:29 RM   
Being a mentor - learning about new things and setting examples   2 2 25/04/2014 16:55 RM 26/04/2014 13:35 RM   
belief about influence   2 6 09/05/2014 10:09 RM 13/05/2014 18:35 RM   
Competitive advantage - APMS   1 3 13/05/2014 19:26 RM 13/05/2014 19:43 RM   
contractual requirement PMS   1 2 14/05/2014 20:33 RM 14/05/2014 20:35 RM   
Different personal beliefs   4 10 06/05/2014 20:40 RM 14/05/2014 21:04 RM   
Different values on different programmes   3 10 06/05/2014 20:33 RM 14/05/2014 20:48 RM   
Feedback about outcomes   2 6 13/05/2014 17:10 RM 14/05/2014 20:33 RM   
Gender and PH issues eg chlamydia, cervical screening   1 1 13/05/2014 10:13 RM 13/05/2014 10:14 RM   
Habit forming   3 4 26/04/2014 14:41 RM 14/05/2014 17:28 RM   
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Having the right patients to deliver   1 2 14/05/2014 20:29 RM 14/05/2014 20:30 RM   
Managing fallout of screening eg false +ves   1 2 13/05/2014 16:16 RM 13/05/2014 16:46 RM   
Own knowledge about subject   1 1 13/05/2014 17:58 RM 13/05/2014 18:00 RM   
peer group learning   6 8 26/04/2014 13:30 RM 14/05/2014 20:20 RM   
Perceived patient needs and benefits   4 13 06/05/2014 19:59 RM 14/05/2014 21:00 RM   
Personal mission   1 3 14/05/2014 21:04 RM 14/05/2014 21:04 RM   
personal satisfaction   1 1 13/05/2014 19:25 RM 13/05/2014 19:25 RM   
Personalities   4 7 06/05/2014 20:41 RM 14/05/2014 20:59 RM   
Pharma reps   5 11 25/04/2014 17:11 RM 13/05/2014 19:57 RM   
Practicalities of implementation   1 1 13/05/2014 20:08 RM 13/05/2014 20:08 RM   
Professionals accepting PH programes   1 2 14/05/2014 18:30 RM 14/05/2014 18:30 RM   
Provenance of message   2 3 13/05/2014 20:06 RM 14/05/2014 18:20 RM   
PUNs DENs   1 2 13/05/2014 10:44 RM 13/05/2014 10:46 RM   
QOF   3 6 26/04/2014 13:39 RM 14/05/2014 20:12 RM   
Reminders   1 1 06/05/2014 15:47 RM 06/05/2014 15:47 RM   
Resistance from patients   2 7 13/05/2014 15:51 RM 14/05/2014 17:49 RM   
scepticism   3 5 06/05/2014 17:11 RM 13/05/2014 18:47 RM   
Seeing results of public health programmes   1 1 14/05/2014 20:34 RM 14/05/2014 20:34 RM   
Tension respecting patient choice and autonomy   1 3 13/05/2014 16:11 RM 13/05/2014 16:58 RM   
Want succint messages   1 1 13/05/2014 09:11 RM 13/05/2014 09:11 RM   
Working as managed network   3 9 26/04/2014 11:52 RM 06/05/2014 20:06 RM   
worried well   1 1 13/05/2014 16:47 RM 13/05/2014 16:47 RM   
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APPENDIX H – Framework Matrix (CD ROM) 
